<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="preprint">
<?all-math-mml yes?>
<?use-mml?>
<?origin ukpmcpa?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">bioRxiv</journal-id>
<journal-title-group>
<journal-title>bioRxiv : the preprint server for biology</journal-title>
</journal-title-group>
<issn pub-type="ppub"/>
</journal-meta>
<article-meta>
<article-id pub-id-type="manuscript">EMS135767</article-id>
<article-id pub-id-type="doi">10.1101/2021.09.24.461631</article-id>
<article-id pub-id-type="archive">PPR400222</article-id>
<article-version article-version-type="publisher-id">1</article-version>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Screening key genes and signaling pathways in COVID-19 infection and its associated complications by integrated bioinformatics analysis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2202-7637</contrib-id>
<name>
<surname>Vastrad</surname>
<given-names>Basavaraj</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3615-4450</contrib-id>
<name>
<surname>Vastrad</surname>
<given-names>Chanabasayya</given-names>
</name>
<xref ref-type="corresp" rid="CR1">*</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India</aff>
<aff id="A2">
<label>2</label>Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001, Karanataka, India</aff>
<author-notes>
<corresp id="CR1">
<label>*</label>Chanabasayya Vastrad, <email>channu.vastrad@gmail.com</email>, Ph: +919480073398, Chanabasava Nilaya, Bharthinagar, Dharwad 580001, Karanataka, India</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>27</day>
<month>09</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="preprint">
<day>25</day>
<month>09</month>
<year>2021</year>
</pub-date>
<permissions>
<ali:free_to_read/>
<license>
<ali:license_ref>https://europepmc.org/downloads/openaccess</ali:license_ref>
<license-p>This preprint is made available via the <ext-link ext-link-type="uri" xlink:href="https://europepmc.org/downloads/openaccess">Europe PMC open access subset</ext-link>, for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original preprint source.</license-p>
</license>
</permissions>
<abstract>
<p id="P1">Severe acute respiratory syndrome corona virus 2 (SARS-CoV-2)/ coronavirus disease 2019 (COVID-19) infection is the leading cause of respiratory tract infection associated mortality worldwide. The aim of the current investigation was to identify the differentially expressed genes (DEGs) and enriched pathways in COVID-19 infection and its associated complications by bioinformatics analysis, and to provide potential targets for diagnosis and treatment. Valid next-generation sequencing (NGS) data of 93 COVID 19 samples and 100 non COVID 19 samples (GSE156063) were obtained from the Gene Expression Omnibus database. Gene ontology (GO) and REACTOME pathway enrichment analysis was conducted to identify the biological role of DEGs. In addition, a protein-protein interaction network, modules, miRNA-hub gene regulatory network, TF-hub gene regulatory network and receiver operating characteristic curve (ROC) analysis were used to identify the key genes. A total of 738 DEGs were identified, including 415 up regulated genes and 323 down regulated genes. Most of the DEGs were significantly enriched in immune system process, cell communication, immune system and signaling by NTRK1 (TRKA). Through PPI, modules, miRNA-hub gene regulatory network, TF-hub gene regulatory network analysis, ESR1, UBD, FYN, STAT1, ISG15, EGR1, ARRB2, UBE2D1, PRKDC and FOS were selected as hub genes, which were expressed in COVID-19 samples relative to those in non COVID-19 samples, respectively. Among them, ESR1, UBD, FYN, STAT1, ISG15, EGR1, ARRB2, UBE2D1, PRKDC and FOS were suggested to be diagonstic factors for COVID-19. The findings from this bioinformatics analysis study identified molecular mechanisms and the key hub genes that might contribute to COVID-19 infection and its associated complications.</p>
</abstract>
<kwd-group>
<kwd>COVID-19</kwd>
<kwd>expression profiling by high throughput sequencing</kwd>
<kwd>bioinformatics analysis</kwd>
<kwd>differentially expressed genes</kwd>
<kwd>biomarkers</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="S1" sec-type="intro">
<title>Introduction</title>
<p id="P2">Severe acute respiratory syndrome corona virus 2 (SARS-CoV-2)/ coronavirus disease 2019 (COVID-19) infection is one of the leading causes of respiratory tract infection [<xref ref-type="bibr" rid="R1">1</xref>]. COVID-19 is the fast spreading infectious disease worldwide, with a more than 200 million confirmed cases and 4.2 million confirmed death during August 2021 across nearly 200 countries according to the information given by the World Health Organization (WHO). The incidence rate of COVID-19 is high, which seriously affects the patient's health complications, which includes diabetes mellitus [<xref ref-type="bibr" rid="R2">2</xref>], cardiovascular complications [<xref ref-type="bibr" rid="R3">3</xref>], neurological complications [<xref ref-type="bibr" rid="R4">4</xref>] and kidney complications [<xref ref-type="bibr" rid="R5">5</xref>]. However, the molecular mechanism underlying many COVID-19 and its associated complications causes remains unclear, resulting in a lack of effective treatment [<xref ref-type="bibr" rid="R6">6</xref>]. The higher prevalence and limited treatments of COVID-19 infection and its associated complications lead to considerable public health and economic difficulty [<xref ref-type="bibr" rid="R7">7</xref>]. Therefore, more reliable prognostic biomarkers should be explored as a target for improving the treatment effect and better understanding the underlying molecular mechanism of COVID-19 infection and its associated complications.</p>
<p id="P3">Studies have shown that genes includes ACE2 [<xref ref-type="bibr" rid="R8">8</xref>-<xref ref-type="bibr" rid="R12">12</xref>], TMPRSS2 [<xref ref-type="bibr" rid="R13">13</xref>-<xref ref-type="bibr" rid="R15">15</xref>], CD26 [<xref ref-type="bibr" rid="R16">16</xref>-<xref ref-type="bibr" rid="R18">18</xref>], <styled-content style-type="color" style="color:#FF0000">HLA-DRB1</styled-content> [<styled-content style-type="color" style="color:#FF0000">
<xref ref-type="bibr" rid="R19">19</xref>
</styled-content>–<styled-content style-type="color" style="color:#FF0000">
<xref ref-type="bibr" rid="R23">23</xref>
</styled-content>] and AKT1 [<xref ref-type="bibr" rid="R24">24</xref>-<xref ref-type="bibr" rid="R28">28</xref>] and signaling pathways includes cytokine signaling [<xref ref-type="bibr" rid="R29">29</xref>-<xref ref-type="bibr" rid="R31">31</xref>], innate immune signaling [<xref ref-type="bibr" rid="R32">32</xref>-<xref ref-type="bibr" rid="R36">36</xref>], JAK-STAT Signaling [<xref ref-type="bibr" rid="R37">37</xref>-<xref ref-type="bibr" rid="R41">41</xref>], IFN-AhR signaling [<xref ref-type="bibr" rid="R42">42</xref>] and STING pathway [<xref ref-type="bibr" rid="R43">43</xref>-<xref ref-type="bibr" rid="R44">44</xref>] are involved in the COVID-19 infection and its associated complications. Therefore, it is significant to further explore the molecular mechanisms of COVID-19 infection and its associated complications, and find molecular targets that can be used to diagnose early, prevent early, and treat early.</p>
<p id="P4">Next-generation sequencing (NGS) has thoroughly heightened the understanding of COVID-19 infection and its associated complications [<xref ref-type="bibr" rid="R45">45</xref>]. It provides a platform for public databases and exploring the molecular mechanisms of COVID-19 infection and its associated complications. A high-quality NGS could potentially link molecular biomarkers to the advancement, diagnosis, and treatment of COVID-19 infection and its associated complications.</p>
<p id="P5">In this investigation, we identified DEGs in expression profiling by high throughput sequencing data GSE156063 [<xref ref-type="bibr" rid="R46">46</xref>] from the Gene Expression Omnibus (GEO) database (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/geo/">http://www.ncbi.nlm.nih.gov/geo/</ext-link>) [<xref ref-type="bibr" rid="R47">47</xref>]. We performed Gene Ontology (GO) and REACTOME functional and pathway enrichment analyses, and constructed and analyzed a protein–protein interaction (PPI) network and isolated modules from PPI network, miRNA-hub gene regulatory network and TF-hub gene regulatory network were constructed and analyzed. Diagnostic values of hub genes were determined by receiver operating characteristic curve (ROC) analysis. Hub genes and the clinical prognosis of patients with COVID-19 infection and its associated complications were compared and analyzed with the objective of identifying novel prognostic biomarkers and therapeutic targets.</p>
</sec>
<sec id="S2" sec-type="materials | methods">
<title>Materials and methods</title>
<sec id="S3">
<title>Data resources</title>
<p id="P6">The expression profiling by high throughput sequencing GSE156063 [<xref ref-type="bibr" rid="R46">46</xref>] was downloaded from the GEO database and was used in this investigation. The dataset consisted of 93 COVID 19 samples and 100 non COVID 19 samples. The platform used was the GPL24676 Illumina NovaSeq 6000 (Homo sapiens).</p>
</sec>
<sec id="S4">
<title>Identification of DEGs</title>
<p id="P7">The limma in R Bioconductor software package [<xref ref-type="bibr" rid="R48">48</xref>] was used to perform the identification of DEGs between COVID 19 samples and non COVID 19 samples. To precise the analysis of statistically significant genes and false-positives, we using the adjusted P-value and Benjamini and Hochberg false discovery rate method [<xref ref-type="bibr" rid="R49">49</xref> An adj P value◻&lt;◻0.05, and a |log FC (fold change) |□&gt;□1 for up regulated genes and a |log FC (fold change) |□&lt;-□0.5 for down regulated genes were defined as the thresholds for DEG screening. The heatmaps of DEGs from each dataset were plotted by the gplots package in the R software. The DEGs are presented as volcano plots, generated using ggplot2 in the R software.</p>
</sec>
<sec id="S5">
<title>GO and REACTOME pathway enrichment analysis of DEGs</title>
<p id="P8">The g:Profiler (<ext-link ext-link-type="uri" xlink:href="http://biit.cs.ut.ee/gprofiler/">http://biit.cs.ut.ee/gprofiler/</ext-link>) [<xref ref-type="bibr" rid="R50">50</xref>] is an online functional annotation tool to provide a comprehensive understanding of biological information of genes and proteins. GO term (<ext-link ext-link-type="uri" xlink:href="http://www.geneontology.org">http://www.geneontology.org</ext-link>) enrichment analysis is used broadly to classify the characteristic biological attributes of genes, gene products, and sequences, including biological process (BP), cell components (CC) and molecular function (MF) [<xref ref-type="bibr" rid="R51">51</xref>]. REACTOME (<ext-link ext-link-type="uri" xlink:href="https://reactome.org/">https://reactome.org/</ext-link>) [<xref ref-type="bibr" rid="R52">52</xref>] pathway enrichment analysis demonstrates the enriched signaling pathways in DEGs. P&lt;0.05 was considered to represent statistical significance.</p>
</sec>
<sec id="S6">
<title>Construction of the PPI network and module analysis</title>
<p id="P9">The IMEx interactome (<ext-link ext-link-type="uri" xlink:href="https://www.imexconsortium.org/">https://www.imexconsortium.org/</ext-link>) is a public database harboring known and predicted protein-protein interactions [<xref ref-type="bibr" rid="R53">53</xref>]. Protein-protein interaction (PPI) is an indispensable approach for research on protein functions as it helps to clarify the interactions among proteins. In this study, the IMEx interactome database was used to construct a PPI network with an interaction score□&gt;□0.4. The network was then visualized using the Cytoscape 3.8.2 (<ext-link ext-link-type="uri" xlink:href="http://www.cytoscape.org/">http://www.cytoscape.org/</ext-link>) [<xref ref-type="bibr" rid="R54">54</xref>]. Moreover, Network Analyzer [<xref ref-type="bibr" rid="R55">55</xref>], which is another plug-in of Cytoscape, was employed to study key nodes in the network with 4 methods includes node degree [<xref ref-type="bibr" rid="R56">56</xref>], betweenness centrality [<xref ref-type="bibr" rid="R57">57</xref>], stress centrality [<xref ref-type="bibr" rid="R58">58</xref>] and closeness centrality [<xref ref-type="bibr" rid="R59">59</xref>] are completed to explore the hub genes that were contained in the PPI network. Significant modules and hub genes were further analyzed and visualized with app PEWCC1 (<ext-link ext-link-type="uri" xlink:href="http://apps.cytoscape.org/apps/PEWCC1">http://apps.cytoscape.org/apps/PEWCC1</ext-link>) [<xref ref-type="bibr" rid="R60">60</xref>] plugged in Cytoscape. The two significant modules were displayed to show the density of nodes by IMEx interactome.</p>
</sec>
<sec id="S7">
<title>MiRNA-hub gene regulatory network construction</title>
<p id="P10">MiRNAs controls gene expression under defined disease conditions through interaction with hub genes was analyzed. We applied miRNet database (<ext-link ext-link-type="uri" xlink:href="https://www.mirnet.ca/">https://www.mirnet.ca/</ext-link>) [<xref ref-type="bibr" rid="R61">61</xref>] to integrate 14 miRNA databases (TarBase, miRTarBase, miRecords, miRanda (S mansoni only), miR2Disease, HMDD, PhenomiR, SM2miR, PharmacomiR, EpimiR, starBase, TransmiR, ADmiRE, and TAM 2.0). We visualized miRNA-hub gene regulatory network by employing Cytoscape 3.8.2 [<xref ref-type="bibr" rid="R54">54</xref>].</p>
</sec>
<sec id="S8">
<title>TF-hub gene regulatory network construction</title>
<p id="P11">TFs controls gene expression under defined disease conditions through interaction with hub genes was analyzed. We applied NetworkAnalyst database (<ext-link ext-link-type="uri" xlink:href="https://www.networkanalyst.ca/">https://www.networkanalyst.ca/</ext-link>) [<xref ref-type="bibr" rid="R62">62</xref>] to integrate TF database (JASPER). We visualized TF-hub gene regulatory network by employing Cytoscape 3.8.2 [<xref ref-type="bibr" rid="R54">54</xref>].</p>
</sec>
<sec id="S9">
<title>Validation of hub genes by receiver operating characteristic curve (ROC) analysis</title>
<p id="P12">Receiver operating characteristic (ROC) analysis was used to assess the diagnostic value of hub genes in this research using pROC package in R statistical software [<xref ref-type="bibr" rid="R63">63</xref>]. Area under curve (AUC) analysis was implemented to determine the diagnostic value of hub genes. The AUC value &gt; 0.8 showed a good diagnostic value for COVID 19.</p>
</sec>
</sec>
<sec id="S10" sec-type="results">
<title>Results</title>
<sec id="S11">
<title>Identification of DEGs</title>
<p id="P13">A total of 738 DEGs (415 up regulated genes and 323 down regulated genes) were identified between COVID 19 samples and non COVID 19 samples according to methods described above. The heatmap of the DEGs has been shown in <xref ref-type="fig" rid="F1">Fig. 1</xref>. The up and down regulated genes were listed in <xref ref-type="table" rid="T1">Table 1</xref>. The volcano plot showed (<xref ref-type="fig" rid="F2">Fig. 2</xref>) that DEGs (up and down regulated genes) with the most significant logFC, and were used to further identify potential biomarkers.</p>
</sec>
<sec id="S12">
<title>GO and REACTOME pathway enrichment analysis of DEGs</title>
<p id="P14">The consistently up and down regulated genes were clustered via the online website g:Profiler for the GO and REACTOME pathway enrichment analyses of DEGs in COVID 19. Three GO category results are presented in <xref ref-type="table" rid="T2">Table 2</xref>. GO terms cover BP, MF and CC categories. As to the BP, DEGs were significantly enriched in immune system process, response to stimulus, cell communication and localization. For the CC, DEGs were enriched in the cell periphery, plasma membrane, cytosol and intracellular anatomical structure. In terms of the MF, DEGs were enriched in binding, identical protein binding, protein binding and ion binding. Pathway enrichment results are presented in <xref ref-type="table" rid="T3">Table 3</xref>. The REACTOME pathway enrichment analysis revealed that DEGs were highly associated with the immune system, HDACs deacetylate histones, signaling by NTRK1 (TRKA) and innate immune system.</p>
</sec>
<sec id="S13">
<title>Construction of the PPI network and module analysis</title>
<p id="P15">PPI network of DEGs was downloaded from IMEx interactome and further analyzed by Cytoscape. The PPI network included 5132 nodes and 12268 edges (<xref ref-type="fig" rid="F3">Fig.3</xref>). The nodes such as ESR1, UBD, FYN, STAT1, ISG15, EGR1, ARRB2, UBE2D1, PRKDC and FOS with high node degree, betweenness centrality, stress centrality and closeness centrality were screened as hub proteins in the PPI network and listed in <xref ref-type="table" rid="T4">Table 4</xref>. In order to improve analysis of the PPI network, 2 significant modules were selected using the PEWCC1 plugin. Module 1 consisted of 16 nodes and 39 edges(<xref ref-type="fig" rid="F4">Fig.4A</xref>), in which up regulated genes, including IFITM1, EIF2AK2, IFIT1, ISG15, IFIT2, GBP1, STAT2, IRF7 and STAT1. Module 2 consisted of 10 nodes and 27 edges (<xref ref-type="fig" rid="F4">Fig.4B</xref>), in which down regulated genes, including GABARAPL1, GABARAP, RASSF5 and MAP1LC3B. Module 1 was mainly involved in immune system, infectious disease, immune system process, response to stimulus, binding, cell periphery and plasma membrane. Module 2 was mainly involved in cell communication, membrane trafficking, localization and cytosol.</p>
</sec>
<sec id="S14">
<title>MiRNA-hub gene regulatory network construction</title>
<p id="P16">The miRNA-hub gene regulatory network is shown in <xref ref-type="fig" rid="F5">Fig. 5</xref>, which has 2626 nodes (hub genes:327; miRNAs: 2299) and 18613 interactions. The nodes with higher degrees are listed in <xref ref-type="table" rid="T5">Table 5</xref>, including IRF4 was the potential target of 140 miRNAs (ex; hsa-mir-4484); ESR1 was the potential target of 98 miRNAs (ex; hsa-mir-3668); EIF2AK2 was the potential target of 98 miRNAs (ex; hsa-mir-190b); STAT1 was the potential target of 63 miRNAs (ex; hsa-mir-4693-5p); FYN was the potential target of 61 miRNAs (ex; hsa-mir-4326); MAPK1 was the potential target of 286 miRNAs (ex; hsa-mir-1470); EEF2 was the potential target of 229 miRNAs (ex; hsa-mir-2110); MYH9 was the potential target of 226 miRNAs (ex; hsa-mir-3615); PRKDC was the potential target of 164 miRNAs (ex; hsa-mir-4511); PABPC1 was the potential target of 151 miRNAs (ex; hsa-mir-1825).</p>
</sec>
<sec id="S15">
<title>TF-hub gene regulatory network construction</title>
<p id="P17">The TF-hub gene regulatory network is shown in <xref ref-type="fig" rid="F6">Fig. 6</xref>, which has 59 nodes (hub genes:84; TFs:328) and 2719 interactions. The nodes with higher degrees are listed in <xref ref-type="table" rid="T5">Table 5</xref>, including ESR1 was the potential target of 22 TFs (ex; STAT3); IRF7 was the potential target of 14 TFs (ex; KLF5); IRF8 was the potential target of 12 TFs (ex; MAX); EIF2AK2 was the potential target of 10 TFs (ex; POU2F2); FYN was the potential target of 10 TFs (ex; ARID3A); BCL6 was the potential target of 17 TFs (ex; SREBF2); CEBPB was the potential target of 12 TFs (ex; E2F6); EGR1 was the potential target of 12 TFs (ex; SRF); RXRA was the potential target of 12 TFs (ex; GATA3); ARRB2 was the potential target of 12 TFs (ex; USF1).</p>
</sec>
<sec id="S16">
<title>Validation of hub genes by receiver operating characteristic curve (ROC) analysis</title>
<p id="P18">The ROC curves (<xref ref-type="fig" rid="F7">Fig.7</xref>) of hub genes showed that their AUC as follows: ESR1 (0.913), UBD (0.928), FYN (0.938), STAT1 (0.931), ISG15 (0.946), EGR1 (0.913), ARRB2 (0.902), UBE2D1 (0.920), PRKDC (0.917) and FOS (0.924). Since ROC curves had good specificity and sensitivity, ESR1, UBD, FYN, STAT1, ISG15, EGR1, ARRB2, UBE2D1, PRKDC and FOS had excellent diagnostic values for distinguishing COVID 19 samples and non COVID 19 samples.</p>
</sec>
</sec>
<sec id="S17" sec-type="discussion">
<title>Discussion</title>
<p id="P19">Although many relevant studies of COVID-19 infection and its associated complications have been performed, early diagnosis, efficacy of treatment and prognosis for COVID-19 infection and its associated complications remain poorly determined. For prognosis, diagnosis and treatment, it is necessary to further understand the molecular mechanisms resulting in occurrence and advancement. Due to the advancement of NGS technology, the genetic modifications due to disease development can be detected, indicating gene targets for diagnosis, therapy and prognosis of infectious diseases. In the present investigation, a total of 738 DEGs between COVID-19 samples and non COVID-19 samples were identified, consisting of 415 up regulated and 323 down regulated genes. <styled-content style-type="color" style="color:#FF0000">CXCL11</styled-content> [<xref ref-type="bibr" rid="R64">64</xref>], CXCL10 [<xref ref-type="bibr" rid="R65">65</xref>], ISG15 [<xref ref-type="bibr" rid="R66">66</xref>], SIGLEC1 [<xref ref-type="bibr" rid="R67">67</xref>] and <styled-content style-type="color" style="color:#FF0000">CXCL9</styled-content> [<xref ref-type="bibr" rid="R64">64</xref>] are identified as a new type of COVID-19 susceptibility genes. CXCL10 might play a role in progression of diabetes mellitus [<xref ref-type="bibr" rid="R68">68</xref>]. CXCL10 [<xref ref-type="bibr" rid="R69">69</xref>], ISG15 [<xref ref-type="bibr" rid="R70">70</xref>], SIGLEC1 [<xref ref-type="bibr" rid="R71">71</xref>], CXCL9 [<xref ref-type="bibr" rid="R72">72</xref>], IFIT3 [<xref ref-type="bibr" rid="R73">73</xref>], KLF15 [<xref ref-type="bibr" rid="R74">74</xref>] and SPRR3 [<xref ref-type="bibr" rid="R75">75</xref>] have a potential role in the diagnosis and treatment of cardiovascular diseases. CXCL10 [<xref ref-type="bibr" rid="R76">76</xref>], SIGLEC1 [<xref ref-type="bibr" rid="R77">77</xref>] and IL1R2 [<xref ref-type="bibr" rid="R78">78</xref>] have been suggested to be associated with neurological diseases. CXCL9 [<xref ref-type="bibr" rid="R79">79</xref>], SIGLEC1 [<xref ref-type="bibr" rid="R80">80</xref>], IL1R2 [<xref ref-type="bibr" rid="R81">81</xref>], KLF15 [<xref ref-type="bibr" rid="R82">82</xref>] and CD207 [<xref ref-type="bibr" rid="R83">83</xref>] are important in the development of kidney diseases..</p>
<p id="P20">GO and REACTOME pathway enrichment pathway analyses were performed using g:Profiler. Immune system [<xref ref-type="bibr" rid="R84">84</xref>], HDACs deacetylate histones [<xref ref-type="bibr" rid="R85">85</xref>], adaptive immune system [<xref ref-type="bibr" rid="R86">86</xref>], innate immune system [<xref ref-type="bibr" rid="R87">87</xref>] and neutrophil degranulation [<xref ref-type="bibr" rid="R88">88</xref>] were linked with progression of COVID-19. Immune system [<xref ref-type="bibr" rid="R89">89</xref>], HDACs deacetylate histones [<xref ref-type="bibr" rid="R90">90</xref>], adaptive immune system [<xref ref-type="bibr" rid="R91">91</xref>], infectious disease [<xref ref-type="bibr" rid="R92">92</xref>], innate immune system [<xref ref-type="bibr" rid="R93">93</xref>] and neutrophil degranulation [<xref ref-type="bibr" rid="R94">94</xref>] were liable for progression of diabetes mellitus. Immune system [<xref ref-type="bibr" rid="R95">95</xref>], HDACs deacetylate histones [<xref ref-type="bibr" rid="R96">96</xref>], adaptive immune system [<xref ref-type="bibr" rid="R97">97</xref>], infectious disease [<xref ref-type="bibr" rid="R98">98</xref>], innate immune system [<xref ref-type="bibr" rid="R99">99</xref>] and neutrophil degranulation [<xref ref-type="bibr" rid="R100">100</xref>] were involved in progression of cardiovascular diseases. Immune system [<xref ref-type="bibr" rid="R101">101</xref>], HDACs deacetylate histones [<xref ref-type="bibr" rid="R102">102</xref>], adaptive immune system [<xref ref-type="bibr" rid="R103">103</xref>], innate immune system [<xref ref-type="bibr" rid="R104">104</xref>] and membrane trafficking [<xref ref-type="bibr" rid="R105">105</xref>] were linked with progression of neurological diseases. Immune system [<xref ref-type="bibr" rid="R106">106</xref>], infectious disease [<xref ref-type="bibr" rid="R107">107</xref>] and innate immune system [<xref ref-type="bibr" rid="R108">108</xref>] were associated with advancement of kidney diseases. IFI27 [<xref ref-type="bibr" rid="R109">109</xref>], UBD (ubiquitin D) [<xref ref-type="bibr" rid="R110">110</xref>], STAT1 [<xref ref-type="bibr" rid="R111">111</xref>], MT2A [<xref ref-type="bibr" rid="R112">112</xref>], CAMK4 [<xref ref-type="bibr" rid="R113">113</xref>], FASLG (Fas ligand) [<xref ref-type="bibr" rid="R114">114</xref>], ISG20 [<xref ref-type="bibr" rid="R115">115</xref>], ADGRF5 [<xref ref-type="bibr" rid="R116">116</xref>], HLA-G [<xref ref-type="bibr" rid="R117">117</xref>], MDK (midkine) [<xref ref-type="bibr" rid="R118">118</xref>], C4A [<xref ref-type="bibr" rid="R119">119</xref>], RGS1 [<xref ref-type="bibr" rid="R120">120</xref>], C1R [<xref ref-type="bibr" rid="R121">121</xref>], CTLA4 [<xref ref-type="bibr" rid="R122">122</xref>], CD38 [<xref ref-type="bibr" rid="R123">123</xref>], CX3CL1 [<xref ref-type="bibr" rid="R124">124</xref>], CD247 [<xref ref-type="bibr" rid="R125">125</xref>], SFRP1 [<xref ref-type="bibr" rid="R126">126</xref>], <styled-content style-type="color" style="color:#FF0000">HLA DRB1</styled-content> [<xref ref-type="bibr" rid="R23">23</xref>], AIM2 [<xref ref-type="bibr" rid="R127">127</xref>], TLR7 [<xref ref-type="bibr" rid="R128">128</xref>], TNFSF13B [<xref ref-type="bibr" rid="R129">129</xref>], CCR1 [<xref ref-type="bibr" rid="R130">130</xref>], TAP2 [<xref ref-type="bibr" rid="R131">131</xref>], APOL1 [<xref ref-type="bibr" rid="R132">132</xref>], CXCL12 [<xref ref-type="bibr" rid="R133">133</xref>], CFH (complement factor H) [<xref ref-type="bibr" rid="R134">134</xref>], RARRES2 [<xref ref-type="bibr" rid="R135">135</xref>], FYN (FYN proto-oncogene, Src family tyrosine kinase) [<xref ref-type="bibr" rid="R136">136</xref>], NLRC5 [<xref ref-type="bibr" rid="R137">137</xref>], CD74 [<xref ref-type="bibr" rid="R138">138</xref>], ACE2 [<xref ref-type="bibr" rid="R139">139</xref>], ABCB1 [<xref ref-type="bibr" rid="R140">140</xref>], POSTN (periostin) [<xref ref-type="bibr" rid="R141">141</xref>], TGM2 [<xref ref-type="bibr" rid="R142">142</xref>], COL4A3 [<xref ref-type="bibr" rid="R143">143</xref>], SLC12A3 [<xref ref-type="bibr" rid="R144">144</xref>], IRS1 [<xref ref-type="bibr" rid="R145">145</xref>], APOL3 [<xref ref-type="bibr" rid="R146">146</xref>], STAT4 [<xref ref-type="bibr" rid="R147">147</xref>], CXCL8 [<xref ref-type="bibr" rid="R148">148</xref>], KLF2 [<xref ref-type="bibr" rid="R149">149</xref>], ADM (adrenomedullin) [<xref ref-type="bibr" rid="R150">150</xref>], EGR1 [<xref ref-type="bibr" rid="R151">151</xref>], TRIB1 [<xref ref-type="bibr" rid="R152">152</xref>], SOD2 [<xref ref-type="bibr" rid="R153">153</xref>], OXSR1 [<xref ref-type="bibr" rid="R154">154</xref>], IL6R [<xref ref-type="bibr" rid="R155">155</xref>], CD44 [<xref ref-type="bibr" rid="R156">156</xref>], LRG1 [<xref ref-type="bibr" rid="R157">157</xref>], PFKFB2 [<xref ref-type="bibr" rid="R158">158</xref>], PACSIN2 [<xref ref-type="bibr" rid="R159">159</xref>], MYH9 [<xref ref-type="bibr" rid="R160">160</xref>], DOT1L [<xref ref-type="bibr" rid="R161">161</xref>], CXCL16 [<xref ref-type="bibr" rid="R162">162</xref>], PTEN (phosphatase and tensin homolog) [<xref ref-type="bibr" rid="R163">163</xref>], FOXO3 [<xref ref-type="bibr" rid="R164">164</xref>], DDIT4 [<xref ref-type="bibr" rid="R165">165</xref>], PINK1 [<xref ref-type="bibr" rid="R166">166</xref>], IQGAP1 [<xref ref-type="bibr" rid="R167">167</xref>], ADIPOR1 [<xref ref-type="bibr" rid="R168">168</xref>], MTMR3 [<xref ref-type="bibr" rid="R169">169</xref>], USF2 [<xref ref-type="bibr" rid="R170">170</xref>], SGK1 [<xref ref-type="bibr" rid="R171">171</xref>], GSTO2 [<xref ref-type="bibr" rid="R172">172</xref>], ETS2 [<xref ref-type="bibr" rid="R173">173</xref>], TKT (transketolase) [<xref ref-type="bibr" rid="R174">174</xref>], CMIP (c-Maf inducing protein) [<xref ref-type="bibr" rid="R175">175</xref>], THBD (thrombomodulin) [<xref ref-type="bibr" rid="R176">176</xref>], ALPL (alkaline phosphatase, biomineralization associated) [<xref ref-type="bibr" rid="R177">177</xref>], GPX3 [<xref ref-type="bibr" rid="R178">178</xref>] and ELL2 [<xref ref-type="bibr" rid="R179">179</xref>] might serve as molecular markers for kidney diseases. OASL (2'-5'-oligoadenylate synthetase like) [<xref ref-type="bibr" rid="R180">180</xref>], IFIT2 [<xref ref-type="bibr" rid="R181">181</xref>], LAG3 [<xref ref-type="bibr" rid="R182">182</xref>], IFITM1 [<xref ref-type="bibr" rid="R183">183</xref>], IFITM3 [<xref ref-type="bibr" rid="R184">184</xref>], MX1 [<xref ref-type="bibr" rid="R185">185</xref>], IFI35 [<xref ref-type="bibr" rid="R186">186</xref>], TRIM22 [<xref ref-type="bibr" rid="R187">187</xref>], CCR1 [<xref ref-type="bibr" rid="R188">188</xref>], ZBP1 [<xref ref-type="bibr" rid="R189">189</xref>], FCGR3A [<xref ref-type="bibr" rid="R190">190</xref>], BPIFA1 [<xref ref-type="bibr" rid="R191">191</xref>], PSMB8 [<xref ref-type="bibr" rid="R192">192</xref>], CALHM6 [<xref ref-type="bibr" rid="R193">193</xref>], ETV7 [<xref ref-type="bibr" rid="R194">194</xref>], PARP12 [<xref ref-type="bibr" rid="R195">195</xref>], BCL6 [<xref ref-type="bibr" rid="R196">196</xref>] and DNAJB1 [<xref ref-type="bibr" rid="R197">197</xref>] were mainly involved in the various viral infections. CCL8 [<xref ref-type="bibr" rid="R198">198</xref>], GZMB (granzyme B) [<xref ref-type="bibr" rid="R199">199</xref>], CCL2 [<xref ref-type="bibr" rid="R200">200</xref>], IDO1 [<xref ref-type="bibr" rid="R201">201</xref>], CD80 [<xref ref-type="bibr" rid="R202">202</xref>], IFNG (interferon gamma) [<xref ref-type="bibr" rid="R203">203</xref>], STAT1 [<xref ref-type="bibr" rid="R204">204</xref>], CCR5 [<xref ref-type="bibr" rid="R205">205</xref>], SAA1 [<xref ref-type="bibr" rid="R206">206</xref>], MT2A [<xref ref-type="bibr" rid="R207">207</xref>], DPP4 [<xref ref-type="bibr" rid="R208">208</xref>], FASLG (Fas ligand) [<xref ref-type="bibr" rid="R209">209</xref>], CMKLR1 [<xref ref-type="bibr" rid="R210">210</xref>], ICOS (inducible T cell costimulator) [<xref ref-type="bibr" rid="R211">211</xref>], PDCD1 [<xref ref-type="bibr" rid="R212">212</xref>], SUCNR1 [<xref ref-type="bibr" rid="R213">213</xref>], IRF7 [<xref ref-type="bibr" rid="R214">214</xref>], HLA-F [<xref ref-type="bibr" rid="R215">215</xref>], HLA-G [<xref ref-type="bibr" rid="R216">216</xref>], MDK (midkine) [<xref ref-type="bibr" rid="R217">217</xref>], TIGIT (T cell immunoreceptor with Ig and ITIM domains) [<xref ref-type="bibr" rid="R218">218</xref>], CTLA4 [<xref ref-type="bibr" rid="R219">219</xref>], CD38 [<xref ref-type="bibr" rid="R220">220</xref>] TLR3 [<xref ref-type="bibr" rid="R221">221</xref>], CX3CL1 [<xref ref-type="bibr" rid="R222">222</xref>], SFRP1 [<xref ref-type="bibr" rid="R223">223</xref>], <styled-content style-type="color" style="color:#FF0000">HLA-DRB1</styled-content> [<xref ref-type="bibr" rid="R21">21</xref>], AIM2 [<xref ref-type="bibr" rid="R224">224</xref>], TLR7 [<xref ref-type="bibr" rid="R225">225</xref>], IRF8 [<xref ref-type="bibr" rid="R226">226</xref>], SLAMF7 [<xref ref-type="bibr" rid="R227">227</xref>], BCL11B [<xref ref-type="bibr" rid="R228">228</xref>], APOD (apolipoprotein D) [<xref ref-type="bibr" rid="R229">229</xref>], APOL1 [<xref ref-type="bibr" rid="R230">230</xref>], CXCL12 [<xref ref-type="bibr" rid="R231">231</xref>], CFH (complement factor H) [<xref ref-type="bibr" rid="R232">232</xref>], RARRES2 [<xref ref-type="bibr" rid="R233">233</xref>], RNASE6 [<xref ref-type="bibr" rid="R234">234</xref>], IL32 [<xref ref-type="bibr" rid="R235">235</xref>], NLRC5 [<xref ref-type="bibr" rid="R236">236</xref>], CD74 [<xref ref-type="bibr" rid="R237">237</xref>], ACE2 [<xref ref-type="bibr" rid="R238">238</xref>], FAP (fibroblast activation protein alpha) [<xref ref-type="bibr" rid="R239">239</xref>], ABCB1 [<xref ref-type="bibr" rid="R240">240</xref>], PCDH17 [<xref ref-type="bibr" rid="R241">241</xref>], POSTN (periostin) [<xref ref-type="bibr" rid="R242">242</xref>], KCNA2 [<xref ref-type="bibr" rid="R243">243</xref>], CD72 [<xref ref-type="bibr" rid="R244">244</xref>], TIMP4 [<xref ref-type="bibr" rid="R245">245</xref>], ESR1 [<xref ref-type="bibr" rid="R246">246</xref>], IRS1 [<xref ref-type="bibr" rid="R247">247</xref>], CMPK2 [<xref ref-type="bibr" rid="R248">248</xref>], IGFBP4 [<xref ref-type="bibr" rid="R249">249</xref>], CYP19A1 [<xref ref-type="bibr" rid="R250">250</xref>], CASQ2 [<xref ref-type="bibr" rid="R251">251</xref>], STAT4 [<xref ref-type="bibr" rid="R252">252</xref>], PPM1K [<xref ref-type="bibr" rid="R253">253</xref>], APOC1 [<xref ref-type="bibr" rid="R254">254</xref>], CXCL8 [<xref ref-type="bibr" rid="R255">255</xref>], KLF2 [<xref ref-type="bibr" rid="R256">256</xref>], ADM (adrenomedullin) [<xref ref-type="bibr" rid="R257">257</xref>], HBEGF (heparin binding EGF like growth factor) [<xref ref-type="bibr" rid="R258">258</xref>], KLF7 [<xref ref-type="bibr" rid="R259">259</xref>], DSC2 [<xref ref-type="bibr" rid="R260">260</xref>], DUSP1 [<xref ref-type="bibr" rid="R261">261</xref>], EGR1 [<xref ref-type="bibr" rid="R262">262</xref>], ADRB3 [<xref ref-type="bibr" rid="R263">263</xref>], ZFP36 [<xref ref-type="bibr" rid="R264">264</xref>], EGR3 [<xref ref-type="bibr" rid="R265">265</xref>], TRIB1 [<xref ref-type="bibr" rid="R266">266</xref>], LITAF (lipopolysaccharide induced TNF factor) [<xref ref-type="bibr" rid="R267">267</xref>], SOD2 [<xref ref-type="bibr" rid="R268">268</xref>], NR4A1 [<xref ref-type="bibr" rid="R269">269</xref>], BCL6 [<xref ref-type="bibr" rid="R270">270</xref>], IL6R [<xref ref-type="bibr" rid="R271">271</xref>], CD44 [<xref ref-type="bibr" rid="R272">272</xref>], MAP2K3 [<xref ref-type="bibr" rid="R273">273</xref>], NFKBIA (NFKB inhibitor alpha) [<xref ref-type="bibr" rid="R274">274</xref>], LRG1 [<xref ref-type="bibr" rid="R275">275</xref>], PFKFB2 [<xref ref-type="bibr" rid="R276">276</xref>], MAP4K4 [<xref ref-type="bibr" rid="R277">277</xref>], NR4A2 [<xref ref-type="bibr" rid="R278">278</xref>], IRS2 [<xref ref-type="bibr" rid="R279">279</xref>], TNIP1 [<xref ref-type="bibr" rid="R280">280</xref>], PTPN12 [<xref ref-type="bibr" rid="R281">281</xref>], DOT1L [<xref ref-type="bibr" rid="R282">282</xref>], CXCL16 [<xref ref-type="bibr" rid="R283">283</xref>], MAP3K11 [<xref ref-type="bibr" rid="R284">284</xref>], SORT1 [<xref ref-type="bibr" rid="R285">285</xref>], FOXO3 [<xref ref-type="bibr" rid="R286">286</xref>], SEMA4A [<xref ref-type="bibr" rid="R287">287</xref>], PINK1 [<xref ref-type="bibr" rid="R288">288</xref>], ADIPOR1 [<xref ref-type="bibr" rid="R289">289</xref>], SGK1 [<xref ref-type="bibr" rid="R290">290</xref>], MAPK1 [<xref ref-type="bibr" rid="R291">291</xref>], KLHL24 [<xref ref-type="bibr" rid="R292">292</xref>], ZFP36 [<xref ref-type="bibr" rid="R293">293</xref>], PFKFB3 [<xref ref-type="bibr" rid="R294">294</xref>], GYS1 [<xref ref-type="bibr" rid="R295">295</xref>], ETS2 [<xref ref-type="bibr" rid="R296">296</xref>], WDR1 [<xref ref-type="bibr" rid="R297">297</xref>], THBD (thrombomodulin) [<xref ref-type="bibr" rid="R298">298</xref>], ALPL (alkaline phosphatase, biomineralization associated) [<xref ref-type="bibr" rid="R299">299</xref>], FOSL2 [<xref ref-type="bibr" rid="R300">300</xref>] and GPX3 [<xref ref-type="bibr" rid="R301">301</xref>] contributes to the progression of cardiovascular diseases. CCL8 [<xref ref-type="bibr" rid="R302">302</xref>], LAG3 [<xref ref-type="bibr" rid="R303">303</xref>], CXCL13 [<xref ref-type="bibr" rid="R304">304</xref>], CCL2 [<xref ref-type="bibr" rid="R305">305</xref>], DDX58 [<xref ref-type="bibr" rid="R306">306</xref>], C1QA [<xref ref-type="bibr" rid="R307">307</xref>], C1QB [<xref ref-type="bibr" rid="R308">308</xref>], IFNG (interferon gamma) [<xref ref-type="bibr" rid="R309">309</xref>], STAT1 [<xref ref-type="bibr" rid="R310">310</xref>], CCR5 [<xref ref-type="bibr" rid="R311">311</xref>], HLA-DMB [<xref ref-type="bibr" rid="R312">312</xref>], CMKLR1 [<xref ref-type="bibr" rid="R313">313</xref>], LAMP3 [<xref ref-type="bibr" rid="R314">314</xref>], HLA-F [<xref ref-type="bibr" rid="R315">315</xref>], HLA-G [<xref ref-type="bibr" rid="R316">316</xref>], MDK (midkine) [<xref ref-type="bibr" rid="R317">317</xref>], IRF4 [<xref ref-type="bibr" rid="R318">318</xref>], C4A [<xref ref-type="bibr" rid="R319">319</xref>], EIF2AK2 [<xref ref-type="bibr" rid="R320">320</xref>], HLA-DRB5 [<xref ref-type="bibr" rid="R321">321</xref>], GSDMB (gasdermin B) [<xref ref-type="bibr" rid="R322">322</xref>], CD244 [<xref ref-type="bibr" rid="R323">323</xref>], C1R [<xref ref-type="bibr" rid="R324">324</xref>], CTLA4 [<xref ref-type="bibr" rid="R325">325</xref>], CD38 [<xref ref-type="bibr" rid="R326">326</xref>], CX3CL1 [<xref ref-type="bibr" rid="R327">327</xref>], HLA-DRB1 [<xref ref-type="bibr" rid="R328">328</xref>], AIM2 [<xref ref-type="bibr" rid="R329">329</xref>], TLR7 [<xref ref-type="bibr" rid="R330">330</xref>], IRF8 [<xref ref-type="bibr" rid="R331">331</xref>], TMEM176B [<xref ref-type="bibr" rid="R332">332</xref>], BCL11B [<xref ref-type="bibr" rid="R333">333</xref>], TAP2 [<xref ref-type="bibr" rid="R334">334</xref>], APOD (apolipoprotein D) [<xref ref-type="bibr" rid="R335">335</xref>], CXCL12 [<xref ref-type="bibr" rid="R336">336</xref>], CFH (complement factor H) [<xref ref-type="bibr" rid="R337">337</xref>], IL32 [<xref ref-type="bibr" rid="R338">338</xref>], NLRC5 [<xref ref-type="bibr" rid="R339">339</xref>], CD33 [<xref ref-type="bibr" rid="R340">340</xref>], ACE2 [<xref ref-type="bibr" rid="R341">341</xref>], KCNA3 [<xref ref-type="bibr" rid="R342">342</xref>], ABCB1 [<xref ref-type="bibr" rid="R343">343</xref>], GABRB2 [<xref ref-type="bibr" rid="R344">344</xref>]. MLC1 [<xref ref-type="bibr" rid="R345">345</xref>], KCNA2 [<xref ref-type="bibr" rid="R346">346</xref>], TIMP4 [<xref ref-type="bibr" rid="R347">347</xref>], EXOC3L4 [<xref ref-type="bibr" rid="R348">348</xref>], SAMD9L [<xref ref-type="bibr" rid="R349">349</xref>], TPX2 [<xref ref-type="bibr" rid="R350">350</xref>], MGAT3 [<xref ref-type="bibr" rid="R351">351</xref>], TMEM187 [<xref ref-type="bibr" rid="R352">352</xref>], ABI3 [<xref ref-type="bibr" rid="R353">353</xref>], TRANK1 [<xref ref-type="bibr" rid="R354">354</xref>], CYP19A1 [<xref ref-type="bibr" rid="R355">355</xref>], SH2D2A [<xref ref-type="bibr" rid="R356">356</xref>], WASF1 [<xref ref-type="bibr" rid="R357">357</xref>], FBXO6 [<xref ref-type="bibr" rid="R358">358</xref>], KIF5C [<xref ref-type="bibr" rid="R359">359</xref>], APOC1 [<xref ref-type="bibr" rid="R360">360</xref>], CXCL8 [<xref ref-type="bibr" rid="R361">361</xref>], KLF2 [<xref ref-type="bibr" rid="R362">362</xref>], ADM (adrenomedullin) [<xref ref-type="bibr" rid="R363">363</xref>], EGR1 [<xref ref-type="bibr" rid="R364">364</xref>], ADRB3 [<xref ref-type="bibr" rid="R365">365</xref>], EGR3 [<xref ref-type="bibr" rid="R366">366</xref>], ANPEP (alanylaminopeptidase, membrane) [<xref ref-type="bibr" rid="R367">367</xref>], SCN2A [<xref ref-type="bibr" rid="R368">368</xref>], KREMEN1 [<xref ref-type="bibr" rid="R369">369</xref>], NEDD9 [<xref ref-type="bibr" rid="R370">370</xref>], GPR85 [<xref ref-type="bibr" rid="R371">371</xref>], NDRG1 [<xref ref-type="bibr" rid="R372">372</xref>], SOD2 [<xref ref-type="bibr" rid="R373">373</xref>], ARRB2 [<xref ref-type="bibr" rid="R374">374</xref>], IL6R [<xref ref-type="bibr" rid="R375">375</xref>], GAB2 [<xref ref-type="bibr" rid="R376">376</xref>], NDEL1 [<xref ref-type="bibr" rid="R377">377</xref>], CEBPB (CCAAT enhancer binding protein beta) [<xref ref-type="bibr" rid="R378">378</xref>], FGD4 [<xref ref-type="bibr" rid="R379">379</xref>], INPP5A [<xref ref-type="bibr" rid="R380">380</xref>], SLC12A6 [<xref ref-type="bibr" rid="R381">381</xref>], PRKDC (protein kinase, DNA-activated, catalytic subunit) [<xref ref-type="bibr" rid="R382">382</xref>], MAP4K4 [<xref ref-type="bibr" rid="R383">383</xref>], PER1 [<xref ref-type="bibr" rid="R384">384</xref>], HIP1R [<xref ref-type="bibr" rid="R385">385</xref>], NR4A2 [<xref ref-type="bibr" rid="R386">386</xref>], INPP5K [<xref ref-type="bibr" rid="R387">387</xref>], IRS2 [<xref ref-type="bibr" rid="R388">388</xref>], ATP6V1B2 [<xref ref-type="bibr" rid="R389">389</xref>], PTEN (phosphatase and tensin homolog) [<xref ref-type="bibr" rid="R390">390</xref>], PELI1 [<xref ref-type="bibr" rid="R391">391</xref>], ZMIZ1 [<xref ref-type="bibr" rid="R392">392</xref>], NDRG2 [<xref ref-type="bibr" rid="R393">393</xref>], FOXO3 [<xref ref-type="bibr" rid="R394">394</xref>], DDIT4 [<xref ref-type="bibr" rid="R395">395</xref>], PINK1 [<xref ref-type="bibr" rid="R396">396</xref>], CPEB4 [<xref ref-type="bibr" rid="R397">397</xref>], ADIPOR1 [<xref ref-type="bibr" rid="R398">398</xref>], GLUL (glutamate-ammonia ligase) [<xref ref-type="bibr" rid="R399">399</xref>], PRKCD (protein kinase C delta) [<xref ref-type="bibr" rid="R400">400</xref>], USF2 [<xref ref-type="bibr" rid="R401">401</xref>], SGK1 [<xref ref-type="bibr" rid="R402">402</xref>], WDR45 [<xref ref-type="bibr" rid="R403">403</xref>], RAB7A [<xref ref-type="bibr" rid="R404">404</xref>], MAPK1 [<xref ref-type="bibr" rid="R405">405</xref>], FTH1 [<xref ref-type="bibr" rid="R406">406</xref>], AMPD2 [<xref ref-type="bibr" rid="R407">407</xref>], PICALM (phosphatidylinositol binding clathrin assembly protein) [<xref ref-type="bibr" rid="R408">408</xref>], UBAP1 [<xref ref-type="bibr" rid="R409">409</xref>], TUBA4A [<xref ref-type="bibr" rid="R410">410</xref>], TFE3 [<xref ref-type="bibr" rid="R411">411</xref>], EEF2 [<xref ref-type="bibr" rid="R412">412</xref>], UBE2H [<xref ref-type="bibr" rid="R413">413</xref>], CMIP (c-Maf inducing protein) [<xref ref-type="bibr" rid="R414">414</xref>], ANXA11 [<xref ref-type="bibr" rid="R415">415</xref>], THBD (thrombomodulin) [<xref ref-type="bibr" rid="R416">416</xref>], TREML2 [<xref ref-type="bibr" rid="R417">417</xref>], SLC25A37 [<xref ref-type="bibr" rid="R418">418</xref>], GPX3 [<xref ref-type="bibr" rid="R419">419</xref>] and KAT8 [<xref ref-type="bibr" rid="R420">420</xref>] have been shown to be activated in neurological diseases. LAG3 [<xref ref-type="bibr" rid="R421">421</xref>], IFITM3 [<xref ref-type="bibr" rid="R422">422</xref>], OAS1 [<xref ref-type="bibr" rid="R423">423</xref>], CXCL13 [<xref ref-type="bibr" rid="R424">424</xref>], CCL2 [<xref ref-type="bibr" rid="R425">425</xref>], IDO1 [<xref ref-type="bibr" rid="R426">426</xref>], CD80 [<xref ref-type="bibr" rid="R427">427</xref>], MX1 [<xref ref-type="bibr" rid="R428">428</xref>], IFNG (interferon gamma) [<xref ref-type="bibr" rid="R429">429</xref>], IFIH1 [<xref ref-type="bibr" rid="R430">430</xref>], PARP9 [<xref ref-type="bibr" rid="R431">431</xref>], <styled-content style-type="color" style="color:#FF0000">STAT1</styled-content> [<xref ref-type="bibr" rid="R432">432</xref>], KLRC2 [<xref ref-type="bibr" rid="R433">433</xref>], CCR5 [<xref ref-type="bibr" rid="R434">434</xref>], PARP14 [<xref ref-type="bibr" rid="R435">435</xref>], DPP4 [<xref ref-type="bibr" rid="R436">436</xref>], CAMK4 [<xref ref-type="bibr" rid="R437">437</xref>], HLA-G [<xref ref-type="bibr" rid="R438">438</xref>], MDK (midkine) [<xref ref-type="bibr" rid="R439">439</xref>], CD38 [<xref ref-type="bibr" rid="R440">440</xref>], TLR3 [<xref ref-type="bibr" rid="R441">441</xref>], CX3CL1 [<xref ref-type="bibr" rid="R442">442</xref>], <styled-content style-type="color" style="color:#FF0000">HLA-DRB1</styled-content> [<xref ref-type="bibr" rid="R19">19</xref>], TLR7 [<xref ref-type="bibr" rid="R443">443</xref>], IL7 [<xref ref-type="bibr" rid="R444">444</xref>], APOL1 [<xref ref-type="bibr" rid="R445">445</xref>], TNFRSF13B [<xref ref-type="bibr" rid="R446">446</xref>], STAT2 [<xref ref-type="bibr" rid="R447">447</xref>], IL32 [<xref ref-type="bibr" rid="R448">448</xref>], CH25H [<xref ref-type="bibr" rid="R449">449</xref>], CD33 [<xref ref-type="bibr" rid="R450">450</xref>], ACE2 [<xref ref-type="bibr" rid="R451">451</xref>], ABCB1 [<xref ref-type="bibr" rid="R452">452</xref>], CXCL8 [<xref ref-type="bibr" rid="R453">453</xref>], KLF2 [<xref ref-type="bibr" rid="R454">454</xref>], ADM (adrenomedullin) [<xref ref-type="bibr" rid="R455">455</xref>], C5AR1 [<xref ref-type="bibr" rid="R456">456</xref>], IL6R [<xref ref-type="bibr" rid="R457">457</xref>] and SDCBP (syndecan binding protein) [<xref ref-type="bibr" rid="R458">458</xref>] were found to be involved in the progression of COVID-19. GZMB (granzyme B) [<xref ref-type="bibr" rid="R459">459</xref>], OAS1 [<xref ref-type="bibr" rid="R460">460</xref>], CCL2 [<xref ref-type="bibr" rid="R461">461</xref>], IDO1 [<xref ref-type="bibr" rid="R462">462</xref>], CD80 [<xref ref-type="bibr" rid="R463">463</xref>], GZMA (granzyme A) [<xref ref-type="bibr" rid="R464">464</xref>], IFNG (interferon gamma) [<xref ref-type="bibr" rid="R465">465</xref>], IFIH1 [<xref ref-type="bibr" rid="R466">466</xref>], STAT1 [<xref ref-type="bibr" rid="R467">467</xref>], CCR5 [<xref ref-type="bibr" rid="R468">468</xref>], ADCY5 [<xref ref-type="bibr" rid="R469">469</xref>], MT2A [<xref ref-type="bibr" rid="R470">470</xref>], DPP4 [<xref ref-type="bibr" rid="R471">471</xref>], FASLG (Fas ligand) [<xref ref-type="bibr" rid="R472">472</xref>], HLA-DMB [<xref ref-type="bibr" rid="R473">473</xref>], CD3D [<xref ref-type="bibr" rid="R474">474</xref>], CMKLR1 [<xref ref-type="bibr" rid="R475">475</xref>], ICOS (inducible T cell costimulator) [<xref ref-type="bibr" rid="R476">476</xref>], PDCD1 [<xref ref-type="bibr" rid="R477">477</xref>], SUCNR1 [<xref ref-type="bibr" rid="R478">478</xref>], IRF7 [<xref ref-type="bibr" rid="R479">479</xref>], DEFB1 [<xref ref-type="bibr" rid="R480">480</xref>], HLA-G [<xref ref-type="bibr" rid="R481">481</xref>], ZAP70 [<xref ref-type="bibr" rid="R482">482</xref>], UBASH3A [<xref ref-type="bibr" rid="R483">483</xref>], HLA-DMA [<xref ref-type="bibr" rid="R484">484</xref>], TAP1 [<xref ref-type="bibr" rid="R485">485</xref>], CTLA4 [<xref ref-type="bibr" rid="R486">486</xref>], CD38 [<xref ref-type="bibr" rid="R487">487</xref>], TLR3 [<xref ref-type="bibr" rid="R488">488</xref>], CX3CL1 [<xref ref-type="bibr" rid="R489">489</xref>], CD247 [<xref ref-type="bibr" rid="R490">490</xref>], NOS2 [<xref ref-type="bibr" rid="R491">491</xref>], <styled-content style-type="color" style="color:#FF0000">HLA-DRB1</styled-content> [<xref ref-type="bibr" rid="R20">20</xref>], AIM2 [<xref ref-type="bibr" rid="R492">492</xref>], CFB (complement factor B) [<xref ref-type="bibr" rid="R493">493</xref>], TLR7 [<xref ref-type="bibr" rid="R494">494</xref>], SLAMF1 [<xref ref-type="bibr" rid="R495">495</xref>], BPIFA1 [<xref ref-type="bibr" rid="R496">496</xref>], CD300E [<xref ref-type="bibr" rid="R497">497</xref>], TAP2 [<xref ref-type="bibr" rid="R498">498</xref>], CD48 [<xref ref-type="bibr" rid="R499">499</xref>], APOL1 [<xref ref-type="bibr" rid="R500">500</xref>], BACH2 [<xref ref-type="bibr" rid="R501">501</xref>], CD226 [<xref ref-type="bibr" rid="R502">502</xref>], CXCL12 [<xref ref-type="bibr" rid="R503">503</xref>], STAT2 [<xref ref-type="bibr" rid="R504">504</xref>], RARRES2 [<xref ref-type="bibr" rid="R505">505</xref>], IL32 [<xref ref-type="bibr" rid="R506">506</xref>], ACE2 [<xref ref-type="bibr" rid="R507">507</xref>], CD72 [<xref ref-type="bibr" rid="R508">508</xref>], TGM2 [<xref ref-type="bibr" rid="R509">509</xref>], CD52 [<xref ref-type="bibr" rid="R510">510</xref>], COL4A3 [<xref ref-type="bibr" rid="R511">511</xref>], SLC12A3 [<xref ref-type="bibr" rid="R512">512</xref>], GPC4 [<xref ref-type="bibr" rid="R513">513</xref>], IRS1 [<xref ref-type="bibr" rid="R514">514</xref>], CYP19A1 [<xref ref-type="bibr" rid="R515">515</xref>], PROX1 [<xref ref-type="bibr" rid="R516">516</xref>], STAT4 [<xref ref-type="bibr" rid="R517">517</xref>], SEC16B [<xref ref-type="bibr" rid="R518">518</xref>], CXCL8 [<xref ref-type="bibr" rid="R519">519</xref>], KLF2 [<xref ref-type="bibr" rid="R520">520</xref>], DGAT2 [<xref ref-type="bibr" rid="R521">521</xref>], ADM (adrenomedullin) [<xref ref-type="bibr" rid="R522">522</xref>], IL1R1 [<xref ref-type="bibr" rid="R523">523</xref>], EGR1 [<xref ref-type="bibr" rid="R524">524</xref>], ADRB3 [<xref ref-type="bibr" rid="R525">525</xref>], SOD2 [<xref ref-type="bibr" rid="R526">526</xref>], ARRB2 [<xref ref-type="bibr" rid="R527">527</xref>], NR4A1 [<xref ref-type="bibr" rid="R528">528</xref>], IL6R [<xref ref-type="bibr" rid="R529">529</xref>], CD44 [<xref ref-type="bibr" rid="R530">530</xref>], LRG1 [<xref ref-type="bibr" rid="R531">531</xref>], FOXO4 [<xref ref-type="bibr" rid="R532">532</xref>], MAP4K4 [<xref ref-type="bibr" rid="R533">533</xref>], MYH9 [<xref ref-type="bibr" rid="R534">534</xref>], IRS2 [<xref ref-type="bibr" rid="R535">535</xref>], SULF2 [<xref ref-type="bibr" rid="R536">536</xref>], CXCL16 [<xref ref-type="bibr" rid="R537">537</xref>], FOXO3 [<xref ref-type="bibr" rid="R538">538</xref>], PINK1 [<xref ref-type="bibr" rid="R539">539</xref>], ADIPOR1 [<xref ref-type="bibr" rid="R540">540</xref>], GLUL (glutamate-ammonia ligase) [<xref ref-type="bibr" rid="R541">541</xref>], SGK1 [<xref ref-type="bibr" rid="R542">542</xref>], PFKFB3 [<xref ref-type="bibr" rid="R543">543</xref>], GYS1 [<xref ref-type="bibr" rid="R544">544</xref>], TP53INP2 [<xref ref-type="bibr" rid="R545">545</xref>], CMIP (c-Maf inducing protein) [<xref ref-type="bibr" rid="R546">546</xref>], STATH (statherin) [<xref ref-type="bibr" rid="R547">547</xref>], FOSL2 [<xref ref-type="bibr" rid="R548">548</xref>], GPX3 [<xref ref-type="bibr" rid="R549">549</xref>], CAMK1D [<xref ref-type="bibr" rid="R550">550</xref>] and RNASEK (ribonuclease K) [<xref ref-type="bibr" rid="R551">551</xref>] were identified to be closely associated with diabetes mellitus.</p>
<p id="P21">The hub genes from PPI network and modules defined in this study might lead to the progression of potential diagnostic, prognostic, or therapeutic biomarkers for COVID-19 infection and its associated complications. UBE2D1, FOS (Fos proto-oncogene, AP-1 transcription factor subunit), IFIT1, GBP1, GABARAPL1, GABARAP (GABA type A receptor-associated protein), RASSF5 and MAP1LC3B were might be the novel biomarkers for COVID-19 infection and its associated complications.</p>
<p id="P22">miRNA-hub gene regulatory network and TF-hub gene regulatory network can be regarded as key to the understanding COVID-19 infection and its associated complications and might also lead to new therapeutic approaches. hsa-mir-4484 [<xref ref-type="bibr" rid="R552">552</xref>], hsa-mir-4511 [<xref ref-type="bibr" rid="R553">553</xref>], STAT3 [<xref ref-type="bibr" rid="R554">554</xref>], KLF5 [<xref ref-type="bibr" rid="R555">555</xref>], SRF (Serum response factor) [<xref ref-type="bibr" rid="R556">556</xref>], GATA3 [<xref ref-type="bibr" rid="R557">557</xref>] and USF1 [<xref ref-type="bibr" rid="R558">558</xref>] have been implicated as a principal mediator of kidney diseases. Studies have reported that hsa-mir-190b [<xref ref-type="bibr" rid="R559">559</xref>], <styled-content style-type="color" style="color:#FF0000">hsa-mir-4693-5p [<xref ref-type="bibr" rid="R560">560</xref>], hsa-mir-1470 [<xref ref-type="bibr" rid="R560">560</xref>],</styled-content> hsa-mir-1825 [<xref ref-type="bibr" rid="R561">561</xref>], STAT3 [<xref ref-type="bibr" rid="R562">562</xref>], SREBF2 [<xref ref-type="bibr" rid="R563">563</xref>] and SRF (Serum response factor) [<xref ref-type="bibr" rid="R564">564</xref>] are necessary for neurological diseases. hsa-mir-4693-5p [<xref ref-type="bibr" rid="R565">565</xref>] and <styled-content style-type="color" style="color:#FF0000">STAT3</styled-content> [<xref ref-type="bibr" rid="R432">432</xref>] expression have been identified in COVID-19 infection. hsa-mir-4326 [<xref ref-type="bibr" rid="R566">566</xref>], <styled-content style-type="color" style="color:#FF0000">hsa-mir-1470 [<xref ref-type="bibr" rid="R567">567</xref>], hsa-mir-2110 [<xref ref-type="bibr" rid="R567">567</xref>],</styled-content> hsa-mir-3615 [<xref ref-type="bibr" rid="R568">568</xref>], hsa-mir-1825 [<xref ref-type="bibr" rid="R569">569</xref>], STAT3 [<xref ref-type="bibr" rid="R570">570</xref>], KLF5 [<xref ref-type="bibr" rid="R571">571</xref>], SREBF2 [<xref ref-type="bibr" rid="R572">572</xref>], E2F6 [<xref ref-type="bibr" rid="R573">573</xref>], GATA3 [<xref ref-type="bibr" rid="R574">574</xref>] and USF1 [<xref ref-type="bibr" rid="R575">575</xref>] have been shown to be activated in cardiovascular diseases. hsa-mir-3615 [<xref ref-type="bibr" rid="R576">576</xref>], hsa-mir-1825 [<xref ref-type="bibr" rid="R577">577</xref>], STAT3 [<xref ref-type="bibr" rid="R578">578</xref>], KLF5 [<xref ref-type="bibr" rid="R579">579</xref>], SREBF2 [<xref ref-type="bibr" rid="R580">580</xref>], GATA3 [Huda et al. 2018] and USF1 [Meex et al. 2008] were identified to be closely associated in patients with diabetes mellitus. PABPC1, RXRA (retinoid X receptor alpha), hsa-mir-3668, MAX (myc-associated factor X), POU2F2 and ARID3A were might be the novel biomarkers for COVID-19 infection and its associated complications.</p>
<p id="P23">In conclusion, the current investigation provided a comprehensive bioinformatics analysis of DEGs in COVID-19 infection. Analysis of these genes provided information regarding the molecular mechanisms of COVID-19 infection and its associated complications, and significant biomarkers or targets for the diagnosis and treatment of COVID-19 infection and its associated complications. However, further molecular biological experiments are required to confirm the function of the DEGs and pathways in COVID-19 infection and its associated complications.</p>
</sec>
<sec sec-type="supplementary-material" id="SM">
<title>Supplementary Material</title>
<supplementary-material content-type="local-data" id="SD1">
<label>Tables</label>
<media xlink:href="EMS135767-supplement-Tables.docx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.wordprocessingml.document" id="N68864" position="anchor"/>
</supplementary-material>
</sec>
</body>
<back>
<ack id="S18">
<title>Acknowledgement</title>
<p>I thank Charles Langelier, University of California San Francisco, Medicine, San Francisco, CA, USA, very much, the author who deposited their profiling by high throughput sequencing dataset GSE156063, into the public GEO database.</p>
</ack>
<sec id="S19" sec-type="data-availability">
<title>Availability of data and materials</title>
<p id="P24">The datasets supporting the conclusions of this article are available in the GEO (Gene Expression Omnibus) (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/">https://www.ncbi.nlm.nih.gov/geo/</ext-link>) repository. [(GSE156063) <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE156063">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE156063</ext-link>)]</p>
</sec>
<fn-group>
<fn id="FN1" fn-type="conflict">
<p id="P25">
<bold>Conflict of interest</bold>
</p>
<p id="P26">The authors declare that they have no conflict of interest.</p>
</fn>
<fn id="FN2">
<p id="P27">
<bold>Ethical approval</bold>
</p>
<p id="P28">This article does not contain any studies with human participants or animals performed by any of the authors.</p>
</fn>
<fn id="FN3">
<p id="P29">
<bold>Informed consent</bold>
</p>
<p id="P30">No informed consent because this study does not contain human or animals participants.</p>
</fn>
<fn id="FN4">
<p id="P31">
<bold>Consent for publication</bold>
</p>
<p id="P32">Not applicable.</p>
</fn>
<fn id="FN5" fn-type="conflict">
<p id="P33">
<bold>Competing interests</bold>
</p>
<p id="P34">The authors declare that they have no competing interests.</p>
</fn>
<fn id="FN6" fn-type="con">
<p id="P35">
<bold>Author Contributions</bold>
</p>
<p id="P36">B. V. - Writing original draft, and review and editing</p>
<p id="P37">C. V. - Software and investigation</p>
</fn>
</fn-group>
<ref-list>
<ref id="R1">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Habas</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Nganwuchu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Shahzad</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Gopalan</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Haque</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rahman</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Majumder</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Nasim</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Resolution of coronavirus disease 2019 (COVID-19)</article-title>
<source>Expert Rev Anti Infect Ther</source>
<year>2020</year>
<volume>18</volume>
<issue>12</issue>
<fpage>1201</fpage>
<lpage>1211</lpage>
<pub-id pub-id-type="doi">10.1080/14787210.2020.1797487</pub-id>
</element-citation>
</ref>
<ref id="R2">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Muniyappa</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Gubbi</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>COVID-19 pandemic, coronaviruses, and diabetes mellitus</article-title>
<source>Am J Physiol Endocrinol Metab</source>
<year>2020</year>
<volume>318</volume>
<issue>5</issue>
<fpage>E736</fpage>
<lpage>E741</lpage>
<pub-id pub-id-type="doi">10.1152/ajpendo.00124.2020</pub-id>
</element-citation>
</ref>
<ref id="R3">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bansal</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Cardiovascular disease and COVID-19</article-title>
<source>Diabetes Metab Syndr</source>
<year>2020</year>
<volume>14</volume>
<issue>3</issue>
<fpage>247</fpage>
<lpage>250</lpage>
<pub-id pub-id-type="doi">10.1016/j.dsx.2020.03.013</pub-id>
</element-citation>
</ref>
<ref id="R4">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yachou</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>El Idrissi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Belapasov</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Ait Benali</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients</article-title>
<source>Neurol Sci</source>
<year>2020</year>
<volume>41</volume>
<issue>10</issue>
<fpage>2657</fpage>
<lpage>2669</lpage>
<pub-id pub-id-type="doi">10.1007/s10072-020-04575-3</pub-id>
</element-citation>
</ref>
<ref id="R5">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ronco</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Reis</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Husain-Syed</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Management of acute kidney injury in patients with COVID-19</article-title>
<source>Lancet Respir Med</source>
<year>2020</year>
<volume>8</volume>
<issue>7</issue>
<fpage>738</fpage>
<lpage>742</lpage>
<pub-id pub-id-type="doi">10.1016/S2213-2600(20)30229-0</pub-id>
</element-citation>
</ref>
<ref id="R6">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Majumder</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Minko</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Recent Developments on Therapeutic and Diagnostic Approaches for COVID-19</article-title>
<source>AAPS J</source>
<year>2021</year>
<volume>23</volume>
<issue>1</issue>
<fpage>14</fpage>
<pub-id pub-id-type="doi">10.1208/s12248-020-00532-2</pub-id>
</element-citation>
</ref>
<ref id="R7">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sreepadmanabh</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sahu</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Chande</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>COVID-19: Advances in diagnostic tools, treatment strategies, and vaccine development</article-title>
<source>J Biosci</source>
<year>2020</year>
<volume>45</volume>
<issue>1</issue>
<fpage>148</fpage>
<pub-id pub-id-type="doi">10.1007/s12038-020-00114-6</pub-id>
</element-citation>
</ref>
<ref id="R8">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pinto</surname>
<given-names>BGG</given-names>
</name>
<name>
<surname>Oliveira</surname>
<given-names>AER</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Jimenez</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Gonçalves</surname>
<given-names>ANA</given-names>
</name>
<name>
<surname>Ogava</surname>
<given-names>RLT</given-names>
</name>
<name>
<surname>Creighton</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Schatzmann Peron</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Nakaya</surname>
<given-names>HI</given-names>
</name>
</person-group>
<article-title>ACE2 Expression Is Increased in the Lungs of Patients With Comorbidities Associated With Severe COVID-19</article-title>
<source>J Infect Dis</source>
<year>2020</year>
<volume>222</volume>
<issue>4</issue>
<fpage>556</fpage>
<lpage>563</lpage>
<pub-id pub-id-type="doi">10.1093/infdis/jiaa332</pub-id>
</element-citation>
</ref>
<ref id="R9">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pal</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Bhansali</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>COVID-19, diabetes mellitus and ACE2: The conundrum</article-title>
<source>Diabetes Res Clin Pract</source>
<year>2020</year>
<volume>162</volume>
<elocation-id>108132</elocation-id>
<pub-id pub-id-type="doi">10.1016/j.diabres.2020.108132</pub-id>
</element-citation>
</ref>
<ref id="R10">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhai</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Duan</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>The role of SARS-CoV-2 target ACE2 in cardiovascular diseases</article-title>
<source>J Cell Mol Med</source>
<year>2021</year>
<volume>25</volume>
<issue>3</issue>
<fpage>1342</fpage>
<lpage>1349</lpage>
<pub-id pub-id-type="doi">10.1111/jcmm.16239</pub-id>
</element-citation>
</ref>
<ref id="R11">
<label>11</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Motaghinejad</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gholami</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Possible Neurological and Mental Outcomes of COVID-19 Infection: A Hypothetical Role of ACE-2\Mas\BDNF Signaling Pathway</article-title>
<source>Int J Prev Med</source>
<year>2020</year>
<volume>11</volume>
<fpage>84</fpage>
<pub-id pub-id-type="doi">10.4103/ijpvm.IJPVM_114_20</pub-id>
</element-citation>
</ref>
<ref id="R12">
<label>12</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lores</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Wysocki</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Batlle</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>ACE2, the kidney and the emergence of COVID-19 two decades after ACE2 discovery</article-title>
<source>Clin Sci (Lond)</source>
<year>2020</year>
<volume>134</volume>
<issue>21</issue>
<fpage>2791</fpage>
<lpage>2805</lpage>
<pub-id pub-id-type="doi">10.1042/CS20200484</pub-id>
</element-citation>
</ref>
<ref id="R13">
<label>13</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Strope</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>PharmD</surname>
<given-names>CHC</given-names>
</name>
<name>
<surname>Figg</surname>
<given-names>WD</given-names>
</name>
</person-group>
<article-title>TMPRSS2: Potential Biomarker for COVID-19 Outcomes</article-title>
<source>J Clin Pharmacol</source>
<year>2020</year>
<volume>60</volume>
<issue>7</issue>
<fpage>801</fpage>
<lpage>807</lpage>
<pub-id pub-id-type="doi">10.1002/jcph.1641</pub-id>
</element-citation>
</ref>
<ref id="R14">
<label>14</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumar</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Faiq</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Pareek</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Raza</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Narayan</surname>
<given-names>RK</given-names>
</name>
<name>
<surname>Prasoon</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Kulandhasamy</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kumari</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kant</surname>
<given-names>K</given-names>
</name>
<etal/>
</person-group>
<article-title>Relevance of SARS-CoV-2 related factors ACE2 and TMPRSS2 expressions in gastrointestinal tissue with pathogenesis of digestive symptoms, diabetes-associated mortality, and disease recurrence in COVID-19 patients</article-title>
<source>Med Hypotheses</source>
<year>2020</year>
<volume>144</volume>
<elocation-id>110271</elocation-id>
<pub-id pub-id-type="doi">10.1016/j.mehy.2020.110271</pub-id>
</element-citation>
</ref>
<ref id="R15">
<label>15</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qiao</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Bao</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Wen</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>The expression of SARS-CoV-2 receptor ACE2 and CD147, and protease TMPRSS2 in human and mouse brain cells and mouse brain tissues</article-title>
<source>Biochem Biophys Res Commun</source>
<year>2020</year>
<volume>533</volume>
<issue>4</issue>
<fpage>867</fpage>
<lpage>871</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbrc.2020.09.042</pub-id>
</element-citation>
</ref>
<ref id="R16">
<label>16</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vankadari</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Wilce</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26</article-title>
<source>Emerg Microbes Infect</source>
<year>2020</year>
<volume>9</volume>
<issue>1</issue>
<fpage>601</fpage>
<lpage>604</lpage>
<pub-id pub-id-type="doi">10.1080/22221751.2020.1739565</pub-id>
</element-citation>
</ref>
<ref id="R17">
<label>17</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ahmed</surname>
<given-names>RH</given-names>
</name>
<name>
<surname>Huri</surname>
<given-names>HZ</given-names>
</name>
<name>
<surname>Al-Hamodi</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Salem</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>Muniandy</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Serum Levels of Soluble CD26/Dipeptidyl Peptidase-IV in Type 2 Diabetes Mellitus and Its Association with Metabolic Syndrome and Therapy with Antidiabetic Agents in Malaysian Subjects</article-title>
<source>PLoS One</source>
<year>2015</year>
<volume>10</volume>
<issue>10</issue>
<elocation-id>e0140618</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0140618</pub-id>
</element-citation>
</ref>
<ref id="R18">
<label>18</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Du</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Shang</surname>
<given-names>G</given-names>
</name>
<etal/>
</person-group>
<article-title>Urinary exosomal CD26 is associated with recovery from acute kidney injury in intensive care units: a prospective cohort study</article-title>
<source>Clin Chem Lab Med</source>
<year>2021</year>
<volume>59</volume>
<issue>9</issue>
<fpage>1535</fpage>
<lpage>1546</lpage>
<pub-id pub-id-type="doi">10.1515/cclm-2021-0040</pub-id>
</element-citation>
</ref>
<ref id="R19">
<label>19</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Romero-López</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Carnalla-Cortés</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pacheco-Olvera</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Ocampo-Godínez</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Oliva-Ramírez</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Moreno-Manjón</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bernal-Alferes</surname>
<given-names>B</given-names>
</name>
<name>
<surname>López-Olmedo</surname>
<given-names>N</given-names>
</name>
<name>
<surname>García-Latorre</surname>
<given-names>E</given-names>
</name>
<etal/>
</person-group>
<article-title>A bioinformatic prediction of antigen presentation from SARS-CoV-2 spike protein revealed a theoretical correlation of HLA-DRB1*01 with COVID-19 fatality in Mexican population: An ecological approach</article-title>
<source>J Med Virol</source>
<year>2021</year>
<volume>93</volume>
<issue>4</issue>
<fpage>2029</fpage>
<lpage>2038</lpage>
<pub-id pub-id-type="doi">10.1002/jmv.26561</pub-id>
</element-citation>
</ref>
<ref id="R20">
<label>20</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Al-Daghri</surname>
<given-names>NM</given-names>
</name>
<name>
<surname>Al-Attas</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Alokail</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Alkharfy</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Draz</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Agliardi</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Mohammed</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Guerini</surname>
<given-names>FR</given-names>
</name>
<name>
<surname>Clerici</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Vitamin D receptor gene polymorphisms and HLA DRB1*04 cosegregation in Saudi type 2 diabetes patients</article-title>
<source>J Immunol</source>
<year>2012</year>
<volume>188</volume>
<issue>3</issue>
<fpage>1325</fpage>
<lpage>1332</lpage>
<pub-id pub-id-type="doi">10.4049/jimmunol.1101954</pub-id>
</element-citation>
</ref>
<ref id="R21">
<label>21</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sreekanth</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Esdan Basha</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Arun Kumar</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Govindaraju</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Pradeep Nayar</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Pitchappan</surname>
<given-names>RM</given-names>
</name>
</person-group>
<article-title>Association of IL-1β +3953 C and HLA-DRB1*15 with Coronary Artery and Rheumatic Heart Diseases in South India</article-title>
<source>Hum Immunol</source>
<year>2016</year>
<volume>77</volume>
<issue>12</issue>
<fpage>1275</fpage>
<lpage>1279</lpage>
<pub-id pub-id-type="doi">10.1016/j.humimm.2016.08.003</pub-id>
</element-citation>
</ref>
<ref id="R22">
<label>22</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sonon</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Brito Ferreira</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Santos Almeida</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Saloum Deghaide</surname>
<given-names>NH</given-names>
</name>
<name>
<surname>Henrique Willcox</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Guimarães</surname>
<given-names>EL</given-names>
</name>
<name>
<surname>da Purificação Júnior</surname>
<given-names>AF</given-names>
</name>
<name>
<surname>Cordeiro</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Antunes de Brito</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>de Albuquerque</surname>
<given-names>MFM</given-names>
</name>
<etal/>
</person-group>
<article-title>Differential Frequencies of HLA-DRB1, DQA1, and DQB1 Alleles and Haplotypes Are Observed in the Arbovirus-Related Neurological Syndromes</article-title>
<source>J Infect Dis</source>
<year>2021</year>
<volume>224</volume>
<issue>3</issue>
<fpage>517</fpage>
<lpage>525</lpage>
<pub-id pub-id-type="doi">10.1093/infdis/jiaa764</pub-id>
</element-citation>
</ref>
<ref id="R23">
<label>23</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shaheen</surname>
<given-names>NM</given-names>
</name>
<name>
<surname>Soliman</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>El-Khashab</surname>
<given-names>SO</given-names>
</name>
<name>
<surname>Hanna</surname>
<given-names>MO</given-names>
</name>
</person-group>
<article-title>HLA DRB1 alleles and hepatitis C virus infection in chronic kidney disease patients</article-title>
<source>Ren Fail</source>
<year>2013</year>
<volume>35</volume>
<issue>3</issue>
<fpage>386</fpage>
<lpage>390</lpage>
<pub-id pub-id-type="doi">10.3109/0886022X.2012.761038</pub-id>
</element-citation>
</ref>
<ref id="R24">
<label>24</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xia</surname>
<given-names>QD</given-names>
</name>
<name>
<surname>Xun</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>YC</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>YY</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>SG</given-names>
</name>
<etal/>
</person-group>
<article-title>Network pharmacology and molecular docking analyses on Lianhua Qingwen capsule indicate Akt1 is a potential target to treat and prevent COVID-19</article-title>
<source>Cell Prolif</source>
<year>2020</year>
<volume>53</volume>
<issue>12</issue>
<elocation-id>e12949</elocation-id>
<pub-id pub-id-type="doi">10.1111/cpr.12949</pub-id>
</element-citation>
</ref>
<ref id="R25">
<label>25</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chong</surname>
<given-names>ZZ</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Shang</surname>
<given-names>YC</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Maiese</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>EPO relies upon novel signaling of Wnt1 that requires Akt1, FoxO3a, GSK-3β, and β-catenin to foster vascular integrity during experimental diabetes</article-title>
<source>Curr Neurovasc Res</source>
<year>2011</year>
<volume>8</volume>
<issue>2</issue>
<fpage>103</fpage>
<lpage>120</lpage>
<pub-id pub-id-type="doi">10.2174/156720211795495402</pub-id>
</element-citation>
</ref>
<ref id="R26">
<label>26</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fernández-Hernando</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ackah</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Suárez</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Murata</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Iwakiri</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Prendergast</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Miao</surname>
<given-names>RQ</given-names>
</name>
<name>
<surname>Birnbaum</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Sessa</surname>
<given-names>WC</given-names>
</name>
</person-group>
<article-title>Loss of Akt1 leads to severe atherosclerosis and occlusive coronary artery disease</article-title>
<source>Cell Metab</source>
<year>2007</year>
<volume>6</volume>
<issue>6</issue>
<fpage>446</fpage>
<lpage>457</lpage>
<pub-id pub-id-type="doi">10.1016/j.cmet.2007.10.007</pub-id>
</element-citation>
</ref>
<ref id="R27">
<label>27</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tao</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Duan</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Puerarin attenuates locomotor and cognitive deficits as well as hippocampal neuronal injury through the PI3K/Akt1/GSK-3β signaling pathway in an in vivo model of cerebral ischemia</article-title>
<source>Oncotarget</source>
<year>2017</year>
<volume>8</volume>
<issue>63</issue>
<fpage>106283</fpage>
<lpage>106295</lpage>
<pub-id pub-id-type="doi">10.18632/oncotarget.22290</pub-id>
</element-citation>
</ref>
<ref id="R28">
<label>28</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>IY</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>YK</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Seong</surname>
<given-names>EY</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Bae</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>SB</given-names>
</name>
</person-group>
<article-title>Role of Akt1 in renal fibrosis and tubular dedifferentiation during the progression of acute kidney injury to chronic kidney disease</article-title>
<source>Korean J Intern Med</source>
<year>2021</year>
<volume>36</volume>
<issue>4</issue>
<fpage>962</fpage>
<lpage>974</lpage>
<pub-id pub-id-type="doi">10.3904/kjim.2020.198</pub-id>
</element-citation>
</ref>
<ref id="R29">
<label>29</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yeleswaram</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Burn</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Covington</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Juvekar</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Squier</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Langmuir</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Inhibition of cytokine signaling by ruxolitinib and implications for COVID-19 treatment</article-title>
<source>Clin Immunol</source>
<year>2020</year>
<volume>218</volume>
<elocation-id>108517</elocation-id>
<pub-id pub-id-type="doi">10.1016/j.clim.2020.108517</pub-id>
</element-citation>
</ref>
<ref id="R30">
<label>30</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Niemi</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Filous</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>DeFrancesco</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lindborg</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Malhotra</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>GN</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Crish</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>Zigmond</surname>
<given-names>RE</given-names>
</name>
</person-group>
<article-title>Injury-induced gp130 cytokine signaling in peripheral ganglia is reduced in diabetes mellitus</article-title>
<source>Exp Neurol</source>
<year>2017</year>
<volume>296</volume>
<fpage>1</fpage>
<lpage>15</lpage>
<pub-id pub-id-type="doi">10.1016/j.expneurol.2017.06.020</pub-id>
</element-citation>
</ref>
<ref id="R31">
<label>31</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wesoly</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sikorski</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>CK</given-names>
</name>
<name>
<surname>Bluyssen</surname>
<given-names>HA</given-names>
</name>
</person-group>
<article-title>Suppressor of cytokine signaling and accelerated atherosclerosis in kidney disease</article-title>
<source>Acta Biochim Pol</source>
<year>2010</year>
<volume>57</volume>
<issue>3</issue>
<fpage>251</fpage>
<lpage>260</lpage>
</element-citation>
</ref>
<ref id="R32">
<label>32</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sallenave</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Guillot</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Innate Immune Signaling and Proteolytic Pathways in the Resolution or Exacerbation of SARS-CoV-2 in Covid-19: Key Therapeutic Targets?</article-title>
<source>Front Immunol</source>
<year>2020</year>
<volume>11</volume>
<elocation-id>1229</elocation-id>
<pub-id pub-id-type="doi">10.3389/fimmu.2020.01229</pub-id>
</element-citation>
</ref>
<ref id="R33">
<label>33</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pino</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Kruger</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Bortell</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>The role of innate immune pathways in type 1 diabetes pathogenesis</article-title>
<source>Curr Opin Endocrinol Diabetes Obes</source>
<year>2010</year>
<volume>17</volume>
<issue>2</issue>
<fpage>126</fpage>
<lpage>130</lpage>
<pub-id pub-id-type="doi">10.1097/MED.0b013e3283372819</pub-id>
</element-citation>
</ref>
<ref id="R34">
<label>34</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>PP</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Innate Immune Signaling and Its Role in Metabolic and Cardiovascular Diseases</article-title>
<source>Physiol Rev</source>
<year>2019</year>
<volume>99</volume>
<issue>1</issue>
<fpage>893</fpage>
<lpage>948</lpage>
<pub-id pub-id-type="doi">10.1152/physrev.00065.2017</pub-id>
</element-citation>
</ref>
<ref id="R35">
<label>35</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tseng</surname>
<given-names>WC</given-names>
</name>
<name>
<surname>Reinhart</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Lanz</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Weber</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Pang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Le</surname>
<given-names>KXV</given-names>
</name>
<name>
<surname>Bell</surname>
<given-names>RD</given-names>
</name>
<name>
<surname>O'Donnell</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Buhl</surname>
<given-names>DL</given-names>
</name>
</person-group>
<article-title>Schizophrenia-associated SLC39A8 polymorphism is a loss-of-function allele altering glutamate receptor and innate immune signaling</article-title>
<source>Transl Psychiatry</source>
<year>2021</year>
<volume>11</volume>
<issue>1</issue>
<fpage>136</fpage>
<pub-id pub-id-type="doi">10.1038/s41398-021-01262-5</pub-id>
</element-citation>
</ref>
<ref id="R36">
<label>36</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Gong</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>Circulating Mitochondrial DNA Stimulates Innate Immune Signaling Pathways to Mediate Acute Kidney Injury</article-title>
<source>Front Immunol</source>
<year>2021</year>
<volume>12</volume>
<elocation-id>680648</elocation-id>
<pub-id pub-id-type="doi">10.3389/fimmu.2021.680648</pub-id>
</element-citation>
</ref>
<ref id="R37">
<label>37</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luo</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>YX</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>LJ</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>DW</given-names>
</name>
</person-group>
<article-title>Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19</article-title>
<source>Trends Pharmacol Sci</source>
<year>2020</year>
<volume>41</volume>
<issue>8</issue>
<fpage>531</fpage>
<lpage>543</lpage>
<pub-id pub-id-type="doi">10.1016/j.tips.2020.06.007</pub-id>
</element-citation>
</ref>
<ref id="R38">
<label>38</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gurzov</surname>
<given-names>EN</given-names>
</name>
<name>
<surname>Stanley</surname>
<given-names>WJ</given-names>
</name>
<name>
<surname>Pappas</surname>
<given-names>EG</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>HE</given-names>
</name>
<name>
<surname>Gough</surname>
<given-names>DJ</given-names>
</name>
</person-group>
<article-title>The JAK/STAT pathway in obesity and diabetes</article-title>
<source>FEBS J</source>
<year>2016</year>
<volume>283</volume>
<issue>16</issue>
<fpage>3002</fpage>
<lpage>3015</lpage>
<pub-id pub-id-type="doi">10.1111/febs.13709</pub-id>
</element-citation>
</ref>
<ref id="R39">
<label>39</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Goldstein</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ge</surname>
<given-names>J</given-names>
</name>
<name>
<surname>He</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Fei</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Ruiz</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Role of the JAK/STAT signaling pathway in the pathogenesis of acute myocardial infarction in rats and its effect on NF-κB expression</article-title>
<source>Mol Med Rep</source>
<year>2013</year>
<volume>7</volume>
<issue>1</issue>
<fpage>93</fpage>
<lpage>98</lpage>
<pub-id pub-id-type="doi">10.3892/mmr.2012.1159</pub-id>
</element-citation>
</ref>
<ref id="R40">
<label>40</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yan</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Gibson</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Buckley</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Benveniste</surname>
<given-names>EN</given-names>
</name>
</person-group>
<article-title>Role of the JAK/STAT signaling pathway in regulation of innate immunity in neuroinflammatory diseases</article-title>
<source>Clin Immunol</source>
<year>2018</year>
<volume>189</volume>
<fpage>4</fpage>
<lpage>13</lpage>
<pub-id pub-id-type="doi">10.1016/j.clim.2016.09.014</pub-id>
</element-citation>
</ref>
<ref id="R41">
<label>41</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>R</given-names>
</name>
<etal/>
</person-group>
<article-title>JAK/STAT pathway promotes the progression of diabetic kidney disease via autophagy in podocytes</article-title>
<source>Eur J Pharmacol</source>
<year>2021</year>
<volume>902</volume>
<elocation-id>174121</elocation-id>
<pub-id pub-id-type="doi">10.1016/j.ejphar.2021.174121</pub-id>
</element-citation>
</ref>
<ref id="R42">
<label>42</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Lv</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lv</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>
<article-title>Mucus production stimulated by IFN-AhR signaling triggers hypoxia of COVID-19</article-title>
<source>Cell Res</source>
<year>2020</year>
<volume>30</volume>
<issue>12</issue>
<fpage>1078</fpage>
<lpage>1087</lpage>
<pub-id pub-id-type="doi">10.1038/s41422-020-00435-z</pub-id>
</element-citation>
</ref>
<ref id="R43">
<label>43</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berthelot</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Drouet</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Lioté</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Kawasaki-like diseases and thrombotic coagulopathy in COVID-19: delayed over-activation of the STING pathway?</article-title>
<source>Emerg Microbes Infect</source>
<year>2020</year>
<volume>9</volume>
<issue>1</issue>
<fpage>1514</fpage>
<lpage>1522</lpage>
<pub-id pub-id-type="doi">10.1080/22221751.2020.1785336</pub-id>
</element-citation>
</ref>
<ref id="R44">
<label>44</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chung</surname>
<given-names>KW</given-names>
</name>
<name>
<surname>Dhillon</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sheng</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Shrestha</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kaufman</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Pei</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Baur</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>
<article-title>Mitochondrial Damage and Activation of the STING Pathway Lead to Renal Inflammation and Fibrosis</article-title>
<source>Cell Metab</source>
<year>2019</year>
<volume>30</volume>
<issue>4</issue>
<fpage>784</fpage>
<lpage>799</lpage>
<elocation-id>e5</elocation-id>
<pub-id pub-id-type="doi">10.1016/j.cmet.2019.08.003</pub-id>
</element-citation>
</ref>
<ref id="R45">
<label>45</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schultheiß</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Paschold</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Simnica</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Mohme</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Willscher</surname>
<given-names>E</given-names>
</name>
<name>
<surname>von Wenserski</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Scholz</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Wieters</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Dahlke</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Tolosa</surname>
<given-names>E</given-names>
</name>
<etal/>
</person-group>
<article-title>Next-Generation Sequencing of T and B Cell Receptor Repertoires from COVID-19 Patients Showed Signatures Associated with Severity of Disease</article-title>
<source>Immunity</source>
<year>2020</year>
<volume>53</volume>
<issue>2</issue>
<fpage>442</fpage>
<lpage>455</lpage>
<elocation-id>e4</elocation-id>
<pub-id pub-id-type="doi">10.1016/j.immuni.2020.06.024</pub-id>
</element-citation>
</ref>
<ref id="R46">
<label>46</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mick</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Kamm</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Pisco</surname>
<given-names>AO</given-names>
</name>
<name>
<surname>Ratnasiri</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Babik</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Castañeda</surname>
<given-names>G</given-names>
</name>
<name>
<surname>DeRisi</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Detweiler</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Hao</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Kangelaris</surname>
<given-names>KN</given-names>
</name>
<etal/>
</person-group>
<article-title>Upper airway gene expression reveals suppressed immune responses to SARS-CoV-2 compared with other respiratory viruses</article-title>
<source>Nat Commun</source>
<year>2020</year>
<volume>11</volume>
<issue>1</issue>
<elocation-id>5854</elocation-id>
<pub-id pub-id-type="doi">10.1038/s41467-020-19587-y</pub-id>
</element-citation>
</ref>
<ref id="R47">
<label>47</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clough</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Barrett</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>The Gene Expression Omnibus Database</article-title>
<source>Methods Mol Biol</source>
<year>2016</year>
<volume>1418</volume>
<fpage>93</fpage>
<lpage>110</lpage>
<pub-id pub-id-type="doi">10.1007/978-1-4939-3578-9_5</pub-id>
</element-citation>
</ref>
<ref id="R48">
<label>48</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ritchie</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Phipson</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Law</surname>
<given-names>CW</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Smyth</surname>
<given-names>GK</given-names>
</name>
</person-group>
<article-title>limma powers differential expression analyses for RNA-sequencing and microarray studies</article-title>
<source>Nucleic Acids Res</source>
<year>2015</year>
<volume>43</volume>
<issue>7</issue>
<elocation-id>e47</elocation-id>
<pub-id pub-id-type="doi">10.1093/nar/gkv007</pub-id>
</element-citation>
</ref>
<ref id="R49">
<label>49</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reiner</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Yekutieli</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Benjamini</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Identifying differentially expressed genes using false discovery rate controlling procedures</article-title>
<source>Bioinformatics</source>
<year>2003</year>
<volume>19</volume>
<issue>3</issue>
<fpage>368</fpage>
<lpage>375</lpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/btf877</pub-id>
</element-citation>
</ref>
<ref id="R50">
<label>50</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reimand</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kull</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Peterson</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Hansen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Vilo</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>g:Profiler--a web-based toolset for functional profiling of gene lists from large-scale experiments</article-title>
<source>Nucleic Acids Res</source>
<year>2007</year>
<volume>35</volume>
<issue>Web Server issue</issue>
<fpage>W193</fpage>
<lpage>W200</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkm226</pub-id>
</element-citation>
</ref>
<ref id="R51">
<label>51</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thomas</surname>
<given-names>PD</given-names>
</name>
</person-group>
<article-title>The Gene Ontology and the Meaning of Biological Function</article-title>
<source>Methods Mol Biol</source>
<year>2017</year>
<volume>1446</volume>
<elocation-id>15L24</elocation-id>
<pub-id pub-id-type="doi">10.1007/978-1-4939-3743-1_2</pub-id>
</element-citation>
</ref>
<ref id="R52">
<label>52</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fabregat</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Jupe</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Matthews</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Sidiropoulos</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Gillespie</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Garapati</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Haw</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Jassal</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Korninger</surname>
<given-names>F</given-names>
</name>
<name>
<surname>May</surname>
<given-names>B</given-names>
</name>
<etal/>
</person-group>
<article-title>The Reactome Pathway Knowledgebase</article-title>
<source>Nucleic Acids Res</source>
<year>2018</year>
<volume>46</volume>
<issue>D1</issue>
<fpage>D649</fpage>
<lpage>D655</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkx1132</pub-id>
</element-citation>
</ref>
<ref id="R53">
<label>53</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Orchard</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kerrien</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Abbani</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Aranda</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Bhate</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bidwell</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bridge</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Briganti</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Brinkman</surname>
<given-names>FS</given-names>
</name>
<name>
<surname>Cesareni</surname>
<given-names>G</given-names>
</name>
<etal/>
</person-group>
<article-title>Protein interaction data curation: the International Molecular Exchange (IMEx) consortium</article-title>
<source>Nat Methods</source>
<year>2012</year>
<volume>9</volume>
<issue>4</issue>
<fpage>345</fpage>
<lpage>350</lpage>
<pub-id pub-id-type="doi">10.1038/nmeth.1931</pub-id>
</element-citation>
</ref>
<ref id="R54">
<label>54</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shannon</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Markiel</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ozier</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Baliga</surname>
<given-names>NS</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Ramage</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Amin</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Schwikowski</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Ideker</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Cytoscape: a software environment for integrated models of biomolecular interaction networks</article-title>
<source>Genome Res</source>
<year>2003</year>
<volume>13</volume>
<issue>11</issue>
<fpage>2498</fpage>
<lpage>2504</lpage>
<pub-id pub-id-type="doi">10.1101/gr.1239303</pub-id>
</element-citation>
</ref>
<ref id="R55">
<label>55</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Assenov</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ramírez</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Schelhorn</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Lengauer</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Albrecht</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Computing topological parameters of biological networks</article-title>
<source>Bioinformatics</source>
<year>2008</year>
<volume>24</volume>
<issue>2</issue>
<fpage>282</fpage>
<lpage>284</lpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/btm554</pub-id>
</element-citation>
</ref>
<ref id="R56">
<label>56</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Przulj</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Wigle</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Jurisica</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>Functional topology in a network of protein interactions</article-title>
<source>Bioinformatics</source>
<year>2004</year>
<volume>20</volume>
<issue>3</issue>
<fpage>340</fpage>
<lpage>348</lpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/btg415</pub-id>
</element-citation>
</ref>
<ref id="R57">
<label>57</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nguyen</surname>
<given-names>TP</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>WC</given-names>
</name>
<name>
<surname>Jordán</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Inferring pleiotropy by network analysis: linked diseases in the human PPI network</article-title>
<source>BMC Syst Biol</source>
<year>2011</year>
<volume>5</volume>
<fpage>179</fpage>
<pub-id pub-id-type="doi">10.1186/1752-0509-5-179</pub-id>
</element-citation>
</ref>
<ref id="R58">
<label>58</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Fast network centrality analysis using GPUs</article-title>
<source>BMC Bioinformatics</source>
<year>2011</year>
<volume>12</volume>
<fpage>149</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2105-12-149</pub-id>
</element-citation>
</ref>
<ref id="R59">
<label>59</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fadhal</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Gamieldien</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Mwambene</surname>
<given-names>EC</given-names>
</name>
</person-group>
<article-title>Protein interaction networks as metric spaces: a novel perspective on distribution of hubs</article-title>
<source>BMC Syst Biol</source>
<year>2014</year>
<volume>8</volume>
<fpage>6</fpage>
<pub-id pub-id-type="doi">10.1186/1752-0509-8-6</pub-id>
</element-citation>
</ref>
<ref id="R60">
<label>60</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zaki</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Efimov</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Berengueres</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Protein complex detection using interaction reliability assessment and weighted clustering coefficient</article-title>
<source>BMC Bioinformatics</source>
<year>2013</year>
<volume>14</volume>
<fpage>163</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2105-14</pub-id>
</element-citation>
</ref>
<ref id="R61">
<label>61</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fan</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>miRNet-Functional Analysis and Visual Exploration of miRNA-Target Interactions in a Network Context</article-title>
<source>Methods Mol Biol</source>
<year>2018</year>
<volume>1819</volume>
<fpage>215</fpage>
<lpage>233</lpage>
<pub-id pub-id-type="doi">10.1007/978-1-4939-8618-7_10</pub-id>
</element-citation>
</ref>
<ref id="R62">
<label>62</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Soufan</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Ewald</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hancock</surname>
<given-names>REW</given-names>
</name>
<name>
<surname>Basu</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis</article-title>
<source>Nucleic Acids Res</source>
<year>2019</year>
<volume>47</volume>
<fpage>W234</fpage>
<lpage>W241</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkz240</pub-id>
</element-citation>
</ref>
<ref id="R63">
<label>63</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Robin</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Turck</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Hainard</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Tiberti</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Lisacek</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Sanchez</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Müller</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>pROC: an open-source package for R and S+ to analyze and compare ROC curves</article-title>
<source>BMC Bioinformatics</source>
<year>2011</year>
<volume>12</volume>
<fpage>77</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2105-12-77</pub-id>
</element-citation>
</ref>
<ref id="R64">
<label>64</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Callahan</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Hawks</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Crawford</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Lehman</surname>
<given-names>CW</given-names>
</name>
<name>
<surname>Morrison</surname>
<given-names>HA</given-names>
</name>
<name>
<surname>Ivester</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Akhrymuk</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Boghdeh</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Flor</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Finkielstein</surname>
<given-names>CV</given-names>
</name>
<etal/>
</person-group>
<article-title>The Pro-Inflammatory Chemokines CXCL9, CXCL10 and CXCL11 Are Upregulated Following SARS-CoV-2 Infection in an AKT-Dependent Manner</article-title>
<source>Viruses</source>
<year>2021</year>
<volume>13</volume>
<issue>6</issue>
<elocation-id>1062</elocation-id>
<pub-id pub-id-type="doi">10.3390/v13061062</pub-id>
</element-citation>
</ref>
<ref id="R65">
<label>65</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oliviero</surname>
<given-names>A</given-names>
</name>
<name>
<surname>de Castro</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Coperchini</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Chiovato</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Rotondi</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>COVID-19 Pulmonary and Olfactory Dysfunctions: Is the Chemokine CXCL10 the Common Denominator?</article-title>
<source>Neuroscientist</source>
<year>2021</year>
<volume>27</volume>
<issue>3</issue>
<fpage>214</fpage>
<lpage>221</lpage>
<pub-id pub-id-type="doi">10.1177/1073858420939033</pub-id>
</element-citation>
</ref>
<ref id="R66">
<label>66</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Parker</surname>
<given-names>ZM</given-names>
</name>
<name>
<surname>Acharya</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Chiang</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>van Gent</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Riedl</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Davis-Gardner</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Wies</surname>
<given-names>E</given-names>
</name>
<etal/>
</person-group>
<article-title>ISG15-dependent activation of the sensor MDA5 is antagonized by the SARS-CoV-2 papain-like protease to evade host innate immunity</article-title>
<source>Nat Microbiol</source>
<year>2021</year>
<volume>6</volume>
<issue>4</issue>
<fpage>467</fpage>
<lpage>478</lpage>
<pub-id pub-id-type="doi">10.1038/s41564-021-00884-1</pub-id>
</element-citation>
</ref>
<ref id="R67">
<label>67</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Doehn</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Tabeling</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Biesen</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Saccomanno</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Madlung</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Pappe</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Gabriel</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Kurth</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Meisel</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Corman</surname>
<given-names>VM</given-names>
</name>
<etal/>
</person-group>
<article-title>CD169/SIGLEC1 is expressed on circulating monocytes in COVID-19 and expression levels are associated with disease severity</article-title>
<source>Infection</source>
<year>2021</year>
<volume>49</volume>
<issue>4</issue>
<fpage>757</fpage>
<lpage>762</lpage>
<pub-id pub-id-type="doi">10.1007/s15010-021-01606-9</pub-id>
</element-citation>
</ref>
<ref id="R68">
<label>68</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Antonelli</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ferrari</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Corrado</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ferrannini</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Fallahi</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>CXCR3, CXCL10 and type 1 diabetes</article-title>
<source>Cytokine Growth Factor Rev</source>
<year>2014</year>
<volume>25</volume>
<issue>1</issue>
<fpage>57</fpage>
<lpage>65</lpage>
<pub-id pub-id-type="doi">10.1016/j.cytogfr.2014.01.006</pub-id>
</element-citation>
</ref>
<ref id="R69">
<label>69</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tavakolian Ferdousie</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Mohammadi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hassanshahi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Khorramdelazad</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Khanamani Falahati-Pour</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Mirzaei</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Allah Tavakoli</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kamiab</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Ahmadi</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Vazirinejad</surname>
<given-names>R</given-names>
</name>
<etal/>
</person-group>
<article-title>Serum CXCL10 and CXCL12 chemokine levels are associated with the severity of coronary artery disease and coronary artery occlusion</article-title>
<source>Int J Cardiol</source>
<year>2017</year>
<volume>233</volume>
<fpage>23</fpage>
<lpage>28</lpage>
<pub-id pub-id-type="doi">10.1016/j.ijcard.2017.02.011</pub-id>
</element-citation>
</ref>
<ref id="R70">
<label>70</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rahnefeld</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Klingel</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Schuermann</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Diny</surname>
<given-names>NL</given-names>
</name>
<name>
<surname>Althof</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Lindner</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bleienheuft</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Savvatis</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Respondek</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Opitz</surname>
<given-names>E</given-names>
</name>
<etal/>
</person-group>
<article-title>Ubiquitin-like protein ISG15 (interferon-stimulated gene of 15 kDa) in host defense against heart failure in a mouse model of virus-induced cardiomyopathy</article-title>
<source>Circulation</source>
<year>2014</year>
<volume>130</volume>
<issue>18</issue>
<fpage>1589</fpage>
<lpage>1600</lpage>
<pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.114.009847</pub-id>
</element-citation>
</ref>
<ref id="R71">
<label>71</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clancy</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Halushka</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rasmussen</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Lhakhang</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Buyon</surname>
<given-names>JP</given-names>
</name>
</person-group>
<article-title>Siglec-1 Macrophages and the Contribution of IFN to the Development of Autoimmune Congenital Heart Block</article-title>
<source>J Immunol</source>
<year>2019</year>
<volume>202</volume>
<issue>1</issue>
<fpage>48</fpage>
<lpage>55</lpage>
<pub-id pub-id-type="doi">10.4049/jimmunol.1800357</pub-id>
</element-citation>
</ref>
<ref id="R72">
<label>72</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname>
<given-names>CF</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>ST</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>HL</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>SL</given-names>
</name>
</person-group>
<article-title>Potential Effects of CXCL9 and CCL20 on Cardiac Fibrosis in Patients with Myocardial Infarction and Isoproterenol-Treated Rats</article-title>
<source>J Clin Med</source>
<year>2019</year>
<volume>8</volume>
<issue>5</issue>
<fpage>659</fpage>
<pub-id pub-id-type="doi">10.3390/jcm8050659</pub-id>
</element-citation>
</ref>
<ref id="R73">
<label>73</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Shang</surname>
<given-names>X</given-names>
</name>
</person-group>
<article-title>Downregulation of IFIT3 relieves the inflammatory response and myocardial fibrosis of mice with myocardial infarction and improves their cardiac function</article-title>
<source>Exp Anim</source>
<year>2021</year>
<pub-id pub-id-type="doi">10.1538/expanim.21-0060</pub-id>
</element-citation>
</ref>
<ref id="R74">
<label>74</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haldar</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Jeyaraj</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Kawanami</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Eapen</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Hao</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Doughman</surname>
<given-names>YQ</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>
<article-title>Klf15 deficiency is a molecular link between heart failure and aortic aneurysm formation</article-title>
<source>Sci Transl Med</source>
<year>2010</year>
<volume>2</volume>
<issue>26</issue>
<elocation-id>26ra26</elocation-id>
<pub-id pub-id-type="doi">10.1126/scitranslmed.3000502</pub-id>
</element-citation>
</ref>
<ref id="R75">
<label>75</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lietman</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Segedy</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Fazio</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Atkinson</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Linton</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>PP</given-names>
</name>
</person-group>
<article-title>Loss of SPRR3 in ApoE-/- mice leads to atheroma vulnerability through Akt dependent and independent effects in VSMCs</article-title>
<source>PLoS One</source>
<year>2017</year>
<volume>12</volume>
<issue>9</issue>
<elocation-id>e0184620</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0184620</pub-id>
</element-citation>
</ref>
<ref id="R76">
<label>76</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sadeghian-Rizi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Behdani</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Khanahmad</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Sadeghi</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Jahanian-Najafabadi</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Generation and Characterization of a Functional Nanobody Against Inflammatory Chemokine CXCL10, as a Novel Strategy for the Treatment of Multiple Sclerosis</article-title>
<source>CNS Neurol Disord Drug Targets</source>
<year>2019</year>
<volume>18</volume>
<issue>2</issue>
<fpage>141</fpage>
<lpage>148</lpage>
<pub-id pub-id-type="doi">10.2174/1871527317666181114134518</pub-id>
</element-citation>
</ref>
<ref id="R77">
<label>77</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ostendorf</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Dittert</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Biesen</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Duchow</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Stiglbauer</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Ruprecht</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Bellmann-Strobl</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Seelow</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Stenzel</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Niesner</surname>
<given-names>RA</given-names>
</name>
<etal/>
</person-group>
<article-title>SIGLEC1 (CD169): a marker of active neuroinflammation in the brain but not in the blood of multiple sclerosis patients</article-title>
<source>Sci Rep</source>
<year>2021</year>
<volume>11</volume>
<issue>1</issue>
<elocation-id>10299</elocation-id>
<pub-id pub-id-type="doi">10.1038/s41598-021-89786-0</pub-id>
</element-citation>
</ref>
<ref id="R78">
<label>78</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fang</surname>
<given-names>HS</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Chao</surname>
<given-names>CY</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>WL</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>YR</given-names>
</name>
</person-group>
<article-title>Association of ITPKB, IL1R2 and COQ7 with Parkinson's disease in Taiwan</article-title>
<source>J Formos Med Assoc</source>
<year>2021</year>
<elocation-id>S0929-6646(21)00296-5</elocation-id>
<comment>[published online ahead of print, 2021 Jul 6]</comment>
<pub-id pub-id-type="doi">10.1016/j.jfma.2021.06.016</pub-id>
</element-citation>
</ref>
<ref id="R79">
<label>79</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Menke</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zeller</surname>
<given-names>GC</given-names>
</name>
<name>
<surname>Kikawada</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Means</surname>
<given-names>TK</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>XR</given-names>
</name>
<name>
<surname>Lan</surname>
<given-names>HY</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Farber</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Luster</surname>
<given-names>AD</given-names>
</name>
<name>
<surname>Kelley</surname>
<given-names>VR</given-names>
</name>
</person-group>
<article-title>CXCL9, but not CXCL10, promotes CXCR3-dependent immune-mediated kidney disease</article-title>
<source>J Am Soc Nephrol</source>
<year>2008</year>
<volume>19</volume>
<issue>6</issue>
<fpage>1177</fpage>
<lpage>1189</lpage>
<pub-id pub-id-type="doi">10.1681/ASN.2007111179</pub-id>
</element-citation>
</ref>
<ref id="R80">
<label>80</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oliveira</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Karrar</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rainbow</surname>
<given-names>DB</given-names>
</name>
<name>
<surname>Pinder</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Rubio García</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Al-Assar</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Burling</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Morris</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>
<article-title>The plasma biomarker soluble SIGLEC-1 is associated with the type I interferon transcriptional signature, ethnic background and renal disease in systemic lupus erythematosus</article-title>
<source>Arthritis Res Ther</source>
<year>2018</year>
<volume>20</volume>
<issue>1</issue>
<fpage>152</fpage>
<pub-id pub-id-type="doi">10.1186/s13075-018-1649-1</pub-id>
</element-citation>
</ref>
<ref id="R81">
<label>81</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xie</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>K</given-names>
</name>
<etal/>
</person-group>
<article-title>Association of genetic polymorphisms in IL-1R1 and IL-1R2 genes with IgA nephropathy in the Han Chinese population</article-title>
<source>Oncotarget</source>
<year>2017</year>
<volume>8</volume>
<issue>31</issue>
<fpage>50673</fpage>
<lpage>50679</lpage>
<pub-id pub-id-type="doi">10.18632/oncotarget.16929</pub-id>
</element-citation>
</ref>
<ref id="R82">
<label>82</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Shan</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>P</given-names>
</name>
<etal/>
</person-group>
<article-title>SIRT3-KLF15 signaling ameliorates kidney injury induced by hypertension</article-title>
<source>Oncotarget</source>
<year>2017</year>
<volume>8</volume>
<issue>24</issue>
<fpage>39592</fpage>
<lpage>39604</lpage>
<pub-id pub-id-type="doi">10.18632/oncotarget.17165</pub-id>
</element-citation>
</ref>
<ref id="R83">
<label>83</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>BW</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>YH</given-names>
</name>
</person-group>
<article-title>Gene Polymorphisms of CD207 (Langerin) Are Associated With End-Stage Renal Disease</article-title>
<source>Transplant Proc</source>
<year>2016</year>
<volume>48</volume>
<issue>3</issue>
<fpage>749</fpage>
<lpage>755</lpage>
<pub-id pub-id-type="doi">10.1016/j.transproceed.2015.12.086</pub-id>
</element-citation>
</ref>
<ref id="R84">
<label>84</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alagawany</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Attia</surname>
<given-names>YA</given-names>
</name>
<name>
<surname>Farag</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Elnesr</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Nagadi</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Shafi</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Khafaga</surname>
<given-names>AF</given-names>
</name>
<name>
<surname>Ohran</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Alaqil</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Abd El-Hack</surname>
<given-names>ME</given-names>
</name>
</person-group>
<article-title>The Strategy of Boosting the Immune System Under the COVID-19 Pandemic</article-title>
<source>Front Vet Sci</source>
<year>2021</year>
<volume>7</volume>
<elocation-id>570748</elocation-id>
<pub-id pub-id-type="doi">10.3389/fvets.2020.570748</pub-id>
</element-citation>
</ref>
<ref id="R85">
<label>85</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Teodori</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Sestili</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Madiai</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Coppari</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Fraternale</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Rocchi</surname>
<given-names>MBL</given-names>
</name>
<name>
<surname>Ramakrishna</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Albertini</surname>
<given-names>MC</given-names>
</name>
</person-group>
<article-title>MicroRNAs Bioinformatics Analyses Identifying HDAC Pathway as a Putative Target for Existing Anti-COVID-19 Therapeutics</article-title>
<source>Front Pharmacol</source>
<year>2020</year>
<volume>11</volume>
<elocation-id>582003</elocation-id>
<pub-id pub-id-type="doi">10.3389/fphar.2020.582003</pub-id>
</element-citation>
</ref>
<ref id="R86">
<label>86</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mudd</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Remy</surname>
<given-names>KE</given-names>
</name>
</person-group>
<article-title>Prolonged adaptive immune activation in COVID-19: implications for maintenance of long-term immunity?</article-title>
<source>J Clin Invest</source>
<year>2021</year>
<volume>131</volume>
<issue>1</issue>
<elocation-id>e143928</elocation-id>
<pub-id pub-id-type="doi">10.1172/JCI143928</pub-id>
</element-citation>
</ref>
<ref id="R87">
<label>87</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McKechnie</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Blish</surname>
<given-names>CA</given-names>
</name>
</person-group>
<article-title>The Innate Immune System: Fighting on the Front Lines or Fanning the Flames of COVID-19?</article-title>
<source>Cell Host Microbe</source>
<year>2020</year>
<volume>27</volume>
<issue>6</issue>
<fpage>863</fpage>
<lpage>869</lpage>
<pub-id pub-id-type="doi">10.1016/j.chom.2020.05.009</pub-id>
</element-citation>
</ref>
<ref id="R88">
<label>88</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Akgun</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Tuzuner</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>Sahin</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Kilercik</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kulah</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Cakiroglu</surname>
<given-names>HN</given-names>
</name>
<name>
<surname>Serteser</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Unsal</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Baykal</surname>
<given-names>AT</given-names>
</name>
</person-group>
<article-title>Proteins associated with neutrophil degranulation are upregulated in nasopharyngeal swabs from SARS-CoV-2 patients</article-title>
<source>PLoS One</source>
<year>2020</year>
<volume>15</volume>
<issue>10</issue>
<elocation-id>e0240012</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0240012</pub-id>
</element-citation>
</ref>
<ref id="R89">
<label>89</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szablewski</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Role of immune system in type 1 diabetes mellitus pathogenesis</article-title>
<source>Int Immunopharmacol</source>
<year>2014</year>
<volume>22</volume>
<issue>1</issue>
<fpage>182</fpage>
<lpage>191</lpage>
<pub-id pub-id-type="doi">10.1016/j.intimp.2014.06.033</pub-id>
</element-citation>
</ref>
<ref id="R90">
<label>90</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Christensen</surname>
<given-names>DP</given-names>
</name>
<name>
<surname>Dahllöf</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lundh</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rasmussen</surname>
<given-names>DN</given-names>
</name>
<name>
<surname>Nielsen</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Billestrup</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Grunnet</surname>
<given-names>LG</given-names>
</name>
<name>
<surname>Mandrup-Poulsen</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Histone deacetylase (HDAC) inhibition as a novel treatment for diabetes mellitus</article-title>
<source>Mol Med</source>
<year>2011</year>
<volume>17</volume>
<issue>5–6</issue>
<fpage>378</fpage>
<lpage>390</lpage>
<pub-id pub-id-type="doi">10.2119/molmed.2011.00021</pub-id>
</element-citation>
</ref>
<ref id="R91">
<label>91</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Role of Adaptive and Innate Immunity in Type 2 Diabetes Mellitus</article-title>
<source>J Diabetes Res</source>
<year>2018</year>
<volume>2018</volume>
<elocation-id>7457269</elocation-id>
<pub-id pub-id-type="doi">10.1155/2018/7457269</pub-id>
</element-citation>
</ref>
<ref id="R92">
<label>92</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takeishi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Mori</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hachiya</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Yumura</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ito</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Shibuya</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hayashi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Fushimi</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Ohashi</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Kawai</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Hypoglycemia and glycemic variability are associated with mortality in non-intensive care unit hospitalized infectious disease patients with diabetes mellitus</article-title>
<source>J Diabetes Investig</source>
<year>2016</year>
<volume>7</volume>
<issue>3</issue>
<fpage>429</fpage>
<lpage>435</lpage>
<pub-id pub-id-type="doi">10.1111/jdi.12436</pub-id>
</element-citation>
</ref>
<ref id="R93">
<label>93</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lazenby</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Crook</surname>
<given-names>MA</given-names>
</name>
</person-group>
<article-title>The innate immune system and diabetes mellitus: the relevance of periodontitis? A hypothesis</article-title>
<source>Clin Sci (Lond)</source>
<year>2010</year>
<volume>119</volume>
<issue>10</issue>
<fpage>423</fpage>
<lpage>429</lpage>
<pub-id pub-id-type="doi">10.1042/CS20100098</pub-id>
</element-citation>
</ref>
<ref id="R94">
<label>94</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ministrini</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Andreozzi</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Montecucco</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Minetti</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bertolotto</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Liberale</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Mannino</surname>
<given-names>GC</given-names>
</name>
<name>
<surname>Succurro</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Cassano</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Miceli</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>
<article-title>Neutrophil degranulation biomarkers characterize restrictive echocardiographic pattern with diastolic dysfunction in patients with diabetes</article-title>
<source>Eur J Clin Invest</source>
<year>2021</year>
<elocation-id>e13640</elocation-id>
<pub-id pub-id-type="doi">10.1111/eci.13640</pub-id>
</element-citation>
</ref>
<ref id="R95">
<label>95</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abboud</surname>
<given-names>FM</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>MV</given-names>
</name>
</person-group>
<article-title>Autonomic regulation of the immune system in cardiovascular diseases</article-title>
<source>Adv Physiol Educ</source>
<year>2017</year>
<volume>41</volume>
<issue>4</issue>
<fpage>578</fpage>
<lpage>593</lpage>
<pub-id pub-id-type="doi">10.1152/advan.00061.2017</pub-id>
</element-citation>
</ref>
<ref id="R96">
<label>96</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bagchi</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Weeks</surname>
<given-names>KL</given-names>
</name>
</person-group>
<article-title>Histone deacetylases in cardiovascular and metabolic diseases</article-title>
<source>J Mol Cell Cardiol</source>
<year>2019</year>
<volume>130</volume>
<fpage>151</fpage>
<lpage>159</lpage>
<pub-id pub-id-type="doi">10.1016/j.yjmcc.2019.04.003</pub-id>
</element-citation>
</ref>
<ref id="R97">
<label>97</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sage</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Mallat</surname>
<given-names>Z</given-names>
</name>
</person-group>
<article-title>Readapting the adaptive immune response - therapeutic strategies for atherosclerosis</article-title>
<source>Br J Pharmacol</source>
<year>2017</year>
<volume>174</volume>
<issue>22</issue>
<fpage>3926</fpage>
<lpage>3939</lpage>
<pub-id pub-id-type="doi">10.1111/bph.13700</pub-id>
</element-citation>
</ref>
<ref id="R98">
<label>98</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Banerjee</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Dwivedi</surname>
<given-names>LK</given-names>
</name>
</person-group>
<article-title>The burden of infectious and cardiovascular diseases in India from 2004 to 2014</article-title>
<source>Epidemiol Health</source>
<year>2016</year>
<volume>38</volume>
<elocation-id>e2016057</elocation-id>
<pub-id pub-id-type="doi">10.4178/epih.e2016057</pub-id>
</element-citation>
</ref>
<ref id="R99">
<label>99</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cai</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Innate Immune Signaling in Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases</article-title>
<source>Annu Rev Pathol</source>
<year>2019</year>
<volume>14</volume>
<fpage>153</fpage>
<lpage>184</lpage>
<pub-id pub-id-type="doi">10.1146/annurev-pathmechdis-012418-013003</pub-id>
</element-citation>
</ref>
<ref id="R100">
<label>100</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bonaventura</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Vecchié</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Abbate</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Montecucco</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Neutrophil Extracellular Traps and Cardiovascular Diseases: An Update</article-title>
<source>Cells</source>
<year>2020</year>
<volume>9</volume>
<issue>1</issue>
<fpage>231</fpage>
<pub-id pub-id-type="doi">10.3390/cells9010231</pub-id>
</element-citation>
</ref>
<ref id="R101">
<label>101</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dalakas</surname>
<given-names>MC</given-names>
</name>
</person-group>
<article-title>Neurological complications of immune checkpoint inhibitors: what happens when you ‘take the brakes off’ the immune system</article-title>
<source>Ther Adv Neurol Disord</source>
<year>2018</year>
<volume>11</volume>
<elocation-id>1756286418799864</elocation-id>
<pub-id pub-id-type="doi">10.1177/1756286418799864</pub-id>
</element-citation>
</ref>
<ref id="R102">
<label>102</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ziemka-Nalecz</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jaworska</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sypecka</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zalewska</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Histone Deacetylase Inhibitors: A Therapeutic Key in Neurological Disorders?</article-title>
<source>J Neuropathol Exp Neurol</source>
<year>2018</year>
<volume>77</volume>
<issue>10</issue>
<fpage>855</fpage>
<lpage>870</lpage>
<pub-id pub-id-type="doi">10.1093/jnen/nly073</pub-id>
</element-citation>
</ref>
<ref id="R103">
<label>103</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mayne</surname>
<given-names>K</given-names>
</name>
<name>
<surname>White</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>McMurran</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Rivera</surname>
<given-names>FJ</given-names>
</name>
<name>
<surname>de la Fuente</surname>
<given-names>AG</given-names>
</name>
</person-group>
<article-title>Aging and Neurodegenerative Disease: Is the Adaptive Immune System a Friend or Foe?</article-title>
<source>Front Aging Neurosci</source>
<year>2020</year>
<volume>12</volume>
<elocation-id>572090</elocation-id>
<pub-id pub-id-type="doi">10.3389/fnagi.2020.572090</pub-id>
</element-citation>
</ref>
<ref id="R104">
<label>104</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McGeer</surname>
<given-names>PL</given-names>
</name>
<name>
<surname>McGeer</surname>
<given-names>EG</given-names>
</name>
</person-group>
<article-title>History of innate immunity in neurodegenerative disorders</article-title>
<source>Front Pharmacol</source>
<year>2011</year>
<volume>2</volume>
<fpage>77</fpage>
<pub-id pub-id-type="doi">10.3389/fphar.2011.00077</pub-id>
</element-citation>
</ref>
<ref id="R105">
<label>105</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schreij</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Fon</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>McPherson</surname>
<given-names>PS</given-names>
</name>
</person-group>
<article-title>Endocytic membrane trafficking and neurodegenerative disease</article-title>
<source>Cell Mol Life Sci</source>
<year>2016</year>
<volume>73</volume>
<issue>8</issue>
<fpage>1529</fpage>
<lpage>1545</lpage>
<pub-id pub-id-type="doi">10.1007/s00018-015-2105-x</pub-id>
</element-citation>
</ref>
<ref id="R106">
<label>106</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kurts</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Panzer</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Anders</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Rees</surname>
<given-names>AJ</given-names>
</name>
</person-group>
<article-title>The immune system and kidney disease: basic concepts and clinical implications</article-title>
<source>Nat Rev Immunol</source>
<year>2013</year>
<volume>13</volume>
<issue>10</issue>
<fpage>738</fpage>
<lpage>753</lpage>
<pub-id pub-id-type="doi">10.1038/nri3523</pub-id>
</element-citation>
</ref>
<ref id="R107">
<label>107</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ishigami</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Matsushita</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Clinical epidemiology of infectious disease among patients with chronic kidney disease</article-title>
<source>Clin Exp Nephrol</source>
<year>2019</year>
<volume>23</volume>
<issue>4</issue>
<fpage>437</fpage>
<lpage>447</lpage>
<pub-id pub-id-type="doi">10.1007/s10157-018-1641-8</pub-id>
</element-citation>
</ref>
<ref id="R108">
<label>108</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jang</surname>
<given-names>HR</given-names>
</name>
<name>
<surname>Rabb</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>The innate immune response in ischemic acute kidney injury</article-title>
<source>Clin Immunol</source>
<year>2009</year>
<volume>130</volume>
<issue>1</issue>
<fpage>41</fpage>
<lpage>50</lpage>
<pub-id pub-id-type="doi">10.1016/j.clim.2008.08.016</pub-id>
</element-citation>
</ref>
<ref id="R109">
<label>109</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nagasawa</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Okuzaki</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Muso</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Shinzawa</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Iwasaki</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Iwatani</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Nakanishi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Isaka</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Nojima</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>IFI27 Is a Useful Genetic Marker for Diagnosis of Immunoglobulin A Nephropathy and Membranous Nephropathy Using Peripheral Blood</article-title>
<source>PLoS One</source>
<year>2016</year>
<volume>11</volume>
<issue>4</issue>
<elocation-id>e0153252</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0153252</pub-id>
</element-citation>
</ref>
<ref id="R110">
<label>110</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Genovese</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>JG</given-names>
</name>
<name>
<surname>Thadhani</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Mottl</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Appel</surname>
<given-names>GB</given-names>
</name>
<name>
<surname>Bick</surname>
<given-names>AG</given-names>
</name>
<etal/>
</person-group>
<article-title>UBD modifies APOL1-induced kidney disease risk</article-title>
<source>Proc Natl Acad Sci U S A</source>
<year>2018</year>
<volume>115</volume>
<issue>13</issue>
<fpage>3446</fpage>
<lpage>3451</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1716113115</pub-id>
</element-citation>
</ref>
<ref id="R111">
<label>111</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hao</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>
<article-title>Periodontitis aggravates kidney injury by upregulating STAT1 expression in a mouse model of hypertension</article-title>
<source>FEBS Open Bio</source>
<year>2021</year>
<volume>11</volume>
<issue>3</issue>
<fpage>880</fpage>
<lpage>889</lpage>
<pub-id pub-id-type="doi">10.1002/2211-5463.13081</pub-id>
</element-citation>
</ref>
<ref id="R112">
<label>112</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hattori</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Naito</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Satoh</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nakatochi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Naito</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kato</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Takagi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Matsunaga</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Seiki</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Sasakabe</surname>
<given-names>T</given-names>
</name>
<etal/>
</person-group>
<article-title>Metallothionein MT2A A-5G Polymorphism as a Risk Factor for Chronic Kidney Disease and Diabetes: Cross-Sectional and Cohort Studies</article-title>
<source>Toxicol Sci</source>
<year>2016</year>
<volume>152</volume>
<issue>1</issue>
<fpage>181</fpage>
<lpage>193</lpage>
<pub-id pub-id-type="doi">10.1093/toxsci/kfw080</pub-id>
</element-citation>
</ref>
<ref id="R113">
<label>113</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maeda</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Otomo</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Yoshida</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Abu-Asab</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Ichinose</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Nishino</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kono</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ferretti</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bhargava</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Maruyama</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>
<article-title>CaMK4 compromises podocyte function in autoimmune and nonautoimmune kidney disease</article-title>
<source>J Clin Invest</source>
<year>2018</year>
<volume>128</volume>
<issue>8</issue>
<fpage>3445</fpage>
<lpage>3459</lpage>
<pub-id pub-id-type="doi">10.1172/JCI99507</pub-id>
</element-citation>
</ref>
<ref id="R114">
<label>114</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Raptis</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Bakogiannis</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Loutradis</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Boutou</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Sioulis</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Balaskas</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Zebekakis</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Sarafidis</surname>
<given-names>PA</given-names>
</name>
</person-group>
<article-title>Serum Fas Ligand, Serum Myostatin and Urine TGF-β1 Are Elevated in Autosomal Dominant Polycystic Kidney Disease Patients with Impaired and Preserved Renal Function</article-title>
<source>Kidney Blood Press Res</source>
<year>2018</year>
<volume>43</volume>
<issue>3</issue>
<fpage>744</fpage>
<lpage>754</lpage>
<pub-id pub-id-type="doi">10.1159/000489911</pub-id>
</element-citation>
</ref>
<ref id="R115">
<label>115</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duan</surname>
<given-names>YR</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>BP</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>SX</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>CY</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>YL</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>LncRNA lnc-ISG20 promotes renal fibrosis in diabetic nephropathy by inducing AKT phosphorylation through miR-486-5p/NFAT5</article-title>
<source>J Cell Mol Med</source>
<year>2021</year>
<volume>25</volume>
<issue>11</issue>
<fpage>4922</fpage>
<lpage>4937</lpage>
<pub-id pub-id-type="doi">10.1111/jcmm.16280</pub-id>
</element-citation>
</ref>
<ref id="R116">
<label>116</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wietelmann</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kojonazarov</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Atzberger</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Schermuly</surname>
<given-names>RT</given-names>
</name>
<name>
<surname>Gröne</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Offermanns</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Developmental vascular remodeling defects and postnatal kidney failure in mice lacking Gpr116 (Adgrf5) and Eltd1 (Adgrl4)</article-title>
<source>PLoS One</source>
<year>2017</year>
<volume>12</volume>
<issue>8</issue>
<elocation-id>e0183166</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0183166</pub-id>
</element-citation>
</ref>
<ref id="R117">
<label>117</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hauer</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Risti</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Miranda</surname>
<given-names>BLM</given-names>
</name>
<name>
<surname>da Silva</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Cidral</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Pozzi</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Contieri</surname>
<given-names>FLC</given-names>
</name>
<name>
<surname>Sadissou</surname>
<given-names>IA</given-names>
</name>
<name>
<surname>Donadi</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Augusto</surname>
<given-names>DG</given-names>
</name>
<etal/>
</person-group>
<article-title>The association of HLA-G polymorphisms and the synergistic effect of sMICA and sHLA-G with chronic kidney disease and allograft acceptance</article-title>
<source>PLoS One</source>
<year>2019</year>
<volume>14</volume>
<issue>2</issue>
<elocation-id>e0212750</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0212750</pub-id>
</element-citation>
</ref>
<ref id="R118">
<label>118</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Byrnes</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Raymond</surname>
<given-names>WD</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Robertson</surname>
<given-names>GR</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>WH</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Prince</surname>
<given-names>RL</given-names>
</name>
<etal/>
</person-group>
<article-title>Serum Midkine, estimated glomerular filtration rate and chronic kidney disease-related events in elderly women: Perth Longitudinal Study of Aging Women</article-title>
<source>Sci Rep</source>
<year>2020</year>
<volume>10</volume>
<issue>1</issue>
<elocation-id>14499</elocation-id>
<pub-id pub-id-type="doi">10.1038/s41598-020-71353-8</pub-id>
</element-citation>
</ref>
<ref id="R119">
<label>119</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Lhotta</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>EK</given-names>
</name>
<name>
<surname>Eder</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Neumair</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>CY</given-names>
</name>
</person-group>
<article-title>Complete complement components C4A and C4B deficiencies in human kidney diseases and systemic lupus erythematosus</article-title>
<source>J Immunol</source>
<year>2004</year>
<volume>173</volume>
<issue>4</issue>
<fpage>2803</fpage>
<lpage>2814</lpage>
<pub-id pub-id-type="doi">10.4049/jimmunol.173.4.2803</pub-id>
</element-citation>
</ref>
<ref id="R120">
<label>120</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>XJ</given-names>
</name>
<name>
<surname>Nath</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Qi</surname>
<given-names>YY</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>YM</given-names>
</name>
<name>
<surname>Lv</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>SF</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>LJ</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>R</given-names>
</name>
<etal/>
</person-group>
<article-title>Novel identified associations of RGS1 and RASGRP1 variants in IgA Nephropathy</article-title>
<source>Sci Rep</source>
<year>2016</year>
<volume>6</volume>
<elocation-id>35781</elocation-id>
<pub-id pub-id-type="doi">10.1038/srep35781</pub-id>
</element-citation>
</ref>
<ref id="R121">
<label>121</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xavier</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sahu</surname>
<given-names>RK</given-names>
</name>
<name>
<surname>Bontha</surname>
<given-names>SV</given-names>
</name>
<name>
<surname>Mass</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>RP</given-names>
</name>
<name>
<surname>Megyesi</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Thielens</surname>
<given-names>NM</given-names>
</name>
<name>
<surname>Portilla</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Complement C1r serine protease contributes to kidney fibrosis</article-title>
<source>Am J Physiol Renal Physiol</source>
<year>2019</year>
<volume>317</volume>
<issue>5</issue>
<fpage>F1293</fpage>
<lpage>F1304</lpage>
<pub-id pub-id-type="doi">10.1152/ajprenal.00357.2019</pub-id>
</element-citation>
</ref>
<ref id="R122">
<label>122</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grywalska</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Smarz-Widelska</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Mertowski</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gosik</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Mielnik</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Podgajna</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Abramiuk</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Drop</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Roliński</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Załuska</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>CTLA-4 Expression Inversely Correlates with Kidney Function and Serum Immunoglobulin Concentration in Patients with Primary Glomerulonephritides</article-title>
<source>Arch Immunol Ther Exp (Warsz)</source>
<year>2019</year>
<volume>67</volume>
<issue>5</issue>
<fpage>335</fpage>
<lpage>349</lpage>
<pub-id pub-id-type="doi">10.1007/s00005-019-00548-3</pub-id>
</element-citation>
</ref>
<ref id="R123">
<label>123</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shu</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Gui</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Xue</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>X</given-names>
</name>
<name>
<surname>He</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Blockade of CD38 diminishes lipopolysaccharide-induced macrophage classical activation and acute kidney injury involving NF-κB signaling suppression</article-title>
<source>Cell Signal</source>
<year>2018</year>
<volume>42</volume>
<fpage>249</fpage>
<lpage>258</lpage>
<pub-id pub-id-type="doi">10.1016/j.cellsig.2017.10.014</pub-id>
</element-citation>
</ref>
<ref id="R124">
<label>124</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>von Vietinghoff</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kurts</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Regulation and function of CX3CR1 and its ligand CX3CL1 in kidney disease</article-title>
<source>Cell Tissue Res</source>
<year>2021</year>
<elocation-id>10.1007/s00441-021-03473-0</elocation-id>
<pub-id pub-id-type="doi">10.1007/s00441-021-03473-0</pub-id>
</element-citation>
</ref>
<ref id="R125">
<label>125</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rudemiller</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Lund</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Jacob</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Geurts</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Mattson</surname>
<given-names>DL</given-names>
</name>
<collab>PhysGen Knockout Program</collab>
</person-group>
<article-title>CD247 modulates blood pressure by altering T-lymphocyte infiltration in the kidney</article-title>
<source>Hypertension</source>
<year>2014</year>
<volume>63</volume>
<issue>3</issue>
<fpage>559</fpage>
<lpage>564</lpage>
<pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.113.02191</pub-id>
</element-citation>
</ref>
<ref id="R126">
<label>126</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Qu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>Y</given-names>
</name>
<etal/>
</person-group>
<article-title>MicroRNA-27a targets Sfrp1 to induce renal fibrosis in diabetic nephropathy by activating Wnt/β-Catenin signalling</article-title>
<source>Biosci Rep</source>
<year>2020</year>
<volume>40</volume>
<issue>6</issue>
<elocation-id>BSR20192794</elocation-id>
<pub-id pub-id-type="doi">10.1042/BSR20192794</pub-id>
</element-citation>
</ref>
<ref id="R127">
<label>127</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ning</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>
<article-title>Expression of inflammasomes NLRP1, NLRP3 and AIM2 in different pathologic classification of lupus nephritis</article-title>
<source>Clin Exp Rheumatol</source>
<year>2020</year>
<volume>38</volume>
<issue>4</issue>
<fpage>680</fpage>
<lpage>690</lpage>
</element-citation>
</ref>
<ref id="R128">
<label>128</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>X</given-names>
</name>
</person-group>
<article-title>TLR7 in B cells promotes renal inflammation and Gd-IgA1 synthesis in IgA nephropathy</article-title>
<source>JCI Insight</source>
<year>2020</year>
<volume>5</volume>
<issue>14</issue>
<elocation-id>e136965</elocation-id>
<pub-id pub-id-type="doi">10.1172/jci.insight.136965</pub-id>
</element-citation>
</ref>
<ref id="R129">
<label>129</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhong</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>SZ</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>ZJ</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>FX</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>PR</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>WT</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Q</given-names>
</name>
<etal/>
</person-group>
<article-title>Association of TNFSF13 polymorphisms with IgA nephropathy in a Chinese Han population</article-title>
<source>J Gene Med</source>
<year>2017</year>
<volume>19</volume>
<issue>6–7</issue>
<elocation-id>10.1002/jgm.2966</elocation-id>
<pub-id pub-id-type="doi">10.1002/jgm.2966</pub-id>
</element-citation>
</ref>
<ref id="R130">
<label>130</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Makitani</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ogo</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Asai</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>STX-0119, a novel STAT3 dimerization inhibitor, prevents fibrotic gene expression in a mouse model of kidney fibrosis by regulating Cxcr4 and Ccr1 expression</article-title>
<source>Physiol Rep</source>
<year>2020</year>
<volume>8</volume>
<issue>20</issue>
<elocation-id>e14627</elocation-id>
<pub-id pub-id-type="doi">10.14814/phy2.14627</pub-id>
</element-citation>
</ref>
<ref id="R131">
<label>131</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>George</surname>
<given-names>GP</given-names>
</name>
<name>
<surname>Mittal</surname>
<given-names>RD</given-names>
</name>
</person-group>
<article-title>Genetic polymorphisms in MHC-encoded antigen processing gene TAP2: a case-control study in end-stage renal disease patients of North India</article-title>
<source>Transpl Immunol</source>
<year>2011</year>
<volume>24</volume>
<issue>4</issue>
<fpage>220</fpage>
<lpage>223</lpage>
<pub-id pub-id-type="doi">10.1016/j.trim.2011.03.003</pub-id>
</element-citation>
</ref>
<ref id="R132">
<label>132</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ekulu</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Nkoy</surname>
<given-names>AB</given-names>
</name>
<name>
<surname>Adebayo</surname>
<given-names>OC</given-names>
</name>
<name>
<surname>Kazadi</surname>
<given-names>OK</given-names>
</name>
<name>
<surname>Aloni</surname>
<given-names>MN</given-names>
</name>
<name>
<surname>Arcolino</surname>
<given-names>FO</given-names>
</name>
<name>
<surname>Ngiyulu</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Gini</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Lepira</surname>
<given-names>FB</given-names>
</name>
<name>
<surname>Van den Heuvel</surname>
<given-names>LP</given-names>
</name>
<etal/>
</person-group>
<article-title>A focus on the association of Apol1 with kidney disease in children</article-title>
<source>Pediatr Nephrol</source>
<year>2021</year>
<volume>36</volume>
<issue>4</issue>
<fpage>777</fpage>
<lpage>788</lpage>
<pub-id pub-id-type="doi">10.1007/s00467-020-04553-z</pub-id>
</element-citation>
</ref>
<ref id="R133">
<label>133</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Song</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>The Role of CXCL12 in Kidney Diseases: A Friend or Foe?</article-title>
<source>Kidney Dis (Basel)</source>
<year>2021</year>
<volume>7</volume>
<issue>3</issue>
<fpage>176</fpage>
<lpage>185</lpage>
<pub-id pub-id-type="doi">10.1159/000514913</pub-id>
</element-citation>
</ref>
<ref id="R134">
<label>134</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zhai</surname>
<given-names>YL</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>FM</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Lv</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>SF</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>LJ</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>MH</given-names>
</name>
<etal/>
</person-group>
<article-title>Variants in Complement Factor H and Complement Factor H-Related Protein Genes, CFHR3 and CFHR1, Affect Complement Activation in IgA Nephropathy</article-title>
<source>J Am Soc Nephrol</source>
<year>2015</year>
<volume>26</volume>
<issue>5</issue>
<fpage>1195</fpage>
<lpage>1204</lpage>
<pub-id pub-id-type="doi">10.1681/ASN.2014010096</pub-id>
</element-citation>
</ref>
<ref id="R135">
<label>135</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X</given-names>
</name>
</person-group>
<article-title>Variants in the RARRES2 gene are associated with serum chemerin and increase the risk of diabetic kidney disease in type 2 diabetes</article-title>
<source>Int J Biol Macromol</source>
<year>2020</year>
<volume>165</volume>
<issue>Pt A</issue>
<fpage>1574</fpage>
<lpage>1580</lpage>
<pub-id pub-id-type="doi">10.1016/j.ijbiomac.2020.10.030</pub-id>
</element-citation>
</ref>
<ref id="R136">
<label>136</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uddin</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Dorotea</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Pak</surname>
<given-names>ES</given-names>
</name>
<name>
<surname>Ha</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Fyn Kinase: A Potential Therapeutic Target in Acute Kidney Injury</article-title>
<source>Biomol Ther (Seoul)</source>
<year>2020</year>
<volume>28</volume>
<issue>3</issue>
<fpage>213</fpage>
<lpage>221</lpage>
<pub-id pub-id-type="doi">10.4062/biomolther.2019.214</pub-id>
</element-citation>
</ref>
<ref id="R137">
<label>137</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luan</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Zhuang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zou</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Shuai</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kou</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>
<article-title>NLRC5 deficiency ameliorates diabetic nephropathy through alleviating inflammation</article-title>
<source>FASEB J</source>
<year>2018</year>
<volume>32</volume>
<issue>2</issue>
<fpage>1070</fpage>
<lpage>1084</lpage>
<pub-id pub-id-type="doi">10.1096/fj.201700511RR</pub-id>
</element-citation>
</ref>
<ref id="R138">
<label>138</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Valiño-Rivas</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Baeza-Bermejillo</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Gonzalez-Lafuente</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Sanz</surname>
<given-names>AB</given-names>
</name>
<name>
<surname>Ortiz</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sanchez-Niño</surname>
<given-names>MD</given-names>
</name>
</person-group>
<article-title>CD74 in Kidney Disease</article-title>
<source>Front Immunol</source>
<year>2015</year>
<volume>6</volume>
<fpage>483</fpage>
<pub-id pub-id-type="doi">10.3389/fimmu.2015.00483</pub-id>
</element-citation>
</ref>
<ref id="R139">
<label>139</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maksimowski</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>VR</given-names>
</name>
<name>
<surname>Scholey</surname>
<given-names>JW</given-names>
</name>
</person-group>
<article-title>Kidney ACE2 expression: Implications for chronic kidney disease</article-title>
<source>PLoS One</source>
<year>2020</year>
<volume>15</volume>
<issue>10</issue>
<elocation-id>e0241534</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0241534</pub-id>
</element-citation>
</ref>
<ref id="R140">
<label>140</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sychev</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Skripka</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ryzhikova</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Bochkov</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Shevchenko</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Krupenin</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Ivashchenko</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Kogay</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Listratov</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Krainyaya</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>
<article-title>Effect of CES1 and ABCB1 genotypes on the pharmacokinetics and clinical outcomes of dabigatran etexilate in patients with atrial fibrillation and chronic kidney disease</article-title>
<source>Drug Metab Pers Ther</source>
<year>2020</year>
<volume>35</volume>
<issue>1</issue>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://www.google.com/search?q=%2Fj%2Fdmdi.2020.35.issue-1%2Fdmpt-2019-0029%2Fdmpt-2019-0029.xml&amp;oq=%2Fj%2Fdmdi.2020.35.issue-1%2Fdmpt-2019-0029%2Fdmpt-2019-0029.xml&amp;aqs=chrome.0.69i59j69i58.1838j0j4&amp;sourceid=chrome&amp;ie=UTF-8">/j/dmdi.2020.35.issue-1/dmpt-2019-0029/dmpt-2019-0029.xml</ext-link>
</comment>
<pub-id pub-id-type="doi">10.1515/dmpt-2019-0029</pub-id>
</element-citation>
</ref>
<ref id="R141">
<label>141</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bian</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Periostin contributes to renal and cardiac dysfunction in rats with chronic kidney disease: Reduction of PPARα</article-title>
<source>Biochimie</source>
<year>2019</year>
<volume>160</volume>
<fpage>172</fpage>
<lpage>182</lpage>
<pub-id pub-id-type="doi">10.1016/j.biochi.2019.03.003</pub-id>
</element-citation>
</ref>
<ref id="R142">
<label>142</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>NX</given-names>
</name>
<name>
<surname>O'Neill</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Kiattisunthorn</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Gattone</surname>
<given-names>VH</given-names>
</name>
<name>
<surname>Moe</surname>
<given-names>SM</given-names>
</name>
</person-group>
<article-title>Transglutaminase 2 accelerates vascular calcification in chronic kidney disease</article-title>
<source>Am J Nephrol</source>
<year>2013</year>
<volume>37</volume>
<issue>3</issue>
<fpage>191</fpage>
<lpage>198</lpage>
<pub-id pub-id-type="doi">10.1159/000347031</pub-id>
</element-citation>
</ref>
<ref id="R143">
<label>143</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L</given-names>
</name>
<etal/>
</person-group>
<article-title>COL4A3 Gene Variants and Diabetic Kidney Disease in MODY</article-title>
<source>Clin J Am Soc Nephrol</source>
<year>2018</year>
<volume>13</volume>
<issue>8</issue>
<fpage>1162</fpage>
<lpage>1171</lpage>
<pub-id pub-id-type="doi">10.2215/CJN.09100817</pub-id>
</element-citation>
</ref>
<ref id="R144">
<label>144</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>XF</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>YC</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>N</given-names>
</name>
<etal/>
</person-group>
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>XF</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>Y</given-names>
</name>
<etal/>
</person-group>
<article-title>The single nucleotide polymorphism rs11643718 in SLC12A3 is associated with the development of diabetic kidney disease in Chinese people with type 2 diabetes</article-title>
<source>Diabet Med</source>
<year>2020</year>
<volume>37</volume>
<issue>11</issue>
<fpage>1879</fpage>
<lpage>1889</lpage>
<pub-id pub-id-type="doi">10.1111/dme.14364</pub-id>
</element-citation>
</ref>
<ref id="R145">
<label>145</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>Z</given-names>
</name>
<etal/>
</person-group>
<article-title>Hyperinsulinemia Can Cause Kidney Disease in the IGT Stage of OLETF Rats via the INS/IRS-1/PI3-K/Akt Signaling Pathway</article-title>
<source>J Diabetes Res</source>
<year>2019</year>
<volume>2019</volume>
<elocation-id>4709715</elocation-id>
<pub-id pub-id-type="doi">10.1155/2019/4709715</pub-id>
</element-citation>
</ref>
<ref id="R146">
<label>146</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uzureau</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lecordier</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Uzureau</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Hennig</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Graversen</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Homblé</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Mfutu</surname>
<given-names>PE</given-names>
</name>
<name>
<surname>Oliveira Arcolino</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Ramos</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>La Rovere</surname>
<given-names>RM</given-names>
</name>
<etal/>
</person-group>
<article-title>APOL1 C-Terminal Variants May Trigger Kidney Disease through Interference with APOL3 Control of Actomyosin</article-title>
<source>Cell Rep</source>
<year>2020</year>
<volume>30</volume>
<issue>11</issue>
<fpage>3821</fpage>
<lpage>3836</lpage>
<elocation-id>e13</elocation-id>
<pub-id pub-id-type="doi">10.1016/j.celrep.2020.02.064</pub-id>
</element-citation>
</ref>
<ref id="R147">
<label>147</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Genetic polymorphisms in HLA-DP and STAT4 are associated with IgA nephropathy in a Southwest Chinese population</article-title>
<source>Oncotarget</source>
<year>2018</year>
<volume>9</volume>
<issue>6</issue>
<fpage>7066</fpage>
<lpage>7074</lpage>
<pub-id pub-id-type="doi">10.18632/oncotarget.23829</pub-id>
</element-citation>
</ref>
<ref id="R148">
<label>148</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bai</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Up-regulation of miR-20a weakens inflammation and apoptosis in high-glucose-induced renal tubular cell mediating diabetic kidney disease by repressing CXCL8 expression</article-title>
<source>Arch Physiol Biochem</source>
<year>2020</year>
<fpage>1</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1080/13813455.2020.1785506</pub-id>
</element-citation>
</ref>
<ref id="R149">
<label>149</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhong</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>K</given-names>
</name>
<name>
<surname>He</surname>
<given-names>JC</given-names>
</name>
</person-group>
<article-title>Role of Krüppel-like factor-2 in kidney disease</article-title>
<source>Nephrology (Carlton)</source>
<year>2018</year>
<volume>23</volume>
<issue>Suppl 4</issue>
<fpage>53</fpage>
<lpage>56</lpage>
<pub-id pub-id-type="doi">10.1111/nep.13456</pub-id>
</element-citation>
</ref>
<ref id="R150">
<label>150</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Velho</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Ragot</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Mohammedi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Gand</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Fraty</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Fumeron</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Saulnier</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Bellili-Munoz</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Bouby</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Potier</surname>
<given-names>L</given-names>
</name>
<etal/>
</person-group>
<article-title>Plasma Adrenomedullin and Allelic Variation in the ADM Gene and Kidney Disease in People With Type 2 Diabetes</article-title>
<source>Diabetes</source>
<year>2015</year>
<volume>64</volume>
<issue>9</issue>
<fpage>3262</fpage>
<lpage>3272</lpage>
<pub-id pub-id-type="doi">10.2337/db14-1852</pub-id>
</element-citation>
</ref>
<ref id="R151">
<label>151</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Xue</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Egr1 Knockdown Combined with an ACE Inhibitor Ameliorates Diabetic Kidney Disease in Mice: Blockade of Compensatory Renin Increase</article-title>
<source>Diabetes Metab Syndr Obes</source>
<year>2020</year>
<volume>13</volume>
<fpage>1005</fpage>
<lpage>1013</lpage>
<pub-id pub-id-type="doi">10.2147/DMSO.S238138</pub-id>
</element-citation>
</ref>
<ref id="R152">
<label>152</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xie</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Fei</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Trib1 Contributes to Recovery From Ischemia/Reperfusion-Induced Acute Kidney Injury by Regulating the Polarization of Renal Macrophages</article-title>
<source>Front Immunol</source>
<year>2020</year>
<volume>11</volume>
<fpage>473</fpage>
<pub-id pub-id-type="doi">10.3389/fimmu.2020.00473</pub-id>
</element-citation>
</ref>
<ref id="R153">
<label>153</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jerotic</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Matic</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Suvakov</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Vucicevic</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Damjanovic</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Savic-Radojevic</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pljesa-Ercegovac</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Coric</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Stefanovic</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>
<article-title>Association of Nrf2, SOD2 and GPX1 Polymorphisms with Biomarkers of Oxidative Distress and Survival in End-Stage Renal Disease Patients</article-title>
<source>Toxins (Basel)</source>
<year>2019</year>
<volume>11</volume>
<issue>7</issue>
<fpage>431</fpage>
<pub-id pub-id-type="doi">10.3390/toxins11070431</pub-id>
</element-citation>
</ref>
<ref id="R154">
<label>154</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Knockdown of circ-FANCA alleviates LPS-induced HK2 cell injury via targeting miR-93-5p/OXSR1 axis in septic acute kidney injury</article-title>
<source>Diabetol Metab Syndr</source>
<year>2021</year>
<volume>13</volume>
<issue>1</issue>
<fpage>7</fpage>
<pub-id pub-id-type="doi">10.1186/s13098-021-00625-8</pub-id>
</element-citation>
</ref>
<ref id="R155">
<label>155</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nechemia-Arbely</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Barkan</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Pizov</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Shriki</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rose-John</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Galun</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Axelrod</surname>
<given-names>JH</given-names>
</name>
</person-group>
<article-title>IL-6/IL-6R axis plays a critical role in acute kidney injury</article-title>
<source>J Am Soc Nephrol</source>
<year>2008</year>
<volume>19</volume>
<issue>6</issue>
<fpage>1106</fpage>
<lpage>1115</lpage>
<pub-id pub-id-type="doi">10.1681/ASN.2007070744</pub-id>
</element-citation>
</ref>
<ref id="R156">
<label>156</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Herrera</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>Bussolati</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Bruno</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Morando</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Mauriello-Romanazzi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Sanavio</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Stamenkovic</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Biancone</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Camussi</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury</article-title>
<source>Kidney Int</source>
<year>2007</year>
<volume>72</volume>
<issue>4</issue>
<fpage>430</fpage>
<lpage>441</lpage>
<pub-id pub-id-type="doi">10.1038/sj.ki.5002334</pub-id>
</element-citation>
</ref>
<ref id="R157">
<label>157</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gurung</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Dorajoo</surname>
<given-names>R</given-names>
</name>
<name>
<surname>M</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Pek</surname>
<given-names>SLT</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Sim</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Shao</surname>
<given-names>YM</given-names>
</name>
<etal/>
</person-group>
<article-title>Association of Genetic Variants for Plasma LRG1 With Rapid Decline in Kidney Function in Patients With Type 2 Diabetes</article-title>
<source>J Clin Endocrinol Metab</source>
<year>2021</year>
<volume>106</volume>
<issue>8</issue>
<fpage>2384</fpage>
<lpage>2394</lpage>
<pub-id pub-id-type="doi">10.1210/clinem/dgab268</pub-id>
</element-citation>
</ref>
<ref id="R158">
<label>158</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Harley</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Katerelos</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gleich</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Sullivan</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Laskowski</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Coughlan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Fraser</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Mount</surname>
<given-names>PF</given-names>
</name>
<name>
<surname>Power</surname>
<given-names>DA</given-names>
</name>
</person-group>
<article-title>Mutation of regulatory phosphorylation sites in PFKFB2 worsens renal fibrosis</article-title>
<source>Sci Rep</source>
<year>2020</year>
<volume>10</volume>
<issue>1</issue>
<elocation-id>14531</elocation-id>
<pub-id pub-id-type="doi">10.1038/s41598-020-71475-z</pub-id>
</element-citation>
</ref>
<ref id="R159">
<label>159</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dumont</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Tolvanen</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Kuusela</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Nyman</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Lindfors</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tienari</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Nisen</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Suetsugu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Plomann</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>
<article-title>PACSIN2 accelerates nephrin trafficking and is up-regulated in diabetic kidney disease</article-title>
<source>FASEB J</source>
<year>2017</year>
<volume>31</volume>
<issue>9</issue>
<fpage>3978</fpage>
<lpage>3990</lpage>
<pub-id pub-id-type="doi">10.1096/fj.201601265R</pub-id>
</element-citation>
</ref>
<ref id="R160">
<label>160</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Otterpohl</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Busselman</surname>
<given-names>BW</given-names>
</name>
<name>
<surname>Ratnayake</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Hart</surname>
<given-names>RG</given-names>
</name>
<name>
<surname>Hart</surname>
<given-names>KR</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Phillips</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Beach</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Ahrenkiel</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Molitoris</surname>
<given-names>BA</given-names>
</name>
<etal/>
</person-group>
<article-title>Conditional Myh9 and Myh10 inactivation in adult mouse renal epithelium results in progressive kidney disease</article-title>
<source>JCI Insight</source>
<year>2020</year>
<volume>5</volume>
<issue>21</issue>
<elocation-id>e138530</elocation-id>
<pub-id pub-id-type="doi">10.1172/jci.insight.138530</pub-id>
</element-citation>
</ref>
<ref id="R161">
<label>161</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Lightle</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Foulke</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Higgins</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>Loss of Histone H3 K79 Methyltransferase Dot1l Facilitates Kidney Fibrosis by Upregulating Endothelin 1 through Histone Deacetylase 2</article-title>
<source>J Am Soc Nephrol</source>
<year>2020</year>
<volume>31</volume>
<issue>2</issue>
<fpage>337</fpage>
<lpage>349</lpage>
<pub-id pub-id-type="doi">10.1681/ASN.2019070739</pub-id>
</element-citation>
</ref>
<ref id="R162">
<label>162</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elewa</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Sanchez-Niño</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Mahillo-Fernández</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Martin-Cleary</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Belen Sanz</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Perez-Gomez</surname>
<given-names>MV</given-names>
</name>
<name>
<surname>Fernandez-Fernandez</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Ortiz</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Circulating CXCL16 in Diabetic Kidney Disease</article-title>
<source>Kidney Blood Press Res</source>
<year>2016</year>
<volume>41</volume>
<issue>5</issue>
<fpage>663</fpage>
<lpage>671</lpage>
<pub-id pub-id-type="doi">10.1159/000447935</pub-id>
</element-citation>
</ref>
<ref id="R163">
<label>163</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Xiang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hsiao</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>TK</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>PK</given-names>
</name>
<name>
<surname>Egranov</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>Ambati</surname>
<given-names>CR</given-names>
</name>
<etal/>
</person-group>
<article-title>PTEN-induced partial epithelial-mesenchymal transition drives diabetic kidney disease</article-title>
<source>J Clin Invest</source>
<year>2019</year>
<volume>129</volume>
<issue>3</issue>
<fpage>1129</fpage>
<lpage>1151</lpage>
<pub-id pub-id-type="doi">10.1172/JCI121987</pub-id>
</element-citation>
</ref>
<ref id="R164">
<label>164</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>DY</given-names>
</name>
<name>
<surname>Ahn</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>JH</given-names>
</name>
</person-group>
<article-title>Suppression of Foxo3-Gatm by miR-132-3p Accelerates Cyst Formation by Up-Regulating ROS in Autosomal Dominant Polycystic Kidney Disease</article-title>
<source>Biomol Ther (Seoul)</source>
<year>2021</year>
<volume>29</volume>
<issue>3</issue>
<fpage>311</fpage>
<lpage>320</lpage>
<pub-id pub-id-type="doi">10.4062/biomolther.2020.197</pub-id>
</element-citation>
</ref>
<ref id="R165">
<label>165</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Qu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>He</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group>
<article-title>In vitro and in vivo inhibition of mTOR by 1,25-dihydroxyvitamin D3 to improve early diabetic nephropathy via the DDIT4/TSC2/mTOR pathway</article-title>
<source>Endocrine</source>
<year>2016</year>
<volume>54</volume>
<issue>2</issue>
<fpage>348</fpage>
<lpage>359</lpage>
<pub-id pub-id-type="doi">10.1007/s12020-016-0999-1</pub-id>
</element-citation>
</ref>
<ref id="R166">
<label>166</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bian</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>XM</given-names>
</name>
<name>
<surname>Pollock</surname>
<given-names>CA</given-names>
</name>
</person-group>
<article-title>The Mitochondrial Kinase PINK1 in Diabetic Kidney Disease</article-title>
<source>Int J Mol Sci</source>
<year>2021</year>
<volume>22</volume>
<issue>4</issue>
<elocation-id>1525</elocation-id>
<pub-id pub-id-type="doi">10.3390/ijms22041525</pub-id>
</element-citation>
</ref>
<ref id="R167">
<label>167</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>QGAP1 mediates podocyte injury in diabetic kidney disease by regulating nephrin endocytosis</article-title>
<source>Cell Signal</source>
<year>2019</year>
<volume>59</volume>
<fpage>13</fpage>
<lpage>23</lpage>
<pub-id pub-id-type="doi">10.1016/j.cellsig.2019.03.009</pub-id>
</element-citation>
</ref>
<ref id="R168">
<label>168</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sopić</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Joksić</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Spasojević-Kalimanovska</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Bogavac-Stanojević</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Simić-Ogrizović</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kravljača</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jelić Ivanović</surname>
<given-names>Z</given-names>
</name>
</person-group>
<article-title>Downregulation of AdipoR1 is Associated with increased Circulating Adiponectin Levels in Serbian Chronic Kidney Disease Patients</article-title>
<source>J Med Biochem</source>
<year>2016</year>
<volume>35</volume>
<issue>4</issue>
<fpage>436</fpage>
<lpage>442</lpage>
<pub-id pub-id-type="doi">10.1515/jomb-2016-0007</pub-id>
</element-citation>
</ref>
<ref id="R169">
<label>169</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>XJ</given-names>
</name>
<name>
<surname>Nath</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Qi</surname>
<given-names>YY</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>FJ</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>HZ</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>N</given-names>
</name>
<etal/>
</person-group>
<article-title>Brief Report: identification of MTMR3 as a novel susceptibility gene for lupus nephritis in northern Han Chinese by shared-gene analysis with IgA nephropathy</article-title>
<source>Arthritis Rheumatol</source>
<year>2014</year>
<volume>66</volume>
<issue>10</issue>
<fpage>2842</fpage>
<lpage>2848</lpage>
<pub-id pub-id-type="doi">10.1002/art.38749</pub-id>
</element-citation>
</ref>
<ref id="R170">
<label>170</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hou</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>Protective mechanism of apigenin in diabetic nephropathy is related to its regulation of miR-423-5P-USF2 axis</article-title>
<source>Am J Transl Res</source>
<year>2021</year>
<volume>13</volume>
<issue>4</issue>
<fpage>2006</fpage>
<lpage>2020</lpage>
</element-citation>
</ref>
<ref id="R171">
<label>171</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sierra-Ramos</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Velazquez-Garcia</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Keskus</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Vastola-Mascolo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rodríguez-Rodríguez</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Luis-Lima</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hernández</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Navarro-González</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Porrini</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Konu</surname>
<given-names>O</given-names>
</name>
<etal/>
</person-group>
<article-title>Increased SGK1 activity potentiates mineralocorticoid/NaCl-induced kidney injury</article-title>
<source>Am J Physiol Renal Physiol</source>
<year>2021</year>
<volume>320</volume>
<issue>4</issue>
<fpage>F628</fpage>
<lpage>F643</lpage>
<pub-id pub-id-type="doi">10.1152/ajprenal.00505.2020</pub-id>
</element-citation>
</ref>
<ref id="R172">
<label>172</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cimbaljevic</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Suvakov</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Matic</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pljesa-Ercegovac</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pekmezovic</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Radic</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Coric</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Damjanovic</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Dimkovic</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Markovic</surname>
<given-names>R</given-names>
</name>
<etal/>
</person-group>
<article-title>Association of GSTO1 and GSTO2 Polymorphism with Risk of End-Stage Renal Disease Development and Patient Survival</article-title>
<source>J Med Biochem</source>
<year>2016</year>
<volume>35</volume>
<issue>3</issue>
<fpage>302</fpage>
<lpage>311</lpage>
<pub-id pub-id-type="doi">10.1515/jomb-2016-0009</pub-id>
</element-citation>
</ref>
<ref id="R173">
<label>173</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chengyu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Long</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Bin</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Xuefei</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Congjuan</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Caixia</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>X</given-names>
</name>
</person-group>
<article-title>Linarin Protects the Kidney against Ischemia/Reperfusion Injury via the Inhibition of Bioactive ETS2/IL-12</article-title>
<source>Biol Pharm Bull</source>
<year>2021</year>
<volume>44</volume>
<issue>1</issue>
<fpage>25</fpage>
<lpage>31</lpage>
<pub-id pub-id-type="doi">10.1248/bpb.b20-00508</pub-id>
</element-citation>
</ref>
<ref id="R174">
<label>174</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pácal</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Tomandl</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Svojanovsky</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Krusová</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Stepánková</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rehorová</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Olsovsky</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Belobrádková</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Tanhäuserová</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Tomandlová</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>
<article-title>Role of thiamine status and genetic variability in transketolase and other pentose phosphate cycle enzymes in the progression of diabetic nephropathy</article-title>
<source>Nephrol Dial Transplant</source>
<year>2011</year>
<volume>26</volume>
<issue>4</issue>
<fpage>1229</fpage>
<lpage>1236</lpage>
<pub-id pub-id-type="doi">10.1093/ndt/gfq550</pub-id>
</element-citation>
</ref>
<ref id="R175">
<label>175</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pan</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>YH</given-names>
</name>
<name>
<surname>Mo</surname>
<given-names>MQ</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>QH</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>RX</given-names>
</name>
</person-group>
<article-title>CMIP SNPs and their haplotypes are associated with dyslipidaemia and clinicopathologic features of IgA nephropathy</article-title>
<source>Biosci Rep</source>
<year>2020</year>
<volume>40</volume>
<issue>10</issue>
<elocation-id>BSR20202628</elocation-id>
<pub-id pub-id-type="doi">10.1042/BSR20202628</pub-id>
</element-citation>
</ref>
<ref id="R176">
<label>176</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takeshita</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Yasuma</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Nishihama</surname>
<given-names>K</given-names>
</name>
<name>
<surname>D'Alessandro-Gabazza</surname>
<given-names>CN</given-names>
</name>
<name>
<surname>Toda</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Totoki</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Okano</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Uchida</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Inoue</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>L</given-names>
</name>
<etal/>
</person-group>
<article-title>Thrombomodulin ameliorates transforming growth factor-β1-mediated chronic kidney disease via the G-protein coupled receptor 15/Akt signal pathway</article-title>
<source>Kidney Int</source>
<year>2020</year>
<volume>98</volume>
<issue>5</issue>
<fpage>1179</fpage>
<lpage>1192</lpage>
<pub-id pub-id-type="doi">10.1016/j.kint.2020.05.041</pub-id>
</element-citation>
</ref>
<ref id="R177">
<label>177</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haarhaus</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gilham</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Kulikowski</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Magnusson</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Kalantar-Zadeh</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Pharmacologic epigenetic modulators of alkaline phosphatase in chronic kidney disease</article-title>
<source>Curr Opin Nephrol Hypertens</source>
<year>2020</year>
<volume>29</volume>
<issue>1</issue>
<fpage>4</fpage>
<lpage>15</lpage>
<pub-id pub-id-type="doi">10.1097/MNH.0000000000000570</pub-id>
</element-citation>
</ref>
<ref id="R178">
<label>178</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pang</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Abbott</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Abdi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Fucci</surname>
<given-names>QA</given-names>
</name>
<name>
<surname>Chauhan</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Mistri</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Proctor</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Chin</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>W</given-names>
</name>
<etal/>
</person-group>
<article-title>Pre-clinical model of severe glutathione peroxidase-3 deficiency and chronic kidney disease results in coronary artery thrombosis and depressed left ventricular function</article-title>
<source>Nephrol Dial Transplant</source>
<year>2018</year>
<volume>33</volume>
<issue>6</issue>
<fpage>923</fpage>
<lpage>934</lpage>
<pub-id pub-id-type="doi">10.1093/ndt/gfx304</pub-id>
</element-citation>
</ref>
<ref id="R179">
<label>179</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>ELL2 Is Downregulated and Associated with Galactose-Deficient IgA1 in IgA Nephropathy</article-title>
<source>Dis Markers</source>
<year>2019</year>
<volume>2019</volume>
<elocation-id>2407067</elocation-id>
<pub-id pub-id-type="doi">10.1155/2019/2407067</pub-id>
</element-citation>
</ref>
<ref id="R180">
<label>180</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghosh</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Shao</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Sampath</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>NV</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Behl</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Parise</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Beumer</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>O'Sullivan</surname>
<given-names>RJ</given-names>
</name>
<etal/>
</person-group>
<article-title>Oligoadenylate-Synthetase-Family Protein OASL Inhibits Activity of the DNA Sensor cGAS during DNA Virus Infection to Limit Interferon Production</article-title>
<source>Immunity</source>
<year>2019</year>
<volume>50</volume>
<issue>1</issue>
<fpage>51</fpage>
<lpage>63</lpage>
<elocation-id>e5</elocation-id>
<pub-id pub-id-type="doi">10.1016/j.immuni.2018.12.013</pub-id>
</element-citation>
</ref>
<ref id="R181">
<label>181</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Das Sarma</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Burrows</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rayman</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Hwang</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Kundu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Bergmann</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Sen</surname>
<given-names>GC</given-names>
</name>
</person-group>
<article-title>Ifit2 deficiency restricts microglial activation and leukocyte migration following murine coronavirus (m-CoV) CNS infection</article-title>
<source>PLoS Pathog</source>
<year>2020</year>
<volume>16</volume>
<issue>11</issue>
<elocation-id>e1009034</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.ppat.1009034</pub-id>
</element-citation>
</ref>
<ref id="R182">
<label>182</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Richter</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Agnellini</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Oxenius</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>On the role of the inhibitory receptor LAG-3 in acute and chronic LCMV infection</article-title>
<source>Int Immunol</source>
<year>2010</year>
<volume>22</volume>
<issue>1</issue>
<fpage>13</fpage>
<lpage>23</lpage>
<pub-id pub-id-type="doi">10.1093/intimm/dxp107</pub-id>
</element-citation>
</ref>
<ref id="R183">
<label>183</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>CF</given-names>
</name>
<name>
<surname>Ming</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>GL</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>BQ</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>GY</given-names>
</name>
<name>
<surname>Chu</surname>
<given-names>BB</given-names>
</name>
</person-group>
<article-title>Porcine IFITM1 is a host restriction factor that inhibits pseudorabies virus infection</article-title>
<source>Int J Biol Macromol</source>
<year>2020</year>
<volume>151</volume>
<fpage>1181</fpage>
<lpage>1193</lpage>
<pub-id pub-id-type="doi">10.1016/j.ijbiomac.2019.10.162</pub-id>
</element-citation>
</ref>
<ref id="R184">
<label>184</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xuan</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>LN</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Zi</surname>
<given-names>HR</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>WJ</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>XB</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>PM</given-names>
</name>
</person-group>
<article-title>IFITM3 rs12252 T&gt;C polymorphism is associated with the risk of severe influenza: a meta-analysis</article-title>
<source>Epidemiol Infect</source>
<year>2015</year>
<volume>143</volume>
<issue>14</issue>
<fpage>2975</fpage>
<lpage>2984</lpage>
<pub-id pub-id-type="doi">10.1017/S0950268815000278</pub-id>
</element-citation>
</ref>
<ref id="R185">
<label>185</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jung</surname>
<given-names>HE</given-names>
</name>
<name>
<surname>Oh</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>HK</given-names>
</name>
</person-group>
<article-title>Cell-Penetrating Mx1 Enhances Anti-Viral Resistance against Mucosal Influenza Viral Infection</article-title>
<source>Viruses</source>
<year>2019</year>
<volume>11</volume>
<issue>2</issue>
<fpage>109</fpage>
<pub-id pub-id-type="doi">10.3390/v11020109</pub-id>
</element-citation>
</ref>
<ref id="R186">
<label>186</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Winkler</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>X</given-names>
</name>
</person-group>
<article-title>Interferon Inducer IFI35 regulates RIG-I-mediated innate antiviral response through mutual antagonism with Influenza protein NS1</article-title>
<source>J Virol</source>
<year>2021</year>
<volume>95</volume>
<issue>11</issue>
<elocation-id>e00283-21</elocation-id>
<pub-id pub-id-type="doi">10.1128/JVI.00283-21</pub-id>
</element-citation>
</ref>
<ref id="R187">
<label>187</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jing</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Tao</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ke</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>H</given-names>
</name>
<etal/>
</person-group>
<article-title>Nuclear localization signal in TRIM22 is essential for inhibition of type 2 porcine reproductive and respiratory syndrome virus replication in MARC-145 cells</article-title>
<source>Virus Genes</source>
<year>2019</year>
<volume>55</volume>
<issue>5</issue>
<fpage>660</fpage>
<lpage>672</lpage>
<pub-id pub-id-type="doi">10.1007/s11262-019-01691-x</pub-id>
</element-citation>
</ref>
<ref id="R188">
<label>188</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hickey</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Held</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Baum</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Lane</surname>
<given-names>TE</given-names>
</name>
</person-group>
<article-title>CCR1 deficiency increases susceptibility to fatal coronavirus infection of the central nervous system</article-title>
<source>Viral Immunol</source>
<year>2007</year>
<volume>20</volume>
<issue>4</issue>
<fpage>599</fpage>
<lpage>608</lpage>
<pub-id pub-id-type="doi">10.1089/vim.2007.0056</pub-id>
</element-citation>
</ref>
<ref id="R189">
<label>189</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuriakose</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Neale</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Kanneganti</surname>
<given-names>TD</given-names>
</name>
</person-group>
<article-title>IRF1 Is a Transcriptional Regulator of ZBP1 Promoting NLRP3 Inflammasome Activation and Cell Death during Influenza Virus Infection</article-title>
<source>J Immunol</source>
<year>2018</year>
<volume>200</volume>
<issue>4</issue>
<fpage>1489</fpage>
<lpage>1495</lpage>
<pub-id pub-id-type="doi">10.4049/jimmunol.1701538</pub-id>
</element-citation>
</ref>
<ref id="R190">
<label>190</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Milligan</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Richardson</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>John-Stewart</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Nduati</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Overbaugh</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>FCGR2A and FCGR3A Genotypes in Human Immunodeficiency Virus Mother-to-Child Transmission</article-title>
<source>Open Forum Infect Dis</source>
<year>2015</year>
<volume>2</volume>
<issue>4</issue>
<elocation-id>ofv149</elocation-id>
<pub-id pub-id-type="doi">10.1093/ofid/ofv149</pub-id>
</element-citation>
</ref>
<ref id="R191">
<label>191</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Akram</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Moyo</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Leeming</surname>
<given-names>GH</given-names>
</name>
<name>
<surname>Bingle</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Jasim</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hussain</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Schorlemmer</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kipar</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Digard</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Tripp</surname>
<given-names>RA</given-names>
</name>
<etal/>
</person-group>
<article-title>An innate defense peptide BPIFA1/SPLUNC1 restricts influenza A virus infection</article-title>
<source>Mucosal Immunol</source>
<year>2018</year>
<volume>11</volume>
<issue>1</issue>
<fpage>71</fpage>
<lpage>81</lpage>
<pub-id pub-id-type="doi">10.1038/mi.2017.45</pub-id>
</element-citation>
</ref>
<ref id="R192">
<label>192</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>More</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Pushparaj</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Sathiaseelan</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Long non-coding RNA PSMB8-AS1 regulates influenza virus replication</article-title>
<source>RNA Biol</source>
<year>2019</year>
<volume>16</volume>
<issue>3</issue>
<fpage>340</fpage>
<lpage>353</lpage>
<pub-id pub-id-type="doi">10.1080/15476286.2019.1572448</pub-id>
</element-citation>
</ref>
<ref id="R193">
<label>193</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jabeen</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Malik</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Mansoor</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Shahzad</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zahid</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Javed</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Effect of oxidative stress and calcium deregulation on FAM26F (CALHM6) expression during hepatitis B virus infection</article-title>
<source>BMC Infect Dis</source>
<year>2021</year>
<volume>21</volume>
<issue>1</issue>
<fpage>228</fpage>
<pub-id pub-id-type="doi">10.1186/s12879-021-05888-0</pub-id>
</element-citation>
</ref>
<ref id="R194">
<label>194</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Froggatt</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Harding</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Chaparian</surname>
<given-names>RR</given-names>
</name>
<name>
<surname>Heaton</surname>
<given-names>NS</given-names>
</name>
</person-group>
<article-title>ETV7 limits antiviral gene expression and control of influenza viruses</article-title>
<source>Sci Signal</source>
<year>2021</year>
<volume>14</volume>
<issue>691</issue>
<elocation-id>eabe1194</elocation-id>
<pub-id pub-id-type="doi">10.1126/scisignal.abe1194</pub-id>
</element-citation>
</ref>
<ref id="R195">
<label>195</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Quanquin</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>CF</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>N</given-names>
</name>
<etal/>
</person-group>
<article-title>PARP12 suppresses Zika virus infection through PARP-dependent degradation of NS1 and NS3 viral proteins</article-title>
<source>Sci Signal</source>
<year>2018</year>
<volume>11</volume>
<issue>535</issue>
<elocation-id>eaas9332</elocation-id>
<pub-id pub-id-type="doi">10.1126/scisignal.aas9332</pub-id>
</element-citation>
</ref>
<ref id="R196">
<label>196</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Xiang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Kita</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Melnick</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Dent</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>BCL6 modulates tissue neutrophil survival and exacerbates pulmonary inflammation following influenza virus infection</article-title>
<source>Proc Natl Acad Sci U S A</source>
<year>2019</year>
<volume>116</volume>
<issue>24</issue>
<fpage>11888</fpage>
<lpage>11893</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1902310116</pub-id>
</element-citation>
</ref>
<ref id="R197">
<label>197</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Batra</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Tripathi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Katz</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Cox</surname>
<given-names>NJ</given-names>
</name>
<name>
<surname>Lal</surname>
<given-names>RB</given-names>
</name>
<name>
<surname>Sambhara</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lal</surname>
<given-names>SK</given-names>
</name>
</person-group>
<article-title>Human Heat shock protein 40 (Hsp40/DnaJB1) promotes influenza A virus replication by assisting nuclear import of viral ribonucleoproteins</article-title>
<source>Sci Rep</source>
<year>2016</year>
<volume>6</volume>
<elocation-id>19063</elocation-id>
<pub-id pub-id-type="doi">10.1038/srep19063</pub-id>
</element-citation>
</ref>
<ref id="R198">
<label>198</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dai</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Z</given-names>
</name>
</person-group>
<article-title>Silencing CCL8 inhibited the proliferation and migration of PDGF-BB-stimulated human aortic smooth muscle cells</article-title>
<source>Biosci Biotechnol Biochem</source>
<year>2020</year>
<volume>84</volume>
<issue>8</issue>
<fpage>1585</fpage>
<lpage>1593</lpage>
<pub-id pub-id-type="doi">10.1080/09168451.2020.1762160</pub-id>
</element-citation>
</ref>
<ref id="R199">
<label>199</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yan</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Guan</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Elevated levels of granzyme B correlated with miR-874-3p downregulation in patients with acute myocardial infarction</article-title>
<source>Biomark Med</source>
<year>2017</year>
<volume>11</volume>
<issue>9</issue>
<fpage>761</fpage>
<lpage>767</lpage>
<pub-id pub-id-type="doi">10.2217/bmm-2017-0144</pub-id>
</element-citation>
</ref>
<ref id="R200">
<label>200</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McDermott</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Kathiresan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Cupples</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Massaro</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Keaney</surname>
<given-names>JF</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Larson</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Vasan</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Hirschhorn</surname>
<given-names>JN</given-names>
</name>
<name>
<surname>O'Donnell</surname>
<given-names>CJ</given-names>
</name>
<etal/>
</person-group>
<article-title>CCL2 polymorphisms are associated with serum monocyte chemoattractant protein-1 levels and myocardial infarction in the Framingham Heart Study</article-title>
<source>Circulation</source>
<year>2005</year>
<volume>112</volume>
<issue>8</issue>
<fpage>1113</fpage>
<lpage>1120</lpage>
<pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.105.543579</pub-id>
</element-citation>
</ref>
<ref id="R201">
<label>201</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Q</given-names>
</name>
</person-group>
<article-title>Indoleamine 2,3-Dioxygenase 1 (IDO1) Promotes Cardiac Hypertrophy via a PI3K-AKT-mTOR-Dependent Mechanism</article-title>
<source>Cardiovasc Toxicol</source>
<year>2021</year>
<volume>21</volume>
<issue>8</issue>
<fpage>655</fpage>
<lpage>668</lpage>
<pub-id pub-id-type="doi">10.1007/s12012-021-09657-y</pub-id>
</element-citation>
</ref>
<ref id="R202">
<label>202</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dopheide</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Sester</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Schlitt</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Horstick</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Rupprecht</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Münzel</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Blankenberg</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Monocyte-derived dendritic cells of patients with coronary artery disease show an increased expression of costimulatory molecules CD40, CD80 and CD86 in vitro</article-title>
<source>Coron Artery Dis</source>
<year>2007</year>
<volume>18</volume>
<issue>7</issue>
<fpage>523</fpage>
<lpage>531</lpage>
<pub-id pub-id-type="doi">10.1097/MCA.0b013e3282eff1ad</pub-id>
</element-citation>
</ref>
<ref id="R203">
<label>203</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nagano</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Mitchell</surname>
<given-names>RN</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>MK</given-names>
</name>
<name>
<surname>Hasegawa</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tilney</surname>
<given-names>NL</given-names>
</name>
<name>
<surname>Libby</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Interferon-gamma deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts</article-title>
<source>J Clin Invest</source>
<year>1997</year>
<volume>100</volume>
<issue>3</issue>
<fpage>550</fpage>
<lpage>557</lpage>
<pub-id pub-id-type="doi">10.1172/JCI119564</pub-id>
</element-citation>
</ref>
<ref id="R204">
<label>204</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>He</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>H</given-names>
</name>
<name>
<surname>He</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>STAT1-avtiviated LINC00961 regulates myocardial infarction by the PI3K/AKT/GSK3β signaling pathway</article-title>
<source>J Cell Biochem</source>
<year>2019</year>
<volume>120</volume>
<issue>8</issue>
<fpage>13226</fpage>
<lpage>13236</lpage>
<pub-id pub-id-type="doi">10.1002/jcb.28596</pub-id>
</element-citation>
</ref>
<ref id="R205">
<label>205</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dinh</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Pedersen</surname>
<given-names>OB</given-names>
</name>
<name>
<surname>Petersen</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Sørensen</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Sørensen</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Kaspersen</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Larsen</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Møller</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Hjalgrim</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ullum</surname>
<given-names>H</given-names>
</name>
<etal/>
</person-group>
<article-title>The impact of CCR5-Δ32 deletion on C-reactive protein levels and cardiovascular disease: Results from the Danish Blood Donor Study</article-title>
<source>Atherosclerosis</source>
<year>2015</year>
<volume>242</volume>
<issue>1</issue>
<fpage>222</fpage>
<lpage>225</lpage>
<pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2015.07.031</pub-id>
</element-citation>
</ref>
<ref id="R206">
<label>206</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leow</surname>
<given-names>KY</given-names>
</name>
<name>
<surname>Goh</surname>
<given-names>WW</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>SZ</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Oh</surname>
<given-names>VM</given-names>
</name>
<name>
<surname>Low</surname>
<given-names>AF</given-names>
</name>
<name>
<surname>Heng</surname>
<given-names>CK</given-names>
</name>
</person-group>
<article-title>Variant screening of the serum amyloid A1 gene and functional study of the p.Gly90Asp variant for its role in atherosclerosis</article-title>
<source>Atherosclerosis</source>
<year>2013</year>
<volume>227</volume>
<issue>1</issue>
<fpage>112</fpage>
<lpage>117</lpage>
<pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2013.01.003</pub-id>
</element-citation>
</ref>
<ref id="R207">
<label>207</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Giacconi</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Cipriano</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Muti</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Costarelli</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Maurizio</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Saba</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Gasparini</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Malavolta</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mocchegiani</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Novel -209A/G MT2A polymorphism in old patients with type 2 diabetes and atherosclerosis: relationship with inflammation (IL-6) and zinc</article-title>
<source>Biogerontology</source>
<year>2005</year>
<volume>6</volume>
<issue>6</issue>
<fpage>407</fpage>
<lpage>413</lpage>
<pub-id pub-id-type="doi">10.1007/s10522-005-4907-y</pub-id>
</element-citation>
</ref>
<ref id="R208">
<label>208</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duan</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Rao</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Rajagopalan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>The regulatory role of DPP4 in atherosclerotic disease</article-title>
<source>Cardiovasc Diabetol</source>
<year>2017</year>
<volume>16</volume>
<issue>1</issue>
<fpage>76</fpage>
<pub-id pub-id-type="doi">10.1186/s12933-017-0558-y</pub-id>
</element-citation>
</ref>
<ref id="R209">
<label>209</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shimizu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Fukuo</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Nagata</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Suhara</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Okuro</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Fujii</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Higashino</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Mogi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hatanaka</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ogihara</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Increased plasma levels of the soluble form of Fas ligand in patients with acute myocardial infarction and unstable angina pectoris</article-title>
<source>J Am Coll Cardiol</source>
<year>2002</year>
<volume>39</volume>
<issue>4</issue>
<fpage>585</fpage>
<lpage>590</lpage>
<pub-id pub-id-type="doi">10.1016/s0735-1097(01)01800-9</pub-id>
</element-citation>
</ref>
<ref id="R210">
<label>210</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kostopoulos</surname>
<given-names>CG</given-names>
</name>
<name>
<surname>Spiroglou</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Varakis</surname>
<given-names>JN</given-names>
</name>
<name>
<surname>Apostolakis</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Papadaki</surname>
<given-names>HH</given-names>
</name>
</person-group>
<article-title>Chemerin and CMKLR1 expression in human arteries and periadventitial fat: a possible role for local chemerin in atherosclerosis?</article-title>
<source>BMC Cardiovasc Disord</source>
<year>2014</year>
<volume>14</volume>
<fpage>56</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2261-14-56</pub-id>
</element-citation>
</ref>
<ref id="R211">
<label>211</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhong</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Gan</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>T cell co-stimulator inducible co-stimulatory (ICOS) exerts potential anti-atherosclerotic roles through downregulation of vascular smooth muscle phagocytosis and proliferation</article-title>
<source>Ann Transl Med</source>
<year>2020</year>
<volume>8</volume>
<issue>23</issue>
<elocation-id>1597</elocation-id>
<pub-id pub-id-type="doi">10.21037/atm-20-7342</pub-id>
</element-citation>
</ref>
<ref id="R212">
<label>212</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bennet</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Alarcón-Riquelme</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wiman</surname>
<given-names>B</given-names>
</name>
<name>
<surname>de Faire</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Prokunina-Olsson</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Decreased risk for myocardial infarction and lower tumor necrosis factor-alpha levels in carriers of variants of the PDCD1 gene</article-title>
<source>Hum Immunol</source>
<year>2006</year>
<volume>67</volume>
<issue>9</issue>
<fpage>700</fpage>
<lpage>705</lpage>
<pub-id pub-id-type="doi">10.1016/j.humimm.2006.05.005</pub-id>
</element-citation>
</ref>
<ref id="R213">
<label>213</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X</given-names>
</name>
</person-group>
<article-title>Circ_0093887 upregulates CCND2 and SUCNR1 to inhibit the ox-LDL-induced endothelial dysfunction in atherosclerosis by functioning as a miR-876-3p sponge</article-title>
<source>Clin Exp Pharmacol Physiol</source>
<year>2021</year>
<volume>48</volume>
<issue>8</issue>
<fpage>1137</fpage>
<lpage>1149</lpage>
<pub-id pub-id-type="doi">10.1111/1440-1681.13504</pub-id>
</element-citation>
</ref>
<ref id="R214">
<label>214</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Becher</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Hinrichs</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Fluschnik</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Hennigs</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Klingel</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Blankenberg</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Westermann</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Lindner</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Role of Toll-like receptors and interferon regulatory factors in different experimental heart failure models of diverse etiology: IRF7 as novel cardiovascular stress-inducible factor</article-title>
<source>PLoS One</source>
<year>2018</year>
<volume>13</volume>
<issue>3</issue>
<elocation-id>e0193844</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0193844</pub-id>
</element-citation>
</ref>
<ref id="R215">
<label>215</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zidi</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Kharrat</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Abdelhedi</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Hassine</surname>
<given-names>AB</given-names>
</name>
<name>
<surname>Laaribi</surname>
<given-names>AB</given-names>
</name>
<name>
<surname>Yahia</surname>
<given-names>HB</given-names>
</name>
<name>
<surname>Abdelmoula</surname>
<given-names>NB</given-names>
</name>
<name>
<surname>Abid</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Rebai</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rizzo</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Nonclassical human leukocyte antigen (HLA-G, HLA-E, and HLA-F) in coronary artery disease</article-title>
<source>Hum Immunol</source>
<year>2016</year>
<volume>77</volume>
<issue>4</issue>
<fpage>325</fpage>
<lpage>329</lpage>
<pub-id pub-id-type="doi">10.1016/j.humimm.2016.01.008</pub-id>
</element-citation>
</ref>
<ref id="R216">
<label>216</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schiano</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Benincasa</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Infante</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Franzese</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Castaldo</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Fiorito</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Mansueto</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Grimaldi</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Della Valle</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Fatone</surname>
<given-names>G</given-names>
</name>
<etal/>
</person-group>
<article-title>Integrated analysis of DNA methylation profile of HLA-G gene and imaging in coronary heart disease: Pilot study</article-title>
<source>PLoS One</source>
<year>2020</year>
<volume>15</volume>
<issue>8</issue>
<elocation-id>e0236951</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0236951</pub-id>
</element-citation>
</ref>
<ref id="R217">
<label>217</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Horiba</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kadomatsu</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Yasui</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Takenaka</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Sumida</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kamiya</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sakuma</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Muramatsu</surname>
<given-names>T</given-names>
</name>
<etal/>
</person-group>
<article-title>Midkine plays a protective role against cardiac ischemia/reperfusion injury through a reduction of apoptotic reaction</article-title>
<source>Circulation</source>
<year>2006</year>
<volume>114</volume>
<issue>16</issue>
<fpage>1713</fpage>
<lpage>1720</lpage>
<pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.106.632273</pub-id>
</element-citation>
</ref>
<ref id="R218">
<label>218</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Foks</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Ran</surname>
<given-names>IA</given-names>
</name>
<name>
<surname>Frodermann</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Bot</surname>
<given-names>I</given-names>
</name>
<name>
<surname>van Santbrink</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Kuiper</surname>
<given-names>J</given-names>
</name>
<name>
<surname>van Puijvelde</surname>
<given-names>GH</given-names>
</name>
</person-group>
<article-title>Agonistic anti-TIGIT treatment inhibits T cell responses in LDLr deficient mice without affecting atherosclerotic lesion development</article-title>
<source>PLoS One</source>
<year>2013</year>
<volume>8</volume>
<issue>12</issue>
<elocation-id>e83134</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0083134</pub-id>
</element-citation>
</ref>
<ref id="R219">
<label>219</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ruppert</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Meyer</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Struwe</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Petersen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Perrot</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Posch</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Ozcelik</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Richter</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Maisch</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Pankuweit</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Evidence for CTLA4 as a susceptibility gene for dilated cardiomyopathy</article-title>
<source>Eur J Hum Genet</source>
<year>2010</year>
<volume>18</volume>
<issue>6</issue>
<fpage>694</fpage>
<lpage>699</lpage>
<pub-id pub-id-type="doi">10.1038/ejhg.2010.3</pub-id>
</element-citation>
</ref>
<ref id="R220">
<label>220</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zuo</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Q</given-names>
</name>
</person-group>
<article-title>CD38: A Potential Therapeutic Target in Cardiovascular Disease</article-title>
<source>Cardiovasc Drugs Ther</source>
<year>2021</year>
<volume>35</volume>
<issue>4</issue>
<fpage>815</fpage>
<lpage>828</lpage>
<pub-id pub-id-type="doi">10.1007/s10557-020-07007-8</pub-id>
</element-citation>
</ref>
<ref id="R221">
<label>221</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shao</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>TLR3 and TLR4 as potential clinically biomarkers of cardiovascular risk in coronary artery disease (CAD) patients</article-title>
<source>Heart Vessels</source>
<year>2014</year>
<volume>29</volume>
<issue>5</issue>
<fpage>690</fpage>
<lpage>698</lpage>
<pub-id pub-id-type="doi">10.1007/s00380-013-0421-3</pub-id>
</element-citation>
</ref>
<ref id="R222">
<label>222</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Apostolakis</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Spandidos</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Chemokines and atherosclerosis: focus on the CX3CL1/CX3CR1 pathway</article-title>
<source>Acta Pharmacol Sin</source>
<year>2013</year>
<volume>34</volume>
<issue>10</issue>
<fpage>1251</fpage>
<lpage>1256</lpage>
<pub-id pub-id-type="doi">10.1038/aps.2013.92</pub-id>
</element-citation>
</ref>
<ref id="R223">
<label>223</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tao</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Adi</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Xiang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>YT</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>BD</given-names>
</name>
</person-group>
<article-title>Sfrp1 protects against acute myocardial ischemia (AMI) injury in aged mice by inhibiting the Wnt/β-catenin signaling pathway</article-title>
<source>J Cardiothorac Surg</source>
<year>2021</year>
<volume>16</volume>
<issue>1</issue>
<fpage>12</fpage>
<pub-id pub-id-type="doi">10.1186/s13019-020-01389-4</pub-id>
</element-citation>
</ref>
<ref id="R224">
<label>224</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>F</given-names>
</name>
<name>
<surname>An</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>AIM2 regulates vascular smooth muscle cell migration in atherosclerosis</article-title>
<source>Biochem Biophys Res Commun</source>
<year>2018</year>
<volume>497</volume>
<issue>1</issue>
<fpage>401</fpage>
<lpage>409</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbrc.2018.02.094</pub-id>
</element-citation>
</ref>
<ref id="R225">
<label>225</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karadimou</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Plunde</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Pawelzik</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Carracedo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Eriksson</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Franco-Cereceda</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Paulsson-Berne</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Bäck</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>TLR7 Expression Is Associated with M2 Macrophage Subset in Calcific Aortic Valve Stenosis</article-title>
<source>Cells</source>
<year>2020</year>
<volume>9</volume>
<issue>7</issue>
<elocation-id>1710</elocation-id>
<pub-id pub-id-type="doi">10.3390/cells9071710</pub-id>
</element-citation>
</ref>
<ref id="R226">
<label>226</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chmielewski</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Piaszyk-Borychowska</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wesoly</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bluyssen</surname>
<given-names>HA</given-names>
</name>
</person-group>
<article-title>STAT1 and IRF8 in Vascular Inflammation and Cardiovascular Disease: Diagnostic and Therapeutic Potential</article-title>
<source>Int Rev Immunol</source>
<year>2016</year>
<volume>35</volume>
<issue>5</issue>
<fpage>434</fpage>
<lpage>454</lpage>
<pub-id pub-id-type="doi">10.3109/08830185.2015.1087519</pub-id>
</element-citation>
</ref>
<ref id="R227">
<label>227</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xia</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Integrated DNA methylation and gene expression analysis identifies SLAMF7 as a key regulator of atherosclerosis</article-title>
<source>Aging (Albany NY)</source>
<year>2018</year>
<volume>10</volume>
<issue>6</issue>
<fpage>1324</fpage>
<lpage>1337</lpage>
<pub-id pub-id-type="doi">10.18632/aging.101470</pub-id>
</element-citation>
</ref>
<ref id="R228">
<label>228</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mitchell</surname>
<given-names>GF</given-names>
</name>
<name>
<surname>Verwoert</surname>
<given-names>GC</given-names>
</name>
<name>
<surname>Tarasov</surname>
<given-names>KV</given-names>
</name>
<name>
<surname>Isaacs</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>AV</given-names>
</name>
<name>
<surname>Yasmin</surname>
<given-names>Rietzschel ER</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Parsa</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>
<article-title>Common genetic variation in the 3'-BCL11B gene desert is associated with carotid-femoral pulse wave velocity and excess cardiovascular disease risk: the AortaGen Consortium</article-title>
<source>Circ Cardiovasc Genet</source>
<year>2012</year>
<volume>5</volume>
<issue>1</issue>
<fpage>81</fpage>
<lpage>90</lpage>
<pub-id pub-id-type="doi">10.1161/CIRCGENETICS.111.959817</pub-id>
</element-citation>
</ref>
<ref id="R229">
<label>229</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perdomo</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Henry Dong</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Apolipoprotein D in lipid metabolism and its functional implication in atherosclerosis and aging</article-title>
<source>Aging (Albany NY)</source>
<year>2009</year>
<volume>1</volume>
<issue>1</issue>
<fpage>17</fpage>
<lpage>27</lpage>
<pub-id pub-id-type="doi">10.18632/aging.100004</pub-id>
</element-citation>
</ref>
<ref id="R230">
<label>230</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bick</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Akwo</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Robinson-Cohen</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Lynch</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Assimes</surname>
<given-names>TL</given-names>
</name>
<name>
<surname>DuVall</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Edwards</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Freiberg</surname>
<given-names>SM</given-names>
</name>
<etal/>
</person-group>
<article-title>Association of APOL1 Risk Alleles With Cardiovascular Disease in Blacks in the Million Veteran Program</article-title>
<source>Circulation</source>
<year>2019</year>
<volume>140</volume>
<issue>12</issue>
<fpage>1031</fpage>
<lpage>1040</lpage>
<pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.118.036589</pub-id>
</element-citation>
</ref>
<ref id="R231">
<label>231</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Döring</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>van der Vorst</surname>
<given-names>EPC</given-names>
</name>
<name>
<surname>Duchene</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Jansen</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Gencer</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bidzhekov</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Atzler</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Santovito</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Rader</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Saleheen</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group>
<article-title>CXCL12 Derived From Endothelial Cells Promotes Atherosclerosis to Drive Coronary Artery Disease</article-title>
<source>Circulation</source>
<year>2019</year>
<volume>139</volume>
<issue>10</issue>
<fpage>1338</fpage>
<lpage>1340</lpage>
<pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.118.037953</pub-id>
</element-citation>
</ref>
<ref id="R232">
<label>232</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sofat</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Casas</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Kumari</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Talmud</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Ireland</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kivimaki</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Marmot</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hughes</surname>
<given-names>AD</given-names>
</name>
<name>
<surname>Thom</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ebrahim</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>
<article-title>Genetic variation in complement factor H and risk of coronary heart disease: eight new studies and a meta-analysis of around 48,000 individuals</article-title>
<source>Atherosclerosis</source>
<year>2010</year>
<volume>213</volume>
<issue>1</issue>
<fpage>184</fpage>
<lpage>190</lpage>
<pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2010.07.021</pub-id>
</element-citation>
</ref>
<ref id="R233">
<label>233</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Er</surname>
<given-names>LK</given-names>
</name>
<name>
<surname>Hsu</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Juang</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Chiang</surname>
<given-names>FT</given-names>
</name>
<name>
<surname>Teng</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Tzeng</surname>
<given-names>IS</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Ko</surname>
<given-names>YL</given-names>
</name>
</person-group>
<article-title>Circulating Chemerin Levels, but not the RARRES2 Polymorphisms, Predict the Long-Term Outcome of Angiographically Confirmed Coronary Artery Disease</article-title>
<source>Int J Mol Sci</source>
<year>2019</year>
<volume>20</volume>
<issue>5</issue>
<elocation-id>1174</elocation-id>
<pub-id pub-id-type="doi">10.3390/ijms20051174</pub-id>
</element-citation>
</ref>
<ref id="R234">
<label>234</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Niu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Hypomethylation of Rnase6 Promoter Enhances Proliferation and Migration of Murine Aortic Vascular Smooth Muscle Cells and Aggravates Atherosclerosis in Mice</article-title>
<source>Front Bioeng Biotechnol</source>
<year>2021</year>
<volume>9</volume>
<elocation-id>695461</elocation-id>
<pub-id pub-id-type="doi">10.3389/fbioe.2021.695461</pub-id>
</element-citation>
</ref>
<ref id="R235">
<label>235</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mohammad-Rezaei</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ahmadi</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Rafiei</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Khaledifar</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Fattahi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Samiei-Sefat</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Emami</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bagheri</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Serum levels of IL-32 in patients with coronary artery disease and its relationship with the serum levels of IL-6 and TNF-α</article-title>
<source>Mol Biol Rep</source>
<year>2021</year>
<volume>48</volume>
<issue>5</issue>
<fpage>4263</fpage>
<lpage>4271</lpage>
<pub-id pub-id-type="doi">10.1007/s11033-021-06441-7</pub-id>
</element-citation>
</ref>
<ref id="R236">
<label>236</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Q</given-names>
</name>
</person-group>
<article-title>LncRNA MALAT1 prevents the protective effects of miR-125b-5p against acute myocardial infarction through positive regulation of NLRC5</article-title>
<source>Exp Ther Med</source>
<year>2020</year>
<volume>19</volume>
<issue>2</issue>
<fpage>990</fpage>
<lpage>998</lpage>
<pub-id pub-id-type="doi">10.3892/etm.2019.8309</pub-id>
</element-citation>
</ref>
<ref id="R237">
<label>237</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheng</surname>
<given-names>WL</given-names>
</name>
<name>
<surname>Kao</surname>
<given-names>YH</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>YC</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>YK</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>YJ</given-names>
</name>
</person-group>
<article-title>Macrophage migration inhibitory factor increases atrial arrhythmogenesis through CD74 signaling</article-title>
<source>Transl Res</source>
<year>2020</year>
<volume>216</volume>
<fpage>43</fpage>
<lpage>56</lpage>
<pub-id pub-id-type="doi">10.1016/j.trsl.2019.10.002</pub-id>
</element-citation>
</ref>
<ref id="R238">
<label>238</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhai</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Duan</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>The role of SARS-CoV-2 target ACE2 in cardiovascular diseases</article-title>
<source>J Cell Mol Med</source>
<year>2021</year>
<volume>25</volume>
<issue>3</issue>
<fpage>1342</fpage>
<lpage>1349</lpage>
<pub-id pub-id-type="doi">10.1111/jcmm.16239</pub-id>
</element-citation>
</ref>
<ref id="R239">
<label>239</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heckmann</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>Reinhardt</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Finke</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Katus</surname>
<given-names>HA</given-names>
</name>
<name>
<surname>Haberkorn</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Leuschner</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Lehmann</surname>
<given-names>LH</given-names>
</name>
</person-group>
<article-title>Relationship Between Cardiac Fibroblast Activation Protein Activity by Positron Emission Tomography and Cardiovascular Disease</article-title>
<source>Circ Cardiovasc Imaging</source>
<year>2020</year>
<volume>13</volume>
<issue>9</issue>
<elocation-id>e010628</elocation-id>
<pub-id pub-id-type="doi">10.1161/CIRCIMAGING.120.010628</pub-id>
</element-citation>
</ref>
<ref id="R240">
<label>240</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Biswas</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rahaman</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Biswas</surname>
<given-names>TK</given-names>
</name>
<name>
<surname>Ibrahim</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Effects of the ABCB1 C3435T single nucleotide polymorphism on major adverse cardiovascular events in acute coronary syndrome or coronary artery disease patients undergoing percutaneous coronary intervention and treated with clopidogrel: A systematic review and meta-analysis</article-title>
<source>Expert Opin Drug Saf</source>
<year>2020</year>
<volume>19</volume>
<issue>12</issue>
<fpage>1605</fpage>
<lpage>1616</lpage>
<pub-id pub-id-type="doi">10.1080/14740338.2020.1836152</pub-id>
</element-citation>
</ref>
<ref id="R241">
<label>241</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Long</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z</given-names>
</name>
</person-group>
<article-title>SP1-induced SNHG14 aggravates hypertrophic response in in vitro model of cardiac hypertrophy via up-regulation of PCDH17</article-title>
<source>J Cell Mol Med</source>
<year>2020</year>
<volume>24</volume>
<issue>13</issue>
<fpage>7115</fpage>
<lpage>7126</lpage>
<pub-id pub-id-type="doi">10.1111/jcmm.15073</pub-id>
</element-citation>
</ref>
<ref id="R242">
<label>242</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Azharuddin</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Adil</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ghosh</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Kapur</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Periostin as a novel biomarker of cardiovascular disease: A systematic evidence landscape of preclinical and clinical studies</article-title>
<source>J Evid Based Med</source>
<year>2019</year>
<volume>12</volume>
<issue>4</issue>
<fpage>325</fpage>
<lpage>336</lpage>
<pub-id pub-id-type="doi">10.1111/jebm.12368</pub-id>
</element-citation>
</ref>
<ref id="R243">
<label>243</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Long</surname>
<given-names>QQ</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>YF</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>BR</given-names>
</name>
<name>
<surname>Meng</surname>
<given-names>HY</given-names>
</name>
<etal/>
</person-group>
<article-title>Long Noncoding RNA Kcna2 Antisense RNA Contributes to Ventricular Arrhythmias via Silencing Kcna2 in Rats With Congestive Heart Failure</article-title>
<source>J Am Heart Assoc</source>
<year>2017</year>
<volume>6</volume>
<issue>12</issue>
<elocation-id>e005965</elocation-id>
<pub-id pub-id-type="doi">10.1161/JAHA.117.005965</pub-id>
</element-citation>
</ref>
<ref id="R244">
<label>244</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ni</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>SN</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>YS</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>ZX</given-names>
</name>
<etal/>
</person-group>
<article-title>Single-cell transcriptomic analyses of cardiac immune cells reveal that Rel-driven CD72-positive macrophages induce cardiomyocyte injury</article-title>
<source>Cardiovasc Res</source>
<year>2021</year>
<elocation-id>cvab193</elocation-id>
<pub-id pub-id-type="doi">10.1093/cvr/cvab193</pub-id>
</element-citation>
</ref>
<ref id="R245">
<label>245</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>ZY</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>ZH</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>CP</given-names>
</name>
<name>
<surname>Meng</surname>
<given-names>XL</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>YJ</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>TGF-β1 and TIMP-4 regulate atrial fibrosis in atrial fibrillation secondary to rheumatic heart disease</article-title>
<source>Mol Cell Biochem</source>
<year>2015</year>
<volume>406</volume>
<issue>1–2</issue>
<fpage>131</fpage>
<lpage>138</lpage>
<pub-id pub-id-type="doi">10.1007/s11010-015-2431-1</pub-id>
</element-citation>
</ref>
<ref id="R246">
<label>246</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Raina</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Panjaliya</surname>
<given-names>RK</given-names>
</name>
<name>
<surname>Dogra</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Bakaya</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Association of ESR1 (rs2234693 and rs9340799), CETP (rs708272), MTHFR (rs1801133 and rs2274976) and MS (rs185087) polymorphisms with Coronary Artery Disease (CAD)</article-title>
<source>BMC Cardiovasc Disord</source>
<year>2020</year>
<volume>20</volume>
<issue>1</issue>
<fpage>340</fpage>
<pub-id pub-id-type="doi">10.1186/s12872-020-01618-7</pub-id>
</element-citation>
</ref>
<ref id="R247">
<label>247</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lim</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>CT</given-names>
</name>
<name>
<surname>Hivert</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>White</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Murabito</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>O'Donnell</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Dupuis</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Florez</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Meigs</surname>
<given-names>JB</given-names>
</name>
</person-group>
<article-title>Common variants in and near IRS1 and subclinical cardiovascular disease in the Framingham Heart Study</article-title>
<source>Atherosclerosis</source>
<year>2013</year>
<volume>229</volume>
<issue>1</issue>
<fpage>149</fpage>
<lpage>154</lpage>
<pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2013.03.037</pub-id>
</element-citation>
</ref>
<ref id="R248">
<label>248</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lai</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Hung</surname>
<given-names>LF</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>CY</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Ho</surname>
<given-names>LJ</given-names>
</name>
</person-group>
<article-title>Mitochondrial protein CMPK2 regulates IFN alpha-enhanced foam cell formation, potentially contributing to premature atherosclerosis in SLE</article-title>
<source>Arthritis Res Ther</source>
<year>2021</year>
<volume>23</volume>
<issue>1</issue>
<fpage>120</fpage>
<pub-id pub-id-type="doi">10.1186/s13075-021-02470-6</pub-id>
</element-citation>
</ref>
<ref id="R249">
<label>249</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Konev</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Kharitonov</surname>
<given-names>AV</given-names>
</name>
<name>
<surname>Rozov</surname>
<given-names>FN</given-names>
</name>
<name>
<surname>Altshuler</surname>
<given-names>EP</given-names>
</name>
<name>
<surname>Serebryanaya</surname>
<given-names>DV</given-names>
</name>
<name>
<surname>Lassus</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Harjola</surname>
<given-names>VP</given-names>
</name>
<name>
<surname>Katrukha</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Postnikov</surname>
<given-names>AB</given-names>
</name>
</person-group>
<article-title>CT-IGFBP-4 as a novel prognostic biomarker in acute heart failure</article-title>
<source>ESC Heart Fail</source>
<year>2020</year>
<volume>7</volume>
<issue>2</issue>
<fpage>434</fpage>
<lpage>444</lpage>
<pub-id pub-id-type="doi">10.1002/ehf2.12590</pub-id>
</element-citation>
</ref>
<ref id="R250">
<label>250</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meng</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Adi</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Abudoukelimu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>F</given-names>
</name>
<etal/>
</person-group>
<article-title>CYP19A1 polymorphisms associated with coronary artery disease and circulating sex hormone levels in a Chinese population</article-title>
<source>Oncotarget</source>
<year>2017</year>
<volume>8</volume>
<issue>57</issue>
<fpage>97101</fpage>
<lpage>97113</lpage>
<pub-id pub-id-type="doi">10.18632/oncotarget.21626</pub-id>
</element-citation>
</ref>
<ref id="R251">
<label>251</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ng</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Titus</surname>
<given-names>EW</given-names>
</name>
<name>
<surname>Lieve</surname>
<given-names>KV</given-names>
</name>
<name>
<surname>Roston</surname>
<given-names>TM</given-names>
</name>
<name>
<surname>Mazzanti</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Deiter</surname>
<given-names>FH</given-names>
</name>
<name>
<surname>Denjoy</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Ingles</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Till</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Robyns</surname>
<given-names>T</given-names>
</name>
<etal/>
</person-group>
<article-title>An International Multicenter Evaluation of Inheritance Patterns, Arrhythmic Risks, and Underlying Mechanisms of CASQ2-Catecholaminergic Polymorphic Ventricular Tachycardia</article-title>
<source>Circulation</source>
<year>2020</year>
<volume>142</volume>
<issue>10</issue>
<fpage>932</fpage>
<lpage>947</lpage>
<pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.120.045723</pub-id>
</element-citation>
</ref>
<ref id="R252">
<label>252</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reid</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hagberg</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Sandling</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Alexsson</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pucholt</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Sjöwall</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Lerang</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Jönsen</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gunnarsson</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Syvänen</surname>
<given-names>AC</given-names>
</name>
<etal/>
</person-group>
<article-title>Interaction between the STAT4 rs11889341(T) risk allele and smoking confers increased risk of myocardial infarction and nephritis in patients with systemic lupus erythematosus</article-title>
<source>Ann Rheum Dis</source>
<year>2021</year>
<volume>80</volume>
<issue>9</issue>
<fpage>1183</fpage>
<lpage>1189</lpage>
<pub-id pub-id-type="doi">10.1136/annrheumdis-2020-219727</pub-id>
</element-citation>
</ref>
<ref id="R253">
<label>253</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Effects of PPM1K rs1440581 and rs7678928 on serum branched-chain amino acid levels and risk of cardiovascular disease</article-title>
<source>Ann Med</source>
<year>2021</year>
<volume>53</volume>
<issue>1</issue>
<fpage>1316</fpage>
<lpage>1326</lpage>
<pub-id pub-id-type="doi">10.1080/07853890.2021.1965204</pub-id>
</element-citation>
</ref>
<ref id="R254">
<label>254</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname>
<given-names>CT</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>HY</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>CY</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>CY</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>FJ</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>CJ</given-names>
</name>
</person-group>
<article-title>Oxidized ApoC1 on MALDI-TOF and glycated-ApoA1 band on gradient gel as potential diagnostic tools for atherosclerotic vascular disease</article-title>
<source>Clin Chim Acta</source>
<year>2013</year>
<volume>420</volume>
<fpage>69</fpage>
<lpage>75</lpage>
<pub-id pub-id-type="doi">10.1016/j.cca.2012.10.017</pub-id>
</element-citation>
</ref>
<ref id="R255">
<label>255</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qin</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Mao</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Kohama</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>F</given-names>
</name>
<etal/>
</person-group>
<article-title>Inhibitory effect of recombinant human CXCL8(3–72)K11R/G31P on atherosclerotic plaques in a mouse model of atherosclerosis</article-title>
<source>Immunopharmacol Immunotoxicol</source>
<year>2019</year>
<volume>41</volume>
<issue>3</issue>
<fpage>446</fpage>
<lpage>454</lpage>
<pub-id pub-id-type="doi">10.1080/08923973.2019.1616753</pub-id>
</element-citation>
</ref>
<ref id="R256">
<label>256</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deng</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Lei</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Mo</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Ou</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>ERK5/KLF2 activation is involved in the reducing effects of puerarin on monocyte adhesion to endothelial cells and atherosclerotic lesion in apolipoprotein E-deficient mice</article-title>
<source>Biochim Biophys Acta Mol Basis Dis</source>
<year>2018</year>
<volume>1864</volume>
<issue>8</issue>
<fpage>2590</fpage>
<lpage>2599</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbadis.2018.04.021</pub-id>
</element-citation>
</ref>
<ref id="R257">
<label>257</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Voors</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Kremer</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Geven</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ter Maaten</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Struck</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bergmann</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pickkers</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Metra</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mebazaa</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Düngen</surname>
<given-names>HD</given-names>
</name>
<etal/>
</person-group>
<article-title>Adrenomedullin in heart failure: pathophysiology and therapeutic application</article-title>
<source>Eur J Heart Fail</source>
<year>2019</year>
<volume>21</volume>
<issue>2</issue>
<fpage>163</fpage>
<lpage>171</lpage>
<pub-id pub-id-type="doi">10.1002/ejhf.1366</pub-id>
</element-citation>
</ref>
<ref id="R258">
<label>258</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miyagawa</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Higashiyama</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kawata</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Inui</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Tamura</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Nishida</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Yamashita</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Matsuzawa</surname>
<given-names>Y</given-names>
</name>
<etal/>
</person-group>
<article-title>Localization of heparin-binding EGF-like growth factor in the smooth muscle cells and macrophages of human atherosclerotic plaques</article-title>
<source>J Clin Invest</source>
<year>1995</year>
<volume>95</volume>
<issue>1</issue>
<fpage>404</fpage>
<lpage>411</lpage>
<pub-id pub-id-type="doi">10.1172/JCI117669</pub-id>
</element-citation>
</ref>
<ref id="R259">
<label>259</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>WH</given-names>
</name>
<name>
<surname>Xue</surname>
<given-names>YJ</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>YJ</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>XG</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>XX</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>XX</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>XX</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>YT</given-names>
</name>
</person-group>
<article-title>KLF7 promotes macrophage activation by activating the NF-κB signaling pathway in epicardial adipose tissue in patients with coronary artery disease</article-title>
<source>Eur Rev Med Pharmacol Sci</source>
<year>2020</year>
<volume>24</volume>
<issue>12</issue>
<fpage>7002</fpage>
<lpage>7014</lpage>
<pub-id pub-id-type="doi">10.26355/eurrev_202006_21693</pub-id>
</element-citation>
</ref>
<ref id="R260">
<label>260</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brodehl</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Weiss</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Debus</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Stanasiuk</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Klauke</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Deutsch</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Fox</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Bax</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ebbinghaus</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Gärtner</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>
<article-title>A homozygous DSC2 deletion associated with arrhythmogenic cardiomyopathy is caused by uniparental isodisomy</article-title>
<source>J Mol Cell Cardiol</source>
<year>2020</year>
<volume>141</volume>
<fpage>17</fpage>
<lpage>29</lpage>
<pub-id pub-id-type="doi">10.1016/j.yjmcc.2020.03.006</pub-id>
</element-citation>
</ref>
<ref id="R261">
<label>261</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khadir</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kavalakatt</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dehbi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Alarouj</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bennakhi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Tiss</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Elkum</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>DUSP1 Is a Potential Marker of Chronic Inflammation in Arabs with Cardiovascular Diseases</article-title>
<source>Dis Markers</source>
<year>2018</year>
<volume>2018</volume>
<elocation-id>9529621</elocation-id>
<pub-id pub-id-type="doi">10.1155/2018/9529621</pub-id>
</element-citation>
</ref>
<ref id="R262">
<label>262</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shin</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Hang</surname>
<given-names>HT</given-names>
</name>
<name>
<surname>Thang</surname>
<given-names>BQ</given-names>
</name>
<name>
<surname>Shimoda</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Sakamoto</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Osaka</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hiramatsu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yamashiro</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yanagisawa</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Role of PAR1-Egr1 in the Initiation of Thoracic Aortic Aneurysm in Fbln4-Deficient Mice</article-title>
<source>Arterioscler Thromb Vasc Biol</source>
<year>2020</year>
<volume>40</volume>
<issue>8</issue>
<fpage>1905</fpage>
<lpage>1917</lpage>
<pub-id pub-id-type="doi">10.1161/ATVBAHA.120.314560</pub-id>
</element-citation>
</ref>
<ref id="R263">
<label>263</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Lan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Rao</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Stratified meta-analysis by ethnicity revealed that ADRB3 Trp64Arg polymorphism was associated with coronary artery disease in Asians, but not in Caucasians</article-title>
<source>Medicine (Baltimore)</source>
<year>2020</year>
<volume>99</volume>
<issue>4</issue>
<elocation-id>e18914</elocation-id>
<pub-id pub-id-type="doi">10.1097/MD.0000000000018914</pub-id>
</element-citation>
</ref>
<ref id="R264">
<label>264</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>WR</given-names>
</name>
<name>
<surname>Joseph</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Caracciolo</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Gonzales</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Sidell</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Seli</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Blackshear</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Kallen</surname>
<given-names>CB</given-names>
</name>
</person-group>
<article-title>mRNA-binding protein ZFP36 is expressed in atherosclerotic lesions and reduces inflammation in aortic endothelial cells</article-title>
<source>Arterioscler Thromb Vasc Biol</source>
<year>2013</year>
<volume>33</volume>
<issue>6</issue>
<fpage>1212</fpage>
<lpage>1220</lpage>
<pub-id pub-id-type="doi">10.1161/ATVBAHA.113.301496</pub-id>
</element-citation>
</ref>
<ref id="R265">
<label>265</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>YT</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>YN</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>YY</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>BD</given-names>
</name>
</person-group>
<article-title>Association of Egr3 genetic polymorphisms and coronary artery disease in the Uygur and Han of China</article-title>
<source>Lipids Health Dis</source>
<year>2014</year>
<volume>13</volume>
<fpage>84</fpage>
<pub-id pub-id-type="doi">10.1186/1476-511X-13-84</pub-id>
</element-citation>
</ref>
<ref id="R266">
<label>266</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Jing</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Association study of genetic variants at newly identified lipid gene TRIB1 with coronary heart disease in Chinese Han population</article-title>
<source>Lipids Health Dis</source>
<year>2015</year>
<volume>14</volume>
<fpage>46</fpage>
<pub-id pub-id-type="doi">10.1186/s12944-015-0043-0</pub-id>
</element-citation>
</ref>
<ref id="R267">
<label>267</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xiang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Zou</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>PX</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>LITAF acts as a novel regulator for pathological cardiac hypertrophy</article-title>
<source>J Mol Cell Cardiol</source>
<year>2021</year>
<volume>156</volume>
<fpage>82</fpage>
<lpage>94</lpage>
<pub-id pub-id-type="doi">10.1016/j.yjmcc.2021.03.012</pub-id>
</element-citation>
</ref>
<ref id="R268">
<label>268</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Gou</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zuo</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Estradiol improves cardiovascular function through up-regulation of SOD2 on vascular wall</article-title>
<source>Redox Biol</source>
<year>2014</year>
<volume>3</volume>
<fpage>88</fpage>
<lpage>99</lpage>
<pub-id pub-id-type="doi">10.1016/j.redox.2014.11.001</pub-id>
</element-citation>
</ref>
<ref id="R269">
<label>269</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hilgendorf</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Gerhardt</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>TC</given-names>
</name>
<name>
<surname>Winter</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Holderried</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Chousterman</surname>
<given-names>BG</given-names>
</name>
<name>
<surname>Iwamoto</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Zirlik</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Scherer-Crosbie</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>
<article-title>Ly-6Chigh monocytes depend on Nr4a1 to balance both inflammatory and reparative phases in the infarcted myocardium</article-title>
<source>Circ Res</source>
<year>2014</year>
<volume>114</volume>
<issue>10</issue>
<fpage>1611</fpage>
<lpage>1622</lpage>
<pub-id pub-id-type="doi">10.1161/CIRCRESAHA.114.303204</pub-id>
</element-citation>
</ref>
<ref id="R270">
<label>270</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wei</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Corbalán-Campos</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Heyll</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Weber</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Schober</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Regulation of Csf1r and Bcl6 in macrophages mediates the stage-specific effects of microRNA-155 on atherosclerosis</article-title>
<source>Arterioscler Thromb Vasc Biol</source>
<year>2015</year>
<volume>35</volume>
<issue>4</issue>
<fpage>796</fpage>
<lpage>803</lpage>
<pub-id pub-id-type="doi">10.1161/ATVBAHA.114.304723</pub-id>
</element-citation>
</ref>
<ref id="R271">
<label>271</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Swerdlow</surname>
<given-names>DI</given-names>
</name>
<name>
<surname>Holmes</surname>
<given-names>MV</given-names>
</name>
<name>
<surname>Kuchenbaecker</surname>
<given-names>KB</given-names>
</name>
<name>
<surname>Engmann</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Shah</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Sofat</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Peasey</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pfister</surname>
<given-names>R</given-names>
</name>
<etal/>
</person-group>
<article-title>The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis</article-title>
<source>Lancet</source>
<year>2012</year>
<volume>379</volume>
<issue>9822</issue>
<fpage>1214</fpage>
<lpage>1224</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(12)60110-X</pub-id>
</element-citation>
</ref>
<ref id="R272">
<label>272</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krolikoski</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Monslow</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Puré</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>The CD44-HA axis and inflammation in atherosclerosis: A temporal perspective</article-title>
<source>Matrix Biol</source>
<year>2019</year>
<volume>78-79</volume>
<fpage>201</fpage>
<lpage>218</lpage>
<pub-id pub-id-type="doi">10.1016/j.matbio.2018.05.007</pub-id>
</element-citation>
</ref>
<ref id="R273">
<label>273</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname>
<given-names>RF</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>HZ</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>YM</given-names>
</name>
<name>
<surname>He</surname>
<given-names>HQ</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>CY</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>ZC</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>ZP</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Panax Notoginseng Saponins Inhibits Ventricular Remodeling after Myocardial Infarction in Rats Through Regulating ATF3/MAP2K3/p38 MAPK and NF κ B Pathway</article-title>
<source>Chin J Integr Med</source>
<year>2020</year>
<volume>26</volume>
<issue>12</issue>
<fpage>897</fpage>
<lpage>904</lpage>
<pub-id pub-id-type="doi">10.1007/s11655-020-2856-6</pub-id>
</element-citation>
</ref>
<ref id="R274">
<label>274</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Song</surname>
<given-names>KY</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>XZ</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>QR</given-names>
</name>
</person-group>
<article-title>Silencing of ATP2B1-AS1 contributes to protection against myocardial infarction in mouse via blocking NFKBIA-mediated NF-κB signalling pathway</article-title>
<source>J Cell Mol Med</source>
<year>2020</year>
<volume>24</volume>
<issue>8</issue>
<fpage>4466</fpage>
<lpage>4479</lpage>
<pub-id pub-id-type="doi">10.1111/jcmm.15105</pub-id>
</element-citation>
</ref>
<ref id="R275">
<label>275</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>FJ</given-names>
</name>
<name>
<surname>Hsieh</surname>
<given-names>CY</given-names>
</name>
<name>
<surname>Shu</surname>
<given-names>KH</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>IY</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>SY</given-names>
</name>
<name>
<surname>Chuang</surname>
<given-names>YF</given-names>
</name>
<name>
<surname>Chiu</surname>
<given-names>YL</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>WS</given-names>
</name>
</person-group>
<article-title>Plasma Leucine-Rich α-2-Glycoprotein 1 Predicts Cardiovascular Disease Risk in End-Stage Renal Disease</article-title>
<source>Sci Rep</source>
<year>2020</year>
<volume>10</volume>
<issue>1</issue>
<elocation-id>5988</elocation-id>
<pub-id pub-id-type="doi">10.1038/s41598-020-62989-7</pub-id>
</element-citation>
</ref>
<ref id="R276">
<label>276</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Lv</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>HIF-1/AKT Signaling-Activated PFKFB2 Alleviates Cardiac Dysfunction and Cardiomyocyte Apoptosis in Response to Hypoxia</article-title>
<source>Int Heart J</source>
<year>2021</year>
<volume>62</volume>
<issue>2</issue>
<fpage>350</fpage>
<lpage>358</lpage>
<pub-id pub-id-type="doi">10.1536/ihj.20-315</pub-id>
</element-citation>
</ref>
<ref id="R277">
<label>277</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Virbasius</surname>
<given-names>JV</given-names>
</name>
<name>
<surname>Czech</surname>
<given-names>MP</given-names>
</name>
</person-group>
<article-title>Map4k4 Signaling Nodes in Metabolic and Cardiovascular Diseases</article-title>
<source>Trends Endocrinol Metab</source>
<year>2016</year>
<volume>27</volume>
<issue>7</issue>
<fpage>484</fpage>
<lpage>492</lpage>
<pub-id pub-id-type="doi">10.1016/j.tem.2016.04.006</pub-id>
</element-citation>
</ref>
<ref id="R278">
<label>278</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kardys</surname>
<given-names>I</given-names>
</name>
<name>
<surname>van Tiel</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>de Vries</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Pannekoek</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Uitterlinden</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Hofman</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Witteman</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>de Maat</surname>
<given-names>MP</given-names>
</name>
</person-group>
<article-title>Haplotypes of the NR4A2/NURR1 gene and cardiovascular disease: the Rotterdam Study</article-title>
<source>Hum Mutat</source>
<year>2009</year>
<volume>30</volume>
<issue>3</issue>
<fpage>417</fpage>
<lpage>423</lpage>
<pub-id pub-id-type="doi">10.1002/humu.20902</pub-id>
</element-citation>
</ref>
<ref id="R279">
<label>279</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>González-Navarro</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Vinué</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Vila-Caballer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Fortuño</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Beloqui</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Zalba</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Burks</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Díez</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Andrés</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>Molecular mechanisms of atherosclerosis in metabolic syndrome: role of reduced IRS2-dependent signaling</article-title>
<source>Arterioscler Thromb Vasc Biol</source>
<year>2008</year>
<volume>28</volume>
<issue>12</issue>
<fpage>2187</fpage>
<lpage>2194</lpage>
<pub-id pub-id-type="doi">10.1161/ATVBAHA.108.175299</pub-id>
</element-citation>
</ref>
<ref id="R280">
<label>280</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Song</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Association between TNIP1, MPHOSPH6 and ZNF208 genetic polymorphisms and the coronary artery disease risk in Chinese Han population</article-title>
<source>Oncotarget</source>
<year>2017</year>
<volume>8</volume>
<issue>44</issue>
<fpage>77233</fpage>
<lpage>77240</lpage>
<pub-id pub-id-type="doi">10.18632/oncotarget.20432</pub-id>
</element-citation>
</ref>
<ref id="R281">
<label>281</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>CF</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>YY</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Hsu</surname>
<given-names>SF</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>YW</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>CY</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>CW</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>SN</given-names>
</name>
<name>
<surname>Shih</surname>
<given-names>RH</given-names>
</name>
<name>
<surname>Hsu</surname>
<given-names>SD</given-names>
</name>
<etal/>
</person-group>
<article-title>Targeting protein tyrosine phosphatase PTP-PEST (PTPN12) for therapeutic intervention in acute myocardial infarction</article-title>
<source>Cardiovasc Res</source>
<year>2020</year>
<volume>116</volume>
<issue>5</issue>
<fpage>1032</fpage>
<lpage>1046</lpage>
<pub-id pub-id-type="doi">10.1093/cvr/cvz165</pub-id>
</element-citation>
</ref>
<ref id="R282">
<label>282</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hirokawa</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Morita</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Tajima</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ashikawa</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Miya</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Shigemizu</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Ozaki</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Sakata</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Nakatani</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group>
<article-title>A genome-wide association study identifies PLCL2 and AP3D1-DOT1L-SF3A2 as new susceptibility loci for myocardial infarction in Japanese</article-title>
<source>Eur J Hum Genet</source>
<year>2015</year>
<volume>23</volume>
<issue>3</issue>
<fpage>374</fpage>
<lpage>380</lpage>
<pub-id pub-id-type="doi">10.1038/ejhg.2014.110</pub-id>
</element-citation>
</ref>
<ref id="R283">
<label>283</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tian</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>PPARG, AGTR1, CXCL16 and LGALS2 polymorphisms are correlated with the risk for coronary heart disease</article-title>
<source>Int J Clin Exp Pathol</source>
<year>2015</year>
<volume>8</volume>
<issue>3</issue>
<fpage>3138</fpage>
<lpage>3143</lpage>
</element-citation>
</ref>
<ref id="R284">
<label>284</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Silva</surname>
<given-names>CT</given-names>
</name>
<name>
<surname>Zorkoltseva</surname>
<given-names>IV</given-names>
</name>
<name>
<surname>Niemeijer</surname>
<given-names>MN</given-names>
</name>
<name>
<surname>van den Berg</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Amin</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Demirkan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>van Leeuwen</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Iglesias</surname>
<given-names>AI</given-names>
</name>
<name>
<surname>Piñeros-Hernández</surname>
<given-names>LB</given-names>
</name>
<name>
<surname>Restrepo</surname>
<given-names>CM</given-names>
</name>
<etal/>
</person-group>
<article-title>A combined linkage, microarray and exome analysis suggests MAP3K11 as a candidate gene for left ventricular hypertrophy</article-title>
<source>BMC Med Genomics</source>
<year>2018</year>
<volume>11</volume>
<issue>1</issue>
<fpage>22</fpage>
<pub-id pub-id-type="doi">10.1186/s12920-018-0339-9</pub-id>
</element-citation>
</ref>
<ref id="R285">
<label>285</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Al-Eitan</surname>
<given-names>LN</given-names>
</name>
<name>
<surname>Elsaqa</surname>
<given-names>BZ</given-names>
</name>
<name>
<surname>Almasri</surname>
<given-names>AY</given-names>
</name>
<name>
<surname>Aman</surname>
<given-names>HA</given-names>
</name>
<name>
<surname>Khasawneh</surname>
<given-names>RH</given-names>
</name>
<name>
<surname>Alghamdi</surname>
<given-names>MA</given-names>
</name>
</person-group>
<article-title>Influence of PSRC1, CELSR2, and SORT1 Gene Polymorphisms on the Variability of Warfarin Dosage and Susceptibility to Cardiovascular Disease</article-title>
<source>Pharmgenomics Pers Med</source>
<year>2020</year>
<volume>13</volume>
<fpage>619</fpage>
<lpage>632</lpage>
<pub-id pub-id-type="doi">10.2147/PGPM.S274246</pub-id>
</element-citation>
</ref>
<ref id="R286">
<label>286</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Su</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>H</given-names>
</name>
<name>
<surname>McAlister</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Lacefield</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Quan</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Mele</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Greasley</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>K</given-names>
</name>
<etal/>
</person-group>
<article-title>Circular RNA Foxo3 in cardiac ischemia-reperfusion injury in heart transplantation: A new regulator and target</article-title>
<source>Am J Transplant</source>
<year>2021</year>
<volume>21</volume>
<issue>9</issue>
<fpage>2992</fpage>
<lpage>3004</lpage>
<pub-id pub-id-type="doi">10.1111/ajt.16475</pub-id>
</element-citation>
</ref>
<ref id="R287">
<label>287</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Makino</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Toyofuku</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Takegahara</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Takamatsu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Okuno</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Nakagawa</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Nojima</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hori</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kikutani</surname>
<given-names>H</given-names>
</name>
<etal/>
</person-group>
<article-title>Involvement of Sema4A in the progression of experimental autoimmune myocarditis</article-title>
<source>FEBS Lett</source>
<year>2008</year>
<volume>582</volume>
<issue>28</issue>
<fpage>3935</fpage>
<lpage>3940</lpage>
<pub-id pub-id-type="doi">10.1016/j.febslet.2008.10.040</pub-id>
</element-citation>
</ref>
<ref id="R288">
<label>288</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Long</surname>
<given-names>TY</given-names>
</name>
<name>
<surname>Bi</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Sheikh</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>CircPAN3 ameliorates myocardial ischaemia/reperfusion injury by targeting miR-421/Pink1 axis-mediated autophagy suppression</article-title>
<source>Lab Invest</source>
<year>2021</year>
<volume>101</volume>
<issue>1</issue>
<fpage>89</fpage>
<lpage>103</lpage>
<pub-id pub-id-type="doi">10.1038/s41374-020-00483-4</pub-id>
</element-citation>
</ref>
<ref id="R289">
<label>289</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sopić</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Joksić</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Spasojević-Kalimanovska</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Kalimanovska-Oštrić</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Anđelković</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Jelić-Ivanović</surname>
<given-names>Z</given-names>
</name>
</person-group>
<article-title>Are decreased AdipoR1 mRNA levels associated with adiponectin resistance in coronary artery disease patients?</article-title>
<source>Clin Exp Pharmacol Physiol</source>
<year>2015</year>
<volume>42</volume>
<issue>4</issue>
<fpage>331</fpage>
<lpage>336</lpage>
<pub-id pub-id-type="doi">10.1111/1440-1681.12361</pub-id>
</element-citation>
</ref>
<ref id="R290">
<label>290</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Gong</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>P</given-names>
</name>
<etal/>
</person-group>
<article-title>Association of SGK1 Polymorphisms With Susceptibility to Coronary Heart Disease in Chinese Han Patients With Comorbid Depression</article-title>
<source>Front Genet</source>
<year>2019</year>
<volume>10</volume>
<fpage>921</fpage>
<pub-id pub-id-type="doi">10.3389/fgene.2019.00921</pub-id>
</element-citation>
</ref>
<ref id="R291">
<label>291</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>miR-194-5p protects against myocardial ischemia/reperfusion injury via MAPK1/PTEN/AKT pathway</article-title>
<source>Ann Transl Med</source>
<year>2021</year>
<volume>9</volume>
<issue>8</issue>
<fpage>654</fpage>
<pub-id pub-id-type="doi">10.21037/atm-21-807</pub-id>
</element-citation>
</ref>
<ref id="R292">
<label>292</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hedberg-Oldfors</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Abramsson</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Osborn</surname>
<given-names>DPS</given-names>
</name>
<name>
<surname>Danielsson</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Fazlinezhad</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Nilipour</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hübbert</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Nennesmo</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Visuttijai</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Bharj</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>
<article-title>Cardiomyopathy with lethal arrhythmias associated with inactivation of KLHL24</article-title>
<source>Hum Mol Genet</source>
<year>2019</year>
<volume>28</volume>
<issue>11</issue>
<fpage>1919</fpage>
<lpage>1929</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddz032</pub-id>
</element-citation>
</ref>
<ref id="R293">
<label>293</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>WR</given-names>
</name>
<name>
<surname>Joseph</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Caracciolo</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Gonzales</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Sidell</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Seli</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Blackshear</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Kallen</surname>
<given-names>CB</given-names>
</name>
</person-group>
<article-title>mRNA-binding protein ZFP36 is expressed in atherosclerotic lesions and reduces inflammation in aortic endothelial cells</article-title>
<source>Arterioscler Thromb Vasc Biol</source>
<year>2013</year>
<volume>33</volume>
<issue>6</issue>
<fpage>1212</fpage>
<lpage>1220</lpage>
<pub-id pub-id-type="doi">10.1161/ATVBAHA.113.301496</pub-id>
</element-citation>
</ref>
<ref id="R294">
<label>294</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poels</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Schnitzler</surname>
<given-names>JG</given-names>
</name>
<name>
<surname>Waissi</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Levels</surname>
<given-names>JHM</given-names>
</name>
<name>
<surname>Stroes</surname>
<given-names>ESG</given-names>
</name>
<name>
<surname>Daemen</surname>
<given-names>MJAP</given-names>
</name>
<name>
<surname>Lutgens</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Pennekamp</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>De Kleijn</surname>
<given-names>DPV</given-names>
</name>
<name>
<surname>Seijkens</surname>
<given-names>TTP</given-names>
</name>
<etal/>
</person-group>
<article-title>Inhibition of PFKFB3 Hampers the Progression of Atherosclerosis and Promotes Plaque Stability</article-title>
<source>Front Cell Dev Biol</source>
<year>2020</year>
<volume>8</volume>
<elocation-id>581641</elocation-id>
<pub-id pub-id-type="doi">10.3389/fcell.2020.581641</pub-id>
</element-citation>
</ref>
<ref id="R295">
<label>295</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fredriksson</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Anevski</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Almgren</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Sjögren</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lyssenko</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Carlson</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Isomaa</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Taskinen</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Groop</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Orho-Melander</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>
<article-title>Variation in GYS1 interacts with exercise and gender to predict cardiovascular mortality</article-title>
<source>PLoS One</source>
<year>2007</year>
<volume>2</volume>
<issue>3</issue>
<elocation-id>e285</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0000285</pub-id>
</element-citation>
</ref>
<ref id="R296">
<label>296</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>X</given-names>
</name>
</person-group>
<article-title>ETS2 and microRNA-155 regulate the pathogenesis of heart failure through targeting and regulating GPR18 expression</article-title>
<source>Exp Ther Med</source>
<year>2020</year>
<volume>19</volume>
<issue>6</issue>
<fpage>3469</fpage>
<lpage>3478</lpage>
<pub-id pub-id-type="doi">10.3892/etm.2020.8642</pub-id>
</element-citation>
</ref>
<ref id="R297">
<label>297</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Z</given-names>
</name>
</person-group>
<article-title>MicroRNA-200a-3p Is a Positive Regulator in Cardiac Hypertrophy Through Directly Targeting WDR1 as Well as Modulating PTEN/PI3K/AKT/CREB/WDR1 Signaling</article-title>
<source>J Cardiovasc Pharmacol</source>
<year>2019</year>
<volume>74</volume>
<issue>5</issue>
<fpage>453</fpage>
<lpage>461</lpage>
<pub-id pub-id-type="doi">10.1097/FJC.0000000000000732</pub-id>
</element-citation>
</ref>
<ref id="R298">
<label>298</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rafiq</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Liaquat</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Saeed</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Shamshad</surname>
<given-names>GU</given-names>
</name>
<name>
<surname>Mumtaz</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>MJ</given-names>
</name>
</person-group>
<article-title>Gene expression of thrombomodulin, TNF-α and NF-KB in coronary artery disease patients of Pakistan</article-title>
<source>Mol Biol Rep</source>
<year>2020</year>
<volume>47</volume>
<issue>10</issue>
<fpage>7575</fpage>
<lpage>7582</lpage>
<pub-id pub-id-type="doi">10.1007/s11033-020-05824-6</pub-id>
</element-citation>
</ref>
<ref id="R299">
<label>299</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haarhaus</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Brandenburg</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Kalantar-Zadeh</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Stenvinkel</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Magnusson</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Alkaline phosphatase: a novel treatment target for cardiovascular disease in CKD</article-title>
<source>Nat Rev Nephrol</source>
<year>2017</year>
<volume>13</volume>
<issue>7</issue>
<fpage>429</fpage>
<lpage>442</lpage>
<pub-id pub-id-type="doi">10.1038/nrneph.2017.60</pub-id>
</element-citation>
</ref>
<ref id="R300">
<label>300</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ning</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>KLRD1, FOSL2 and LILRB3 as potential biomarkers for plaques progression in acute myocardial infarction and stable coronary artery disease</article-title>
<source>BMC Cardiovasc Disord</source>
<year>2021</year>
<volume>21</volume>
<issue>1</issue>
<fpage>344</fpage>
<pub-id pub-id-type="doi">10.1186/s12872-021-01997-5</pub-id>
</element-citation>
</ref>
<ref id="R301">
<label>301</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Decharatchakul</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Settasatian</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Settasatian</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Komanasin</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Kukongviriyapan</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Intharapetch</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Senthong</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Sawanyawisuth</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Association of combined genetic variations in SOD3, GPX3, PON1, and GSTT1 with hypertension and severity of coronary artery disease</article-title>
<source>Heart Vessels</source>
<year>2020</year>
<volume>35</volume>
<issue>7</issue>
<fpage>918</fpage>
<lpage>929</lpage>
<pub-id pub-id-type="doi">10.1007/s00380-020-01564-6</pub-id>
</element-citation>
</ref>
<ref id="R302">
<label>302</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Villa</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Venturelli</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Fenoglio</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Clerici</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Marcone</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Benussi</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ghidoni</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Gallone</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Cortini</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Scalabrini</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group>
<article-title>CCL8/MCP-2 association analysis in patients with Alzheimer's disease and frontotemporal lobar degeneration</article-title>
<source>J Neurol</source>
<year>2009</year>
<volume>256</volume>
<issue>8</issue>
<fpage>1379</fpage>
<lpage>1381</lpage>
<pub-id pub-id-type="doi">10.1007/s00415-009-5138-y</pub-id>
</element-citation>
</ref>
<ref id="R303">
<label>303</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Angelopoulou</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Paudel</surname>
<given-names>YN</given-names>
</name>
<name>
<surname>Villa</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Shaikh</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Piperi</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Lymphocyte-Activation Gene 3 (LAG3) Protein as a Possible Therapeutic Target for Parkinson's Disease: Molecular Mechanisms Connecting Neuroinflammation to α-Synuclein Spreading Pathology</article-title>
<source>Biology (Basel)</source>
<year>2020</year>
<volume>9</volume>
<issue>4</issue>
<fpage>86</fpage>
<pub-id pub-id-type="doi">10.3390/biology9040086</pub-id>
</element-citation>
</ref>
<ref id="R304">
<label>304</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Markowicz</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Schötta</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Kundi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bogovič</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Ogrinc</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Strle</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Stanek</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>CXCL13 concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other neurological disorders determined by Luminex and ELISA</article-title>
<source>Ticks Tick Borne Dis</source>
<year>2018</year>
<volume>9</volume>
<issue>5</issue>
<fpage>1137</fpage>
<lpage>1142</lpage>
<pub-id pub-id-type="doi">10.1016/j.ttbdis.2018.04.008</pub-id>
</element-citation>
</ref>
<ref id="R305">
<label>305</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bose</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Role of chemokine CCL2 and its receptor CCR2 in neurodegenerative diseases</article-title>
<source>Arch Pharm Res</source>
<year>2013</year>
<volume>36</volume>
<issue>9</issue>
<fpage>1039</fpage>
<lpage>1050</lpage>
<pub-id pub-id-type="doi">10.1007/s12272-013-0161-z</pub-id>
</element-citation>
</ref>
<ref id="R306">
<label>306</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>MacNair</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Miletic</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Ghani</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Julien</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Keith</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zinman</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Rogaeva</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Robertson</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>MTHFSD and DDX58 are novel RNA-binding proteins abnormally regulated in amyotrophic lateral sclerosis</article-title>
<source>Brain</source>
<year>2016</year>
<volume>139</volume>
<issue>Pt 1</issue>
<fpage>86</fpage>
<lpage>100</lpage>
<pub-id pub-id-type="doi">10.1093/brain/awv308</pub-id>
</element-citation>
</ref>
<ref id="R307">
<label>307</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Purves-Tyson</surname>
<given-names>TD</given-names>
</name>
<name>
<surname>Robinson</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Boerrigter</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>HQ</given-names>
</name>
<name>
<surname>Weissleder</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Owens</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Rothmond</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Shannon Weickert</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Increased Macrophages and C1qA, C3, C4 Transcripts in the Midbrain of People With Schizophrenia</article-title>
<source>Front Immunol</source>
<year>2020</year>
<volume>11</volume>
<elocation-id>2002</elocation-id>
<pub-id pub-id-type="doi">10.3389/fimmu.2020.02002</pub-id>
</element-citation>
</ref>
<ref id="R308">
<label>308</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zakharyan</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Khoyetsyan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Arakelyan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Boyajyan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gevorgyan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Stahelova</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mrazek</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Petrek</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Association of C1QB gene polymorphism with schizophrenia in Armenian population</article-title>
<source>BMC Med Genet</source>
<year>2011</year>
<volume>12</volume>
<fpage>126</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2350-12-126</pub-id>
</element-citation>
</ref>
<ref id="R309">
<label>309</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mohr</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Genain</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Social support as a buffer in the relationship between treatment for depression and T-cell production of interferon gamma in patients with multiple sclerosis</article-title>
<source>J Psychosom Res</source>
<year>2004</year>
<volume>57</volume>
<issue>2</issue>
<fpage>155</fpage>
<lpage>158</lpage>
<pub-id pub-id-type="doi">10.1016/S0022-3999(03)00601-9</pub-id>
</element-citation>
</ref>
<ref id="R310">
<label>310</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Butturini</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Boriero</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Carcereri de Prati</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mariotto</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>STAT1 drives M1 microglia activation and neuroinflammation under hypoxia</article-title>
<source>Arch Biochem Biophys</source>
<year>2019</year>
<volume>669</volume>
<fpage>22</fpage>
<lpage>30</lpage>
<pub-id pub-id-type="doi">10.1016/j.abb.2019.05.011</pub-id>
</element-citation>
</ref>
<ref id="R311">
<label>311</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Louboutin</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Strayer</surname>
<given-names>DS</given-names>
</name>
</person-group>
<article-title>Relationship between the chemokine receptor CCR5 and microglia in neurological disorders: consequences of targeting CCR5 on neuroinflammation, neuronal death and regeneration in a model of epilepsy</article-title>
<source>CNS Neurol Disord Drug Targets</source>
<year>2013</year>
<volume>12</volume>
<issue>6</issue>
<fpage>815</fpage>
<lpage>829</lpage>
<pub-id pub-id-type="doi">10.2174/18715273113126660173</pub-id>
</element-citation>
</ref>
<ref id="R312">
<label>312</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bennetts</surname>
<given-names>BH</given-names>
</name>
<name>
<surname>Teutsch</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Buhler</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Heard</surname>
<given-names>RN</given-names>
</name>
<name>
<surname>Stewart</surname>
<given-names>GJ</given-names>
</name>
</person-group>
<article-title>HLA-DMB gene and HLA-DRA promoter region polymorphisms in Australian multiple sclerosis patients</article-title>
<source>Hum Immunol</source>
<year>1999</year>
<volume>60</volume>
<issue>9</issue>
<fpage>886</fpage>
<lpage>893</lpage>
<pub-id pub-id-type="doi">10.1016/s0198-8859(99)00054-3</pub-id>
</element-citation>
</ref>
<ref id="R313">
<label>313</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peng</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S</given-names>
</name>
<name>
<surname>He</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>RD</given-names>
</name>
</person-group>
<article-title>The chemerin receptor CMKLR1 is a functional receptor for amyloid-β peptide</article-title>
<source>J Alzheimers Dis</source>
<year>2015</year>
<volume>43</volume>
<issue>1</issue>
<fpage>227</fpage>
<lpage>242</lpage>
<pub-id pub-id-type="doi">10.3233/JAD-141227</pub-id>
</element-citation>
</ref>
<ref id="R314">
<label>314</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lim</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>EY</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>SY</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>AH</given-names>
</name>
<name>
<surname>Abdul-Aziz</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Ibrahim</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Gopalai</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Tay</surname>
<given-names>YW</given-names>
</name>
<name>
<surname>Vijayanathan</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Toh</surname>
<given-names>TS</given-names>
</name>
<etal/>
</person-group>
<article-title>Association study of MCCC1/LAMP3 and DGKQ variants with Parkinson's disease in patients of Malay ancestry</article-title>
<source>Neurol Sci</source>
<year>2021</year>
<elocation-id>10.1007/s10072-021-05056-x</elocation-id>
<pub-id pub-id-type="doi">10.1007/s10072-021-05056-x</pub-id>
</element-citation>
</ref>
<ref id="R315">
<label>315</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sonon</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Collares</surname>
<given-names>CVA</given-names>
</name>
<name>
<surname>Ferreira</surname>
<given-names>MLB</given-names>
</name>
<name>
<surname>Almeida</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Sadissou</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Cordeiro</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>de Fátima Militão de Albuquerque</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Castelli</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>Lucena-Silva</surname>
<given-names>N</given-names>
</name>
<etal/>
</person-group>
<article-title>Peripheral spectrum neurological disorder after arbovirus infection is associated with HLA-F variants among Northeastern Brazilians</article-title>
<source>Infect Genet Evol</source>
<year>2021</year>
<volume>92</volume>
<elocation-id>104855</elocation-id>
<pub-id pub-id-type="doi">10.1016/j.meegid.2021.104855</pub-id>
</element-citation>
</ref>
<ref id="R316">
<label>316</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fainardi</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Rizzo</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Melchiorri</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Stignani</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Castellazzi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Caniatti</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Baldi</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Tola</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Granieri</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Baricordi</surname>
<given-names>OR</given-names>
</name>
<etal/>
</person-group>
<article-title>Soluble HLA-G molecules are released as HLA-G5 and not as soluble HLA-G1 isoforms in CSF of patients with relapsing-remitting multiple sclerosis</article-title>
<source>J Neuroimmunol</source>
<year>2007</year>
<volume>192</volume>
<issue>1–2</issue>
<fpage>219</fpage>
<lpage>225</lpage>
<pub-id pub-id-type="doi">10.1016/j.jneuroim.2007.10.002</pub-id>
</element-citation>
</ref>
<ref id="R317">
<label>317</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takada</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sakakima</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Matsuyama</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Otsuka</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Nakanishi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Norimatsu</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Itashiki</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Tani</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kikuchi</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Disruption of Midkine gene reduces traumatic brain injury through the modulation of neuroinflammation</article-title>
<source>J Neuroinflammation</source>
<year>2020</year>
<volume>17</volume>
<issue>1</issue>
<fpage>40</fpage>
<pub-id pub-id-type="doi">10.1186/s12974-020-1709-8</pub-id>
</element-citation>
</ref>
<ref id="R318">
<label>318</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>An</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>H3K27 demethylase KDM6B aggravates ischemic brain injury through demethylation of IRF4 and Notch2-dependent SOX9 activation</article-title>
<source>Mol Ther Nucleic Acids</source>
<year>2021</year>
<volume>24</volume>
<fpage>622</fpage>
<lpage>633</lpage>
<pub-id pub-id-type="doi">10.1016/j.omtn.2021.01.021</pub-id>
</element-citation>
</ref>
<ref id="R319">
<label>319</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Melbourne</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Rosen</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Feiner</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>RP</given-names>
</name>
</person-group>
<article-title>C4A mRNA expression in PBMCs predicts the presence and severity of delusions in schizophrenia and bipolar disorder with psychosis</article-title>
<source>Schizophr Res</source>
<year>2018</year>
<volume>197</volume>
<fpage>321</fpage>
<lpage>327</lpage>
<pub-id pub-id-type="doi">10.1016/j.schres.2018.01.018</pub-id>
</element-citation>
</ref>
<ref id="R320">
<label>320</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Calame</surname>
<given-names>DG</given-names>
</name>
<name>
<surname>Hainlen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Takacs</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Ferrante</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Pence</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Emrick</surname>
<given-names>LT</given-names>
</name>
<name>
<surname>Chao</surname>
<given-names>HT</given-names>
</name>
</person-group>
<article-title>EIF2AK2-related Neurodevelopmental Disorder With Leukoencephalopathy, Developmental Delay, and Episodic Neurologic Regression Mimics Pelizaeus-Merzbacher Disease</article-title>
<source>Neurol Genet</source>
<year>2020</year>
<volume>7</volume>
<issue>1</issue>
<elocation-id>e539</elocation-id>
<pub-id pub-id-type="doi">10.1212/NXG.0000000000000539</pub-id>
</element-citation>
</ref>
<ref id="R321">
<label>321</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>An</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>HLA-DRA/HLA-DRB5 polymorphism affects risk of sporadic ALS and survival in a southwest Chinese cohort</article-title>
<source>J Neurol Sci</source>
<year>2017</year>
<volume>373</volume>
<fpage>124</fpage>
<lpage>128</lpage>
<pub-id pub-id-type="doi">10.1016/j.jns.2016.12.055</pub-id>
</element-citation>
</ref>
<ref id="R322">
<label>322</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cardamone</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Paraboschi</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Rimoldi</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Duga</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Soldà</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Asselta</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>The Characterization of GSDMB Splicing and Backsplicing Profiles Identifies Novel Isoforms and a Circular RNA That Are Dysregulated in Multiple Sclerosis</article-title>
<source>Int J Mol Sci</source>
<year>2017</year>
<volume>18</volume>
<issue>3</issue>
<fpage>576</fpage>
<pub-id pub-id-type="doi">10.3390/ijms18030576</pub-id>
</element-citation>
</ref>
<ref id="R323">
<label>323</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Enose-Akahata</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Matsuura</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Oh</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Jacobson</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>High expression of CD244 and SAP regulated CD8 T cell responses of patients with HTLV-I associated neurologic disease</article-title>
<source>PLoS Pathog</source>
<year>2009</year>
<volume>5</volume>
<issue>12</issue>
<elocation-id>e1000682</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.ppat.1000682</pub-id>
</element-citation>
</ref>
<ref id="R324">
<label>324</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rosenmann</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Meiner</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Kahana</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Aladjem</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Friedman</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Ben-Yehuda</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Grenader</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Wertman</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Abramsky</surname>
<given-names>O</given-names>
</name>
</person-group>
<article-title>A polymorphism in the complement component C1r is not associated with sporadic Alzheimer's disease</article-title>
<source>Neurosci Lett</source>
<year>2003</year>
<volume>336</volume>
<issue>2</issue>
<fpage>101</fpage>
<lpage>104</lpage>
<pub-id pub-id-type="doi">10.1016/s0304-3940(02)01218-1</pub-id>
</element-citation>
</ref>
<ref id="R325">
<label>325</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schindler</surname>
<given-names>MK</given-names>
</name>
<name>
<surname>Pittaluga</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Enose-Akahata</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>Rao</surname>
<given-names>VK</given-names>
</name>
<name>
<surname>Rump</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Jacobson</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Cortese</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Reich</surname>
<given-names>DS</given-names>
</name>
<name>
<surname>Uzel</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Haploinsufficiency of immune checkpoint receptor CTLA4 induces a distinct neuroinflammatory disorder</article-title>
<source>J Clin Invest</source>
<year>2020</year>
<volume>130</volume>
<issue>10</issue>
<fpage>5551</fpage>
<lpage>5561</lpage>
<pub-id pub-id-type="doi">10.1172/JCI135947</pub-id>
</element-citation>
</ref>
<ref id="R326">
<label>326</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guerreiro</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Privat</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Bressac</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Toulorge</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>CD38 in Neurodegeneration and Neuroinflammation</article-title>
<source>Cells</source>
<year>2020</year>
<volume>9</volume>
<issue>2</issue>
<fpage>471</fpage>
<pub-id pub-id-type="doi">10.3390/cells9020471</pub-id>
</element-citation>
</ref>
<ref id="R327">
<label>327</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pawelec</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Ziemka-Nalecz</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sypecka</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zalewska</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>The Impact of the CX3CL1/CX3CR1 Axis in Neurological Disorders</article-title>
<source>Cells</source>
<year>2020</year>
<volume>9</volume>
<issue>10</issue>
<elocation-id>2277</elocation-id>
<pub-id pub-id-type="doi">10.3390/cells9102277</pub-id>
</element-citation>
</ref>
<ref id="R328">
<label>328</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ahmed</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Tamouza</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Delord</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Krishnamoorthy</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Tzourio</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Mulot</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Nacfer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lambert</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Beaune</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Laurent-Puig</surname>
<given-names>P</given-names>
</name>
<etal/>
</person-group>
<article-title>Association between Parkinson's disease and the HLA-DRB1 locus</article-title>
<source>Mov Disord</source>
<year>2012</year>
<volume>27</volume>
<issue>9</issue>
<fpage>1104</fpage>
<lpage>1110</lpage>
<pub-id pub-id-type="doi">10.1002/mds.25035</pub-id>
</element-citation>
</ref>
<ref id="R329">
<label>329</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>YK</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>JG</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>The emerging roles of absent in melanoma 2 (AIM2) inflammasome in central nervous system disorders</article-title>
<source>Neurochem Int</source>
<year>2021</year>
<volume>149</volume>
<elocation-id>105122</elocation-id>
<pub-id pub-id-type="doi">10.1016/j.neuint.2021.105122</pub-id>
</element-citation>
</ref>
<ref id="R330">
<label>330</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trend</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Leffler</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cooper</surname>
<given-names>MN</given-names>
</name>
<name>
<surname>Byrne</surname>
<given-names>SN</given-names>
</name>
<name>
<surname>Kermode</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>French</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Hart</surname>
<given-names>PH</given-names>
</name>
</person-group>
<article-title>Narrowband UVB phototherapy reduces TNF production by B-cell subsets stimulated via TLR7 from individuals with early multiple sclerosis</article-title>
<source>Clin Transl Immunology</source>
<year>2020</year>
<volume>9</volume>
<issue>10</issue>
<elocation-id>e1197</elocation-id>
<pub-id pub-id-type="doi">10.1002/cti2.1197</pub-id>
</element-citation>
</ref>
<ref id="R331">
<label>331</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chorąży</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wawrusiewicz-Kurylonek</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Posmyk</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Zajkowska</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kapica-Topczewska</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Krętowski</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Kochanowicz</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kułakowska</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Analysis of chosen SNVs in GPC5, CD58 and IRF8 genes in multiple sclerosis patients</article-title>
<source>Adv Med Sci</source>
<year>2019</year>
<volume>64</volume>
<issue>2</issue>
<fpage>230</fpage>
<lpage>234</lpage>
<pub-id pub-id-type="doi">10.1016/j.advms.2018.12.004</pub-id>
</element-citation>
</ref>
<ref id="R332">
<label>332</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Melchior</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Garcia</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Hsiung</surname>
<given-names>BK</given-names>
</name>
<name>
<surname>Lo</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Doose</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Thrash</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Stalder</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Staufenbiel</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Neumann</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Carson</surname>
<given-names>MJ</given-names>
</name>
</person-group>
<article-title>Dual induction of TREM2 and tolerance-related transcript, Tmem176b, in amyloid transgenic mice: implications for vaccine-based therapies for Alzheimer's disease</article-title>
<source>ASN Neuro</source>
<year>2010</year>
<volume>2</volume>
<issue>3</issue>
<elocation-id>e00037</elocation-id>
<pub-id pub-id-type="doi">10.1042/AN20100010</pub-id>
</element-citation>
</ref>
<ref id="R333">
<label>333</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lennon</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>SP</given-names>
</name>
<name>
<surname>Lovelace</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Guillemin</surname>
<given-names>GJ</given-names>
</name>
<name>
<surname>Brew</surname>
<given-names>BJ</given-names>
</name>
</person-group>
<article-title>Bcl11b: A New Piece to the Complex Puzzle of Amyotrophic Lateral Sclerosis Neuropathogenesis?</article-title>
<source>Neurotox Res</source>
<year>2016</year>
<volume>29</volume>
<issue>2</issue>
<fpage>201</fpage>
<lpage>207</lpage>
<pub-id pub-id-type="doi">10.1007/s12640-015-9573-5</pub-id>
</element-citation>
</ref>
<ref id="R334">
<label>334</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bullido</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Martínez-García</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Artiga</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Aldudo</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sastre</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Gil</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Coria</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Muñoz</surname>
<given-names>DG</given-names>
</name>
<name>
<surname>Hachinski</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Frank</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>
<article-title>A TAP2 genotype associated with Alzheimer's disease in APOE4 carriers</article-title>
<source>Neurobiol Aging</source>
<year>2007</year>
<volume>28</volume>
<issue>4</issue>
<fpage>519</fpage>
<lpage>523</lpage>
<pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2006.02.011</pub-id>
</element-citation>
</ref>
<ref id="R335">
<label>335</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Waldner</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Dassati</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Redl</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Smania</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Gandolfi</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Apolipoprotein D Concentration in Human Plasma during Aging and in Parkinson's Disease: A Cross-Sectional Study</article-title>
<source>Parkinsons Dis</source>
<year>2018</year>
<volume>2018</volume>
<elocation-id>3751516</elocation-id>
<pub-id pub-id-type="doi">10.1155/2018/3751516</pub-id>
</element-citation>
</ref>
<ref id="R336">
<label>336</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khorramdelazad</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Bagheri</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Hassanshahi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Zeinali</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Vakilian</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>New insights into the role of stromal cell-derived factor 1 (SDF-1/CXCL12) in the pathophysiology of multiple sclerosis</article-title>
<source>J Neuroimmunol</source>
<year>2016</year>
<volume>290</volume>
<fpage>70</fpage>
<lpage>75</lpage>
<pub-id pub-id-type="doi">10.1016/j.jneuroim.2015.11.021</pub-id>
</element-citation>
</ref>
<ref id="R337">
<label>337</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lukiw</surname>
<given-names>WJ</given-names>
</name>
<name>
<surname>Alexandrov</surname>
<given-names>PN</given-names>
</name>
</person-group>
<article-title>Regulation of complement factor H (CFH) by multiple miRNAs in Alzheimer's disease (AD) brain</article-title>
<source>Mol Neurobiol</source>
<year>2012</year>
<volume>46</volume>
<issue>1</issue>
<fpage>11</fpage>
<lpage>19</lpage>
<pub-id pub-id-type="doi">10.1007/s12035-012-8234-4</pub-id>
</element-citation>
</ref>
<ref id="R338">
<label>338</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gong</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Ouyang</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>Interleukin 32: A novel player in perioperative neurocognitive disorders</article-title>
<source>Med Hypotheses</source>
<year>2020</year>
<volume>144</volume>
<elocation-id>110158</elocation-id>
<pub-id pub-id-type="doi">10.1016/j.mehy.2020.110158</pub-id>
</element-citation>
</ref>
<ref id="R339">
<label>339</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Jiao</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Mao</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>NLRC5: A Potential Target for Central Nervous System Disorders</article-title>
<source>Front Immunol</source>
<year>2021</year>
<volume>12</volume>
<elocation-id>704989</elocation-id>
<pub-id pub-id-type="doi">10.3389/fimmu.2021.704989</pub-id>
</element-citation>
</ref>
<ref id="R340">
<label>340</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Griciuc</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Federico</surname>
<given-names>AN</given-names>
</name>
<name>
<surname>Natasan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Forte</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>McGinty</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Volak</surname>
<given-names>A</given-names>
</name>
<name>
<surname>LeRoy</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gandhi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lerner</surname>
<given-names>EP</given-names>
</name>
<etal/>
</person-group>
<article-title>Gene therapy for Alzheimer's disease targeting CD33 reduces amyloid beta accumulation and neuroinflammation</article-title>
<source>Hum Mol Genet</source>
<year>2020</year>
<volume>29</volume>
<issue>17</issue>
<fpage>2920</fpage>
<lpage>2935</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddaa179</pub-id>
</element-citation>
</ref>
<ref id="R341">
<label>341</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cui</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>The Altered Anatomical Distribution of ACE2 in the Brain With Alzheimer's Disease Pathology</article-title>
<source>Front Cell Dev Biol</source>
<year>2021</year>
<volume>9</volume>
<elocation-id>684874</elocation-id>
<pub-id pub-id-type="doi">10.3389/fcell.2021.684874</pub-id>
</element-citation>
</ref>
<ref id="R342">
<label>342</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lioudyno</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Abdurasulova</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Negoreeva</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Stoliarov</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Kudriavtsev</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Serebryakova</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Klimenko</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Lioudyno</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>A common genetic variant rs2821557 in KCNA3 is linked to the severity of multiple sclerosis</article-title>
<source>J Neurosci Res</source>
<year>2021</year>
<volume>99</volume>
<issue>1</issue>
<fpage>200</fpage>
<lpage>208</lpage>
<pub-id pub-id-type="doi">10.1002/jnr.24596</pub-id>
</element-citation>
</ref>
<ref id="R343">
<label>343</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>KD</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>PT</given-names>
</name>
<name>
<surname>Ping</surname>
<given-names>YH</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>Yeh</surname>
<given-names>CW</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>PN</given-names>
</name>
</person-group>
<article-title>Gene expression profiling of peripheral blood leukocytes identifies and validates ABCB1 as a novel biomarker for Alzheimer's disease</article-title>
<source>Neurobiol Dis</source>
<year>2011</year>
<volume>43</volume>
<issue>3</issue>
<fpage>698</fpage>
<lpage>705</lpage>
<pub-id pub-id-type="doi">10.1016/j.nbd.2011.05.023</pub-id>
</element-citation>
</ref>
<ref id="R344">
<label>344</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>El Achkar</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Harrer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Kelly</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Iqbal</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Maljevic</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Niturad</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Vissers</surname>
<given-names>LELM</given-names>
</name>
<name>
<surname>Poduri</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>E</given-names>
</name>
<etal/>
</person-group>
<article-title>Characterization of the GABRB2-Associated Neurodevelopmental Disorders</article-title>
<source>Ann Neurol</source>
<year>2021</year>
<volume>89</volume>
<issue>3</issue>
<fpage>573</fpage>
<lpage>586</lpage>
<pub-id pub-id-type="doi">10.1002/ana.25985</pub-id>
</element-citation>
</ref>
<ref id="R345">
<label>345</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Verma</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Mukerji</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Grover</surname>
<given-names>D</given-names>
</name>
<name>
<surname>B-Rao</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Das</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Kubendran</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Jain</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Brahmachari</surname>
<given-names>SK</given-names>
</name>
</person-group>
<article-title>MLC1 gene is associated with schizophrenia and bipolar disorder in Southern India</article-title>
<source>Biol Psychiatry</source>
<year>2005</year>
<volume>58</volume>
<issue>1</issue>
<fpage>16</fpage>
<lpage>22</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2005.03.027</pub-id>
</element-citation>
</ref>
<ref id="R346">
<label>346</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Döring</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Schröter</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Jüngling</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Biskup</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Klotz</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Bast</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Dietel</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Korenke</surname>
<given-names>GC</given-names>
</name>
<name>
<surname>Christoph</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Brennenstuhl</surname>
<given-names>H</given-names>
</name>
<etal/>
</person-group>
<article-title>Refining Genotypes and Phenotypes in KCNA2-Related Neurological Disorders</article-title>
<source>Int J Mol Sci</source>
<year>2021</year>
<volume>22</volume>
<issue>6</issue>
<elocation-id>2824</elocation-id>
<pub-id pub-id-type="doi">10.3390/ijms22062824</pub-id>
</element-citation>
</ref>
<ref id="R347">
<label>347</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haerian</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Sha'ari</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Fong</surname>
<given-names>CY</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Ong</surname>
<given-names>LC</given-names>
</name>
<name>
<surname>Raymond</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>CT</given-names>
</name>
<name>
<surname>Mohamed</surname>
<given-names>Z</given-names>
</name>
</person-group>
<article-title>Contribution of TIMP4 rs3755724 polymorphism to susceptibility to focal epilepsy in Malaysian Chinese</article-title>
<source>J Neuroimmunol</source>
<year>2015</year>
<volume>278</volume>
<fpage>137</fpage>
<lpage>143</lpage>
<pub-id pub-id-type="doi">10.1016/j.jneuroim.2014.12.016</pub-id>
</element-citation>
</ref>
<ref id="R348">
<label>348</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miller</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Shivakumar</surname>
<given-names>MK</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Horgousluoglu</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Risacher</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Saykin</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Nho</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Rare variants in the splicing regulatory elements of EXOC3L4 are associated with brain glucose metabolism in Alzheimer's disease</article-title>
<source>BMC Med Genomics</source>
<year>2018</year>
<volume>11</volume>
<issue>Suppl 3</issue>
<fpage>76</fpage>
<pub-id pub-id-type="doi">10.1186/s12920-018-0390-6</pub-id>
</element-citation>
</ref>
<ref id="R349">
<label>349</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vaughan</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Bogdanova-Mihaylova</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Costello</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Sweeney</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>McNamara</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Walsh</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>SM</given-names>
</name>
</person-group>
<article-title>Ataxia pancytopenia syndrome due to SAMD9L mutation presenting as demyelinating neuropathy</article-title>
<source>J Peripher Nerv Syst</source>
<year>2020</year>
<volume>25</volume>
<issue>4</issue>
<fpage>433</fpage>
<lpage>437</lpage>
<pub-id pub-id-type="doi">10.1111/jns.12409</pub-id>
</element-citation>
</ref>
<ref id="R350">
<label>350</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liang</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Protective effects and mechanism of TPX2 on neurocyte apoptosis of rats in Alzheimer's disease model</article-title>
<source>Exp Ther Med</source>
<year>2017</year>
<volume>13</volume>
<issue>2</issue>
<fpage>576</fpage>
<lpage>580</lpage>
<pub-id pub-id-type="doi">10.3892/etm.2016.4006</pub-id>
</element-citation>
</ref>
<ref id="R351">
<label>351</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fiala</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mahanian</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rosenthal</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mizwicki</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Tse</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Sayre</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Weitzman</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Porter</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>MGAT3 mRNA: a biomarker for prognosis and therapy of Alzheimer's disease by vitamin D and curcuminoids</article-title>
<source>J Alzheimers Dis</source>
<year>2011</year>
<volume>25</volume>
<issue>1</issue>
<fpage>135</fpage>
<lpage>144</lpage>
<pub-id pub-id-type="doi">10.3233/JAD-2011-101950</pub-id>
</element-citation>
</ref>
<ref id="R352">
<label>352</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rafi</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Fernández-Jaén</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Álvarez</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Nadeau</surname>
<given-names>OW</given-names>
</name>
<name>
<surname>Butler</surname>
<given-names>MG</given-names>
</name>
</person-group>
<article-title>High Functioning Autism with Missense Mutations in Synaptotagmin-Like Protein 4 (SYTL4) and Transmembrane Protein 187 (TMEM187) Genes: SYTL4-Protein Modeling, Protein-Protein Interaction, Expression Profiling and MicroRNA Studies</article-title>
<source>Int J Mol Sci</source>
<year>2019</year>
<volume>20</volume>
<issue>13</issue>
<elocation-id>3358</elocation-id>
<pub-id pub-id-type="doi">10.3390/ijms20133358</pub-id>
</element-citation>
</ref>
<ref id="R353">
<label>353</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Strickland</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Morel</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Prusinski</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Allen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Carrasquillo</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Conway</surname>
<given-names>OJ</given-names>
</name>
<name>
<surname>Lincoln</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Reddy</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>T</given-names>
</name>
<etal/>
</person-group>
<article-title>Association of ABI3 and PLCG2 missense variants with disease risk and neuropathology in Lewy body disease and progressive supranuclear palsy</article-title>
<source>Acta Neuropathol Commun</source>
<year>2020</year>
<volume>8</volume>
<issue>1</issue>
<fpage>172</fpage>
<pub-id pub-id-type="doi">10.1186/s40478-020-01050-0</pub-id>
</element-citation>
</ref>
<ref id="R354">
<label>354</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>CY</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L</given-names>
</name>
<etal/>
</person-group>
<article-title>Independent replications and integrative analyses confirm TRANK1 as a susceptibility gene for bipolar disorder</article-title>
<source>Neuropsychopharmacology</source>
<year>2021</year>
<volume>46</volume>
<issue>6</issue>
<fpage>1103</fpage>
<lpage>1112</lpage>
<pub-id pub-id-type="doi">10.1038/s41386-020-00788-4</pub-id>
</element-citation>
</ref>
<ref id="R355">
<label>355</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>The CYP19A1 rs3751592 variant confers susceptibility to Alzheimer disease in the Chinese Han population</article-title>
<source>Medicine (Baltimore)</source>
<year>2016</year>
<volume>95</volume>
<issue>35</issue>
<elocation-id>e4742</elocation-id>
<pub-id pub-id-type="doi">10.1097/MD.0000000000004742</pub-id>
</element-citation>
</ref>
<ref id="R356">
<label>356</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uncini</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Notturno</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Pace</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Caporale</surname>
<given-names>CM</given-names>
</name>
</person-group>
<article-title>Polymorphism of CD1 and SH2D2A genes in inflammatory neuropathies</article-title>
<source>J Peripher Nerv Syst</source>
<year>2011</year>
<volume>16</volume>
<issue>Suppl 1</issue>
<fpage>48</fpage>
<lpage>51</lpage>
<pub-id pub-id-type="doi">10.1111/j.1529-8027.2011.00307.x</pub-id>
</element-citation>
</ref>
<ref id="R357">
<label>357</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Srivastava</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Macke</surname>
<given-names>EL</given-names>
</name>
<name>
<surname>Swanson</surname>
<given-names>LC</given-names>
</name>
<name>
<surname>Coulter</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Klee</surname>
<given-names>EW</given-names>
</name>
<name>
<surname>Mullegama</surname>
<given-names>SV</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Lanpher</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Bedoukian</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>Skraban</surname>
<given-names>CM</given-names>
</name>
<etal/>
</person-group>
<article-title>Expansion of the Genotypic and Phenotypic Spectrum of WASF1-Related Neurodevelopmental Disorder</article-title>
<source>Brain Sci</source>
<year>2021</year>
<volume>11</volume>
<issue>7</issue>
<fpage>931</fpage>
<pub-id pub-id-type="doi">10.3390/brainsci11070931</pub-id>
</element-citation>
</ref>
<ref id="R358">
<label>358</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yuan</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Genetic Analysis of FBXO2, FBXO6, FBXO12, and FBXO41 Variants in Han Chinese Patients with Sporadic Parkinson's Disease</article-title>
<source>Neurosci Bull</source>
<year>2017</year>
<volume>33</volume>
<issue>5</issue>
<fpage>510</fpage>
<lpage>514</lpage>
<pub-id pub-id-type="doi">10.1007/s12264-017-0122-5</pub-id>
</element-citation>
</ref>
<ref id="R359">
<label>359</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Michels</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Foss</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Golden-Grant</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Saneto</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Lopez</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Mirzaa</surname>
<given-names>GM</given-names>
</name>
</person-group>
<article-title>Mutations of KIF5C cause a neurodevelopmental disorder of infantile-onset epilepsy, absent language, and distinctive malformations of cortical development</article-title>
<source>Am J Med Genet A</source>
<year>2017</year>
<volume>173</volume>
<issue>12</issue>
<fpage>3127</fpage>
<lpage>3131</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.38496</pub-id>
</element-citation>
</ref>
<ref id="R360">
<label>360</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Curtis</surname>
<given-names>D</given-names>
</name>
<collab>Alzheimer's Disease Neuroimaging Initiative</collab>
</person-group>
<article-title>Analysis of whole genome sequenced cases and controls shows that the association of variants in TOMM40, BCAM, NECTIN2 and APOC1 with late onset Alzheimer's disease is driven by linkage disequilibrium with APOE ε2/ε3/ε4 alleles</article-title>
<source>J Neurogenet</source>
<year>2021</year>
<volume>35</volume>
<issue>2</issue>
<fpage>59</fpage>
<lpage>66</lpage>
<pub-id pub-id-type="doi">10.1080/01677063.2020.1866569</pub-id>
</element-citation>
</ref>
<ref id="R361">
<label>361</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liba</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Nohejlova</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Capek</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Krsek</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Sediva</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kayserova</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Utility of chemokines CCL2, CXCL8, 10 and 13 and interleukin 6 in the pediatric cohort for the recognition of neuroinflammation and in the context of traditional cerebrospinal fluid neuroinflammatory biomarkers</article-title>
<source>PLoS One</source>
<year>2019</year>
<volume>14</volume>
<issue>7</issue>
<elocation-id>e0219987</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0219987</pub-id>
</element-citation>
</ref>
<ref id="R362">
<label>362</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ruan</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Meng</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Q</given-names>
</name>
</person-group>
<article-title>microRNA-125b and its downstream Smurf1/KLF2/ATF2 axis as important promoters on neurological function recovery in rats with spinal cord injury</article-title>
<source>J Cell Mol Med</source>
<year>2021</year>
<volume>25</volume>
<issue>13</issue>
<fpage>5924</fpage>
<lpage>5939</lpage>
<pub-id pub-id-type="doi">10.1111/jcmm.16283</pub-id>
</element-citation>
</ref>
<ref id="R363">
<label>363</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Akpinar</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Yaman</surname>
<given-names>GB</given-names>
</name>
<name>
<surname>Demirdas</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Onal</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Possible role of adrenomedullin and nitric oxide in major depression</article-title>
<source>Prog Neuropsychopharmacol Biol Psychiatry</source>
<year>2013</year>
<volume>46</volume>
<fpage>120</fpage>
<lpage>125</lpage>
<pub-id pub-id-type="doi">10.1016/j.pnpbp.2013.07.003</pub-id>
</element-citation>
</ref>
<ref id="R364">
<label>364</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gallo</surname>
<given-names>FT</given-names>
</name>
<name>
<surname>Katche</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Morici</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Medina</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Weisstaub</surname>
<given-names>NV</given-names>
</name>
</person-group>
<article-title>Immediate Early Genes, Memory and Psychiatric Disorders: Focus on c-Fos, Egr1 and Arc</article-title>
<source>Front Behav Neurosci</source>
<year>2018</year>
<volume>12</volume>
<fpage>79</fpage>
<pub-id pub-id-type="doi">10.3389/fnbeh.2018.00079</pub-id>
</element-citation>
</ref>
<ref id="R365">
<label>365</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sasayama</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Hori</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Teraishi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hattori</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ota</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tatsumi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Higuchi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Amano</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Kunugi</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Possible impact of ADRB3 Trp64Arg polymorphism on BMI in patients with schizophrenia</article-title>
<source>Prog Neuropsychopharmacol Biol Psychiatry</source>
<year>2012</year>
<volume>38</volume>
<issue>2</issue>
<fpage>341</fpage>
<lpage>344</lpage>
<pub-id pub-id-type="doi">10.1016/j.pnpbp.2012.05.007</pub-id>
</element-citation>
</ref>
<ref id="R366">
<label>366</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pfaffenseller</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Kapczinski</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Gallitano</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Klamt</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>EGR3 Immediate Early Gene and the Brain-Derived Neurotrophic Factor in Bipolar Disorder</article-title>
<source>Front Behav Neurosci</source>
<year>2018</year>
<volume>12</volume>
<fpage>15</fpage>
<pub-id pub-id-type="doi">10.3389/fnbeh.2018.00015</pub-id>
</element-citation>
</ref>
<ref id="R367">
<label>367</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lowes</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Robertson</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Pyle</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hussain</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Coxhead</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Jane Yarnall</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Burn</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Payne</surname>
<given-names>BAI</given-names>
</name>
<name>
<surname>Santibanez-Koref</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hudson</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>The Human Coronavirus Receptor ANPEP (CD13) Is Overexpressed in Parkinson's Disease</article-title>
<source>Mov Disord</source>
<year>2020</year>
<volume>35</volume>
<issue>12</issue>
<fpage>2134</fpage>
<lpage>2136</lpage>
<pub-id pub-id-type="doi">10.1002/mds.28354</pub-id>
</element-citation>
</ref>
<ref id="R368">
<label>368</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berg</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Palac</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Wilkening</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Zelko</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Schust Meyer</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>SCN2A-Developmental and Epileptic Encephalopathies: Challenges to trial-readiness for non-seizure outcomes</article-title>
<source>Epilepsia</source>
<year>2021</year>
<volume>62</volume>
<issue>1</issue>
<fpage>258</fpage>
<lpage>268</lpage>
<pub-id pub-id-type="doi">10.1111/epi.16750</pub-id>
</element-citation>
</ref>
<ref id="R369">
<label>369</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ross</surname>
<given-names>SP</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>KE</given-names>
</name>
<name>
<surname>Fisher</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hoff</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Pak</surname>
<given-names>ES</given-names>
</name>
<name>
<surname>Murashov</surname>
<given-names>AK</given-names>
</name>
</person-group>
<article-title>miRNA-431 Prevents Amyloid-β-Induced Synapse Loss in Neuronal Cell Culture Model of Alzheimer's Disease by Silencing Kremen1</article-title>
<source>Front Cell Neurosci</source>
<year>2018</year>
<volume>12</volume>
<fpage>87</fpage>
<pub-id pub-id-type="doi">10.3389/fncel.2018.00087</pub-id>
</element-citation>
</ref>
<ref id="R370">
<label>370</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beck</surname>
<given-names>TN</given-names>
</name>
<name>
<surname>Nicolas</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Kopp</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Golemis</surname>
<given-names>EA</given-names>
</name>
</person-group>
<article-title>Adaptors for disorders of the brain? The cancer signaling proteins NEDD9, CASS4, and PTK2B in Alzheimer's disease</article-title>
<source>Oncoscience</source>
<year>2014</year>
<volume>1</volume>
<issue>7</issue>
<fpage>486</fpage>
<lpage>503</lpage>
<pub-id pub-id-type="doi">10.18632/oncoscience.64</pub-id>
</element-citation>
</ref>
<ref id="R371">
<label>371</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fujita-Jimbo</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Tanabe</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Kojima</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Mori</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Iwamoto</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yamagata</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Momoi</surname>
<given-names>MY</given-names>
</name>
<name>
<surname>Momoi</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>The association of GPR85 with PSD-95-neuroligin complex and autism spectrum disorder: a molecular analysis</article-title>
<source>Mol Autism</source>
<year>2015</year>
<volume>6</volume>
<fpage>17</fpage>
<pub-id pub-id-type="doi">10.1186/s13229-015-0012-5</pub-id>
</element-citation>
</ref>
<ref id="R372">
<label>372</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Okuda</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Higashi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kokame</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kondoh</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Miyata</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Ndrg1-deficient mice exhibit a progressive demyelinating disorder of peripheral nerves</article-title>
<source>Mol Cell Biol</source>
<year>2004</year>
<volume>24</volume>
<issue>9</issue>
<fpage>3949</fpage>
<lpage>3956</lpage>
<pub-id pub-id-type="doi">10.1128/MCB.24.9.3949-3956.2004</pub-id>
</element-citation>
</ref>
<ref id="R373">
<label>373</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Santiago</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Scherzer</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Potashkin</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>Network analysis identifies SOD2 mRNA as a potential biomarker for Parkinson's disease</article-title>
<source>PLoS One</source>
<year>2014</year>
<volume>9</volume>
<issue>10</issue>
<elocation-id>e109042</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0109042</pub-id>
</element-citation>
</ref>
<ref id="R374">
<label>374</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>
<article-title>Opposing functions of β-arrestin 1 and 2 in Parkinson's disease via microglia inflammation and Nprl3</article-title>
<source>Cell Death Differ</source>
<year>2021</year>
<volume>28</volume>
<issue>6</issue>
<fpage>1822</fpage>
<lpage>1836</lpage>
<pub-id pub-id-type="doi">10.1038/s41418-020-00704-9</pub-id>
</element-citation>
</ref>
<ref id="R375">
<label>375</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Strafella</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Caputo</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Termine</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Barati</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Caltagirone</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Giardina</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Cascella</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Investigation of Genetic Variations of IL6 and IL6R as Potential Prognostic and Pharmacogenetics Biomarkers: Implications for COVID-19 and Neuroinflammatory Disorders</article-title>
<source>Life (Basel)</source>
<year>2020</year>
<volume>10</volume>
<issue>12</issue>
<fpage>351</fpage>
<pub-id pub-id-type="doi">10.3390/life10120351</pub-id>
</element-citation>
</ref>
<ref id="R376">
<label>376</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Lei</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hao</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Meta-analysis of the Association between Alzheimer Disease and Variants in GAB2, PICALM, and SORL1</article-title>
<source>Mol Neurobiol</source>
<year>2016</year>
<volume>53</volume>
<issue>9</issue>
<fpage>6501</fpage>
<lpage>6510</lpage>
<pub-id pub-id-type="doi">10.1007/s12035-015-9546-y</pub-id>
</element-citation>
</ref>
<ref id="R377">
<label>377</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ota</surname>
<given-names>VK</given-names>
</name>
<name>
<surname>Noto</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Santoro</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Spindola</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Gouvea</surname>
<given-names>ES</given-names>
</name>
<name>
<surname>Carvalho</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Santos</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Xavier</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Higuchi</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Yonamine</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group>
<article-title>Increased expression of NDEL1 and MBP genes in the peripheral blood of antipsychotic-naïve patients with first-episode psychosis</article-title>
<source>Eur Neuropsychopharmacol</source>
<year>2015</year>
<volume>25</volume>
<issue>12</issue>
<fpage>2416</fpage>
<lpage>2425</lpage>
<pub-id pub-id-type="doi">10.1016/j.euroneuro.2015.09.013</pub-id>
</element-citation>
</ref>
<ref id="R378">
<label>378</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>ZH</given-names>
</name>
<name>
<surname>Gong</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>ZZ</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>SP</given-names>
</name>
<name>
<surname>Manfredsson</surname>
<given-names>FP</given-names>
</name>
<name>
<surname>Sandoval</surname>
<given-names>IM</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>PF</given-names>
</name>
<etal/>
</person-group>
<article-title>C/EBPβ regulates delta-secretase expression and mediates pathogenesis in mouse models of Alzheimer's disease</article-title>
<source>Nat Commun</source>
<year>2018</year>
<volume>9</volume>
<issue>1</issue>
<elocation-id>1784</elocation-id>
<pub-id pub-id-type="doi">10.1038/s41467-018-04120-z</pub-id>
</element-citation>
</ref>
<ref id="R379">
<label>379</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wei</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group>
<article-title>Identification of TYW3/CRYZ and FGD4 as susceptibility genes for amyotrophic lateral sclerosis</article-title>
<source>Neurol Genet</source>
<year>2019</year>
<volume>5</volume>
<issue>6</issue>
<elocation-id>e375</elocation-id>
<pub-id pub-id-type="doi">10.1212/NXG.0000000000000375</pub-id>
</element-citation>
</ref>
<ref id="R380">
<label>380</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fernandez</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Drozd</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Thümmler</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bardoni</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Askenazy</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Capovilla</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>A novel microduplication in INPP5A segregates with schizophrenia spectrum disorder in the family of a patient with both childhood onset schizophrenia and autism spectrum disorder</article-title>
<source>Am J Med Genet A</source>
<year>2021</year>
<volume>185</volume>
<issue>6</issue>
<fpage>1841</fpage>
<lpage>1847</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.62155</pub-id>
</element-citation>
</ref>
<ref id="R381">
<label>381</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Flores</surname>
<given-names>BR</given-names>
</name>
<name>
<surname>Scherer</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kuepper</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Rossi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rupprich</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Rautenberg</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Deininger</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Weichselbaum</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Grimm</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>
<article-title>De novo variants in SLC12A6 cause sporadic early-onset progressive sensorimotor neuropathy</article-title>
<source>J Med Genet</source>
<year>2020</year>
<volume>57</volume>
<issue>4</issue>
<fpage>283</fpage>
<lpage>288</lpage>
<pub-id pub-id-type="doi">10.1136/jmedgenet-2019-106273</pub-id>
</element-citation>
</ref>
<ref id="R382">
<label>382</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Woodbine</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Neal</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Sasi</surname>
<given-names>NK</given-names>
</name>
<name>
<surname>Shimada</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Deem</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Coleman</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Dobyns</surname>
<given-names>WB</given-names>
</name>
<name>
<surname>Ogi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Meek</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Davies</surname>
<given-names>EG</given-names>
</name>
<etal/>
</person-group>
<article-title>PRKDC mutations in a SCID patient with profound neurological abnormalities</article-title>
<source>J Clin Invest</source>
<year>2013</year>
<volume>123</volume>
<issue>7</issue>
<fpage>2969</fpage>
<lpage>2980</lpage>
<pub-id pub-id-type="doi">10.1172/JCI67349</pub-id>
</element-citation>
</ref>
<ref id="R383">
<label>383</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Watts</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Rubin</surname>
<given-names>LL</given-names>
</name>
</person-group>
<article-title>Suppression of MAP4K4 Signaling Ameliorates Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis-Molecular Studies Toward New Therapeutics</article-title>
<source>J Exp Neurosci</source>
<year>2019</year>
<volume>13</volume>
<elocation-id>1179069519862798</elocation-id>
<pub-id pub-id-type="doi">10.1177/1179069519862798</pub-id>
</element-citation>
</ref>
<ref id="R384">
<label>384</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lim</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Shulman</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Raj</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Chibnik</surname>
<given-names>LB</given-names>
</name>
<name>
<surname>Cain</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Rothamel</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Benoist</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Myers</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Czeisler</surname>
<given-names>CA</given-names>
</name>
<etal/>
</person-group>
<article-title>A common polymorphism near PER1 and the timing of human behavioral rhythms</article-title>
<source>Ann Neurol</source>
<year>2012</year>
<volume>72</volume>
<issue>3</issue>
<fpage>324</fpage>
<lpage>334</lpage>
<pub-id pub-id-type="doi">10.1002/ana.23636</pub-id>
</element-citation>
</ref>
<ref id="R385">
<label>385</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>D'Mello</surname>
<given-names>SR</given-names>
</name>
</person-group>
<article-title>Proteomic analysis identifies NPTX1 and HIP1R as potential targets of histone deacetylase-3-mediated neurodegeneration</article-title>
<source>Exp Biol Med (Maywood)</source>
<year>2018</year>
<volume>243</volume>
<issue>7</issue>
<fpage>627</fpage>
<lpage>638</lpage>
<pub-id pub-id-type="doi">10.1177/1535370218761149</pub-id>
</element-citation>
</ref>
<ref id="R386">
<label>386</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ruiz-Sánchez</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Jiménez-Genchi</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Alcántara-Flores</surname>
<given-names>YM</given-names>
</name>
<name>
<surname>Castañeda-González</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Aviña-Cervantes</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Yescas</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Del Socorro González-Valadez</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Martínez-Rodríguez</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Ríos-Ortiz</surname>
<given-names>A</given-names>
</name>
<name>
<surname>González-González</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>
<article-title>Working memory deficits in schizophrenia are associated with the rs34884856 variant and expression levels of the NR4A2 gene in a sample Mexican population: a case control study</article-title>
<source>BMC Psychiatry</source>
<year>2021</year>
<volume>21</volume>
<issue>1</issue>
<fpage>86</fpage>
<pub-id pub-id-type="doi">10.1186/s12888-021-03081-w</pub-id>
</element-citation>
</ref>
<ref id="R387">
<label>387</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Adnan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Huo</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Pang</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Association analysis of NUCKS1 and INPP5K polymorphism with Parkinson's disease</article-title>
<source>Genes Genet Syst</source>
<year>2018</year>
<volume>93</volume>
<issue>2</issue>
<fpage>59</fpage>
<lpage>64</lpage>
<pub-id pub-id-type="doi">10.1266/ggs.17-00038</pub-id>
</element-citation>
</ref>
<ref id="R388">
<label>388</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>White</surname>
<given-names>MF</given-names>
</name>
</person-group>
<article-title>IRS2 integrates insulin/IGF1 signalling with metabolism, neurodegeneration and longevity</article-title>
<source>Diabetes Obes Metab</source>
<year>2014</year>
<volume>16</volume>
<issue>Suppl 1</issue>
<fpage>4</fpage>
<lpage>15</lpage>
<pub-id pub-id-type="doi">10.1111/dom.12347</pub-id>
</element-citation>
</ref>
<ref id="R389">
<label>389</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shaw</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Winczewska-Wiktor</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Badura-Stronka</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Koirala</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gardner</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kuszel</surname>
<given-names>Ł</given-names>
</name>
<name>
<surname>Kowal</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Steinborn</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Starczewska</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Garry</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>
<person-group person-group-type="author">
<name>
<surname>Badura-Stronka</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>
<article-title>EXOME REPORT: Novel mutation in ATP6V1B2 segregating with autosomal dominant epilepsy, intellectual disability and mild gingival and nail abnormalities</article-title>
<source>Eur J Med Genet</source>
<year>2020</year>
<volume>63</volume>
<issue>4</issue>
<elocation-id>103799</elocation-id>
<pub-id pub-id-type="doi">10.1016/j.ejmg.2019.103799</pub-id>
</element-citation>
</ref>
<ref id="R390">
<label>390</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sekar</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Taghibiglou</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Elevated nuclear phosphatase and tensin homolog (PTEN) and altered insulin signaling in substantia nigral region of patients with Parkinson's disease</article-title>
<source>Neurosci Lett</source>
<year>2018</year>
<volume>666</volume>
<fpage>139</fpage>
<lpage>143</lpage>
<pub-id pub-id-type="doi">10.1016/j.neulet.2017.12.049</pub-id>
</element-citation>
</ref>
<ref id="R391">
<label>391</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xie</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Lv</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Ni</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Z</given-names>
</name>
<etal/>
</person-group>
<article-title>HPD degradation regulated by the TTC36-STK33-PELI1 signaling axis induces tyrosinemia and neurological damage</article-title>
<source>Nat Commun</source>
<year>2019</year>
<volume>10</volume>
<issue>1</issue>
<elocation-id>4266</elocation-id>
<pub-id pub-id-type="doi">10.1038/s41467-019-12011-0</pub-id>
</element-citation>
</ref>
<ref id="R392">
<label>392</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Latchman</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Calder</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Morel</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Rhodes</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Juusola</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Tekin</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Autosomal dominant inheritance in a recently described ZMIZ1-related neurodevelopmental disorder: Case report of siblings and an affected parent</article-title>
<source>Am J Med Genet A</source>
<year>2020</year>
<volume>182</volume>
<issue>3</issue>
<fpage>548</fpage>
<lpage>552</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.61446</pub-id>
</element-citation>
</ref>
<ref id="R393">
<label>393</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Astrocyte-specific NDRG2 gene: functions in the brain and neurological diseases</article-title>
<source>Cell Mol Life Sci</source>
<year>2020</year>
<volume>77</volume>
<issue>13</issue>
<fpage>2461</fpage>
<lpage>2472</lpage>
<pub-id pub-id-type="doi">10.1007/s00018-019-03406-9</pub-id>
</element-citation>
</ref>
<ref id="R394">
<label>394</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>He</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Q</given-names>
</name>
</person-group>
<article-title>Licoricidin improves neurological dysfunction after traumatic brain injury in mice via regulating FoxO3/Wnt/β-catenin pathway</article-title>
<source>J Nat Med</source>
<year>2020</year>
<volume>74</volume>
<issue>4</issue>
<fpage>767</fpage>
<lpage>776</lpage>
<pub-id pub-id-type="doi">10.1007/s11418-020-01434-5</pub-id>
</element-citation>
</ref>
<ref id="R395">
<label>395</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Downregulation of microRNAL124L3p suppresses the mTOR signaling pathway by targeting DDIT4 in males with major depressive disorder</article-title>
<source>Int J Mol Med</source>
<year>2018</year>
<volume>41</volume>
<issue>1</issue>
<fpage>493</fpage>
<lpage>500</lpage>
<pub-id pub-id-type="doi">10.3892/ijmm.2017.3235</pub-id>
</element-citation>
</ref>
<ref id="R396">
<label>396</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krohn</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Grenn</surname>
<given-names>FP</given-names>
</name>
<name>
<surname>Makarious</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Bandres-Ciga</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Roosen</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Gan-Or</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Nalls</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Singleton</surname>
<given-names>AB</given-names>
</name>
<name>
<surname>Blauwendraat</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group>
<article-title>Comprehensive assessment of PINK1 variants in Parkinson's disease</article-title>
<source>Neurobiol Aging</source>
<year>2020</year>
<volume>91</volume>
<fpage>168.e1</fpage>
<lpage>168.e5</lpage>
<pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2020.03.003</pub-id>
</element-citation>
</ref>
<ref id="R397">
<label>397</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shin</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Salameh</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Richter</surname>
<given-names>JD</given-names>
</name>
</person-group>
<article-title>Impaired neurodevelopment by the low complexity domain of CPEB4 reveals a convergent pathway with neurodegeneration</article-title>
<source>Sci Rep</source>
<year>2016</year>
<volume>6</volume>
<elocation-id>29395</elocation-id>
<pub-id pub-id-type="doi">10.1038/srep29395</pub-id>
</element-citation>
</ref>
<ref id="R398">
<label>398</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Shao</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>AdipoRon Attenuates Neuroinflammation After Intracerebral Hemorrhage Through AdipoR1-AMPK Pathway</article-title>
<source>Neuroscience</source>
<year>2019</year>
<volume>412</volume>
<fpage>116</fpage>
<lpage>130</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroscience.2019.05.060</pub-id>
</element-citation>
</ref>
<ref id="R399">
<label>399</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Griffin</surname>
<given-names>JWD</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Bradshaw</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>In Silico Preliminary Association of Ammonia Metabolism Genes GLS, CPS1, and GLUL with Risk of Alzheimer's Disease, Major Depressive Disorder, and Type 2 Diabetes</article-title>
<source>J Mol Neurosci</source>
<year>2018</year>
<volume>64</volume>
<issue>3</issue>
<fpage>385</fpage>
<lpage>396</lpage>
<pub-id pub-id-type="doi">10.1007/s12031-018-1035-0</pub-id>
</element-citation>
</ref>
<ref id="R400">
<label>400</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Afeseh Ngwa</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kanthasamy</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Anantharam</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Witte</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Houk</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Kanthasamy</surname>
<given-names>AG</given-names>
</name>
</person-group>
<article-title>Vanadium induces dopaminergic neurotoxicity via protein kinase Cdelta dependent oxidative signaling mechanisms: relevance to etiopathogenesis of Parkinson's disease</article-title>
<source>Toxicol Appl Pharmacol</source>
<year>2009</year>
<volume>240</volume>
<issue>2</issue>
<fpage>273</fpage>
<lpage>285</lpage>
<pub-id pub-id-type="doi">10.1016/j.taap.2009.07.025</pub-id>
</element-citation>
</ref>
<ref id="R401">
<label>401</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shibata</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Ohnuma</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Higashi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Higashi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Usui</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ohkubo</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kawashima</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Kitajima</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ueki</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>
<article-title>Genetic association between USF 1 and USF 2 gene polymorphisms and Japanese Alzheimer's disease</article-title>
<source>J Gerontol A Biol Sci Med Sci</source>
<year>2006</year>
<volume>61</volume>
<issue>7</issue>
<fpage>660</fpage>
<lpage>662</lpage>
<pub-id pub-id-type="doi">10.1093/gerona/61.7.660</pub-id>
</element-citation>
</ref>
<ref id="R402">
<label>402</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elahi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Motoi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Shimonaka</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ishida</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hioki</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Takanashi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ishiguro</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Imai</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hattori</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>High-fat diet-induced activation of SGK1 promotes Alzheimer's disease-associated tau pathology</article-title>
<source>Hum Mol Genet</source>
<year>2021</year>
<volume>30</volume>
<issue>18</issue>
<fpage>1693</fpage>
<lpage>1710</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddab115</pub-id>
</element-citation>
</ref>
<ref id="R403">
<label>403</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Christoforou</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Christodoulou</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Anastasiadou</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Nicolaides</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Early-onset presentation of a new subtype of β-Propeller protein-associated neurodegeneration (BPAN) caused by a de novo WDR45 deletion in a 6 year-old female patient</article-title>
<source>Eur J Med Genet</source>
<year>2020</year>
<volume>63</volume>
<issue>3</issue>
<elocation-id>103765</elocation-id>
<pub-id pub-id-type="doi">10.1016/j.ejmg.2019.103765</pub-id>
</element-citation>
</ref>
<ref id="R404">
<label>404</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zafar</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Younas</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Correia</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Shafiq</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tahir</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Schmitz</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ferrer</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Andréoletti</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Zerr</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>Strain-Specific Altered Regulatory Response of Rab7a and Tau in Creutzfeldt-Jakob Disease and Alzheimer's Disease</article-title>
<source>Mol Neurobiol</source>
<year>2017</year>
<volume>54</volume>
<issue>1</issue>
<fpage>697</fpage>
<lpage>709</lpage>
<pub-id pub-id-type="doi">10.1007/s12035-016-9694-8</pub-id>
</element-citation>
</ref>
<ref id="R405">
<label>405</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Calabrò</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mandelli</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Crisafulli</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Sidoti</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Jun</surname>
<given-names>TY</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Patkar</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Masand</surname>
<given-names>PS</given-names>
</name>
<name>
<surname>Pae</surname>
<given-names>CU</given-names>
</name>
<etal/>
</person-group>
<article-title>Genes Involved in Neurodevelopment, Neuroplasticity, and Bipolar Disorder: CACNA1C, CHRNA1, and MAPK1</article-title>
<source>Neuropsychobiology</source>
<year>2016</year>
<volume>74</volume>
<issue>3</issue>
<fpage>159</fpage>
<lpage>168</lpage>
<pub-id pub-id-type="doi">10.1159/000468543</pub-id>
</element-citation>
</ref>
<ref id="R406">
<label>406</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tian</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hao</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kuang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group>
<article-title>FTH1 Inhibits Ferroptosis Through Ferritinophagy in the 6-OHDA Model of Parkinson's Disease</article-title>
<source>Neurotherapeutics</source>
<year>2020</year>
<volume>17</volume>
<issue>4</issue>
<fpage>1796</fpage>
<lpage>1812</lpage>
<pub-id pub-id-type="doi">10.1007/s13311-020-00929-z</pub-id>
</element-citation>
</ref>
<ref id="R407">
<label>407</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marsh</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Lukic</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Pope</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Bromhead</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Tankard</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ryan</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Yiu</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Sim</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Delatycki</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>Amor</surname>
<given-names>DJ</given-names>
</name>
<etal/>
</person-group>
<article-title>Complete callosal agenesis, pontocerebellar hypoplasia, and axonal neuropathy due to AMPD2 loss</article-title>
<source>Neurol Genet</source>
<year>2015</year>
<volume>1</volume>
<issue>2</issue>
<elocation-id>e16</elocation-id>
<pub-id pub-id-type="doi">10.1212/NXG.0000000000000014</pub-id>
</element-citation>
</ref>
<ref id="R408">
<label>408</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seripa</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Panza</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Paroni</surname>
<given-names>G</given-names>
</name>
<name>
<surname>D'Onofrio</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Bisceglia</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Gravina</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Urbano</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lozupone</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Solfrizzi</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Bizzarro</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>
<article-title>Role of CLU, PICALM, and TNK1 Genotypes in Aging With and Without Alzheimer's Disease</article-title>
<source>Mol Neurobiol</source>
<year>2018</year>
<volume>55</volume>
<issue>5</issue>
<fpage>4333</fpage>
<lpage>4344</lpage>
<pub-id pub-id-type="doi">10.1007/s12035-017-0547-x</pub-id>
</element-citation>
</ref>
<ref id="R409">
<label>409</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rollinson</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rizzu</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Sikkink</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Halliwell</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Snowden</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Traynor</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Ruano</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Cairns</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Rohrer</surname>
<given-names>JD</given-names>
</name>
<etal/>
</person-group>
<article-title>Ubiquitin associated protein 1 is a risk factor for frontotemporal lobar degeneration</article-title>
<source>Neurobiol Aging</source>
<year>2009</year>
<volume>30</volume>
<issue>4</issue>
<fpage>656</fpage>
<lpage>665</lpage>
<pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2009.01.009</pub-id>
</element-citation>
</ref>
<ref id="R410">
<label>410</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mol</surname>
<given-names>MO</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>TH</given-names>
</name>
<name>
<surname>Melhem</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Basu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Viscusi</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Galjart</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Rozemuller</surname>
<given-names>AJM</given-names>
</name>
<name>
<surname>Fallini</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Landers</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Kaat</surname>
<given-names>LD</given-names>
</name>
<etal/>
</person-group>
<article-title>Novel TUBA4A Variant Associated With Familial Frontotemporal Dementia</article-title>
<source>Neurol Genet</source>
<year>2021</year>
<volume>7</volume>
<issue>3</issue>
<elocation-id>e596</elocation-id>
<pub-id pub-id-type="doi">10.1212/NXG.0000000000000596</pub-id>
</element-citation>
</ref>
<ref id="R411">
<label>411</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Diaz</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Berger</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Leon</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>TFE3-associated neurodevelopmental disorder: A distinct recognizable syndrome</article-title>
<source>Am J Med Genet A</source>
<year>2020</year>
<volume>182</volume>
<issue>3</issue>
<fpage>584</fpage>
<lpage>590</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.61437</pub-id>
</element-citation>
</ref>
<ref id="R412">
<label>412</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nabais Sá</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Olson</surname>
<given-names>AN</given-names>
</name>
<name>
<surname>Yoon</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Nimmo</surname>
<given-names>GAM</given-names>
</name>
<name>
<surname>Gomez</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Willemsen</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Millan</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Schneider</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pfundt</surname>
<given-names>R</given-names>
</name>
<name>
<surname>de Brouwer</surname>
<given-names>APM</given-names>
</name>
<etal/>
</person-group>
<article-title>De Novo variants in EEF2 cause a neurodevelopmental disorder with benign external hydrocephalus</article-title>
<source>Hum Mol Genet</source>
<year>2021</year>
<volume>29</volume>
<issue>24</issue>
<fpage>3892</fpage>
<lpage>3899</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddaa270</pub-id>
</element-citation>
</ref>
<ref id="R413">
<label>413</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lim</surname>
<given-names>KH</given-names>
</name>
<name>
<surname>Joo</surname>
<given-names>JY</given-names>
</name>
</person-group>
<article-title>Predictive Potential of Circulating Ube2h mRNA as an E2 Ubiquitin-Conjugating Enzyme for Diagnosis or Treatment of Alzheimer's Disease</article-title>
<source>Int J Mol Sci</source>
<year>2020</year>
<volume>21</volume>
<issue>9</issue>
<elocation-id>3398</elocation-id>
<pub-id pub-id-type="doi">10.3390/ijms21093398</pub-id>
</element-citation>
</ref>
<ref id="R414">
<label>414</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Bai</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Association between C-Maf-inducing protein gene rs2287112 polymorphism and schizophrenia</article-title>
<source>PeerJ</source>
<year>2021</year>
<volume>9</volume>
<elocation-id>e11907</elocation-id>
<pub-id pub-id-type="doi">10.7717/peerj.11907</pub-id>
</element-citation>
</ref>
<ref id="R415">
<label>415</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sainouchi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hatano</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Tada</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ishihara</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ando</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kato</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Tokunaga</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ito</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Miyahara</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Toyoshima</surname>
<given-names>Y</given-names>
</name>
<etal/>
</person-group>
<article-title>A novel splicing variant of ANXA11 in a patient with amyotrophic lateral sclerosis: histologic and biochemical features</article-title>
<source>Acta Neuropathol Commun</source>
<year>2021</year>
<volume>9</volume>
<issue>1</issue>
<fpage>106</fpage>
<pub-id pub-id-type="doi">10.1186/s40478-021-01202-w</pub-id>
</element-citation>
</ref>
<ref id="R416">
<label>416</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Festoff</surname>
<given-names>BW</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Woodhams</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Lynch</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Soluble thrombomodulin levels in plasma of multiple sclerosis patients and their implication</article-title>
<source>J Neurol Sci</source>
<year>2012</year>
<volume>323</volume>
<issue>1–2</issue>
<fpage>61</fpage>
<lpage>65</lpage>
<pub-id pub-id-type="doi">10.1016/j.jns.2012.08.008</pub-id>
</element-citation>
</ref>
<ref id="R417">
<label>417</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>SY</given-names>
</name>
<name>
<surname>Gong</surname>
<given-names>PY</given-names>
</name>
<name>
<surname>E</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>YD</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>The Role of TREML2 in Alzheimer's Disease</article-title>
<source>J Alzheimers Dis</source>
<year>2020</year>
<volume>76</volume>
<issue>3</issue>
<fpage>799</fpage>
<lpage>806</lpage>
<pub-id pub-id-type="doi">10.3233/JAD-200406</pub-id>
</element-citation>
</ref>
<ref id="R418">
<label>418</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huo</surname>
<given-names>YX</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>DF</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>YG</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>YR</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>XJ</given-names>
</name>
</person-group>
<article-title>Identification of SLC25A37 as a major depressive disorder risk gene</article-title>
<source>J Psychiatr Res</source>
<year>2016</year>
<volume>83</volume>
<fpage>168</fpage>
<lpage>175</lpage>
<pub-id pub-id-type="doi">10.1016/j.jpsychires.2016.09.011</pub-id>
</element-citation>
</ref>
<ref id="R419">
<label>419</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benyamin</surname>
<given-names>B</given-names>
</name>
<name>
<surname>He</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Gratten</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Garton</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Leo</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Mangelsdorf</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Al-Chalabi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>L</given-names>
</name>
<etal/>
</person-group>
<article-title>Cross-ethnic meta-analysis identifies association of the GPX3-TNIP1 locus with amyotrophic lateral sclerosis</article-title>
<source>Nat Commun</source>
<year>2017</year>
<volume>8</volume>
<issue>1</issue>
<fpage>611</fpage>
<pub-id pub-id-type="doi">10.1038/s41467-017-00471-1</pub-id>
</element-citation>
</ref>
<ref id="R420">
<label>420</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>X</given-names>
</name>
</person-group>
<article-title>miR-149-5p inhibition reduces Alzheimer's disease β-amyloid generation in 293/APPsw cells by upregulating H4K16ac via KAT8</article-title>
<source>Exp Ther Med</source>
<year>2020</year>
<volume>20</volume>
<issue>5</issue>
<fpage>88</fpage>
<pub-id pub-id-type="doi">10.3892/etm.2020.9216</pub-id>
</element-citation>
</ref>
<ref id="R421">
<label>421</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Herrmann</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Schulte</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wildner</surname>
<given-names>NH</given-names>
</name>
<name>
<surname>Wittner</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Brehm</surname>
<given-names>TT</given-names>
</name>
<name>
<surname>Ramharter</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Woost</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Lohse</surname>
<given-names>AW</given-names>
</name>
<name>
<surname>Jacobs</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Schulze Zur Wiesch</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Analysis of Co-inhibitory Receptor Expression in COVID-19 Infection Compared to Acute Plasmodium falciparum Malaria: LAG-3 and TIM-3 Correlate With T Cell Activation and Course of Disease</article-title>
<source>Front Immunol</source>
<year>2020</year>
<volume>11</volume>
<elocation-id>1870</elocation-id>
<pub-id pub-id-type="doi">10.3389/fimmu.2020.01870</pub-id>
</element-citation>
</ref>
<ref id="R422">
<label>422</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>YC</given-names>
</name>
<name>
<surname>Jeong</surname>
<given-names>BH</given-names>
</name>
</person-group>
<article-title>Strong Correlation between the Case Fatality Rate of COVID-19 and the rs6598045 Single Nucleotide Polymorphism (SNP) of the Interferon-Induced Transmembrane Protein 3 (IFITM3) Gene at the Population-Level</article-title>
<source>Genes (Basel)</source>
<year>2020</year>
<volume>12</volume>
<issue>1</issue>
<fpage>42</fpage>
<pub-id pub-id-type="doi">10.3390/genes12010042</pub-id>
</element-citation>
</ref>
<ref id="R423">
<label>423</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Butler-Laporte</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Nakanishi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Morrison</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Afilalo</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Afilalo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Laurent</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Pietzner</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kerrison</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>K</given-names>
</name>
<etal/>
</person-group>
<article-title>A Neanderthal OAS1 isoform protects individuals of European ancestry against COVID-19 susceptibility and severity</article-title>
<source>Nat Med</source>
<year>2021</year>
<volume>27</volume>
<issue>4</issue>
<fpage>659</fpage>
<lpage>667</lpage>
<pub-id pub-id-type="doi">10.1038/s41591-021-01281-1</pub-id>
</element-citation>
</ref>
<ref id="R424">
<label>424</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Horspool</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Kieffer</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Russ</surname>
<given-names>BP</given-names>
</name>
<name>
<surname>DeJong</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Wolf</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Karakiozis</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Hickey</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Fagone</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Tacker</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Bevere</surname>
<given-names>JR</given-names>
</name>
<etal/>
</person-group>
<article-title>Interplay of Antibody and Cytokine Production Reveals CXCL13 as a Potential Novel Biomarker of Lethal SARS-CoV-2 Infection</article-title>
<source>mSphere</source>
<year>2021</year>
<volume>6</volume>
<issue>1</issue>
<elocation-id>e01324-20</elocation-id>
<pub-id pub-id-type="doi">10.1128/mSphere.01324-20</pub-id>
</element-citation>
</ref>
<ref id="R425">
<label>425</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nieri</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Neri</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Barbieri</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Moneta</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Morelli</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Mingardi</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Spinelli</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ghiadoni</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Falcone</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tiseo</surname>
<given-names>G</given-names>
</name>
<etal/>
</person-group>
<article-title>C-C motive chemokine ligand 2 and thromboinflammation in COVID-19-associated pneumonia: A retrospective study</article-title>
<source>Thromb Res</source>
<year>2021</year>
<volume>204</volume>
<fpage>88</fpage>
<lpage>94</lpage>
<pub-id pub-id-type="doi">10.1016/j.thromres.2021.06.003</pub-id>
</element-citation>
</ref>
<ref id="R426">
<label>426</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Turski</surname>
<given-names>WA</given-names>
</name>
<name>
<surname>Wnorowski</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Turski</surname>
<given-names>GN</given-names>
</name>
<name>
<surname>Turski</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Turski</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>AhR and IDO1 in pathogenesis of Covid-19 and the "Systemic AhR Activation Syndrome:" a translational review and therapeutic perspectives</article-title>
<source>Restor Neurol Neurosci</source>
<year>2020</year>
<volume>38</volume>
<issue>4</issue>
<fpage>343</fpage>
<lpage>354</lpage>
<pub-id pub-id-type="doi">10.3233/RNN-201042</pub-id>
</element-citation>
</ref>
<ref id="R427">
<label>427</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Julià</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bonafonte-Pardàs</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Gómez</surname>
<given-names>A</given-names>
</name>
<name>
<surname>López-Lasanta</surname>
<given-names>M</given-names>
</name>
<name>
<surname>López-Corbeto</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Martínez-Mateu</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Lladós</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Rodríguez-Nunez</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Myers</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Marsal</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Targeting of the CD80/86 proinflammatory axis as a therapeutic strategy to prevent severe COVID-19</article-title>
<source>Sci Rep</source>
<year>2021</year>
<volume>11</volume>
<issue>1</issue>
<elocation-id>11462</elocation-id>
<pub-id pub-id-type="doi">10.1038/s41598-021-90797-0</pub-id>
</element-citation>
</ref>
<ref id="R428">
<label>428</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bizzotto</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sanchis</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Abbate</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lage-Vickers</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lavignolle</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Toro</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Olszevicki</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sabater</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Cascardo</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Vazquez</surname>
<given-names>E</given-names>
</name>
<etal/>
</person-group>
<article-title>SARS-CoV-2 Infection Boosts MX1 Antiviral Effector in COVID-19 Patients</article-title>
<source>iScience</source>
<year>2020</year>
<volume>23</volume>
<issue>10</issue>
<elocation-id>101585</elocation-id>
<pub-id pub-id-type="doi">10.1016/j.isci.2020.101585</pub-id>
</element-citation>
</ref>
<ref id="R429">
<label>429</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ward</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Cornaby</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Schmitz</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Indeterminate QuantiFERON Gold Plus results reveal deficient IFN-γ responses in severely ill COVID-19 patients</article-title>
<source>J Clin Microbiol</source>
<year>2021</year>
<elocation-id>JCM0081121</elocation-id>
<pub-id pub-id-type="doi">10.1128/JCM.00811-21</pub-id>
</element-citation>
</ref>
<ref id="R430">
<label>430</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maiti</surname>
<given-names>AK</given-names>
</name>
</person-group>
<article-title>The African-American population with a low allele frequency of SNP rs1990760 (T allele) in IFIH1 predicts less IFN-beta expression and potential vulnerability to COVID-19 infection</article-title>
<source>Immunogenetics</source>
<year>2020</year>
<volume>72</volume>
<issue>6–7</issue>
<fpage>387</fpage>
<lpage>391</lpage>
<pub-id pub-id-type="doi">10.1007/s00251-020-01174-6</pub-id>
</element-citation>
</ref>
<ref id="R431">
<label>431</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Russo</surname>
<given-names>LC</given-names>
</name>
<name>
<surname>Tomasin</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Matos</surname>
<given-names>IA</given-names>
</name>
<name>
<surname>Manucci</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Sowa</surname>
<given-names>ST</given-names>
</name>
<name>
<surname>Dale</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Caldecott</surname>
<given-names>KW</given-names>
</name>
<name>
<surname>Lehtiö</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Schechtman</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Meotti</surname>
<given-names>FC</given-names>
</name>
<etal/>
</person-group>
<article-title>The SARS-CoV-2 Nsp3 macrodomain reverses PARP9/DTX3L-dependent ADP-ribosylation induced by interferon signalling</article-title>
<source>J Biol Chem</source>
<year>2021</year>
<elocation-id>101041</elocation-id>
<pub-id pub-id-type="doi">10.1016/j.jbc.2021.101041</pub-id>
</element-citation>
</ref>
<ref id="R432">
<label>432</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laha</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Saha</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Dutta</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Basu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Chatterjee</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ghosh</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bhattacharyya</surname>
<given-names>NP</given-names>
</name>
</person-group>
<article-title>In silico analysis of altered expression of long non-coding RNA in SARS-CoV-2 infected cells and their possible regulation by STAT1, STAT3 and interferon regulatory factors</article-title>
<source>Heliyon</source>
<year>2021</year>
<volume>7</volume>
<issue>3</issue>
<elocation-id>e06395</elocation-id>
<pub-id pub-id-type="doi">10.1016/j.heliyon.2021.e06395</pub-id>
</element-citation>
</ref>
<ref id="R433">
<label>433</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vietzen</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zoufaly</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Traugott</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Aberle</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Aberle</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Puchhammer-Stöckl</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Deletion of the NKG2C receptor encoding KLRC2 gene and HLA-E variants are risk factors for severe COVID-19</article-title>
<source>Genet Med</source>
<year>2021</year>
<volume>23</volume>
<issue>5</issue>
<fpage>963</fpage>
<lpage>967</lpage>
<pub-id pub-id-type="doi">10.1038/s41436-020-01077-7</pub-id>
</element-citation>
</ref>
<ref id="R434">
<label>434</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patterson</surname>
<given-names>BK</given-names>
</name>
<name>
<surname>Seethamraju</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Dhody</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Corley</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Kazempour</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Lalezari</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Pang</surname>
<given-names>APS</given-names>
</name>
<name>
<surname>Sugai</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Mahyari</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Francisco</surname>
<given-names>EB</given-names>
</name>
<etal/>
</person-group>
<article-title>CCR5 inhibition in critical COVID-19 patients decreases inflammatory cytokines, increases CD8 T-cells, and decreases SARS-CoV2 RNA in plasma by day 14</article-title>
<source>Int J Infect Dis</source>
<year>2021</year>
<volume>103</volume>
<fpage>25</fpage>
<lpage>32</lpage>
<pub-id pub-id-type="doi">10.1016/j.ijid.2020.10.101</pub-id>
</element-citation>
</ref>
<ref id="R435">
<label>435</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tauber</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Schweiker</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Levonis</surname>
<given-names>SM</given-names>
</name>
</person-group>
<article-title>The potential association between PARP14 and SARS-CoV-2 infection (COVID-19)</article-title>
<source>Future Med Chem</source>
<year>2021</year>
<volume>13</volume>
<issue>6</issue>
<fpage>587</fpage>
<lpage>592</lpage>
<pub-id pub-id-type="doi">10.4155/fmc-2020-0226</pub-id>
</element-citation>
</ref>
<ref id="R436">
<label>436</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Solerte</surname>
<given-names>SB</given-names>
</name>
<name>
<surname>Di Sabatino</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Galli</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Fiorina</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19</article-title>
<source>Acta Diabetol</source>
<year>2020</year>
<volume>57</volume>
<issue>7</issue>
<fpage>779</fpage>
<lpage>783</lpage>
<pub-id pub-id-type="doi">10.1007/s00592-020-01539-z</pub-id>
</element-citation>
</ref>
<ref id="R437">
<label>437</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jamaly</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tsokos</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Bhargava</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Brook</surname>
<given-names>OR</given-names>
</name>
<name>
<surname>Hecht</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Abdi</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Moulton</surname>
<given-names>VR</given-names>
</name>
<name>
<surname>Satyam</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Tsokos</surname>
<given-names>GC</given-names>
</name>
</person-group>
<article-title>Complement activation and increased expression of Syk, mucin-1 and CaMK4 in kidneys of patients with COVID-19</article-title>
<source>Clin Immunol</source>
<year>2021</year>
<volume>229</volume>
<elocation-id>108795</elocation-id>
<pub-id pub-id-type="doi">10.1016/j.clim.2021.108795</pub-id>
</element-citation>
</ref>
<ref id="R438">
<label>438</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Al-Bayatee</surname>
<given-names>NT</given-names>
</name>
<name>
<surname>Ad'hiah</surname>
<given-names>AH</given-names>
</name>
</person-group>
<article-title>Soluble HLA-G is upregulated in serum of patients with severe COVID-19</article-title>
<source>Hum Immunol</source>
<year>2021</year>
<elocation-id>S0198-8859(21)00181-6</elocation-id>
<pub-id pub-id-type="doi">10.1016/j.humimm.2021.07.007</pub-id>
</element-citation>
</ref>
<ref id="R439">
<label>439</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sanino</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Bosco</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Terrazzano</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Physiology of Midkine and Its Potential Pathophysiological Role in COVID-19</article-title>
<source>Front Physiol</source>
<year>2020</year>
<volume>11</volume>
<elocation-id>616552</elocation-id>
<pub-id pub-id-type="doi">10.3389/fphys.2020.616552</pub-id>
</element-citation>
</ref>
<ref id="R440">
<label>440</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Horenstein</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Faini</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Malavasi</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>CD38 in the age of COVID-19: a medical perspective</article-title>
<source>Physiol Rev</source>
<year>2021</year>
<volume>101</volume>
<issue>4</issue>
<fpage>1457</fpage>
<lpage>1486</lpage>
<pub-id pub-id-type="doi">10.1152/physrev.00046.2020</pub-id>
</element-citation>
</ref>
<ref id="R441">
<label>441</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dhangadamajhi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Rout</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Association of TLR3 functional variant (rs3775291) with COVID-19 susceptibility and death: a population-scale study</article-title>
<source>Hum Cell</source>
<year>2021</year>
<volume>34</volume>
<issue>3</issue>
<fpage>1025</fpage>
<lpage>1027</lpage>
<pub-id pub-id-type="doi">10.1007/s13577-021-00510-6</pub-id>
</element-citation>
</ref>
<ref id="R442">
<label>442</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rivas-Fuentes</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Valdés</surname>
<given-names>VJ</given-names>
</name>
<name>
<surname>Espinosa</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Gorocica-Rosete</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Salgado-Aguayo</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Could SARS-CoV-2 blocking of ACE2 in endothelial cells result in upregulation of CX3CL1, promoting thrombosis in COVID-19 patients?</article-title>
<source>Med Hypotheses</source>
<year>2021</year>
<volume>151</volume>
<elocation-id>110570</elocation-id>
<pub-id pub-id-type="doi">10.1016/j.mehy.2021.110570</pub-id>
</element-citation>
</ref>
<ref id="R443">
<label>443</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Asano</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Boisson</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Onodi</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Matuozzo</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Moncada-Velez</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Maglorius Renkilaraj</surname>
<given-names>MRL</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Meertens</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Bolze</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Materna</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>
<article-title>X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19</article-title>
<source>Sci Immunol</source>
<year>2021</year>
<volume>6</volume>
<issue>62</issue>
<elocation-id>eabl4348</elocation-id>
<pub-id pub-id-type="doi">10.1126/sciimmunol.abl4348</pub-id>
</element-citation>
</ref>
<ref id="R444">
<label>444</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laterre</surname>
<given-names>PF</given-names>
</name>
<name>
<surname>François</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Collienne</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Hantson</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Jeannet</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Remy</surname>
<given-names>KE</given-names>
</name>
<name>
<surname>Hotchkiss</surname>
<given-names>RS</given-names>
</name>
</person-group>
<article-title>Association of Interleukin 7 Immunotherapy With Lymphocyte Counts Among Patients With Severe Coronavirus Disease 2019 (COVID-19)</article-title>
<source>JAMA Netw Open</source>
<year>2020</year>
<volume>3</volume>
<issue>7</issue>
<elocation-id>e2016485</elocation-id>
<pub-id pub-id-type="doi">10.1001/jamanetworkopen.2020.16485</pub-id>
</element-citation>
</ref>
<ref id="R445">
<label>445</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Friedman</surname>
<given-names>DJ</given-names>
</name>
</person-group>
<article-title>COVID-19 and APOL1: Understanding Disease Mechanisms through Clinical Observation</article-title>
<source>J Am Soc Nephrol</source>
<year>2021</year>
<volume>32</volume>
<issue>1</issue>
<fpage>1</fpage>
<lpage>2</lpage>
<pub-id pub-id-type="doi">10.1681/ASN.2020111629</pub-id>
</element-citation>
</ref>
<ref id="R446">
<label>446</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schmidt</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Peters</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Knaus</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sabir</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Hamsen</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Maj</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Fazaal</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sivalingam</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Savchenko</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Mantri</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>
<article-title>TBK1 and TNFRSF13B mutations and an autoinflammatory disease in a child with lethal COVID-19</article-title>
<source>NPJ Genom Med</source>
<year>2021</year>
<volume>6</volume>
<issue>1</issue>
<fpage>55</fpage>
<pub-id pub-id-type="doi">10.1038/s41525-021-00220-w</pub-id>
</element-citation>
</ref>
<ref id="R447">
<label>447</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boudewijns</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Thibaut</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Kaptein</surname>
<given-names>SJF</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Vergote</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Seldeslachts</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Van Weyenbergh</surname>
<given-names>J</given-names>
</name>
<name>
<surname>De Keyzer</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bervoets</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>
<article-title>STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters</article-title>
<source>Nat Commun</source>
<year>2020</year>
<volume>11</volume>
<issue>1</issue>
<elocation-id>5838</elocation-id>
<pub-id pub-id-type="doi">10.1038/s41467-020-19684-y</pub-id>
</element-citation>
</ref>
<ref id="R448">
<label>448</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Law</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Puranik</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Fei</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hambly</surname>
<given-names>BD</given-names>
</name>
<name>
<surname>Bao</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Clinical Implications of IL-32, IL-34 and IL-37 in Atherosclerosis: Speculative Role in Cardiovascular Manifestations of COVID-19</article-title>
<source>Front Cardiovasc Med</source>
<year>2021</year>
<volume>8</volume>
<elocation-id>630767</elocation-id>
<pub-id pub-id-type="doi">10.3389/fcvm.2021.630767</pub-id>
</element-citation>
</ref>
<ref id="R449">
<label>449</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Hui</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Tiwari</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Croker</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Rawlings</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Carlin</surname>
<given-names>AF</given-names>
</name>
<name>
<surname>Rana</surname>
<given-names>TM</given-names>
</name>
</person-group>
<article-title>Cholesterol 25-Hydroxylase inhibits SARS-CoV-2 and other coronaviruses by depleting membrane cholesterol</article-title>
<source>EMBO J</source>
<year>2020</year>
<volume>39</volume>
<issue>21</issue>
<elocation-id>e106057</elocation-id>
<pub-id pub-id-type="doi">10.15252/embj.2020106057</pub-id>
</element-citation>
</ref>
<ref id="R450">
<label>450</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murch</surname>
<given-names>SH</given-names>
</name>
</person-group>
<article-title>Common determinants of severe Covid-19 infection are explicable by SARS-CoV-2 secreted glycoprotein interaction with the CD33-related Siglecs, Siglec-3 and Siglec-5/14</article-title>
<source>Med Hypotheses</source>
<year>2020</year>
<volume>144</volume>
<elocation-id>110168</elocation-id>
<pub-id pub-id-type="doi">10.1016/j.mehy.2020.110168</pub-id>
</element-citation>
</ref>
<ref id="R451">
<label>451</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jia</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Neptune</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Targeting ACE2 for COVID-19 Therapy: Opportunities and Challenges</article-title>
<source>Am J Respir Cell Mol Biol</source>
<year>2021</year>
<volume>64</volume>
<issue>4</issue>
<fpage>416</fpage>
<lpage>425</lpage>
<pub-id pub-id-type="doi">10.1165/rcmb.2020-0322PS</pub-id>
</element-citation>
</ref>
<ref id="R452">
<label>452</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scherrmann</surname>
<given-names>JM</given-names>
</name>
</person-group>
<article-title>Possible Role of ABCB1 in Lysosomal Accumulation of Azithromycin in COVID-19 Therapy</article-title>
<source>Clin Pharmacol Ther</source>
<year>2021</year>
<volume>109</volume>
<issue>5</issue>
<elocation-id>1180</elocation-id>
<pub-id pub-id-type="doi">10.1002/cpt.2020</pub-id>
</element-citation>
</ref>
<ref id="R453">
<label>453</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>HK</given-names>
</name>
</person-group>
<article-title>Re-analysis of Single Cell Transcriptome Reveals That the NR3C1-CXCL8-Neutrophil Axis Determines the Severity of COVID-19</article-title>
<source>Front Immunol</source>
<year>2020</year>
<volume>11</volume>
<elocation-id>2145</elocation-id>
<pub-id pub-id-type="doi">10.3389/fimmu.2020.02145</pub-id>
</element-citation>
</ref>
<ref id="R454">
<label>454</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Ilyas</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>
<article-title>The zinc finger transcription factor, KLF2, protects against COVID-19 associated endothelial dysfunction</article-title>
<source>Signal Transduct Target Ther</source>
<year>2021</year>
<volume>6</volume>
<issue>1</issue>
<fpage>266</fpage>
<pub-id pub-id-type="doi">10.1038/s41392-021-00690-5</pub-id>
</element-citation>
</ref>
<ref id="R455">
<label>455</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Simon</surname>
<given-names>TP</given-names>
</name>
<name>
<surname>Stoppe</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Breuer</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Stiehler</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Dreher</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kersten</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kluge</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Karakas</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zechendorf</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Marx</surname>
<given-names>G</given-names>
</name>
<etal/>
</person-group>
<article-title>Prognostic Value of Bioactive Adrenomedullin in Critically Ill Patients with COVID-19 in Germany: An Observational Cohort Study</article-title>
<source>J Clin Med</source>
<year>2021</year>
<volume>10</volume>
<issue>8</issue>
<elocation-id>1667</elocation-id>
<pub-id pub-id-type="doi">10.3390/jcm10081667</pub-id>
</element-citation>
</ref>
<ref id="R456">
<label>456</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carvelli</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Demaria</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Vély</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Batista</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Chouaki Benmansour</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Fares</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Carpentier</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Thibult</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Morel</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Remark</surname>
<given-names>R</given-names>
</name>
<etal/>
</person-group>
<article-title>Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis</article-title>
<source>Nature</source>
<year>2020</year>
<volume>588</volume>
<issue>7836</issue>
<fpage>146</fpage>
<lpage>150</lpage>
<pub-id pub-id-type="doi">10.1038/s41586-020-2600-6</pub-id>
</element-citation>
</ref>
<ref id="R457">
<label>457</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Larsson</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Burgess</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gill</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Genetically proxied interleukin-6 receptor inhibition: opposing associations with COVID-19 and pneumonia</article-title>
<source>Eur Respir J</source>
<year>2021</year>
<volume>57</volume>
<issue>1</issue>
<elocation-id>2003545</elocation-id>
<pub-id pub-id-type="doi">10.1183/13993003.03545-2020</pub-id>
</element-citation>
</ref>
<ref id="R458">
<label>458</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>He</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>
<article-title>Single-cell RNA sequencing identify SDCBP in ACE2-positive bronchial epithelial cells negatively correlates with COVID-19 severity</article-title>
<source>J Cell Mol Med</source>
<year>2021</year>
<volume>25</volume>
<issue>14</issue>
<fpage>7001</fpage>
<lpage>7012</lpage>
<pub-id pub-id-type="doi">10.1111/jcmm.16714</pub-id>
</element-citation>
</ref>
<ref id="R459">
<label>459</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>El Mesallamy</surname>
<given-names>HO</given-names>
</name>
<name>
<surname>Hamdy</surname>
<given-names>NM</given-names>
</name>
<name>
<surname>Mostafa</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Amin</surname>
<given-names>AI</given-names>
</name>
</person-group>
<article-title>The serine protease granzyme B as an inflammatory marker, in relation to the insulin receptor cleavage in human obesity and type 2 diabetes mellitus</article-title>
<source>J Interferon Cytokine Res</source>
<year>2014</year>
<volume>34</volume>
<issue>3</issue>
<fpage>179</fpage>
<lpage>186</lpage>
<pub-id pub-id-type="doi">10.1089/jir.2013.0059</pub-id>
</element-citation>
</ref>
<ref id="R460">
<label>460</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sabouri</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Mikulski</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>von Herrath</surname>
<given-names>MG</given-names>
</name>
</person-group>
<article-title>OAS1 is not associated with MHC class I hyperexpression in the islets of donors with T1D regardless of disease duration</article-title>
<source>Clin Immunol</source>
<year>2018</year>
<volume>191</volume>
<fpage>34</fpage>
<lpage>36</lpage>
<pub-id pub-id-type="doi">10.1016/j.clim.2018.03.006</pub-id>
</element-citation>
</ref>
<ref id="R461">
<label>461</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Igoillo-Esteve</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Marselli</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Cunha</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Ladrière</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ortis</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Grieco</surname>
<given-names>FA</given-names>
</name>
<name>
<surname>Dotta</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Weir</surname>
<given-names>GC</given-names>
</name>
<name>
<surname>Marchetti</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Eizirik</surname>
<given-names>DL</given-names>
</name>
<etal/>
</person-group>
<article-title>Palmitate induces a pro-inflammatory response in human pancreatic islets that mimics CCL2 expression by beta cells in type 2 diabetes</article-title>
<source>Diabetologia</source>
<year>2010</year>
<volume>53</volume>
<issue>7</issue>
<fpage>1395</fpage>
<lpage>1405</lpage>
<pub-id pub-id-type="doi">10.1007/s00125-010-1707-y</pub-id>
</element-citation>
</ref>
<ref id="R462">
<label>462</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anquetil</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Mondanelli</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Gonzalez</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Rodriguez Calvo</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Zapardiel Gonzalo</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Krogvold</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Dahl-Jørgensen</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Van den Eynde</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Orabona</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Grohmann</surname>
<given-names>U</given-names>
</name>
<etal/>
</person-group>
<article-title>Loss of IDO1 Expression From Human Pancreatic β-Cells Precedes Their Destruction During the Development of Type 1 Diabetes</article-title>
<source>Diabetes</source>
<year>2018</year>
<volume>67</volume>
<issue>9</issue>
<fpage>1858</fpage>
<lpage>1866</lpage>
<pub-id pub-id-type="doi">10.2337/db17-1281</pub-id>
</element-citation>
</ref>
<ref id="R463">
<label>463</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pechhold</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Karges</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Blum</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Boehm</surname>
<given-names>BO</given-names>
</name>
<name>
<surname>Harlan</surname>
<given-names>DM</given-names>
</name>
</person-group>
<article-title>Beta cell-specific CD80 (B7-1) expression disrupts tissue protection from autoantigen-specific CTL-mediated diabetes</article-title>
<source>J Autoimmun</source>
<year>2003</year>
<volume>20</volume>
<issue>1</issue>
<fpage>1</fpage>
<lpage>13</lpage>
<pub-id pub-id-type="doi">10.1016/s0896-8411(02)00105-1</pub-id>
</element-citation>
</ref>
<ref id="R464">
<label>464</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mollah</surname>
<given-names>ZUA</given-names>
</name>
<name>
<surname>Quah</surname>
<given-names>HS</given-names>
</name>
<name>
<surname>Graham</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Jhala</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Krishnamurthy</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Dharma</surname>
<given-names>JFM</given-names>
</name>
<name>
<surname>Chee</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Trivedi</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Pappas</surname>
<given-names>EG</given-names>
</name>
<name>
<surname>Mackin</surname>
<given-names>L</given-names>
</name>
<etal/>
</person-group>
<article-title>Granzyme A Deficiency Breaks Immune Tolerance and Promotes Autoimmune Diabetes Through a Type I Interferon-Dependent Pathway</article-title>
<source>Diabetes</source>
<year>2017</year>
<volume>66</volume>
<issue>12</issue>
<fpage>3041</fpage>
<lpage>3050</lpage>
<pub-id pub-id-type="doi">10.2337/db17-0517</pub-id>
</element-citation>
</ref>
<ref id="R465">
<label>465</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Serreze</surname>
<given-names>DV</given-names>
</name>
<name>
<surname>Post</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Chapman</surname>
<given-names>HD</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Rothman</surname>
<given-names>PB</given-names>
</name>
</person-group>
<article-title>Interferon-gamma receptor signaling is dispensable in the development of autoimmune type 1 diabetes in NOD mice</article-title>
<source>Diabetes</source>
<year>2000</year>
<volume>49</volume>
<issue>12</issue>
<fpage>2007</fpage>
<lpage>2011</lpage>
<pub-id pub-id-type="doi">10.2337/diabetes.49.12.2007</pub-id>
</element-citation>
</ref>
<ref id="R466">
<label>466</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jermendy</surname>
<given-names>Á</given-names>
</name>
<name>
<surname>Szatmári</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Körner</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Szabó</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Tóth-Heyn</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Hermann</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Association between interferon-induced helicase (IFIH1) rs1990760 polymorphism and seasonal variation in the onset of type 1 diabetes mellitus</article-title>
<source>Pediatr Diabetes</source>
<year>2018</year>
<volume>19</volume>
<issue>2</issue>
<fpage>300</fpage>
<lpage>304</lpage>
<pub-id pub-id-type="doi">10.1111/pedi.12569</pub-id>
</element-citation>
</ref>
<ref id="R467">
<label>467</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lopez-Sanz</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Bernal</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Recio</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Lazaro</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Oguiza</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Melgar</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Jimenez-Castilla</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Egido</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gomez-Guerrero</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>SOCS1-targeted therapy ameliorates renal and vascular oxidative stress in diabetes via STAT1 and PI3K inhibition</article-title>
<source>Lab Invest</source>
<year>2018</year>
<volume>98</volume>
<issue>10</issue>
<fpage>1276</fpage>
<lpage>1290</lpage>
<pub-id pub-id-type="doi">10.1038/s41374-018-0043-6</pub-id>
</element-citation>
</ref>
<ref id="R468">
<label>468</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arababadi</surname>
<given-names>MK</given-names>
</name>
<name>
<surname>Naghavi</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Hassanshahi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Mahmoodi</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Is CCR5-Delta32 mutation associated with diabetic nephropathy in type 2 diabetes?</article-title>
<source>Ann Saudi Med</source>
<year>2009</year>
<volume>29</volume>
<issue>5</issue>
<fpage>413</fpage>
<pub-id pub-id-type="doi">10.4103/0256-4947.55177</pub-id>
</element-citation>
</ref>
<ref id="R469">
<label>469</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holstein</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Patzer</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Körner</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Stumvoll</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kovacs</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Holstein</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Genetic variants in GCKR, GIPR, ADCY5 and VPS13C and the risk of severe sulfonylurea-induced hypoglycaemia in patients with type 2 diabetes</article-title>
<source>Exp Clin Endocrinol Diabetes</source>
<year>2013</year>
<volume>121</volume>
<issue>1</issue>
<fpage>54</fpage>
<lpage>57</lpage>
<pub-id pub-id-type="doi">10.1055/s-0032-1321834</pub-id>
</element-citation>
</ref>
<ref id="R470">
<label>470</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hattori</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Naito</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Satoh</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nakatochi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Naito</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kato</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Takagi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Matsunaga</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Seiki</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Sasakabe</surname>
<given-names>T</given-names>
</name>
<etal/>
</person-group>
<article-title>Metallothionein MT2A A-5G Polymorphism as a Risk Factor for Chronic Kidney Disease and Diabetes: Cross-Sectional and Cohort Studies</article-title>
<source>Toxicol Sci</source>
<year>2016</year>
<volume>152</volume>
<issue>1</issue>
<fpage>181</fpage>
<lpage>193</lpage>
<pub-id pub-id-type="doi">10.1093/toxsci/kfw080</pub-id>
</element-citation>
</ref>
<ref id="R471">
<label>471</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Strollo</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Maddaloni</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Dauriz</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pedone</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Buzzetti</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Pozzilli</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Use of DPP4 inhibitors in Italy does not correlate with diabetes prevalence among COVID-19 deaths</article-title>
<source>Diabetes Res Clin Pract</source>
<year>2021</year>
<volume>171</volume>
<elocation-id>108444</elocation-id>
<pub-id pub-id-type="doi">10.1016/j.diabres.2020.108444</pub-id>
</element-citation>
</ref>
<ref id="R472">
<label>472</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moriwaki</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Itoh</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Miyagawa</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Imagawa</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Yamagata</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Iwahashi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Nakajima</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Namba</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nagata</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>
<article-title>Fas and Fas ligand expression in inflamed islets in pancreas sections of patients with recent-onset Type I diabetes mellitus</article-title>
<source>Diabetologia</source>
<year>1999</year>
<volume>42</volume>
<issue>11</issue>
<fpage>1332</fpage>
<lpage>1340</lpage>
<pub-id pub-id-type="doi">10.1007/s001250051446</pub-id>
</element-citation>
</ref>
<ref id="R473">
<label>473</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Siegmund</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Donner</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Braun</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Usadel</surname>
<given-names>KH</given-names>
</name>
<name>
<surname>Badenhoop</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>HLA-DMA and HLA-DMB alleles in German patients with type 1 diabetes mellitus</article-title>
<source>Tissue Antigens</source>
<year>1999</year>
<volume>54</volume>
<issue>3</issue>
<fpage>291</fpage>
<lpage>294</lpage>
<pub-id pub-id-type="doi">10.1034/j.1399-0039.1999.540313.x</pub-id>
</element-citation>
</ref>
<ref id="R474">
<label>474</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aparicio</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Wakisaka</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Takada</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Matsuura</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Yoshiki</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Non-HLA genetic factors and insulin dependent diabetes mellitus in the Japanese: TCRA, TCRB, TCRG, INS, THY1, CD3D and ETS1</article-title>
<source>Dis Markers</source>
<year>1990</year>
<volume>8</volume>
<issue>5</issue>
<fpage>283</fpage>
<lpage>294</lpage>
</element-citation>
</ref>
<ref id="R475">
<label>475</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Qu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
</person-group>
<article-title>Aerobic exercise decreases chemerin/CMKLR1 in the serum and peripheral metabolic organs of obesity and diabetes rats by increasing PPARγ</article-title>
<source>Nutr Metab (Lond)</source>
<year>2019</year>
<volume>16</volume>
<fpage>17</fpage>
<pub-id pub-id-type="doi">10.1186/s12986-019-0344-9</pub-id>
</element-citation>
</ref>
<ref id="R476">
<label>476</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hawiger</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Tran</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Booth</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Wen</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Flavell</surname>
<given-names>RA</given-names>
</name>
</person-group>
<article-title>ICOS mediates the development of insulin-dependent diabetes mellitus in nonobese diabetic mice</article-title>
<source>J Immunol</source>
<year>2008</year>
<volume>180</volume>
<issue>5</issue>
<fpage>3140</fpage>
<lpage>3147</lpage>
<pub-id pub-id-type="doi">10.4049/jimmunol.180.5.3140</pub-id>
</element-citation>
</ref>
<ref id="R477">
<label>477</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fichna</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zurawek</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Januszkiewicz-Lewandowska</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Fichna</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Nowak</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>PTPN22, PDCD1 and CYP27B1 polymorphisms and susceptibility to type 1 diabetes in Polish patients</article-title>
<source>Int J Immunogenet</source>
<year>2010</year>
<volume>37</volume>
<issue>5</issue>
<fpage>367</fpage>
<lpage>372</lpage>
<pub-id pub-id-type="doi">10.1111/j.1744-313X.2010.00935.x</pub-id>
</element-citation>
</ref>
<ref id="R478">
<label>478</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Du</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>N</given-names>
</name>
<etal/>
</person-group>
<article-title>Associations of SUCNR1, GRK4, CAMK1D gene polymorphisms and the susceptibility of type 2 diabetes mellitus and essential hypertension in a northern Chinese Han population</article-title>
<source>J Diabetes Complications</source>
<year>2021</year>
<volume>35</volume>
<issue>1</issue>
<elocation-id>107752</elocation-id>
<pub-id pub-id-type="doi">10.1016/j.jdiacomp.2020.107752</pub-id>
</element-citation>
</ref>
<ref id="R479">
<label>479</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>CY</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Z</given-names>
</name>
</person-group>
<article-title>DNA methylation impairs TLR9 induced Foxp3 expression by attenuating IRF-7 binding activity in fulminant type 1 diabetes</article-title>
<source>J Autoimmun</source>
<year>2013</year>
<volume>41</volume>
<fpage>50</fpage>
<lpage>59</lpage>
<pub-id pub-id-type="doi">10.1016/j.jaut.2013.01.009</pub-id>
</element-citation>
</ref>
<ref id="R480">
<label>480</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Soraia Aguiar de Melo Dias</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Carlos Mourão Pinho</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Almeida</surname>
<given-names>FR</given-names>
</name>
<name>
<surname>Alfredo Farias Bandeira</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Celerino da Silva</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Crovella</surname>
<given-names>S</given-names>
</name>
<name>
<surname>de Carvalho Farias Vajgel</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Cimões</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Evaluation of DEFB1 polymorphisms in individuals with chronic periodontitis and diabetes mellitus type 2 in a population of northeastern Brazil</article-title>
<source>Spec Care Dentist</source>
<year>2018</year>
<volume>38</volume>
<issue>4</issue>
<fpage>227</fpage>
<lpage>233</lpage>
<pub-id pub-id-type="doi">10.1111/scd.12296</pub-id>
</element-citation>
</ref>
<ref id="R481">
<label>481</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Albuquerque</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Mendes-Junior</surname>
<given-names>CT</given-names>
</name>
<name>
<surname>Lucena-Silva</surname>
<given-names>N</given-names>
</name>
<name>
<surname>da Silva</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Rassi</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Veiga-Castelli</surname>
<given-names>LC</given-names>
</name>
<name>
<surname>Foss-Freitas</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Foss</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Deghaide</surname>
<given-names>NH</given-names>
</name>
<etal/>
</person-group>
<article-title>Association of HLA-G 3' untranslated region variants with type 1 diabetes mellitus</article-title>
<source>Hum Immunol</source>
<year>2016</year>
<volume>77</volume>
<issue>4</issue>
<fpage>358</fpage>
<lpage>364</lpage>
<pub-id pub-id-type="doi">10.1016/j.humimm.2016.02.001</pub-id>
</element-citation>
</ref>
<ref id="R482">
<label>482</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferjeni</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Bouzid</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Fourati</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Stayoussef</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Abida</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Kammoun</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hachicha</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Penha-Gonçalves</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Masmoudi</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Association of TCR/CD3, PTPN22, CD28 and ZAP70 gene polymorphisms with type 1 diabetes risk in Tunisian population: family based association study</article-title>
<source>Immunol Lett</source>
<year>2015</year>
<volume>163</volume>
<issue>1</issue>
<fpage>1</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1016/j.imlet.2014.11.005</pub-id>
</element-citation>
</ref>
<ref id="R483">
<label>483</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>YG</given-names>
</name>
<name>
<surname>Ciecko</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Khaja</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Grzybowski</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Geurts</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Lieberman</surname>
<given-names>SM</given-names>
</name>
</person-group>
<article-title>UBASH3A deficiency accelerates type 1 diabetes development and enhances salivary gland inflammation in NOD mice</article-title>
<source>Sci Rep</source>
<year>2020</year>
<volume>10</volume>
<issue>1</issue>
<elocation-id>12019</elocation-id>
<pub-id pub-id-type="doi">10.1038/s41598-020-68956-6</pub-id>
</element-citation>
</ref>
<ref id="R484">
<label>484</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Siegmund</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Donner</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Braun</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Usadel</surname>
<given-names>KH</given-names>
</name>
<name>
<surname>Badenhoop</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>HLA-DMA and HLA-DMB alleles in German patients with type 1 diabetes mellitus</article-title>
<source>Tissue Antigens</source>
<year>1999</year>
<volume>54</volume>
<issue>3</issue>
<fpage>291</fpage>
<lpage>294</lpage>
<pub-id pub-id-type="doi">10.1034/j.1399-0039.1999.540313.x</pub-id>
</element-citation>
</ref>
<ref id="R485">
<label>485</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>YY</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Pang</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Min</surname>
<given-names>XY</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>ZJ</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>XZ</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>LS</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>XM</given-names>
</name>
<name>
<surname>Qian</surname>
<given-names>Y</given-names>
</name>
<etal/>
</person-group>
<article-title>TAP1 I333V gene polymorphism and type 1 diabetes mellitus: a meta-analysis of 2248 cases</article-title>
<source>J Cell Mol Med</source>
<year>2014</year>
<volume>18</volume>
<issue>5</issue>
<fpage>929</fpage>
<lpage>937</lpage>
<pub-id pub-id-type="doi">10.1111/jcmm.12244</pub-id>
</element-citation>
</ref>
<ref id="R486">
<label>486</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Short</surname>
<given-names>AD</given-names>
</name>
<name>
<surname>Saleh</surname>
<given-names>NM</given-names>
</name>
<name>
<surname>Catchpole</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Kennedy</surname>
<given-names>LJ</given-names>
</name>
<name>
<surname>Barnes</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Fretwell</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Ollier</surname>
<given-names>WE</given-names>
</name>
</person-group>
<article-title>CTLA4 promoter polymorphisms are associated with canine diabetes mellitus</article-title>
<source>Tissue Antigens</source>
<year>2010</year>
<volume>75</volume>
<issue>3</issue>
<fpage>242</fpage>
<lpage>252</lpage>
<pub-id pub-id-type="doi">10.1111/j.1399-0039.2009.01434.x</pub-id>
</element-citation>
</ref>
<ref id="R487">
<label>487</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Antonelli</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Tuomi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Nannipieri</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Fallahi</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Nesti</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Okamoto</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Groop</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ferrannini</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Autoimmunity to CD38 and GAD in Type I, Type II diabetes: CD38 and HLA genotypes and clinical phenotypes</article-title>
<source>Diabetologia</source>
<year>2002</year>
<volume>45</volume>
<issue>9</issue>
<fpage>1298</fpage>
<lpage>1306</lpage>
<pub-id pub-id-type="doi">10.1007/s00125-002-0886-6</pub-id>
</element-citation>
</ref>
<ref id="R488">
<label>488</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Nie</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Ou</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group>
<article-title>The effects of TLR3, TRIF and TRAF3 SNPs and interactions with environmental factors on type 2 diabetes mellitus and vascular complications in a Han Chinese population</article-title>
<source>Gene</source>
<year>2017</year>
<volume>626</volume>
<fpage>41</fpage>
<lpage>47</lpage>
<pub-id pub-id-type="doi">10.1016/j.gene.2017.05.011</pub-id>
</element-citation>
</ref>
<ref id="R489">
<label>489</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shah</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Matthews</surname>
<given-names>GJ</given-names>
</name>
<name>
<surname>Shah</surname>
<given-names>RY</given-names>
</name>
<name>
<surname>McLaughlin</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wolman</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Master</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Chai</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Rader</surname>
<given-names>DJ</given-names>
</name>
<etal/>
</person-group>
<article-title>Serum Fractalkine (CX3CL1) and Cardiovascular Outcomes and Diabetes: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study</article-title>
<source>Am J Kidney Dis</source>
<year>2015</year>
<volume>66</volume>
<issue>2</issue>
<fpage>266</fpage>
<lpage>273</lpage>
<pub-id pub-id-type="doi">10.1053/j.ajkd.2015.01.021</pub-id>
</element-citation>
</ref>
<ref id="R490">
<label>490</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eldor</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Klieger</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Sade-Feldman</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Vaknin</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Varfolomeev</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Fuchs</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Baniyash</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>CD247, a novel T cell-derived diagnostic and prognostic biomarker for detecting disease progression and severity in patients with type 2 diabetes</article-title>
<source>Diabetes Care</source>
<year>2015</year>
<volume>38</volume>
<issue>1</issue>
<fpage>113</fpage>
<lpage>118</lpage>
<pub-id pub-id-type="doi">10.2337/dc14-1544</pub-id>
</element-citation>
</ref>
<ref id="R491">
<label>491</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>YM</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>LQ</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>CG</given-names>
</name>
<name>
<surname>Zhuang</surname>
<given-names>ZX</given-names>
</name>
</person-group>
<article-title>Association of NOS2 and NOS3 gene polymorphisms with susceptibility to type 2 diabetes mellitus and diabetic nephropathy in the Chinese Han population</article-title>
<source>IUBMB Life</source>
<year>2016</year>
<volume>68</volume>
<issue>7</issue>
<fpage>516</fpage>
<lpage>525</lpage>
<pub-id pub-id-type="doi">10.1002/iub.1513</pub-id>
</element-citation>
</ref>
<ref id="R492">
<label>492</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nie</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Yue</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Q</given-names>
</name>
</person-group>
<article-title>Diabetes induces macrophage dysfunction through cytoplasmic dsDNA/AIM2 associated pyroptosis</article-title>
<source>J Leukoc Biol</source>
<year>2021</year>
<volume>110</volume>
<issue>3</issue>
<fpage>497</fpage>
<lpage>510</lpage>
<pub-id pub-id-type="doi">10.1002/JLB.3MA0321-745R</pub-id>
</element-citation>
</ref>
<ref id="R493">
<label>493</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>YB</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>GD</given-names>
</name>
<name>
<surname>Teng</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>XM</given-names>
</name>
</person-group>
<article-title>Association of CFH and CFB gene polymorphisms with retinopathy in type 2 diabetic patients</article-title>
<source>Mediators Inflamm</source>
<year>2013</year>
<volume>2013</volume>
<elocation-id>748435</elocation-id>
<pub-id pub-id-type="doi">10.1155/2013/748435</pub-id>
</element-citation>
</ref>
<ref id="R494">
<label>494</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Pearson</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Efthimiou</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Tai</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Xing</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>
<article-title>Toll-like receptor 7 deficiency suppresses type 1 diabetes development by modulating B-cell differentiation and function</article-title>
<source>Cell Mol Immunol</source>
<year>2021</year>
<volume>18</volume>
<issue>2</issue>
<fpage>328</fpage>
<lpage>338</lpage>
<pub-id pub-id-type="doi">10.1038/s41423-020-00590-8</pub-id>
</element-citation>
</ref>
<ref id="R495">
<label>495</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tabassum</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Mahajan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Dwivedi</surname>
<given-names>OP</given-names>
</name>
<name>
<surname>Chauhan</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Spurgeon</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>MV</given-names>
</name>
<name>
<surname>Ghosh</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Madhu</surname>
<given-names>SV</given-names>
</name>
<name>
<surname>Mathur</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Chandak</surname>
<given-names>GR</given-names>
</name>
<etal/>
</person-group>
<article-title>Common variants of SLAMF1 and ITLN1 on 1q21 are associated with type 2 diabetes in Indian population</article-title>
<source>J Hum Genet</source>
<year>2012</year>
<volume>57</volume>
<issue>3</issue>
<fpage>184</fpage>
<lpage>190</lpage>
<pub-id pub-id-type="doi">10.1038/jhg.2011.150</pub-id>
</element-citation>
</ref>
<ref id="R496">
<label>496</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>LN</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>CY</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>YZ</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>HD</given-names>
</name>
</person-group>
<article-title>Associations of Salivary BPIFA1 Protein in Chronic Periodontitis Patients with Type 2 Diabetes Mellitus</article-title>
<source>Int J Endocrinol</source>
<year>2017</year>
<volume>2017</volume>
<elocation-id>1087017</elocation-id>
<pub-id pub-id-type="doi">10.1155/2017/1087017</pub-id>
</element-citation>
</ref>
<ref id="R497">
<label>497</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haseda</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Imagawa</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Nishikawa</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Mitsui</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tsutsumi</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Fujisawa</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Sano</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Murase-Mishiba</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Terasaki</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sakaguchi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hanafusa</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Antibody to CMRF35-Like Molecule 2, CD300e A Novel Biomarker Detected in Patients with Fulminant Type 1 Diabetes</article-title>
<source>PLoS One</source>
<year>2016</year>
<volume>11</volume>
<issue>8</issue>
<elocation-id>e0160576</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0160576</pub-id>
</element-citation>
</ref>
<ref id="R498">
<label>498</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Penfornis</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Tuomilehto-Wolf</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Faustman</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Hitman</surname>
<given-names>GA</given-names>
</name>
<collab>DiMe (Childhood Diabetes in Finland) Study Group</collab>
</person-group>
<article-title>Analysis of TAP2 polymorphisms in Finnish individuals with type I diabetes</article-title>
<source>Hum Immunol</source>
<year>2002</year>
<volume>63</volume>
<issue>1</issue>
<fpage>61</fpage>
<lpage>70</lpage>
<pub-id pub-id-type="doi">10.1016/s0198-8859(01)00365-2</pub-id>
</element-citation>
</ref>
<ref id="R499">
<label>499</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramos-Lopez</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Ghebru</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Van Autreve</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Aminkeng</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Herwig</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Seifried</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Seidl</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Van der Auwera</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Badenhoop</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Neither an intronic CA repeat within the CD48 gene nor the HERV-K18 polymorphisms are associated with type 1 diabetes</article-title>
<source>Tissue Antigens</source>
<year>2006</year>
<volume>68</volume>
<issue>2</issue>
<fpage>147</fpage>
<lpage>152</lpage>
<pub-id pub-id-type="doi">10.1111/j.1399-0039.2006.00637.x</pub-id>
</element-citation>
</ref>
<ref id="R500">
<label>500</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Freedman</surname>
<given-names>BI</given-names>
</name>
<name>
<surname>Langefeld</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Palmer</surname>
<given-names>ND</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Bagwell</surname>
<given-names>BM</given-names>
</name>
<name>
<surname>Hicks</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wagenknecht</surname>
<given-names>LE</given-names>
</name>
<name>
<surname>Raffield</surname>
<given-names>LM</given-names>
</name>
<etal/>
</person-group>
<article-title>APOL1 associations with nephropathy, atherosclerosis, and all-cause mortality in African Americans with type 2 diabetes</article-title>
<source>Kidney Int</source>
<year>2015</year>
<volume>87</volume>
<issue>1</issue>
<fpage>176</fpage>
<lpage>181</lpage>
<pub-id pub-id-type="doi">10.1038/ki.2014.255</pub-id>
</element-citation>
</ref>
<ref id="R501">
<label>501</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dieter</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Lemos</surname>
<given-names>NE</given-names>
</name>
<name>
<surname>Dorfman</surname>
<given-names>LE</given-names>
</name>
<name>
<surname>Duarte</surname>
<given-names>GCK</given-names>
</name>
<name>
<surname>Assmann</surname>
<given-names>TS</given-names>
</name>
<name>
<surname>Crispim</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>The rs11755527 polymorphism in the BACH2 gene and type 1 diabetes mellitus: case control study in a Brazilian population</article-title>
<source>Arch Endocrinol Metab</source>
<year>2020</year>
<volume>64</volume>
<issue>2</issue>
<fpage>138</fpage>
<lpage>143</lpage>
<pub-id pub-id-type="doi">10.20945/2359-3997000000214</pub-id>
</element-citation>
</ref>
<ref id="R502">
<label>502</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abu El-Ella</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Khattab</surname>
<given-names>ESAEH</given-names>
</name>
<name>
<surname>El-Mekkawy</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>El-Shamy</surname>
<given-names>AA</given-names>
</name>
</person-group>
<article-title>CD226 gene polymorphism (rs763361 C&gt;T) is associated with susceptibility to type 1 diabetes mellitus among Egyptian children</article-title>
<source>Arch Pediatr</source>
<year>2018</year>
<volume>25</volume>
<issue>6</issue>
<fpage>378</fpage>
<lpage>382</lpage>
<pub-id pub-id-type="doi">10.1016/j.arcped.2018.06.009</pub-id>
</element-citation>
</ref>
<ref id="R503">
<label>503</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Darakhshan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Fatehi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hassanshahi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Mahmoodi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hashemi</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Karimabad</surname>
<given-names>MN</given-names>
</name>
</person-group>
<article-title>Serum concentration of angiogenic (CXCL1, CXCL12) and angiostasis (CXCL9, CXCL10) CXC chemokines are differentially altered in normal and gestational diabetes mellitus associated pregnancies</article-title>
<source>J Diabetes Metab Disord</source>
<year>2019</year>
<volume>18</volume>
<issue>2</issue>
<fpage>371</fpage>
<lpage>378</lpage>
<pub-id pub-id-type="doi">10.1007/s40200-019-00421-2</pub-id>
</element-citation>
</ref>
<ref id="R504">
<label>504</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mine</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Nagafuchi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hatano</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Mori</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Anzai</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Yoshikai</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Impaired upregulation of Stat2 gene restrictive to pancreatic β-cells is responsible for virus-induced diabetes in DBA/2 mice</article-title>
<source>Biochem Biophys Res Commun</source>
<year>2020</year>
<volume>521</volume>
<issue>4</issue>
<fpage>853</fpage>
<lpage>860</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbrc.2019.10.193</pub-id>
</element-citation>
</ref>
<ref id="R505">
<label>505</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>HW</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>BY</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>YX</given-names>
</name>
</person-group>
<article-title>Association of Polymorphisms in STRA6 and RARRES2 Genes with Type 2 Diabetes in Southern Han Chinese</article-title>
<source>Biomed Res Int</source>
<year>2016</year>
<volume>2016</volume>
<elocation-id>6589793</elocation-id>
<pub-id pub-id-type="doi">10.1155/2016/6589793</pub-id>
</element-citation>
</ref>
<ref id="R506">
<label>506</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fadaei</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Bagheri</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Heidarian</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Nouri</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hesari</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Moradi</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Ahmadi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ahmadi</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Serum levels of IL-32 in patients with type 2 diabetes mellitus and its relationship with TNF-α and IL-6</article-title>
<source>Cytokine</source>
<year>2020</year>
<volume>125</volume>
<elocation-id>154832</elocation-id>
<pub-id pub-id-type="doi">10.1016/j.cyto.2019.154832</pub-id>
</element-citation>
</ref>
<ref id="R507">
<label>507</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Valencia</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Peiró</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Lorenzo</surname>
<given-names>Ó</given-names>
</name>
<name>
<surname>Sánchez-Ferrer</surname>
<given-names>CF</given-names>
</name>
<name>
<surname>Eckel</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Romacho</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?</article-title>
<source>Front Pharmacol</source>
<year>2020</year>
<volume>11</volume>
<elocation-id>1161</elocation-id>
<pub-id pub-id-type="doi">10.3389/fphar.2020.01161</pub-id>
</element-citation>
</ref>
<ref id="R508">
<label>508</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rojas</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Rojas</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>JW</given-names>
</name>
</person-group>
<article-title>Structure and function of CD72 in the non-obese diabetic (NOD) mouse</article-title>
<source>Autoimmunity</source>
<year>2003</year>
<volume>36</volume>
<issue>4</issue>
<fpage>233</fpage>
<lpage>239</lpage>
<pub-id pub-id-type="doi">10.1080/0891693031000141059</pub-id>
</element-citation>
</ref>
<ref id="R509">
<label>509</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ludvigsen</surname>
<given-names>TP</given-names>
</name>
<name>
<surname>Olsen</surname>
<given-names>LH</given-names>
</name>
<name>
<surname>Pedersen</surname>
<given-names>HD</given-names>
</name>
<name>
<surname>Christoffersen</surname>
<given-names>BØ</given-names>
</name>
<name>
<surname>Jensen</surname>
<given-names>LJ</given-names>
</name>
</person-group>
<article-title>Hyperglycemia-induced transcriptional regulation of ROCK1 and TGM2 expression is involved in small artery remodeling in obese diabetic Göttingen Minipigs</article-title>
<source>Clin Sci (Lond)</source>
<year>2019</year>
<volume>133</volume>
<issue>24</issue>
<fpage>2499</fpage>
<lpage>2516</lpage>
<pub-id pub-id-type="doi">10.1042/CS20191066</pub-id>
</element-citation>
</ref>
<ref id="R510">
<label>510</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mao</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>High expression of CD52 in adipocytes: a potential therapeutic target for obesity with type 2 diabetes</article-title>
<source>Aging (Albany NY)</source>
<year>2021</year>
<volume>13</volume>
<issue>8</issue>
<fpage>11043</fpage>
<lpage>11060</lpage>
<pub-id pub-id-type="doi">10.18632/aging.202714</pub-id>
</element-citation>
</ref>
<ref id="R511">
<label>511</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saravani</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yari</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Saravani</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Azadi Ahmadabadi</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Association of COL4A3 (rs55703767), MMP-9 (rs17576)and TIMP-1 (rs6609533) gene polymorphisms with susceptibility to type 2 diabetes</article-title>
<source>Biomed Rep</source>
<year>2017</year>
<volume>6</volume>
<issue>3</issue>
<fpage>329</fpage>
<lpage>334</lpage>
<pub-id pub-id-type="doi">10.3892/br.2017.856</pub-id>
</element-citation>
</ref>
<ref id="R512">
<label>512</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Shao</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>A novel compound heterozygous variant of the SLC12A3 gene in Gitelman syndrome with diabetes and the choices of the appropriate hypoglycemic drugs: a case report</article-title>
<source>BMC Med Genomics</source>
<year>2021</year>
<volume>14</volume>
<issue>1</issue>
<fpage>198</fpage>
<pub-id pub-id-type="doi">10.1186/s12920-021-01047-1</pub-id>
</element-citation>
</ref>
<ref id="R513">
<label>513</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Koh</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Yoo</surname>
<given-names>SY</given-names>
</name>
<name>
<surname>Chin</surname>
<given-names>SO</given-names>
</name>
</person-group>
<article-title>Correlation of Glypican-4 Level with Basal Active Glucagon-Like Peptide 1 Level in Patients with Type 2 Diabetes Mellitus</article-title>
<source>Endocrinol Metab (Seoul)</source>
<year>2016</year>
<volume>31</volume>
<issue>3</issue>
<fpage>439</fpage>
<lpage>445</lpage>
<pub-id pub-id-type="doi">10.3803/EnM.2016.31.3.439</pub-id>
</element-citation>
</ref>
<ref id="R514">
<label>514</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yousef</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Behiry</surname>
<given-names>EG</given-names>
</name>
<name>
<surname>Allah</surname>
<given-names>WMA</given-names>
</name>
<name>
<surname>Hussien</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Abdelmoneam</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Imam</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Hikal</surname>
<given-names>DM</given-names>
</name>
</person-group>
<article-title>IRS-1 genetic polymorphism (r.2963G&gt;A) in type 2 diabetes mellitus patients associated with insulin resistance</article-title>
<source>Appl Clin Genet</source>
<year>2018</year>
<volume>11</volume>
<fpage>99</fpage>
<lpage>106</lpage>
<pub-id pub-id-type="doi">10.2147/TACG.S171096</pub-id>
</element-citation>
</ref>
<ref id="R515">
<label>515</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Association of CYP19A1 and CYP1A2 genetic polymorphisms with type 2 diabetes mellitus risk in the Chinese Han population</article-title>
<source>Lipids Health Dis</source>
<year>2020</year>
<volume>19</volume>
<issue>1</issue>
<fpage>187</fpage>
<pub-id pub-id-type="doi">10.1186/s12944-020-01366-9</pub-id>
</element-citation>
</ref>
<ref id="R516">
<label>516</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hamet</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Haloui</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Harvey</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Marois-Blanchet</surname>
<given-names>FC</given-names>
</name>
<name>
<surname>Sylvestre</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Tahir</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Simon</surname>
<given-names>PH</given-names>
</name>
<name>
<surname>Kanzki</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Raelson</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Long</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group>
<article-title>PROX1 gene CC genotype as a major determinant of early onset of type 2 diabetes in slavic study participants from Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation study</article-title>
<source>J Hypertens</source>
<year>2017</year>
<volume>35</volume>
<issue>Suppl 1(Suppl 1)</issue>
<fpage>S24</fpage>
<lpage>S32</lpage>
<pub-id pub-id-type="doi">10.1097/HJH.0000000000001241</pub-id>
</element-citation>
</ref>
<ref id="R517">
<label>517</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abdelmajed</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>El-Dessouky</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>SalahElDin</surname>
<given-names>DS</given-names>
</name>
<name>
<surname>Hassan</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Zaki</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Ismail</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Assessing the association of rs7574865 STAT4 gene variant and type 1 diabetes mellitus among Egyptian patients</article-title>
<source>J Genet Eng Biotechnol</source>
<year>2021</year>
<volume>19</volume>
<issue>1</issue>
<fpage>112</fpage>
<pub-id pub-id-type="doi">10.1186/s43141-021-00214-2</pub-id>
</element-citation>
</ref>
<ref id="R518">
<label>518</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ng</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Tam</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>So</surname>
<given-names>WY</given-names>
</name>
<name>
<surname>Ho</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>AW</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Lam</surname>
<given-names>VK</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>RC</given-names>
</name>
</person-group>
<article-title>Implication of genetic variants near NEGR1, SEC16B, TMEM18, ETV5/DGKG, GNPDA2, LIN7C/BDNF, MTCH2, BCDIN3D/FAIM2, SH2B1, FTO, MC4R, and KCTD15 with obesity and type 2 diabetes in 7705 Chinese</article-title>
<source>J Clin Endocrinol Metab</source>
<year>2010</year>
<volume>95</volume>
<issue>5</issue>
<fpage>2418</fpage>
<lpage>2425</lpage>
<pub-id pub-id-type="doi">10.1210/jc.2009-2077</pub-id>
</element-citation>
</ref>
<ref id="R519">
<label>519</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Silva</surname>
<given-names>BRD</given-names>
</name>
<name>
<surname>Cirelli</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Nepomuceno</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Theodoro</surname>
<given-names>LH</given-names>
</name>
<name>
<surname>Orrico</surname>
<given-names>SRP</given-names>
</name>
<name>
<surname>Cirelli</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Barros</surname>
<given-names>SP</given-names>
</name>
<name>
<surname>Scarel-Caminaga</surname>
<given-names>RM</given-names>
</name>
</person-group>
<article-title>Functional haplotype in the Interleukin8 (CXCL8) gene is associated with type 2 Diabetes Mellitus and Periodontitis in Brazilian population</article-title>
<source>Diabetes Metab Syndr</source>
<year>2020</year>
<volume>14</volume>
<issue>6</issue>
<fpage>1665</fpage>
<lpage>1672</lpage>
<pub-id pub-id-type="doi">10.1016/j.dsx.2020.08.036</pub-id>
</element-citation>
</ref>
<ref id="R520">
<label>520</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bian</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>MiRNA-92a protects pancreatic B-cell function by targeting KLF2 in diabetes mellitus</article-title>
<source>Biochem Biophys Res Commun</source>
<year>2018</year>
<volume>500</volume>
<issue>3</issue>
<fpage>577</fpage>
<lpage>582</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbrc.2018.04.097</pub-id>
</element-citation>
</ref>
<ref id="R521">
<label>521</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>He</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Tangduqing Granules Attenuate Insulin Resistance and Abnormal Lipid Metabolism through the Coordinated Regulation of PPARγ and DGAT2 in Type 2 Diabetic Rats</article-title>
<source>J Diabetes Res</source>
<year>2019</year>
<volume>2019</volume>
<elocation-id>7403978</elocation-id>
<pub-id pub-id-type="doi">10.1155/2019/7403978</pub-id>
</element-citation>
</ref>
<ref id="R522">
<label>522</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wong</surname>
<given-names>HK</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Cheung</surname>
<given-names>TT</given-names>
</name>
<name>
<surname>Cheung</surname>
<given-names>BM</given-names>
</name>
</person-group>
<article-title>Adrenomedullin and diabetes</article-title>
<source>World J Diabetes</source>
<year>2014</year>
<volume>5</volume>
<issue>3</issue>
<fpage>364</fpage>
<lpage>371</lpage>
<pub-id pub-id-type="doi">10.4239/wjd.v5.i3.364</pub-id>
</element-citation>
</ref>
<ref id="R523">
<label>523</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roshanzamir</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Hassan-Zadeh</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>Methylation of Specific CpG Sites in IL-1β and IL1R1 Genes is Affected by Hyperglycaemia in Type 2 Diabetic Patients</article-title>
<source>Immunol Invest</source>
<year>2020</year>
<volume>49</volume>
<issue>3</issue>
<fpage>287</fpage>
<lpage>298</lpage>
<pub-id pub-id-type="doi">10.1080/08820139.2019.1656227</pub-id>
</element-citation>
</ref>
<ref id="R524">
<label>524</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ao</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Egr1 mediates retinal vascular dysfunction in diabetes mellitus via promoting p53 transcription</article-title>
<source>J Cell Mol Med</source>
<year>2019</year>
<volume>23</volume>
<issue>5</issue>
<fpage>3345</fpage>
<lpage>3356</lpage>
<pub-id pub-id-type="doi">10.1111/jcmm.14225</pub-id>
</element-citation>
</ref>
<ref id="R525">
<label>525</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>TL</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>XH</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>YS</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>XP</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>
<article-title>Two novel functional single nucleotide polymorphisms of ADRB3 are associated with type 2 diabetes in the Chinese population</article-title>
<source>J Clin Endocrinol Metab</source>
<year>2013</year>
<volume>98</volume>
<issue>7</issue>
<fpage>E1272</fpage>
<lpage>E1277</lpage>
<pub-id pub-id-type="doi">10.1210/jc.2013-1137</pub-id>
</element-citation>
</ref>
<ref id="R526">
<label>526</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vats</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Sagar</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>TP</given-names>
</name>
<name>
<surname>Banerjee</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Association of Superoxide dismutases (SOD1 and SOD2) and Glutathione peroxidase 1 (GPx1) gene polymorphisms with type 2 diabetes mellitus</article-title>
<source>Free Radic Res</source>
<year>2015</year>
<volume>49</volume>
<issue>1</issue>
<fpage>17</fpage>
<lpage>24</lpage>
<pub-id pub-id-type="doi">10.3109/10715762.2014.971782</pub-id>
</element-citation>
</ref>
<ref id="R527">
<label>527</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>β-arrestin-2 is involved in irisin induced glucose metabolism in type 2 diabetes via p38 MAPK signaling</article-title>
<source>Exp Cell Res</source>
<year>2017</year>
<volume>360</volume>
<issue>2</issue>
<fpage>199</fpage>
<lpage>204</lpage>
<pub-id pub-id-type="doi">10.1016/j.yexcr.2017.09.006</pub-id>
</element-citation>
</ref>
<ref id="R528">
<label>528</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ming</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Z</given-names>
</name>
</person-group>
<article-title>Interaction of Nuclear Receptor Subfamily 4 Group A Member 1 (Nr4a1) and Liver Linase B1 (LKB1) Mitigates Type 2 Diabetes Mellitus by Activating Monophosphate-Activated Protein Kinase (AMPK)/Sirtuin 1 (SIRT1) Axis and Inhibiting Nuclear Factor-kappa B (NF-κB) Activation</article-title>
<source>Med Sci Monit</source>
<year>2020</year>
<volume>26</volume>
<elocation-id>e920278</elocation-id>
<pub-id pub-id-type="doi">10.12659/MSM.920278</pub-id>
</element-citation>
</ref>
<ref id="R529">
<label>529</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>K</given-names>
</name>
<etal/>
</person-group>
<article-title>IL6R inhibits viability and apoptosis of pancreatic beta-cells in type 2 diabetes mellitus via regulation by miR-22 of the JAK/STAT signaling pathway</article-title>
<source>Diabetes Metab Syndr Obes</source>
<year>2019</year>
<volume>12</volume>
<fpage>1645</fpage>
<lpage>1657</lpage>
<pub-id pub-id-type="doi">10.2147/DMSO.S211700</pub-id>
</element-citation>
</ref>
<ref id="R530">
<label>530</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Assayag-Asherie</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Sever</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Bogdani</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Weiss</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ginzberg</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Perles</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Weiss</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Sebban</surname>
<given-names>LE</given-names>
</name>
<name>
<surname>Turley</surname>
<given-names>EA</given-names>
</name>
<etal/>
</person-group>
<article-title>Can CD44 Be a Mediator of Cell Destruction? The Challenge of Type 1 Diabetes</article-title>
<source>PLoS One</source>
<year>2015</year>
<volume>10</volume>
<issue>12</issue>
<elocation-id>e0143589</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0143589</pub-id>
</element-citation>
</ref>
<ref id="R531">
<label>531</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pek</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Tavintharan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Woon</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Yeoh</surname>
<given-names>LY</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sum</surname>
<given-names>CF</given-names>
</name>
</person-group>
<article-title>Elevation of a novel angiogenic factor, leucine-rich-α2-glycoprotein (LRG1), is associated with arterial stiffness, endothelial dysfunction, and peripheral arterial disease in patients with type 2 diabetes</article-title>
<source>J Clin Endocrinol Metab</source>
<year>2015</year>
<volume>100</volume>
<issue>4</issue>
<fpage>1586</fpage>
<lpage>1593</lpage>
<pub-id pub-id-type="doi">10.1210/jc.2014-3855</pub-id>
</element-citation>
</ref>
<ref id="R532">
<label>532</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chuang</surname>
<given-names>PY</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>R</given-names>
</name>
<name>
<surname>He</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kretzler</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jim</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Cohen</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>He</surname>
<given-names>JC</given-names>
</name>
</person-group>
<article-title>Alteration of forkhead box O (foxo4) acetylation mediates apoptosis of podocytes in diabetes mellitus</article-title>
<source>PLoS One</source>
<year>2011</year>
<volume>6</volume>
<issue>8</issue>
<elocation-id>e23566</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0023566</pub-id>
</element-citation>
</ref>
<ref id="R533">
<label>533</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chuang</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>TH</given-names>
</name>
</person-group>
<article-title>MAP4K4 and IL-6+ Th17 cells play important roles in non-obese type 2 diabetes</article-title>
<source>J Biomed Sci</source>
<year>2017</year>
<volume>24</volume>
<issue>1</issue>
<fpage>4</fpage>
<pub-id pub-id-type="doi">10.1186/s12929-016-0307-7</pub-id>
</element-citation>
</ref>
<ref id="R534">
<label>534</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Freedman</surname>
<given-names>BI</given-names>
</name>
<name>
<surname>Langefeld</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Divers</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Comeau</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Kopp</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Winkler</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>GW</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Palmer</surname>
<given-names>ND</given-names>
</name>
<etal/>
</person-group>
<article-title>Differential effects of MYH9 and APOL1 risk variants on FRMD3 Association with Diabetic ESRD in African Americans</article-title>
<source>PLoS Genet</source>
<year>2011</year>
<volume>7</volume>
<issue>6</issue>
<elocation-id>e1002150</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1002150</pub-id>
</element-citation>
</ref>
<ref id="R535">
<label>535</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Babaya</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Noso</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hiromine</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ito</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Taketomo</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kawabata</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ikegami</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Early-Onset Diabetes Mellitus in a Patient With a Chromosome 13q34qter Microdeletion Including IRS2</article-title>
<source>J Endocr Soc</source>
<year>2018</year>
<volume>2</volume>
<issue>10</issue>
<fpage>1207</fpage>
<lpage>1213</lpage>
<pub-id pub-id-type="doi">10.1210/js.2018-00175</pub-id>
</element-citation>
</ref>
<ref id="R536">
<label>536</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hassing</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>Surendran</surname>
<given-names>RP</given-names>
</name>
<name>
<surname>Derudas</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Verrijken</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Francque</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Mooij</surname>
<given-names>HL</given-names>
</name>
<name>
<surname>Bernelot Moens</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Hart</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Nijpels</surname>
<given-names>G</given-names>
</name>
<etal/>
</person-group>
<article-title>SULF2 strongly prediposes to fasting and postprandial triglycerides in patients with obesity and type 2 diabetes mellitus</article-title>
<source>Obesity (Silver Spring)</source>
<year>2014</year>
<volume>22</volume>
<issue>5</issue>
<fpage>1309</fpage>
<lpage>1316</lpage>
<pub-id pub-id-type="doi">10.1002/oby.20682</pub-id>
</element-citation>
</ref>
<ref id="R537">
<label>537</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Darwish</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Abdel-Bakky</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Messiha</surname>
<given-names>BAS</given-names>
</name>
<name>
<surname>Abo-Saif</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Abo-Youssef</surname>
<given-names>AM</given-names>
</name>
</person-group>
<article-title>Resveratrol mitigates pancreatic TF activation and autophagy-mediated beta cell death via inhibition of CXCL16/ox-LDL pathway: A novel protective mechanism against type 1 diabetes mellitus in mice</article-title>
<source>Eur J Pharmacol</source>
<year>2021</year>
<volume>901</volume>
<elocation-id>174059</elocation-id>
<pub-id pub-id-type="doi">10.1016/j.ejphar.2021.174059</pub-id>
</element-citation>
</ref>
<ref id="R538">
<label>538</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hussain</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dwivedi</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Yadav</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Usman</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Nath</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Khattri</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>No Association Between a Genetic Variant of FOXO3 and Risk of Type 2 Diabetes Mellitus in the Elderly Population of North India</article-title>
<source>Indian J Clin Biochem</source>
<year>2021</year>
<volume>36</volume>
<issue>3</issue>
<fpage>330</fpage>
<lpage>336</lpage>
<pub-id pub-id-type="doi">10.1007/s12291-020-00917-2</pub-id>
</element-citation>
</ref>
<ref id="R539">
<label>539</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xiang</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Cong</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>ZJ</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>LL</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>GY</given-names>
</name>
</person-group>
<article-title>Type 2 diabetes-induced hyposalivation of the submandibular gland through PINK1/Parkin-mediated mitophagy</article-title>
<source>J Cell Physiol</source>
<year>2020</year>
<volume>235</volume>
<issue>1</issue>
<fpage>232</fpage>
<lpage>244</lpage>
<pub-id pub-id-type="doi">10.1002/jcp.28962</pub-id>
</element-citation>
</ref>
<ref id="R540">
<label>540</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choi</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kobayashi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Okuda</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Harada</surname>
<given-names>KH</given-names>
</name>
<name>
<surname>Takeda</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Fujimoto</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Yamane</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Youssefian</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Inagaki</surname>
<given-names>N</given-names>
</name>
<etal/>
</person-group>
<article-title>β-cell-specific overexpression of adiponectin receptor 1 does not improve diabetes mellitus in Akita mice</article-title>
<source>PLoS One</source>
<year>2018</year>
<volume>13</volume>
<issue>1</issue>
<elocation-id>e0190863</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0190863</pub-id>
</element-citation>
</ref>
<ref id="R541">
<label>541</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prudente</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Shah</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Bailetti</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Pezzolesi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Buranasupkajorn</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Mercuri</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Mendonca</surname>
<given-names>C</given-names>
</name>
<name>
<surname>De Cosmo</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Niewczas</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Trischitta</surname>
<given-names>V</given-names>
</name>
<etal/>
</person-group>
<article-title>Genetic Variant at the GLUL Locus Predicts All-Cause Mortality in Patients With Type 2 Diabetes</article-title>
<source>Diabetes</source>
<year>2015</year>
<volume>64</volume>
<issue>7</issue>
<fpage>2658</fpage>
<lpage>2663</lpage>
<pub-id pub-id-type="doi">10.2337/db14-1653</pub-id>
</element-citation>
</ref>
<ref id="R542">
<label>542</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Hao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>SGK1 is regulated by metabolic-related factors in 3T3-L1 adipocytes and overexpressed in the adipose tissue of subjects with obesity and diabetes</article-title>
<source>Diabetes Res Clin Pract</source>
<year>2013</year>
<volume>102</volume>
<issue>1</issue>
<fpage>35</fpage>
<lpage>42</lpage>
<pub-id pub-id-type="doi">10.1016/j.diabres.2013.08.009</pub-id>
</element-citation>
</ref>
<ref id="R543">
<label>543</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nomoto</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Pei</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Montemurro</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Rosenberger</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Furterer</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Coppola</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Nadel</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Pellegrini</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gurlo</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Butler</surname>
<given-names>PC</given-names>
</name>
<etal/>
</person-group>
<article-title>Activation of the HIF1α/PFKFB3 stress response pathway in beta cells in type 1 diabetes</article-title>
<source>Diabetologia</source>
<year>2020</year>
<volume>63</volume>
<issue>1</issue>
<fpage>149</fpage>
<lpage>161</lpage>
<pub-id pub-id-type="doi">10.1007/s00125-019-05030-5</pub-id>
</element-citation>
</ref>
<ref id="R544">
<label>544</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Niu</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>X</given-names>
</name>
</person-group>
<article-title>Association of GYS1 and beta(3)-AR gene with postprandial hyperglycemia and serum uric acid in type 2 diabetes mellitus</article-title>
<source>Chin Med J (Engl)</source>
<year>2002</year>
<volume>115</volume>
<issue>9</issue>
<fpage>1308</fpage>
<lpage>1311</lpage>
</element-citation>
</ref>
<ref id="R545">
<label>545</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sala</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Ivanova</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Plana</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Ribas</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Duran</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bach</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Turkseven</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Laville</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Vidal</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Karczewska-Kupczewska</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>
<article-title>Autophagy-regulating TP53INP2 mediates muscle wasting and is repressed in diabetes</article-title>
<source>J Clin Invest</source>
<year>2014</year>
<volume>124</volume>
<issue>5</issue>
<fpage>1914</fpage>
<lpage>1927</lpage>
<pub-id pub-id-type="doi">10.1172/JCI72327</pub-id>
</element-citation>
</ref>
<ref id="R546">
<label>546</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Juan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Opposite Genetic Effects of CMIP Polymorphisms on the Risk of Type 2 Diabetes and Obesity: A Family-Based Study in China</article-title>
<source>Int J Mol Sci</source>
<year>2018</year>
<volume>19</volume>
<issue>4</issue>
<elocation-id>1011</elocation-id>
<pub-id pub-id-type="doi">10.3390/ijms19041011</pub-id>
</element-citation>
</ref>
<ref id="R547">
<label>547</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Izumi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>BX</given-names>
</name>
<name>
<surname>Dean</surname>
<given-names>DD</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Saunders</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Hazuda</surname>
<given-names>HP</given-names>
</name>
<name>
<surname>Yeh</surname>
<given-names>CK</given-names>
</name>
</person-group>
<article-title>Secretion of salivary statherin is compromised in uncontrolled diabetic patients</article-title>
<source>BBA Clin</source>
<year>2015</year>
<volume>3</volume>
<fpage>135</fpage>
<lpage>140</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbacli.2015.01.002</pub-id>
</element-citation>
</ref>
<ref id="R548">
<label>548</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Duan</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Z</given-names>
</name>
</person-group>
<article-title>microRNA-143-3p contributes to inflammatory reactions by targeting FOSL2 in PBMCs from patients with autoimmune diabetes mellitus</article-title>
<source>Acta Diabetol</source>
<year>2021</year>
<volume>58</volume>
<issue>1</issue>
<fpage>63</fpage>
<lpage>72</lpage>
<pub-id pub-id-type="doi">10.1007/s00592-020-01591-9</pub-id>
</element-citation>
</ref>
<ref id="R549">
<label>549</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Z</given-names>
</name>
</person-group>
<article-title>Evaluation of the oxidative stress-related genes ALOX5, ALOX5AP, GPX1, GPX3 and MPO for contribution to the risk of type 2 diabetes mellitus in the Han Chinese population</article-title>
<source>Diab Vasc Dis Res</source>
<year>2018</year>
<volume>15</volume>
<issue>4</issue>
<fpage>336</fpage>
<lpage>339</lpage>
<pub-id pub-id-type="doi">10.1177/1479164118755044</pub-id>
</element-citation>
</ref>
<ref id="R550">
<label>550</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Du</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>N</given-names>
</name>
<etal/>
</person-group>
<article-title>Associations of SUCNR1, GRK4, CAMK1D gene polymorphisms and the susceptibility of type 2 diabetes mellitus and essential hypertension in a northern Chinese Han population</article-title>
<source>J Diabetes Complications</source>
<year>2021</year>
<volume>35</volume>
<issue>1</issue>
<elocation-id>107752</elocation-id>
<pub-id pub-id-type="doi">10.1016/j.jdiacomp.2020.107752</pub-id>
</element-citation>
</ref>
<ref id="R551">
<label>551</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Traurig</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hanson</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Marinelarena</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kobes</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Piaggi</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Cole</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Curran</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Blangero</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Göring</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>
<article-title>Analysis of SLC16A11 Variants in 12,811 American Indians: Genotype-Obesity Interaction for Type 2 Diabetes and an Association With RNASEK Expression</article-title>
<source>Diabetes</source>
<year>2016</year>
<volume>65</volume>
<issue>2</issue>
<fpage>510</fpage>
<lpage>519</lpage>
<pub-id pub-id-type="doi">10.2337/db15-0571</pub-id>
</element-citation>
</ref>
<ref id="R552">
<label>552</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kiyanpour</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Abedi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gheisari</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>A systematic integrative approach reveals novel microRNAs in diabetic nephropathy</article-title>
<source>J Res Med Sci</source>
<year>2020</year>
<volume>25</volume>
<fpage>1</fpage>
<pub-id pub-id-type="doi">10.4103/jrms.JRMS_289_19</pub-id>
</element-citation>
</ref>
<ref id="R553">
<label>553</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Navarro-Quiroz</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Pacheco-Lugo</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Navarro-Quiroz</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Lorenzi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>España-Puccini</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Díaz-Olmos</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Almendrales</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Olave</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Gonzalez-Torres</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Diaz-Perez</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>
<article-title>Profiling analysis of circulating microRNA in peripheral blood of patients with class IV lupus nephritis</article-title>
<source>PLoS One</source>
<year>2017</year>
<volume>12</volume>
<issue>11</issue>
<elocation-id>e0187973</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0187973</pub-id>
</element-citation>
</ref>
<ref id="R554">
<label>554</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Complement C5 activation promotes type 2 diabetic kidney disease via activating STAT3 pathway and disrupting the gut-kidney axis</article-title>
<source>J Cell Mol Med</source>
<year>2021</year>
<volume>25</volume>
<issue>2</issue>
<fpage>960</fpage>
<lpage>974</lpage>
<pub-id pub-id-type="doi">10.1111/jcmm.16157</pub-id>
</element-citation>
</ref>
<ref id="R555">
<label>555</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>ZL</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Lv</surname>
<given-names>LL</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>TT</given-names>
</name>
<name>
<surname>Wen</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>XX</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>ST</given-names>
</name>
<name>
<surname>Crowley</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>BC</given-names>
</name>
</person-group>
<article-title>FIH-1-modulated HIF-1α C-TAD promotes acute kidney injury to chronic kidney disease progression via regulating KLF5 signaling</article-title>
<source>Acta Pharmacol Sin</source>
<year>2021</year>
<elocation-id>10.1038/s41401-021-00617-4</elocation-id>
<pub-id pub-id-type="doi">10.1038/s41401-021-00617-4</pub-id>
</element-citation>
</ref>
<ref id="R556">
<label>556</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Guan</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Luan</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Bu</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Che</surname>
<given-names>L</given-names>
</name>
<etal/>
</person-group>
<article-title>Serum response factor, a novel early diagnostic biomarker of acute kidney injury</article-title>
<source>Aging (Albany NY)</source>
<year>2021</year>
<volume>13</volume>
<issue>2</issue>
<fpage>2885</fpage>
<lpage>2894</lpage>
<pub-id pub-id-type="doi">10.18632/aging.202381</pub-id>
</element-citation>
</ref>
<ref id="R557">
<label>557</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grigorieva</surname>
<given-names>IV</given-names>
</name>
<name>
<surname>Oszwald</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Grigorieva</surname>
<given-names>EF</given-names>
</name>
<name>
<surname>Schachner</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Neudert</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Ostendorf</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Floege</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lindenmeyer</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Cohen</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Panzer</surname>
<given-names>U</given-names>
</name>
<etal/>
</person-group>
<article-title>A Novel Role for GATA3 in Mesangial Cells in Glomerular Development and Injury</article-title>
<source>J Am Soc Nephrol</source>
<year>2019</year>
<volume>30</volume>
<issue>9</issue>
<fpage>1641</fpage>
<lpage>1658</lpage>
<pub-id pub-id-type="doi">10.1681/ASN.2018111143</pub-id>
</element-citation>
</ref>
<ref id="R558">
<label>558</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sanchez</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>J</given-names>
</name>
<name>
<surname>You</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Declèves</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Diamond-Stanic</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Role of the USF1 transcription factor in diabetic kidney disease</article-title>
<source>Am J Physiol Renal Physiol</source>
<year>2011</year>
<volume>301</volume>
<issue>2</issue>
<fpage>F271</fpage>
<lpage>F279</lpage>
<pub-id pub-id-type="doi">10.1152/ajprenal.00221.2011</pub-id>
</element-citation>
</ref>
<ref id="R559">
<label>559</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>He</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Lv</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Comprehensive investigation of aberrant microRNAs expression in cells culture model of MnCl2-induced neurodegenerative disease</article-title>
<source>Biochem Biophys Res Commun</source>
<year>2017</year>
<volume>486</volume>
<issue>2</issue>
<fpage>342</fpage>
<lpage>348</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbrc.2017.03.041</pub-id>
</element-citation>
</ref>
<ref id="R560">
<label>560</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dehghanzad</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Panahi Moghadam</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Shirvani Farsani</surname>
<given-names>Z</given-names>
</name>
</person-group>
<article-title>Prediction of Single-Nucleotide Polymorphisms within microRNAs Binding Sites of Neuronal Genes Related to Multiple Sclerosis: A Preliminary Study</article-title>
<source>Adv Biomed Res</source>
<year>2021</year>
<volume>10</volume>
<fpage>8</fpage>
<pub-id pub-id-type="doi">10.4103/abr.abr_143_20</pub-id>
</element-citation>
</ref>
<ref id="R561">
<label>561</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qin</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Lv</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Shu</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Expression profile of plasma microRNAs and their roles in diagnosis of mild to severe traumatic brain injury</article-title>
<source>PLoS One</source>
<year>2018</year>
<volume>13</volume>
<issue>9</issue>
<elocation-id>e0204051</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0204051</pub-id>
</element-citation>
</ref>
<ref id="R562">
<label>562</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>CNTF-STAT3-IL-6 Axis Mediates Neuroinflammatory Cascade across Schwann Cell-Neuron-Microglia</article-title>
<source>Cell Rep</source>
<year>2020</year>
<volume>31</volume>
<issue>7</issue>
<elocation-id>107657</elocation-id>
<pub-id pub-id-type="doi">10.1016/j.celrep.2020.107657</pub-id>
</element-citation>
</ref>
<ref id="R563">
<label>563</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poletti</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Aggio</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Bollettini</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Falini</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Colombo</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Benedetti</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>SREBF-2 polymorphism influences white matter microstructure in bipolar disorder</article-title>
<source>Psychiatry Res Neuroimaging</source>
<year>2016</year>
<volume>257</volume>
<fpage>39</fpage>
<lpage>46</lpage>
<pub-id pub-id-type="doi">10.1016/j.pscychresns.2016.10.001</pub-id>
</element-citation>
</ref>
<ref id="R564">
<label>564</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Förstner</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Knöll</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Interference of neuronal activity-mediated gene expression through serum response factor deletion enhances mortality and hyperactivity after traumatic brain injury</article-title>
<source>FASEB J</source>
<year>2020</year>
<volume>34</volume>
<issue>3</issue>
<fpage>3855</fpage>
<lpage>3873</lpage>
<pub-id pub-id-type="doi">10.1096/fj.201902257RR</pub-id>
</element-citation>
</ref>
<ref id="R565">
<label>565</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Satyam</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Bhardwaj</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Goel</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Jha</surname>
<given-names>NK</given-names>
</name>
<name>
<surname>Jha</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Nand</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Ruokolainen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kamal</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Kesari</surname>
<given-names>KK</given-names>
</name>
</person-group>
<article-title>miRNAs in SARS-CoV 2: A Spoke in the Wheel of Pathogenesis</article-title>
<source>Curr Pharm Des</source>
<year>2021</year>
<volume>27</volume>
<issue>13</issue>
<fpage>1628</fpage>
<lpage>1641</lpage>
<pub-id pub-id-type="doi">10.2174/1381612826999201001200529</pub-id>
</element-citation>
</ref>
<ref id="R566">
<label>566</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Min</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z</given-names>
</name>
</person-group>
<article-title>Differentially expressed miRNAs in circulating exosomes between atrial fibrillation and sinus rhythm</article-title>
<source>J Thorac Dis</source>
<year>2019</year>
<volume>11</volume>
<issue>10</issue>
<fpage>4337</fpage>
<lpage>4348</lpage>
<pub-id pub-id-type="doi">10.21037/jtd.2019.09.50</pub-id>
</element-citation>
</ref>
<ref id="R567">
<label>567</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bai</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>A subset of circulating microRNAs is expressed differently in patients with myocardial infarction</article-title>
<source>Mol Med Rep</source>
<year>2015</year>
<volume>12</volume>
<issue>1</issue>
<fpage>243</fpage>
<lpage>247</lpage>
<pub-id pub-id-type="doi">10.3892/mmr.2015.3422</pub-id>
</element-citation>
</ref>
<ref id="R568">
<label>568</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Ruan</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>B</given-names>
</name>
<etal/>
</person-group>
<article-title>Evaluation of exosomal miRNAs as potential diagnostic biomarkers for acute myocardial infarction using next-generation sequencing</article-title>
<source>Ann Transl Med</source>
<year>2021</year>
<volume>9</volume>
<issue>3</issue>
<fpage>219</fpage>
<pub-id pub-id-type="doi">10.21037/atm-20-2337</pub-id>
</element-citation>
</ref>
<ref id="R569">
<label>569</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cakmak</surname>
<given-names>HA</given-names>
</name>
<name>
<surname>Coskunpinar</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Ikitimur</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Barman</surname>
<given-names>HA</given-names>
</name>
<name>
<surname>Karadag</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Tiryakioglu</surname>
<given-names>NO</given-names>
</name>
<name>
<surname>Kahraman</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Vural</surname>
<given-names>VA</given-names>
</name>
</person-group>
<article-title>The prognostic value of circulating microRNAs in heart failure: preliminary results from a genome-wide expression study</article-title>
<source>J Cardiovasc Med (Hagerstown)</source>
<year>2015</year>
<volume>16</volume>
<issue>6</issue>
<fpage>431</fpage>
<lpage>437</lpage>
<pub-id pub-id-type="doi">10.2459/JCM.0000000000000233</pub-id>
</element-citation>
</ref>
<ref id="R570">
<label>570</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>PARP1 interacts with STAT3 and retains active phosphorylated-STAT3 in nucleus during pathological myocardial hypertrophy</article-title>
<source>Mol Cell Endocrinol</source>
<year>2018</year>
<volume>474</volume>
<fpage>137</fpage>
<lpage>150</lpage>
<pub-id pub-id-type="doi">10.1016/j.mce.2018.02.020</pub-id>
</element-citation>
</ref>
<ref id="R571">
<label>571</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Ge</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>KLF5/LINC00346/miRL148aL3p axis regulates inflammation and endothelial cell injury in atherosclerosis</article-title>
<source>Int J Mol Med</source>
<year>2021</year>
<volume>48</volume>
<issue>2</issue>
<fpage>152</fpage>
<pub-id pub-id-type="doi">10.3892/ijmm.2021.4985</pub-id>
</element-citation>
</ref>
<ref id="R572">
<label>572</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vargas-Alarcon</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Gonzalez-Pacheco</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Perez-Mendez</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Posadas-Sanchez</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Cardoso-Saldaña</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Ramirez-Bello</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Escobedo</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Nieto-Lima</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Fragoso</surname>
<given-names>JM</given-names>
</name>
</person-group>
<article-title>SREBF1c and SREBF2 gene polymorphisms are associated with acute coronary syndrome and blood lipid levels in Mexican population</article-title>
<source>PLoS One</source>
<year>2019</year>
<volume>14</volume>
<issue>9</issue>
<elocation-id>e0222017</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0222017</pub-id>
</element-citation>
</ref>
<ref id="R573">
<label>573</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Major</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Dewan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Salih</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Leddy</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Tuana</surname>
<given-names>BS</given-names>
</name>
</person-group>
<article-title>E2F6 Impairs Glycolysis and Activates BDH1 Expression Prior to Dilated Cardiomyopathy</article-title>
<source>PLoS One</source>
<year>2017</year>
<volume>12</volume>
<issue>1</issue>
<elocation-id>e0170066</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0170066</pub-id>
</element-citation>
</ref>
<ref id="R574">
<label>574</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Yukht</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ruther</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ghiasi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Sharifi</surname>
<given-names>BG</given-names>
</name>
<name>
<surname>Shah</surname>
<given-names>PK</given-names>
</name>
</person-group>
<article-title>Deficiency of GATA3-Positive Macrophages Improves Cardiac Function Following Myocardial Infarction or Pressure Overload Hypertrophy</article-title>
<source>J Am Coll Cardiol</source>
<year>2018</year>
<volume>72</volume>
<issue>8</issue>
<fpage>885</fpage>
<lpage>904</lpage>
<pub-id pub-id-type="doi">10.1016/j.jacc.2018.05.061</pub-id>
</element-citation>
</ref>
<ref id="R575">
<label>575</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Weissglas-Volkov</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Kyttälä</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sinsheimer</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Jokiaho</surname>
<given-names>A</given-names>
</name>
<name>
<surname>de Bruin</surname>
<given-names>TW</given-names>
</name>
<name>
<surname>Lusis</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Brennan</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>van Greevenbroek</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>van der Kallen</surname>
<given-names>CJ</given-names>
</name>
<etal/>
</person-group>
<article-title>USF1 contributes to high serum lipid levels in Dutch FCHL families and U.S. whites with coronary artery disease</article-title>
<source>Arterioscler Thromb Vasc Biol</source>
<year>2007</year>
<volume>27</volume>
<issue>10</issue>
<fpage>2222</fpage>
<lpage>2227</lpage>
<pub-id pub-id-type="doi">10.1161/ATVBAHA.107.151530</pub-id>
</element-citation>
</ref>
<ref id="R576">
<label>576</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matsha</surname>
<given-names>TE</given-names>
</name>
<name>
<surname>Kengne</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Hector</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Mbu</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Yako</surname>
<given-names>YY</given-names>
</name>
<name>
<surname>Erasmus</surname>
<given-names>RT</given-names>
</name>
</person-group>
<article-title>MicroRNA profiling and their pathways in South African individuals with prediabetes and newly diagnosed type 2 diabetes mellitus</article-title>
<source>Oncotarget</source>
<year>2018</year>
<volume>9</volume>
<issue>55</issue>
<fpage>30485</fpage>
<lpage>30498</lpage>
<pub-id pub-id-type="doi">10.18632/oncotarget.25271</pub-id>
</element-citation>
</ref>
<ref id="R577">
<label>577</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Catanzaro</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Besharat</surname>
<given-names>ZM</given-names>
</name>
<name>
<surname>Chiacchiarini</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Abballe</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Sabato</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Vacca</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Borgiani</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Dotta</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Tesauro</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Po</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>
<article-title>Circulating MicroRNAs in Elderly Type 2 Diabetic Patients</article-title>
<source>Int J Endocrinol</source>
<year>2018</year>
<volume>2018</volume>
<elocation-id>6872635</elocation-id>
<pub-id pub-id-type="doi">10.1155/2018/6872635</pub-id>
</element-citation>
</ref>
<ref id="R578">
<label>578</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Qi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>miR-125a-5p ameliorates hepatic glycolipid metabolism disorder in type 2 diabetes mellitus through targeting of STAT3</article-title>
<source>Theranostics</source>
<year>2018</year>
<volume>8</volume>
<issue>20</issue>
<fpage>5593</fpage>
<lpage>5609</lpage>
<pub-id pub-id-type="doi">10.7150/thno.27425</pub-id>
</element-citation>
</ref>
<ref id="R579">
<label>579</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>ZL</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Lv</surname>
<given-names>LL</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>TT</given-names>
</name>
<name>
<surname>Wen</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>XX</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>ST</given-names>
</name>
<name>
<surname>Crowley</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>BC</given-names>
</name>
</person-group>
<article-title>FIH-1-modulated HIF-1α C-TAD promotes acute kidney injury to chronic kidney disease progression via regulating KLF5 signaling</article-title>
<source>Acta Pharmacol Sin</source>
<year>2021</year>
<elocation-id>10.1038/s41401-021-00617-4</elocation-id>
<pub-id pub-id-type="doi">10.1038/s41401-021-00617-4</pub-id>
</element-citation>
</ref>
<ref id="R580">
<label>580</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Galavi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Noorzehi</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Saravani</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Sargazi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Mollashahee-Kohkan</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Shahraki</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Association study of SREBF-2 gene polymorphisms and the risk of type 2 diabetes in a sample of Iranian population</article-title>
<source>Gene</source>
<year>2018</year>
<volume>660</volume>
<fpage>145</fpage>
<lpage>150</lpage>
<pub-id pub-id-type="doi">10.1016/j.gene.2018.03.080</pub-id>
</element-citation>
</ref>
<ref id="R581">
<label>581</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huda</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Hosen</surname>
<given-names>MI</given-names>
</name>
<name>
<surname>Yasmin</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Sarkar</surname>
<given-names>PK</given-names>
</name>
<name>
<surname>Hasan</surname>
<given-names>AKMM</given-names>
</name>
<name>
<surname>Nabi</surname>
<given-names>AHMN</given-names>
</name>
</person-group>
<article-title>Genetic variation of the transcription factor GATA3, not STAT4, is associated with the risk of type 2 diabetes in the Bangladeshi population</article-title>
<source>PLoS One</source>
<year>2018</year>
<volume>13</volume>
<issue>7</issue>
<elocation-id>e0198507</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0198507</pub-id>
</element-citation>
</ref>
<ref id="R582">
<label>582</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meex</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>van Vliet-Ostaptchouk</surname>
<given-names>JV</given-names>
</name>
<name>
<surname>van der Kallen</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>van Greevenbroek</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Schalkwijk</surname>
<given-names>CG</given-names>
</name>
<name>
<surname>Feskens</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Blaak</surname>
<given-names>EE</given-names>
</name>
<name>
<surname>Wijmenga</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Hofker</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Stehouwer</surname>
<given-names>CD</given-names>
</name>
<etal/>
</person-group>
<article-title>Upstream transcription factor 1 (USF1) in risk of type 2 diabetes: association study in 2000 Dutch Caucasians</article-title>
<source>Mol Genet Metab</source>
<year>2008</year>
<volume>94</volume>
<issue>3</issue>
<fpage>352</fpage>
<lpage>355</lpage>
<pub-id pub-id-type="doi">10.1016/j.ymgme.2008.03.011</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="F1" position="float">
<label>Fig. 1</label>
<caption>
<p>Heat map of differentially expressed genes. Legend on the top left indicate log fold change of genes. (A1 – A93= COVID 19 samples; B1 – B100= non COVID 19 samples)</p>
</caption>
<graphic xlink:href="EMS135767-f001"/>
</fig>
<fig id="F2" position="float">
<label>Fig. 2</label>
<caption>
<p>Volcano plot of differentially expressed genes. Genes with a significant change of more than two-fold were selected. Green dot represented up regulated significant genes and red dot represented down regulated significant genes.</p>
</caption>
<graphic xlink:href="EMS135767-f002"/>
</fig>
<fig id="F3" position="float">
<label>Fig. 3</label>
<caption>
<title>PPI network of DEGs. Up regulated genes are marked in green; down regulated genes are marked in red</title>
</caption>
<graphic xlink:href="EMS135767-f003"/>
</fig>
<fig id="F4" position="float">
<label>Fig. 4</label>
<caption>
<title>Modules of isolated form PPI of DEGs.</title>
<p>(A) The most significant module was obtained from PPI networ with 16 nodes and 39 edges for up regulated genes (B) The most significant module was obtained from PPI network with 10 nodes and 27 edges for down regulated genes. Up regulated genes are marked in green; down regulated genes are marked in red</p>
</caption>
<graphic xlink:href="EMS135767-f004"/>
</fig>
<fig id="F5" position="float">
<label>Fig. 5</label>
<caption>
<p>Target gene - miRNA regulatory network between target genes. The blue color diamond nodes represent the key miRNAs; up regulated genes are marked in green; down regulated genes are marked in red.</p>
</caption>
<graphic xlink:href="EMS135767-f005"/>
</fig>
<fig id="F6" position="float">
<label>Fig. 6</label>
<caption>
<p>Target gene - TF regulatory network between target genes. The gray color triangle nodes represent the key TFs; up regulated genes are marked in green; down regulated genes are marked in red.</p>
</caption>
<graphic xlink:href="EMS135767-f006"/>
</fig>
<fig id="F7" position="float">
<label>Fig. 7</label>
<caption>
<title>ROC curve analyses of hub genes.</title>
<p>A) ESR1 B) UBD C) FYN D) STAT1 E) ISG15 F) EGR1 G) ARRB2 H) UBE2D1 I) PRKDC J) FOS</p>
</caption>
<graphic xlink:href="EMS135767-f007"/>
</fig>
<table-wrap id="T1" position="float" orientation="portrait">
<label>Table 1</label>
<caption>
<title>The statistical metrics for key differentially expressed genes (DEGs)</title>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" valign="top">Gene Symbol</th>
<th align="center" valign="top">logFC</th>
<th align="center" valign="top">pValue</th>
<th align="center" valign="top">adj.P.Val</th>
<th align="center" valign="top">tvalue</th>
<th align="center" valign="top">Regulations</th>
<th align="center" valign="top">GeneName</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" valign="top">CXCL11</td>
<td align="center" valign="top">4.401406</td>
<td align="center" valign="top">2.57E-23</td>
<td align="center" valign="top">1.87E-20</td>
<td align="center" valign="top">11.33776</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">C-X-C motif chemokine ligand 11</td>
</tr>
<tr>
<td align="center" valign="top">CXCL10</td>
<td align="center" valign="top">4.252551</td>
<td align="center" valign="top">4.53E-21</td>
<td align="center" valign="top">2.19E-18</td>
<td align="center" valign="top">10.58757</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">C-X-C motif chemokine ligand 10</td>
</tr>
<tr>
<td align="center" valign="top">ISG15</td>
<td align="center" valign="top">3.825839</td>
<td align="center" valign="top">5.15E-24</td>
<td align="center" valign="top">4.57E-21</td>
<td align="center" valign="top">11.56876</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">ISG15 ubiquitin like modifier</td>
</tr>
<tr>
<td align="center" valign="top">IFI6</td>
<td align="center" valign="top">3.773996</td>
<td align="center" valign="top">4.72E-43</td>
<td align="center" valign="top">7.55E-39</td>
<td align="center" valign="top">17.79855</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">interferon alpha inducible protein 6</td>
</tr>
<tr>
<td align="center" valign="top">SIGLEC1</td>
<td align="center" valign="top">3.715637</td>
<td align="center" valign="top">1.95E-23</td>
<td align="center" valign="top">1.48E-20</td>
<td align="center" valign="top">11.37744</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">sialic acid binding Ig like lectin 1</td>
</tr>
<tr>
<td align="center" valign="top">CXCL9</td>
<td align="center" valign="top">3.571786</td>
<td align="center" valign="top">2.15E-19</td>
<td align="center" valign="top">9.3E-17</td>
<td align="center" valign="top">10.01823</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">C-X-C motif chemokine ligand 9</td>
</tr>
<tr>
<td align="center" valign="top">IFI44L</td>
<td align="center" valign="top">3.477758</td>
<td align="center" valign="top">1.13E-37</td>
<td align="center" valign="top">9.04E-34</td>
<td align="center" valign="top">16.02092</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">interferon induced protein 44 like</td>
</tr>
<tr>
<td align="center" valign="top">IFIT3</td>
<td align="center" valign="top">3.104665</td>
<td align="center" valign="top">4.23E-24</td>
<td align="center" valign="top">4.1E-21</td>
<td align="center" valign="top">11.59678</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">interferon induced protein with tetratricopeptide repeats 3</td>
</tr>
<tr>
<td align="center" valign="top">IFIT1</td>
<td align="center" valign="top">2.830657</td>
<td align="center" valign="top">2.02E-27</td>
<td align="center" valign="top">4.02E-24</td>
<td align="center" valign="top">12.68592</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">interferon induced protein with tetratricopeptide repeats 1</td>
</tr>
<tr>
<td align="center" valign="top">BST2</td>
<td align="center" valign="top">2.680852</td>
<td align="center" valign="top">7.94E-28</td>
<td align="center" valign="top">1.81E-24</td>
<td align="center" valign="top">12.81766</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">bone marrow stromal cell antigen 2</td>
</tr>
<tr>
<td align="center" valign="top">IFI27</td>
<td align="center" valign="top">2.674207</td>
<td align="center" valign="top">1.39E-33</td>
<td align="center" valign="top">5.57E-30</td>
<td align="center" valign="top">14.68738</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">interferon alpha inducible protein 27</td>
</tr>
<tr>
<td align="center" valign="top">RSAD2</td>
<td align="center" valign="top">2.60122</td>
<td align="center" valign="top">4.23E-22</td>
<td align="center" valign="top">2.41E-19</td>
<td align="center" valign="top">10.93301</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">radical S-adenosyl methionine domain containing 2</td>
</tr>
<tr>
<td align="center" valign="top">OASL</td>
<td align="center" valign="top">2.578652</td>
<td align="center" valign="top">7.91E-18</td>
<td align="center" valign="top">2.94E-15</td>
<td align="center" valign="top">9.477793</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">2'-5'-oligoadenylate synthetase like</td>
</tr>
<tr>
<td align="center" valign="top">SERPING1</td>
<td align="center" valign="top">2.57786</td>
<td align="center" valign="top">3.41E-22</td>
<td align="center" valign="top">2.02E-19</td>
<td align="center" valign="top">10.96417</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">serpin family G member 1</td>
</tr>
<tr>
<td align="center" valign="top">IFIT2</td>
<td align="center" valign="top">2.564315</td>
<td align="center" valign="top">5.96E-16</td>
<td align="center" valign="top">1.62E-13</td>
<td align="center" valign="top">8.814323</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">interferon induced protein with tetratricopeptide repeats 2</td>
</tr>
<tr>
<td align="center" valign="top">USP18</td>
<td align="center" valign="top">2.563927</td>
<td align="center" valign="top">1.19E-25</td>
<td align="center" valign="top">1.74E-22</td>
<td align="center" valign="top">12.10636</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">ubiquitin specific peptidase 18</td>
</tr>
<tr>
<td align="center" valign="top">EPSTI1</td>
<td align="center" valign="top">2.552049</td>
<td align="center" valign="top">3.77E-27</td>
<td align="center" valign="top">6.69E-24</td>
<td align="center" valign="top">12.59731</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">epithelial stromal interaction 1</td>
</tr>
<tr>
<td align="center" valign="top">UBD</td>
<td align="center" valign="top">2.521131</td>
<td align="center" valign="top">2.37E-13</td>
<td align="center" valign="top">4.99E-11</td>
<td align="center" valign="top">7.858649</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">ubiquitin D</td>
</tr>
<tr>
<td align="center" valign="top">IFI44</td>
<td align="center" valign="top">2.483417</td>
<td align="center" valign="top">1.92E-34</td>
<td align="center" valign="top">1.02E-30</td>
<td align="center" valign="top">14.9671</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">interferon induced protein 44</td>
</tr>
<tr>
<td align="center" valign="top">CMPK2</td>
<td align="center" valign="top">2.442471</td>
<td align="center" valign="top">1.33E-22</td>
<td align="center" valign="top">8.84E-20</td>
<td align="center" valign="top">11.10071</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">cytidine/uridine monophosphate kinase 2</td>
</tr>
<tr>
<td align="center" valign="top">KLHDC7B</td>
<td align="center" valign="top">2.416369</td>
<td align="center" valign="top">5.09E-17</td>
<td align="center" valign="top">1.59E-14</td>
<td align="center" valign="top">9.194299</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">kelch domain containing 7B</td>
</tr>
<tr>
<td align="center" valign="top">CCL8</td>
<td align="center" valign="top">2.408896</td>
<td align="center" valign="top">3.1E-09</td>
<td align="center" valign="top">3.02E-07</td>
<td align="center" valign="top">6.205329</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">C-C motif chemokine ligand 8</td>
</tr>
<tr>
<td align="center" valign="top">LAG3</td>
<td align="center" valign="top">2.349605</td>
<td align="center" valign="top">3.81E-17</td>
<td align="center" valign="top">1.24E-14</td>
<td align="center" valign="top">9.238763</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">lymphocyte activating 3</td>
</tr>
<tr>
<td align="center" valign="top">PLVAP</td>
<td align="center" valign="top">2.330148</td>
<td align="center" valign="top">2.11E-17</td>
<td align="center" valign="top">7.19E-15</td>
<td align="center" valign="top">9.328442</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">plasmalemma vesicle associated protein</td>
</tr>
<tr>
<td align="center" valign="top">HERC6</td>
<td align="center" valign="top">2.303403</td>
<td align="center" valign="top">3.03E-31</td>
<td align="center" valign="top">9.68E-28</td>
<td align="center" valign="top">13.92863</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">HECT and RLD domain containing E3 ubiquitin protein ligase family member 6</td>
</tr>
<tr>
<td align="center" valign="top">OAS3</td>
<td align="center" valign="top">2.3013</td>
<td align="center" valign="top">1.06E-24</td>
<td align="center" valign="top">1.3E-21</td>
<td align="center" valign="top">11.79514</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">2'-5'-oligoadenylate synthetase 3</td>
</tr>
<tr>
<td align="center" valign="top">IFITM1</td>
<td align="center" valign="top">2.298229</td>
<td align="center" valign="top">1.01E-17</td>
<td align="center" valign="top">3.58E-15</td>
<td align="center" valign="top">9.441038</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">interferon induced transmembrane protein 1</td>
</tr>
<tr>
<td align="center" valign="top">RUFY4</td>
<td align="center" valign="top">2.260049</td>
<td align="center" valign="top">1.64E-15</td>
<td align="center" valign="top">4.09E-13</td>
<td align="center" valign="top">8.656511</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">RUN and FYVE domain containing 4</td>
</tr>
<tr>
<td align="center" valign="top">PLAAT2</td>
<td align="center" valign="top">2.221665</td>
<td align="center" valign="top">8.55E-18</td>
<td align="center" valign="top">3.1E-15</td>
<td align="center" valign="top">9.466031</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">phospholipase A and acyltransferase 2</td>
</tr>
<tr>
<td align="center" valign="top">GZMB</td>
<td align="center" valign="top">2.205584</td>
<td align="center" valign="top">3.31E-11</td>
<td align="center" valign="top">4.86E-09</td>
<td align="center" valign="top">7.024641</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">granzyme B</td>
</tr>
<tr>
<td align="center" valign="top">CCDC194</td>
<td align="center" valign="top">2.18719</td>
<td align="center" valign="top">1.33E-15</td>
<td align="center" valign="top">3.49E-13</td>
<td align="center" valign="top">8.688581</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">coiled-coil domain containing 194</td>
</tr>
<tr>
<td align="center" valign="top">RTP4</td>
<td align="center" valign="top">2.153042</td>
<td align="center" valign="top">6.9E-24</td>
<td align="center" valign="top">5.8E-21</td>
<td align="center" valign="top">11.52677</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">receptor transporter protein 4</td>
</tr>
<tr>
<td align="center" valign="top">IFITM3</td>
<td align="center" valign="top">2.120491</td>
<td align="center" valign="top">1.48E-23</td>
<td align="center" valign="top">1.18E-20</td>
<td align="center" valign="top">11.41728</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">interferon induced transmembrane protein 3</td>
</tr>
<tr>
<td align="center" valign="top">OAS2</td>
<td align="center" valign="top">2.091757</td>
<td align="center" valign="top">1.6E-28</td>
<td align="center" valign="top">4.27E-25</td>
<td align="center" valign="top">13.04386</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">2'-5'-oligoadenylate synthetase 2</td>
</tr>
<tr>
<td align="center" valign="top">GIMAP7</td>
<td align="center" valign="top">2.076202</td>
<td align="center" valign="top">1.96E-12</td>
<td align="center" valign="top">3.72E-10</td>
<td align="center" valign="top">7.508424</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">GTPase, IMAP family member 7</td>
</tr>
<tr>
<td align="center" valign="top">PTPRCAP</td>
<td align="center" valign="top">2.075752</td>
<td align="center" valign="top">7.66E-11</td>
<td align="center" valign="top">1.05E-08</td>
<td align="center" valign="top">6.877829</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">protein tyrosine phosphatase receptor type C associated protein</td>
</tr>
<tr>
<td align="center" valign="top">ANXA10</td>
<td align="center" valign="top">2.069933</td>
<td align="center" valign="top">1.91E-14</td>
<td align="center" valign="top">4.37E-12</td>
<td align="center" valign="top">8.266857</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">annexin A10</td>
</tr>
<tr>
<td align="center" valign="top">SMTNL1</td>
<td align="center" valign="top">2.060448</td>
<td align="center" valign="top">2.93E-13</td>
<td align="center" valign="top">5.92E-11</td>
<td align="center" valign="top">7.82434</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">smoothelin like 1</td>
</tr>
<tr>
<td align="center" valign="top">OAS1</td>
<td align="center" valign="top">2.055079</td>
<td align="center" valign="top">1.6E-24</td>
<td align="center" valign="top">1.7E-21</td>
<td align="center" valign="top">11.73649</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">2'-5'-oligoadenylate synthetase 1</td>
</tr>
<tr>
<td align="center" valign="top">DDX60</td>
<td align="center" valign="top">2.051508</td>
<td align="center" valign="top">1.23E-24</td>
<td align="center" valign="top">1.41E-21</td>
<td align="center" valign="top">11.77317</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">DExD/H-box helicase 60</td>
</tr>
<tr>
<td align="center" valign="top">TFEC</td>
<td align="center" valign="top">2.015633</td>
<td align="center" valign="top">3.07E-09</td>
<td align="center" valign="top">3.01E-07</td>
<td align="center" valign="top">6.207019</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">transcription factor EC</td>
</tr>
<tr>
<td align="center" valign="top">CXCL13</td>
<td align="center" valign="top">2.001792</td>
<td align="center" valign="top">5.85E-09</td>
<td align="center" valign="top">5.25E-07</td>
<td align="center" valign="top">6.085515</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">C-X-C motif chemokine ligand 13</td>
</tr>
<tr>
<td align="center" valign="top">CCL2</td>
<td align="center" valign="top">1.922935</td>
<td align="center" valign="top">9.35E-07</td>
<td align="center" valign="top">4.76E-05</td>
<td align="center" valign="top">5.063183</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">C-C motif chemokine ligand 2</td>
</tr>
<tr>
<td align="center" valign="top">PRF1</td>
<td align="center" valign="top">1.921821</td>
<td align="center" valign="top">7.22E-10</td>
<td align="center" valign="top">7.9E-08</td>
<td align="center" valign="top">6.475198</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">perforin 1</td>
</tr>
<tr>
<td align="center" valign="top">SAA4</td>
<td align="center" valign="top">1.902739</td>
<td align="center" valign="top">4.4E-08</td>
<td align="center" valign="top">3.21E-06</td>
<td align="center" valign="top">5.693817</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">serum amyloid A4, constitutive</td>
</tr>
<tr>
<td align="center" valign="top">ETV7</td>
<td align="center" valign="top">1.880738</td>
<td align="center" valign="top">2.07E-15</td>
<td align="center" valign="top">4.93E-13</td>
<td align="center" valign="top">8.619913</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">ETS variant transcription factor 7</td>
</tr>
<tr>
<td align="center" valign="top">OTOF</td>
<td align="center" valign="top">1.86563</td>
<td align="center" valign="top">6.04E-10</td>
<td align="center" valign="top">6.8E-08</td>
<td align="center" valign="top">6.507751</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">otoferlin</td>
</tr>
<tr>
<td align="center" valign="top">SAMD9L</td>
<td align="center" valign="top">1.854541</td>
<td align="center" valign="top">3.87E-19</td>
<td align="center" valign="top">1.63E-16</td>
<td align="center" valign="top">9.930956</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">sterile alpha motif domain containing 9 like</td>
</tr>
<tr>
<td align="center" valign="top">GIMAP8</td>
<td align="center" valign="top">1.84869</td>
<td align="center" valign="top">2.21E-11</td>
<td align="center" valign="top">3.43E-09</td>
<td align="center" valign="top">7.094874</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">GTPase, IMAP family member 8</td>
</tr>
<tr>
<td align="center" valign="top">IDO1</td>
<td align="center" valign="top">1.841864</td>
<td align="center" valign="top">7.39E-11</td>
<td align="center" valign="top">1.02E-08</td>
<td align="center" valign="top">6.884227</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">indoleamine 2,3-dioxygenase 1</td>
</tr>
<tr>
<td align="center" valign="top">CD80</td>
<td align="center" valign="top">1.839225</td>
<td align="center" valign="top">6.32E-09</td>
<td align="center" valign="top">5.64E-07</td>
<td align="center" valign="top">6.070935</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">CD80 molecule</td>
</tr>
<tr>
<td align="center" valign="top">GIMAP5</td>
<td align="center" valign="top">1.832542</td>
<td align="center" valign="top">3.26E-11</td>
<td align="center" valign="top">4.83E-09</td>
<td align="center" valign="top">7.027451</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">GTPase, IMAP family member 5</td>
</tr>
<tr>
<td align="center" valign="top">DDX58</td>
<td align="center" valign="top">1.818209</td>
<td align="center" valign="top">6.74E-20</td>
<td align="center" valign="top">3.17E-17</td>
<td align="center" valign="top">10.19033</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">DExD/H-box helicase 58</td>
</tr>
<tr>
<td align="center" valign="top">HERC5</td>
<td align="center" valign="top">1.789057</td>
<td align="center" valign="top">2.81E-14</td>
<td align="center" valign="top">6.32E-12</td>
<td align="center" valign="top">8.205216</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">HECT and RLD domain containing E3 ubiquitin protein ligase 5</td>
</tr>
<tr>
<td align="center" valign="top">GZMA</td>
<td align="center" valign="top">1.782817</td>
<td align="center" valign="top">2.1E-10</td>
<td align="center" valign="top">2.67E-08</td>
<td align="center" valign="top">6.698487</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">granzyme A</td>
</tr>
<tr>
<td align="center" valign="top">C1QA</td>
<td align="center" valign="top">1.773784</td>
<td align="center" valign="top">2.35E-11</td>
<td align="center" valign="top">3.62E-09</td>
<td align="center" valign="top">7.084184</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">complement C1q A chain</td>
</tr>
<tr>
<td align="center" valign="top">BATF2</td>
<td align="center" valign="top">1.764917</td>
<td align="center" valign="top">2.23E-13</td>
<td align="center" valign="top">4.75E-11</td>
<td align="center" valign="top">7.86879</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">basic leucine zipper ATF-like transcription factor 2</td>
</tr>
<tr>
<td align="center" valign="top">MX1</td>
<td align="center" valign="top">1.763338</td>
<td align="center" valign="top">3.86E-26</td>
<td align="center" valign="top">6.16E-23</td>
<td align="center" valign="top">12.26722</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">MX dynamin like GTPase 1</td>
</tr>
<tr>
<td align="center" valign="top">GZMH</td>
<td align="center" valign="top">1.754885</td>
<td align="center" valign="top">9.71E-10</td>
<td align="center" valign="top">1.02E-07</td>
<td align="center" valign="top">6.420881</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">granzyme H</td>
</tr>
<tr>
<td align="center" valign="top">C1QB</td>
<td align="center" valign="top">1.740957</td>
<td align="center" valign="top">2.16E-10</td>
<td align="center" valign="top">2.72E-08</td>
<td align="center" valign="top">6.693226</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">complement C1q B chain</td>
</tr>
<tr>
<td align="center" valign="top">IFIT5</td>
<td align="center" valign="top">1.683532</td>
<td align="center" valign="top">1.72E-18</td>
<td align="center" valign="top">6.87E-16</td>
<td align="center" valign="top">9.707937</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">interferon induced protein with tetratricopeptide repeats 5</td>
</tr>
<tr>
<td align="center" valign="top">GIMAP6</td>
<td align="center" valign="top">1.682011</td>
<td align="center" valign="top">9.61E-10</td>
<td align="center" valign="top">1.02E-07</td>
<td align="center" valign="top">6.422861</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">GTPase, IMAP family member 6</td>
</tr>
<tr>
<td align="center" valign="top">ACE2</td>
<td align="center" valign="top">1.678445</td>
<td align="center" valign="top">1.54E-11</td>
<td align="center" valign="top">2.56E-09</td>
<td align="center" valign="top">7.157836</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">angiotensin I converting enzyme 2</td>
</tr>
<tr>
<td align="center" valign="top">TRO</td>
<td align="center" valign="top">1.670472</td>
<td align="center" valign="top">1.4E-10</td>
<td align="center" valign="top">1.84E-08</td>
<td align="center" valign="top">6.770644</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">trophinin</td>
</tr>
<tr>
<td align="center" valign="top">PRRX2</td>
<td align="center" valign="top">1.660273</td>
<td align="center" valign="top">2.83E-10</td>
<td align="center" valign="top">3.47E-08</td>
<td align="center" valign="top">6.645352</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">paired related homeobox 2</td>
</tr>
<tr>
<td align="center" valign="top">PTPRO</td>
<td align="center" valign="top">1.650953</td>
<td align="center" valign="top">1.55E-10</td>
<td align="center" valign="top">1.99E-08</td>
<td align="center" valign="top">6.753348</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">protein tyrosine phosphatase receptor type O</td>
</tr>
<tr>
<td align="center" valign="top">KCNA3</td>
<td align="center" valign="top">1.64492</td>
<td align="center" valign="top">1.01E-08</td>
<td align="center" valign="top">8.56E-07</td>
<td align="center" valign="top">5.981651</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">potassium voltage-gated channel subfamily A member 3</td>
</tr>
<tr>
<td align="center" valign="top">NKG7</td>
<td align="center" valign="top">1.642654</td>
<td align="center" valign="top">3.97E-08</td>
<td align="center" valign="top">2.94E-06</td>
<td align="center" valign="top">5.714211</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">natural killer cell granule protein 7</td>
</tr>
<tr>
<td align="center" valign="top">H2AC4</td>
<td align="center" valign="top">1.633797</td>
<td align="center" valign="top">2.05E-09</td>
<td align="center" valign="top">2.08E-07</td>
<td align="center" valign="top">6.28235</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">H2A clustered histone 4</td>
</tr>
<tr>
<td align="center" valign="top">GIMAP4</td>
<td align="center" valign="top">1.631037</td>
<td align="center" valign="top">7.71E-09</td>
<td align="center" valign="top">6.81E-07</td>
<td align="center" valign="top">6.032911</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">GTPase, IMAP family member 4</td>
</tr>
<tr>
<td align="center" valign="top">IL4I1</td>
<td align="center" valign="top">1.628141</td>
<td align="center" valign="top">5.9E-08</td>
<td align="center" valign="top">4.17E-06</td>
<td align="center" valign="top">5.635588</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">interleukin 4 induced 1</td>
</tr>
<tr>
<td align="center" valign="top">H2AC16</td>
<td align="center" valign="top">1.625668</td>
<td align="center" valign="top">7.5E-10</td>
<td align="center" valign="top">8.15E-08</td>
<td align="center" valign="top">6.468328</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">H2A clustered histone 16</td>
</tr>
<tr>
<td align="center" valign="top">IFNG</td>
<td align="center" valign="top">1.611797</td>
<td align="center" valign="top">2.1E-07</td>
<td align="center" valign="top">1.31E-05</td>
<td align="center" valign="top">5.377281</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">interferon gamma</td>
</tr>
<tr>
<td align="center" valign="top">SLC38A5</td>
<td align="center" valign="top">1.610227</td>
<td align="center" valign="top">1.14E-08</td>
<td align="center" valign="top">9.48E-07</td>
<td align="center" valign="top">5.957179</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">solute carrier family 38 member 5</td>
</tr>
<tr>
<td align="center" valign="top">APOL3</td>
<td align="center" valign="top">1.609793</td>
<td align="center" valign="top">2.62E-13</td>
<td align="center" valign="top">5.36E-11</td>
<td align="center" valign="top">7.842663</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">apolipoprotein L3</td>
</tr>
<tr>
<td align="center" valign="top">PCSK5</td>
<td align="center" valign="top">1.609514</td>
<td align="center" valign="top">8.7E-08</td>
<td align="center" valign="top">5.94E-06</td>
<td align="center" valign="top">5.557486</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">proproteinconvertasesubtilisin/kexin type 5</td>
</tr>
<tr>
<td align="center" valign="top">SAA2-SAA4</td>
<td align="center" valign="top">1.599454</td>
<td align="center" valign="top">6.09E-06</td>
<td align="center" valign="top">0.000236</td>
<td align="center" valign="top">4.647977</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">SAA2-SAA4 readthrough</td>
</tr>
<tr>
<td align="center" valign="top">H3C7</td>
<td align="center" valign="top">1.599106</td>
<td align="center" valign="top">6.05E-08</td>
<td align="center" valign="top">4.26E-06</td>
<td align="center" valign="top">5.630552</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">H3 clustered histone 7</td>
</tr>
<tr>
<td align="center" valign="top">H2AC19</td>
<td align="center" valign="top">1.596973</td>
<td align="center" valign="top">1.05E-05</td>
<td align="center" valign="top">0.000369</td>
<td align="center" valign="top">4.5218</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">H2A clustered histone 19</td>
</tr>
<tr>
<td align="center" valign="top">IFIH1</td>
<td align="center" valign="top">1.596331</td>
<td align="center" valign="top">4.7E-18</td>
<td align="center" valign="top">1.79E-15</td>
<td align="center" valign="top">9.556547</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">interferon induced with helicase C domain 1</td>
</tr>
<tr>
<td align="center" valign="top">JCHAIN</td>
<td align="center" valign="top">1.595812</td>
<td align="center" valign="top">5.33E-06</td>
<td align="center" valign="top">0.00021</td>
<td align="center" valign="top">4.678371</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">joining chain of multimeric IgA and IgM</td>
</tr>
<tr>
<td align="center" valign="top">TICAM2</td>
<td align="center" valign="top">1.581335</td>
<td align="center" valign="top">4.2E-07</td>
<td align="center" valign="top">2.4E-05</td>
<td align="center" valign="top">5.233376</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">toll like receptor adaptor molecule 2</td>
</tr>
<tr>
<td align="center" valign="top">CD2</td>
<td align="center" valign="top">1.57353</td>
<td align="center" valign="top">3.05E-08</td>
<td align="center" valign="top">2.33E-06</td>
<td align="center" valign="top">5.766258</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">CD2 molecule</td>
</tr>
<tr>
<td align="center" valign="top">LRRN2</td>
<td align="center" valign="top">1.57115</td>
<td align="center" valign="top">5.41E-08</td>
<td align="center" valign="top">3.88E-06</td>
<td align="center" valign="top">5.652736</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">leucine rich repeat neuronal 2</td>
</tr>
<tr>
<td align="center" valign="top">ZNF831</td>
<td align="center" valign="top">1.568621</td>
<td align="center" valign="top">4.26E-07</td>
<td align="center" valign="top">2.42E-05</td>
<td align="center" valign="top">5.230346</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">zinc finger protein 831</td>
</tr>
<tr>
<td align="center" valign="top">H3C12</td>
<td align="center" valign="top">1.557481</td>
<td align="center" valign="top">3.2E-08</td>
<td align="center" valign="top">2.42E-06</td>
<td align="center" valign="top">5.756689</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">H3 clustered histone 12</td>
</tr>
<tr>
<td align="center" valign="top">SLC43A1</td>
<td align="center" valign="top">1.555024</td>
<td align="center" valign="top">1.04E-09</td>
<td align="center" valign="top">1.09E-07</td>
<td align="center" valign="top">6.408465</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">solute carrier family 43 member 1</td>
</tr>
<tr>
<td align="center" valign="top">MUC13</td>
<td align="center" valign="top">1.541793</td>
<td align="center" valign="top">4.56E-09</td>
<td align="center" valign="top">4.16E-07</td>
<td align="center" valign="top">6.132722</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">mucin 13, cell surface associated</td>
</tr>
<tr>
<td align="center" valign="top">IGLL5</td>
<td align="center" valign="top">1.541699</td>
<td align="center" valign="top">0.000463</td>
<td align="center" valign="top">0.006583</td>
<td align="center" valign="top">3.560105</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">immunoglobulin lambda like polypeptide 5</td>
</tr>
<tr>
<td align="center" valign="top">ACOD1</td>
<td align="center" valign="top">1.540224</td>
<td align="center" valign="top">2.55E-05</td>
<td align="center" valign="top">0.000749</td>
<td align="center" valign="top">4.311696</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">aconitate decarboxylase 1</td>
</tr>
<tr>
<td align="center" valign="top">ADAMDEC1</td>
<td align="center" valign="top">1.538375</td>
<td align="center" valign="top">2.82E-10</td>
<td align="center" valign="top">3.47E-08</td>
<td align="center" valign="top">6.645769</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">ADAM like decysin 1</td>
</tr>
<tr>
<td align="center" valign="top">PARP9</td>
<td align="center" valign="top">1.533732</td>
<td align="center" valign="top">4.36E-24</td>
<td align="center" valign="top">4.1E-21</td>
<td align="center" valign="top">11.59255</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">poly(ADP-ribose) polymerase family member 9</td>
</tr>
<tr>
<td align="center" valign="top">C1QC</td>
<td align="center" valign="top">1.53228</td>
<td align="center" valign="top">1.27E-10</td>
<td align="center" valign="top">1.69E-08</td>
<td align="center" valign="top">6.788098</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">complement C1q C chain</td>
</tr>
<tr>
<td align="center" valign="top">MYBL2</td>
<td align="center" valign="top">1.52936</td>
<td align="center" valign="top">8.79E-08</td>
<td align="center" valign="top">5.97E-06</td>
<td align="center" valign="top">5.555484</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">MYB proto-oncogene like 2</td>
</tr>
<tr>
<td align="center" valign="top">STAT1</td>
<td align="center" valign="top">1.528207</td>
<td align="center" valign="top">3.26E-22</td>
<td align="center" valign="top">2E-19</td>
<td align="center" valign="top">10.97078</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">signal transducer and activator of transcription 1</td>
</tr>
<tr>
<td align="center" valign="top">KLRC2</td>
<td align="center" valign="top">1.526789</td>
<td align="center" valign="top">3.22E-07</td>
<td align="center" valign="top">1.91E-05</td>
<td align="center" valign="top">5.289043</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">killer cell lectin like receptor C2</td>
</tr>
<tr>
<td align="center" valign="top">UBQLNL</td>
<td align="center" valign="top">1.513469</td>
<td align="center" valign="top">1.81E-10</td>
<td align="center" valign="top">2.32E-08</td>
<td align="center" valign="top">6.724706</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">ubiquilin like</td>
</tr>
<tr>
<td align="center" valign="top">H2AC14</td>
<td align="center" valign="top">1.513406</td>
<td align="center" valign="top">3.11E-08</td>
<td align="center" valign="top">2.37E-06</td>
<td align="center" valign="top">5.762362</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">H2A clustered histone 14</td>
</tr>
<tr>
<td align="center" valign="top">FAP</td>
<td align="center" valign="top">1.507317</td>
<td align="center" valign="top">6.58E-06</td>
<td align="center" valign="top">0.00025</td>
<td align="center" valign="top">4.630106</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">fibroblast activation protein alpha</td>
</tr>
<tr>
<td align="center" valign="top">CCR5</td>
<td align="center" valign="top">1.506698</td>
<td align="center" valign="top">2.01E-09</td>
<td align="center" valign="top">2.05E-07</td>
<td align="center" valign="top">6.286076</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">C-C motif chemokine receptor 5 (gene/pseudogene)</td>
</tr>
<tr>
<td align="center" valign="top">PARP14</td>
<td align="center" valign="top">1.501339</td>
<td align="center" valign="top">2.82E-21</td>
<td align="center" valign="top">1.41E-18</td>
<td align="center" valign="top">10.65663</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">poly(ADP-ribose) polymerase family member 14</td>
</tr>
<tr>
<td align="center" valign="top">NRSN1</td>
<td align="center" valign="top">1.499224</td>
<td align="center" valign="top">7.81E-08</td>
<td align="center" valign="top">5.4E-06</td>
<td align="center" valign="top">5.57921</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">neurensin 1</td>
</tr>
<tr>
<td align="center" valign="top">PTN</td>
<td align="center" valign="top">1.495135</td>
<td align="center" valign="top">3.02E-08</td>
<td align="center" valign="top">2.32E-06</td>
<td align="center" valign="top">5.76828</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">pleiotrophin</td>
</tr>
<tr>
<td align="center" valign="top">UBE2L6</td>
<td align="center" valign="top">1.487839</td>
<td align="center" valign="top">7.71E-19</td>
<td align="center" valign="top">3.16E-16</td>
<td align="center" valign="top">9.827978</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">ubiquitin conjugating enzyme E2 L6</td>
</tr>
<tr>
<td align="center" valign="top">BTN3A3</td>
<td align="center" valign="top">1.477444</td>
<td align="center" valign="top">1.32E-16</td>
<td align="center" valign="top">3.85E-14</td>
<td align="center" valign="top">9.047461</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">butyrophilin subfamily 3 member A3</td>
</tr>
<tr>
<td align="center" valign="top">SAA1</td>
<td align="center" valign="top">1.475907</td>
<td align="center" valign="top">1.03E-05</td>
<td align="center" valign="top">0.000365</td>
<td align="center" valign="top">4.525706</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">serum amyloid A1</td>
</tr>
<tr>
<td align="center" valign="top">SAA2</td>
<td align="center" valign="top">1.466291</td>
<td align="center" valign="top">7.87E-06</td>
<td align="center" valign="top">0.000294</td>
<td align="center" valign="top">4.588937</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">serum amyloid A2</td>
</tr>
<tr>
<td align="center" valign="top">H1-5</td>
<td align="center" valign="top">1.461102</td>
<td align="center" valign="top">1.02E-06</td>
<td align="center" valign="top">5.09E-05</td>
<td align="center" valign="top">5.045246</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">H1.5 linker histone, cluster member</td>
</tr>
<tr>
<td align="center" valign="top">C4B</td>
<td align="center" valign="top">1.460596</td>
<td align="center" valign="top">3.53E-09</td>
<td align="center" valign="top">3.38E-07</td>
<td align="center" valign="top">6.180924</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">complement C4B (Chido blood group)</td>
</tr>
<tr>
<td align="center" valign="top">LGR6</td>
<td align="center" valign="top">1.457593</td>
<td align="center" valign="top">4.14E-10</td>
<td align="center" valign="top">4.9E-08</td>
<td align="center" valign="top">6.576465</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">leucine rich repeat containing G protein-coupled receptor 6</td>
</tr>
<tr>
<td align="center" valign="top">LY6E</td>
<td align="center" valign="top">1.456796</td>
<td align="center" valign="top">2.48E-25</td>
<td align="center" valign="top">3.3E-22</td>
<td align="center" valign="top">12.00248</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">lymphocyte antigen 6 family member E</td>
</tr>
<tr>
<td align="center" valign="top">LAP3</td>
<td align="center" valign="top">1.453984</td>
<td align="center" valign="top">4.06E-23</td>
<td align="center" valign="top">2.82E-20</td>
<td align="center" valign="top">11.27188</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">leucineaminopeptidase 3</td>
</tr>
<tr>
<td align="center" valign="top">SAMD9</td>
<td align="center" valign="top">1.451563</td>
<td align="center" valign="top">2.29E-16</td>
<td align="center" valign="top">6.3E-14</td>
<td align="center" valign="top">8.963159</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">sterile alpha motif domain containing 9</td>
</tr>
<tr>
<td align="center" valign="top">PDCD1LG2</td>
<td align="center" valign="top">1.448347</td>
<td align="center" valign="top">8.92E-09</td>
<td align="center" valign="top">7.63E-07</td>
<td align="center" valign="top">6.004903</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">programmed cell death 1 ligand 2</td>
</tr>
<tr>
<td align="center" valign="top">H2BC11</td>
<td align="center" valign="top">1.446626</td>
<td align="center" valign="top">1.92E-09</td>
<td align="center" valign="top">1.97E-07</td>
<td align="center" valign="top">6.295053</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">H2B clustered histone 11</td>
</tr>
<tr>
<td align="center" valign="top">BOLL</td>
<td align="center" valign="top">1.443221</td>
<td align="center" valign="top">4.22E-09</td>
<td align="center" valign="top">3.92E-07</td>
<td align="center" valign="top">6.147325</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">boule homolog, RNA binding protein</td>
</tr>
<tr>
<td align="center" valign="top">IFI35</td>
<td align="center" valign="top">1.436444</td>
<td align="center" valign="top">8.37E-17</td>
<td align="center" valign="top">2.52E-14</td>
<td align="center" valign="top">9.118111</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">interferon induced protein 35</td>
</tr>
<tr>
<td align="center" valign="top">ADCY5</td>
<td align="center" valign="top">1.430895</td>
<td align="center" valign="top">4.58E-07</td>
<td align="center" valign="top">2.59E-05</td>
<td align="center" valign="top">5.21523</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">adenylatecyclase 5</td>
</tr>
<tr>
<td align="center" valign="top">HLA-DOB</td>
<td align="center" valign="top">1.425989</td>
<td align="center" valign="top">8.32E-07</td>
<td align="center" valign="top">4.3E-05</td>
<td align="center" valign="top">5.08832</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">major histocompatibility complex, class II, DO beta</td>
</tr>
<tr>
<td align="center" valign="top">MT2A</td>
<td align="center" valign="top">1.421462</td>
<td align="center" valign="top">2.47E-13</td>
<td align="center" valign="top">5.12E-11</td>
<td align="center" valign="top">7.852393</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">metallothionein 2A</td>
</tr>
<tr>
<td align="center" valign="top">WDR74</td>
<td align="center" valign="top">1.418729</td>
<td align="center" valign="top">5.7E-11</td>
<td align="center" valign="top">7.99E-09</td>
<td align="center" valign="top">6.92983</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">WD repeat domain 74</td>
</tr>
<tr>
<td align="center" valign="top">FPR3</td>
<td align="center" valign="top">1.416451</td>
<td align="center" valign="top">1.04E-10</td>
<td align="center" valign="top">1.42E-08</td>
<td align="center" valign="top">6.822927</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">formyl peptide receptor 3</td>
</tr>
<tr>
<td align="center" valign="top">FBXO39</td>
<td align="center" valign="top">1.414865</td>
<td align="center" valign="top">1.34E-07</td>
<td align="center" valign="top">8.81E-06</td>
<td align="center" valign="top">5.469165</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">F-box protein 39</td>
</tr>
<tr>
<td align="center" valign="top">DPP4</td>
<td align="center" valign="top">1.413951</td>
<td align="center" valign="top">2.68E-06</td>
<td align="center" valign="top">0.000115</td>
<td align="center" valign="top">4.833276</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">dipeptidyl peptidase 4</td>
</tr>
<tr>
<td align="center" valign="top">TNFSF10</td>
<td align="center" valign="top">1.413089</td>
<td align="center" valign="top">2.73E-22</td>
<td align="center" valign="top">1.75E-19</td>
<td align="center" valign="top">10.99633</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">TNF superfamily member 10</td>
</tr>
<tr>
<td align="center" valign="top">H3C2</td>
<td align="center" valign="top">1.407793</td>
<td align="center" valign="top">2.95E-06</td>
<td align="center" valign="top">0.000125</td>
<td align="center" valign="top">4.811757</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">H3 clustered histone 2</td>
</tr>
<tr>
<td align="center" valign="top">HAPLN3</td>
<td align="center" valign="top">1.406707</td>
<td align="center" valign="top">1.04E-08</td>
<td align="center" valign="top">8.8E-07</td>
<td align="center" valign="top">5.974626</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">hyaluronan and proteoglycan link protein 3</td>
</tr>
<tr>
<td align="center" valign="top">TBX21</td>
<td align="center" valign="top">1.406435</td>
<td align="center" valign="top">9.38E-07</td>
<td align="center" valign="top">4.76E-05</td>
<td align="center" valign="top">5.062474</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">T-box transcription factor 21</td>
</tr>
<tr>
<td align="center" valign="top">H2BC14</td>
<td align="center" valign="top">1.394612</td>
<td align="center" valign="top">9.16E-07</td>
<td align="center" valign="top">4.68E-05</td>
<td align="center" valign="top">5.067688</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">H2B clustered histone 14</td>
</tr>
<tr>
<td align="center" valign="top">H2BC17</td>
<td align="center" valign="top">1.39358</td>
<td align="center" valign="top">2.26E-07</td>
<td align="center" valign="top">1.4E-05</td>
<td align="center" valign="top">5.362739</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">H2B clustered histone 17</td>
</tr>
<tr>
<td align="center" valign="top">H2AC12</td>
<td align="center" valign="top">1.387431</td>
<td align="center" valign="top">2.66E-08</td>
<td align="center" valign="top">2.07E-06</td>
<td align="center" valign="top">5.793394</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">H2A clustered histone 12</td>
</tr>
<tr>
<td align="center" valign="top">PPAN-P2RY11</td>
<td align="center" valign="top">1.384448</td>
<td align="center" valign="top">1.07E-06</td>
<td align="center" valign="top">5.33E-05</td>
<td align="center" valign="top">5.034009</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">PPAN-P2RY11 readthrough</td>
</tr>
<tr>
<td align="center" valign="top">FAM83A</td>
<td align="center" valign="top">1.384419</td>
<td align="center" valign="top">6.27E-12</td>
<td align="center" valign="top">1.14E-09</td>
<td align="center" valign="top">7.311617</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">family with sequence similarity 83 member A</td>
</tr>
<tr>
<td align="center" valign="top">PSMB9</td>
<td align="center" valign="top">1.383189</td>
<td align="center" valign="top">1.31E-15</td>
<td align="center" valign="top">3.49E-13</td>
<td align="center" valign="top">8.69114</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">proteasome 20S subunit beta 9</td>
</tr>
<tr>
<td align="center" valign="top">CAMK4</td>
<td align="center" valign="top">1.383067</td>
<td align="center" valign="top">6.21E-07</td>
<td align="center" valign="top">3.36E-05</td>
<td align="center" valign="top">5.150833</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">calcium/calmodulin dependent protein kinase IV</td>
</tr>
<tr>
<td align="center" valign="top">FASLG</td>
<td align="center" valign="top">1.379234</td>
<td align="center" valign="top">2.35E-08</td>
<td align="center" valign="top">1.85E-06</td>
<td align="center" valign="top">5.817488</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">Fas ligand</td>
</tr>
<tr>
<td align="center" valign="top">DHX58</td>
<td align="center" valign="top">1.376598</td>
<td align="center" valign="top">1.96E-15</td>
<td align="center" valign="top">4.74E-13</td>
<td align="center" valign="top">8.628561</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">DExH-box helicase 58</td>
</tr>
<tr>
<td align="center" valign="top">HLA-DMB</td>
<td align="center" valign="top">1.376028</td>
<td align="center" valign="top">3.7E-09</td>
<td align="center" valign="top">3.48E-07</td>
<td align="center" valign="top">6.171933</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">major histocompatibility complex, class II, DM beta</td>
</tr>
<tr>
<td align="center" valign="top">ABCB1</td>
<td align="center" valign="top">1.375395</td>
<td align="center" valign="top">1.51E-06</td>
<td align="center" valign="top">7.05E-05</td>
<td align="center" valign="top">4.959</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">ATP binding cassette subfamily B member 1</td>
</tr>
<tr>
<td align="center" valign="top">H4C13</td>
<td align="center" valign="top">1.366251</td>
<td align="center" valign="top">2.57E-07</td>
<td align="center" valign="top">1.57E-05</td>
<td align="center" valign="top">5.335674</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">H4 clustered histone 13</td>
</tr>
<tr>
<td align="center" valign="top">MS4A4A</td>
<td align="center" valign="top">1.366197</td>
<td align="center" valign="top">7.9E-09</td>
<td align="center" valign="top">6.94E-07</td>
<td align="center" valign="top">6.02822</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">membrane spanning 4-domains A4A</td>
</tr>
<tr>
<td align="center" valign="top">RNF43</td>
<td align="center" valign="top">1.358987</td>
<td align="center" valign="top">0.000178</td>
<td align="center" valign="top">0.003349</td>
<td align="center" valign="top">3.81965</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">ring finger protein 43</td>
</tr>
<tr>
<td align="center" valign="top">BTN3A1</td>
<td align="center" valign="top">1.357653</td>
<td align="center" valign="top">6.58E-12</td>
<td align="center" valign="top">1.18E-09</td>
<td align="center" valign="top">7.303358</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">butyrophilin subfamily 3 member A1</td>
</tr>
<tr>
<td align="center" valign="top">CD3D</td>
<td align="center" valign="top">1.35711</td>
<td align="center" valign="top">4.15E-07</td>
<td align="center" valign="top">2.38E-05</td>
<td align="center" valign="top">5.235751</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">CD3d molecule</td>
</tr>
<tr>
<td align="center" valign="top">CD3E</td>
<td align="center" valign="top">1.355388</td>
<td align="center" valign="top">3.51E-07</td>
<td align="center" valign="top">2.05E-05</td>
<td align="center" valign="top">5.271208</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">CD3e molecule</td>
</tr>
<tr>
<td align="center" valign="top">IGSF9B</td>
<td align="center" valign="top">1.34921</td>
<td align="center" valign="top">1.06E-05</td>
<td align="center" valign="top">0.00037</td>
<td align="center" valign="top">4.520117</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">immunoglobulin superfamily member 9B</td>
</tr>
<tr>
<td align="center" valign="top">P2RX5</td>
<td align="center" valign="top">1.34915</td>
<td align="center" valign="top">2.45E-05</td>
<td align="center" valign="top">0.00073</td>
<td align="center" valign="top">4.321142</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">purinergic receptor P2X 5</td>
</tr>
<tr>
<td align="center" valign="top">CMKLR1</td>
<td align="center" valign="top">1.343192</td>
<td align="center" valign="top">1.84E-06</td>
<td align="center" valign="top">8.25E-05</td>
<td align="center" valign="top">4.916279</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">chemerin chemokine-like receptor 1</td>
</tr>
<tr>
<td align="center" valign="top">ICOS</td>
<td align="center" valign="top">1.341532</td>
<td align="center" valign="top">5.98E-07</td>
<td align="center" valign="top">3.25E-05</td>
<td align="center" valign="top">5.158662</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">inducible T cell costimulator</td>
</tr>
<tr>
<td align="center" valign="top">CALHM6</td>
<td align="center" valign="top">1.340715</td>
<td align="center" valign="top">3.04E-06</td>
<td align="center" valign="top">0.000128</td>
<td align="center" valign="top">4.805062</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">calcium homeostasis modulator family member 6</td>
</tr>
<tr>
<td align="center" valign="top">H2BC3</td>
<td align="center" valign="top">1.340252</td>
<td align="center" valign="top">1.47E-07</td>
<td align="center" valign="top">9.48E-06</td>
<td align="center" valign="top">5.451527</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">H2B clustered histone 3</td>
</tr>
<tr>
<td align="center" valign="top">GBP1</td>
<td align="center" valign="top">1.339844</td>
<td align="center" valign="top">3.54E-10</td>
<td align="center" valign="top">4.22E-08</td>
<td align="center" valign="top">6.604802</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">guanylate binding protein 1</td>
</tr>
<tr>
<td align="center" valign="top">H4C14</td>
<td align="center" valign="top">1.336797</td>
<td align="center" valign="top">4.17E-12</td>
<td align="center" valign="top">7.75E-10</td>
<td align="center" valign="top">7.380672</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">H4 clustered histone 14</td>
</tr>
<tr>
<td align="center" valign="top">GRAP2</td>
<td align="center" valign="top">1.333151</td>
<td align="center" valign="top">3.44E-06</td>
<td align="center" valign="top">0.000141</td>
<td align="center" valign="top">4.777415</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">GRB2 related adaptor protein 2</td>
</tr>
<tr>
<td align="center" valign="top">XAF1</td>
<td align="center" valign="top">1.321697</td>
<td align="center" valign="top">4.12E-17</td>
<td align="center" valign="top">1.32E-14</td>
<td align="center" valign="top">9.226759</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">XIAP associated factor 1</td>
</tr>
<tr>
<td align="center" valign="top">PRLR</td>
<td align="center" valign="top">1.317945</td>
<td align="center" valign="top">4.41E-06</td>
<td align="center" valign="top">0.000177</td>
<td align="center" valign="top">4.721282</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">prolactin receptor</td>
</tr>
<tr>
<td align="center" valign="top">TRIM22</td>
<td align="center" valign="top">1.310769</td>
<td align="center" valign="top">6.88E-22</td>
<td align="center" valign="top">3.79E-19</td>
<td align="center" valign="top">10.86216</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">tripartite motif containing 22</td>
</tr>
<tr>
<td align="center" valign="top">TPX2</td>
<td align="center" valign="top">1.308316</td>
<td align="center" valign="top">4.31E-09</td>
<td align="center" valign="top">3.98E-07</td>
<td align="center" valign="top">6.143296</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">TPX2 microtubule nucleation factor</td>
</tr>
<tr>
<td align="center" valign="top">LAMP3</td>
<td align="center" valign="top">1.307967</td>
<td align="center" valign="top">1.74E-15</td>
<td align="center" valign="top">4.27E-13</td>
<td align="center" valign="top">8.647092</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">lysosomal associated membrane protein 3</td>
</tr>
<tr>
<td align="center" valign="top">IQSEC3</td>
<td align="center" valign="top">1.304031</td>
<td align="center" valign="top">1.73E-05</td>
<td align="center" valign="top">0.000545</td>
<td align="center" valign="top">4.404463</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">IQ motif and Sec7 domain ArfGEF 3</td>
</tr>
<tr>
<td align="center" valign="top">H3C3</td>
<td align="center" valign="top">1.303964</td>
<td align="center" valign="top">5.36E-07</td>
<td align="center" valign="top">2.96E-05</td>
<td align="center" valign="top">5.182123</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">H3 clustered histone 3</td>
</tr>
<tr>
<td align="center" valign="top">NMI</td>
<td align="center" valign="top">1.296479</td>
<td align="center" valign="top">8.7E-15</td>
<td align="center" valign="top">2.02E-12</td>
<td align="center" valign="top">8.392554</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">N-myc and STAT interactor</td>
</tr>
<tr>
<td align="center" valign="top">EOMES</td>
<td align="center" valign="top">1.292873</td>
<td align="center" valign="top">1.67E-06</td>
<td align="center" valign="top">7.65E-05</td>
<td align="center" valign="top">4.937302</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">eomesodermin</td>
</tr>
<tr>
<td align="center" valign="top">COL5A1</td>
<td align="center" valign="top">1.285448</td>
<td align="center" valign="top">2.94E-05</td>
<td align="center" valign="top">0.000831</td>
<td align="center" valign="top">4.276862</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">collagen type V alpha 1 chain</td>
</tr>
<tr>
<td align="center" valign="top">THEMIS</td>
<td align="center" valign="top">1.275577</td>
<td align="center" valign="top">2.3E-06</td>
<td align="center" valign="top">0.0001</td>
<td align="center" valign="top">4.866994</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">thymocyte selection associated</td>
</tr>
<tr>
<td align="center" valign="top">PDCD1</td>
<td align="center" valign="top">1.274703</td>
<td align="center" valign="top">2.83E-05</td>
<td align="center" valign="top">0.000806</td>
<td align="center" valign="top">4.286</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">programmed cell death 1</td>
</tr>
<tr>
<td align="center" valign="top">ISG20</td>
<td align="center" valign="top">1.273865</td>
<td align="center" valign="top">1.07E-09</td>
<td align="center" valign="top">1.11E-07</td>
<td align="center" valign="top">6.402836</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">interferon stimulated exonuclease gene 20</td>
</tr>
<tr>
<td align="center" valign="top">NT5C3A</td>
<td align="center" valign="top">1.26918</td>
<td align="center" valign="top">5.78E-17</td>
<td align="center" valign="top">1.77E-14</td>
<td align="center" valign="top">9.174944</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">5'-nucleotidase, cytosolic IIIA</td>
</tr>
<tr>
<td align="center" valign="top">SUCNR1</td>
<td align="center" valign="top">1.267652</td>
<td align="center" valign="top">1.63E-06</td>
<td align="center" valign="top">7.5E-05</td>
<td align="center" valign="top">4.942182</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">succinate receptor 1</td>
</tr>
<tr>
<td align="center" valign="top">PSAT1</td>
<td align="center" valign="top">1.266509</td>
<td align="center" valign="top">2.18E-08</td>
<td align="center" valign="top">1.74E-06</td>
<td align="center" valign="top">5.832345</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">phosphoserine aminotransferase 1</td>
</tr>
<tr>
<td align="center" valign="top">PLK4</td>
<td align="center" valign="top">1.263388</td>
<td align="center" valign="top">2.72E-07</td>
<td align="center" valign="top">1.64E-05</td>
<td align="center" valign="top">5.324066</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">polo like kinase 4</td>
</tr>
<tr>
<td align="center" valign="top">IRF7</td>
<td align="center" valign="top">1.261576</td>
<td align="center" valign="top">4.31E-08</td>
<td align="center" valign="top">3.16E-06</td>
<td align="center" valign="top">5.698151</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">interferon regulatory factor 7</td>
</tr>
<tr>
<td align="center" valign="top">HLA-F</td>
<td align="center" valign="top">1.260994</td>
<td align="center" valign="top">6.67E-14</td>
<td align="center" valign="top">1.46E-11</td>
<td align="center" valign="top">8.065758</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">major histocompatibility complex, class I, F</td>
</tr>
<tr>
<td align="center" valign="top">MGAT3</td>
<td align="center" valign="top">1.257607</td>
<td align="center" valign="top">7.14E-08</td>
<td align="center" valign="top">4.98E-06</td>
<td align="center" valign="top">5.597203</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase</td>
</tr>
<tr>
<td align="center" valign="top">GABRB2</td>
<td align="center" valign="top">1.245678</td>
<td align="center" valign="top">4.01E-06</td>
<td align="center" valign="top">0.000162</td>
<td align="center" valign="top">4.742989</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">gamma-aminobutyric acid type A receptor beta2 subunit</td>
</tr>
<tr>
<td align="center" valign="top">PPM1J</td>
<td align="center" valign="top">1.241277</td>
<td align="center" valign="top">1.68E-07</td>
<td align="center" valign="top">1.07E-05</td>
<td align="center" valign="top">5.424044</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">protein phosphatase, Mg2+/Mn2+ dependent 1J</td>
</tr>
<tr>
<td align="center" valign="top">HESX1</td>
<td align="center" valign="top">1.235182</td>
<td align="center" valign="top">4E-08</td>
<td align="center" valign="top">2.95E-06</td>
<td align="center" valign="top">5.712576</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">HESX homeobox 1</td>
</tr>
<tr>
<td align="center" valign="top">LGALS3BP</td>
<td align="center" valign="top">1.228479</td>
<td align="center" valign="top">1.17E-19</td>
<td align="center" valign="top">5.34E-17</td>
<td align="center" valign="top">10.10869</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">galectin 3 binding protein</td>
</tr>
<tr>
<td align="center" valign="top">GPR171</td>
<td align="center" valign="top">1.228274</td>
<td align="center" valign="top">1.15E-05</td>
<td align="center" valign="top">0.000398</td>
<td align="center" valign="top">4.500169</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">G protein-coupled receptor 171</td>
</tr>
<tr>
<td align="center" valign="top">ADGRF5</td>
<td align="center" valign="top">1.218011</td>
<td align="center" valign="top">2.69E-06</td>
<td align="center" valign="top">0.000115</td>
<td align="center" valign="top">4.832296</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">adhesion G protein-coupled receptor F5</td>
</tr>
<tr>
<td align="center" valign="top">PARP12</td>
<td align="center" valign="top">1.215013</td>
<td align="center" valign="top">1.4E-15</td>
<td align="center" valign="top">3.61E-13</td>
<td align="center" valign="top">8.681068</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">poly(ADP-ribose) polymerase family member 12</td>
</tr>
<tr>
<td align="center" valign="top">ATP10A</td>
<td align="center" valign="top">1.213572</td>
<td align="center" valign="top">3.81E-09</td>
<td align="center" valign="top">3.56E-07</td>
<td align="center" valign="top">6.166388</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">ATPase phospholipid transporting 10A (putative)</td>
</tr>
<tr>
<td align="center" valign="top">DEFB1</td>
<td align="center" valign="top">1.211219</td>
<td align="center" valign="top">7.3E-07</td>
<td align="center" valign="top">3.86E-05</td>
<td align="center" valign="top">5.11622</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">defensin beta 1</td>
</tr>
<tr>
<td align="center" valign="top">SHFL</td>
<td align="center" valign="top">1.210974</td>
<td align="center" valign="top">4.35E-15</td>
<td align="center" valign="top">1.02E-12</td>
<td align="center" valign="top">8.502576</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">shiftless antiviral inhibitor of ribosomal frameshifting</td>
</tr>
<tr>
<td align="center" valign="top">CD8A</td>
<td align="center" valign="top">1.20866</td>
<td align="center" valign="top">5.74E-07</td>
<td align="center" valign="top">3.14E-05</td>
<td align="center" valign="top">5.167479</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">CD8a molecule</td>
</tr>
<tr>
<td align="center" valign="top">H3C8</td>
<td align="center" valign="top">1.207391</td>
<td align="center" valign="top">1.01E-06</td>
<td align="center" valign="top">5.05E-05</td>
<td align="center" valign="top">5.047585</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">H3 clustered histone 8</td>
</tr>
<tr>
<td align="center" valign="top">GRAP</td>
<td align="center" valign="top">1.206435</td>
<td align="center" valign="top">0.000182</td>
<td align="center" valign="top">0.003405</td>
<td align="center" valign="top">3.813859</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">GRB2 related adaptor protein</td>
</tr>
<tr>
<td align="center" valign="top">KRT39</td>
<td align="center" valign="top">1.205387</td>
<td align="center" valign="top">3.05E-07</td>
<td align="center" valign="top">1.83E-05</td>
<td align="center" valign="top">5.300073</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">keratin 39</td>
</tr>
<tr>
<td align="center" valign="top">HLA-G</td>
<td align="center" valign="top">1.201932</td>
<td align="center" valign="top">2.92E-08</td>
<td align="center" valign="top">2.26E-06</td>
<td align="center" valign="top">5.774564</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">major histocompatibility complex, class I, G</td>
</tr>
<tr>
<td align="center" valign="top">HSH2D</td>
<td align="center" valign="top">1.200504</td>
<td align="center" valign="top">1.84E-11</td>
<td align="center" valign="top">2.93E-09</td>
<td align="center" valign="top">7.127183</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">hematopoietic SH2 domain containing</td>
</tr>
<tr>
<td align="center" valign="top">CD8B</td>
<td align="center" valign="top">1.198553</td>
<td align="center" valign="top">1.4E-05</td>
<td align="center" valign="top">0.000463</td>
<td align="center" valign="top">4.454297</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">CD8b molecule</td>
</tr>
<tr>
<td align="center" valign="top">C17orf67</td>
<td align="center" valign="top">1.196268</td>
<td align="center" valign="top">1.67E-07</td>
<td align="center" valign="top">1.06E-05</td>
<td align="center" valign="top">5.425354</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">chromosome 17 open reading frame 67</td>
</tr>
<tr>
<td align="center" valign="top">FUOM</td>
<td align="center" valign="top">1.195372</td>
<td align="center" valign="top">1.11E-06</td>
<td align="center" valign="top">5.46E-05</td>
<td align="center" valign="top">5.026106</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">fucosemutarotase</td>
</tr>
<tr>
<td align="center" valign="top">MDK</td>
<td align="center" valign="top">1.1953</td>
<td align="center" valign="top">3.03E-13</td>
<td align="center" valign="top">6.06E-11</td>
<td align="center" valign="top">7.818336</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">midkine</td>
</tr>
<tr>
<td align="center" valign="top">GGT1</td>
<td align="center" valign="top">1.194131</td>
<td align="center" valign="top">0.001344</td>
<td align="center" valign="top">0.013767</td>
<td align="center" valign="top">3.252355</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">gamma-glutamyltransferase 1</td>
</tr>
<tr>
<td align="center" valign="top">H3C10</td>
<td align="center" valign="top">1.181443</td>
<td align="center" valign="top">5.05E-07</td>
<td align="center" valign="top">2.8E-05</td>
<td align="center" valign="top">5.194589</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">H3 clustered histone 10</td>
</tr>
<tr>
<td align="center" valign="top">CACNA2D1</td>
<td align="center" valign="top">1.181064</td>
<td align="center" valign="top">0.000174</td>
<td align="center" valign="top">0.003292</td>
<td align="center" valign="top">3.826508</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">calcium voltage-gated channel auxiliary subunit alpha2delta 1</td>
</tr>
<tr>
<td align="center" valign="top">RBM11</td>
<td align="center" valign="top">1.178008</td>
<td align="center" valign="top">3.22E-08</td>
<td align="center" valign="top">2.43E-06</td>
<td align="center" valign="top">5.755448</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">RNA binding motif protein 11</td>
</tr>
<tr>
<td align="center" valign="top">IRF4</td>
<td align="center" valign="top">1.176965</td>
<td align="center" valign="top">3.94E-05</td>
<td align="center" valign="top">0.00105</td>
<td align="center" valign="top">4.204992</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">interferon regulatory factor 4</td>
</tr>
<tr>
<td align="center" valign="top">SIRPG</td>
<td align="center" valign="top">1.175205</td>
<td align="center" valign="top">2.49E-05</td>
<td align="center" valign="top">0.000737</td>
<td align="center" valign="top">4.316981</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">signal regulatory protein gamma</td>
</tr>
<tr>
<td align="center" valign="top">ASCL3</td>
<td align="center" valign="top">1.174818</td>
<td align="center" valign="top">9.33E-06</td>
<td align="center" valign="top">0.000335</td>
<td align="center" valign="top">4.549529</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">achaete-scute family bHLH transcription factor 3</td>
</tr>
<tr>
<td align="center" valign="top">C4A</td>
<td align="center" valign="top">1.173587</td>
<td align="center" valign="top">1.27E-06</td>
<td align="center" valign="top">6.13E-05</td>
<td align="center" valign="top">4.997223</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">complement C4A (Rodgers blood group)</td>
</tr>
<tr>
<td align="center" valign="top">EIF2AK2</td>
<td align="center" valign="top">1.169837</td>
<td align="center" valign="top">1.64E-21</td>
<td align="center" valign="top">8.44E-19</td>
<td align="center" valign="top">10.73595</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">eukaryotic translation initiation factor 2 alpha kinase 2</td>
</tr>
<tr>
<td align="center" valign="top">SH2D1A</td>
<td align="center" valign="top">1.168984</td>
<td align="center" valign="top">5.76E-05</td>
<td align="center" valign="top">0.001391</td>
<td align="center" valign="top">4.11067</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">SH2 domain containing 1A</td>
</tr>
<tr>
<td align="center" valign="top">ZAP70</td>
<td align="center" valign="top">1.168554</td>
<td align="center" valign="top">1.4E-05</td>
<td align="center" valign="top">0.000463</td>
<td align="center" valign="top">4.455069</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">zeta chain of T cell receptor associated protein kinase 70</td>
</tr>
<tr>
<td align="center" valign="top">TIGIT</td>
<td align="center" valign="top">1.163349</td>
<td align="center" valign="top">1.57E-05</td>
<td align="center" valign="top">0.000501</td>
<td align="center" valign="top">4.428093</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">T cell immunoreceptor with Ig and ITIM domains</td>
</tr>
<tr>
<td align="center" valign="top">RGS1</td>
<td align="center" valign="top">1.163058</td>
<td align="center" valign="top">1.59E-05</td>
<td align="center" valign="top">0.000506</td>
<td align="center" valign="top">4.424014</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">regulator of G protein signaling 1</td>
</tr>
<tr>
<td align="center" valign="top">ZNF683</td>
<td align="center" valign="top">1.160545</td>
<td align="center" valign="top">7.74E-05</td>
<td align="center" valign="top">0.001797</td>
<td align="center" valign="top">4.036373</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">zinc finger protein 683</td>
</tr>
<tr>
<td align="center" valign="top">KIF15</td>
<td align="center" valign="top">1.157673</td>
<td align="center" valign="top">3.77E-06</td>
<td align="center" valign="top">0.000154</td>
<td align="center" valign="top">4.756825</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">kinesin family member 15</td>
</tr>
<tr>
<td align="center" valign="top">PCDH17</td>
<td align="center" valign="top">1.153155</td>
<td align="center" valign="top">3.96E-06</td>
<td align="center" valign="top">0.000161</td>
<td align="center" valign="top">4.74579</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">protocadherin 17</td>
</tr>
<tr>
<td align="center" valign="top">HLA-DRB5</td>
<td align="center" valign="top">1.152815</td>
<td align="center" valign="top">1.24E-06</td>
<td align="center" valign="top">6.03E-05</td>
<td align="center" valign="top">5.001415</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">major histocompatibility complex, class II, DR beta 5</td>
</tr>
<tr>
<td align="center" valign="top">GSDMB</td>
<td align="center" valign="top">1.149462</td>
<td align="center" valign="top">1.79E-11</td>
<td align="center" valign="top">2.9E-09</td>
<td align="center" valign="top">7.131056</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">gasdermin B</td>
</tr>
<tr>
<td align="center" valign="top">UBASH3A</td>
<td align="center" valign="top">1.14733</td>
<td align="center" valign="top">8.6E-06</td>
<td align="center" valign="top">0.000315</td>
<td align="center" valign="top">4.568519</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">ubiquitin associated and SH3 domain containing A</td>
</tr>
<tr>
<td align="center" valign="top">H2AC17</td>
<td align="center" valign="top">1.146451</td>
<td align="center" valign="top">4.91E-07</td>
<td align="center" valign="top">2.75E-05</td>
<td align="center" valign="top">5.200351</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">H2A clustered histone 17</td>
</tr>
<tr>
<td align="center" valign="top">LOC114483834</td>
<td align="center" valign="top">1.145693</td>
<td align="center" valign="top">0.000267</td>
<td align="center" valign="top">0.004444</td>
<td align="center" valign="top">3.711776</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">ABCF2-H2B readthrough</td>
</tr>
<tr>
<td align="center" valign="top">CD244</td>
<td align="center" valign="top">1.143792</td>
<td align="center" valign="top">1.27E-05</td>
<td align="center" valign="top">0.00043</td>
<td align="center" valign="top">4.477359</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">CD244 molecule</td>
</tr>
<tr>
<td align="center" valign="top">RORB</td>
<td align="center" valign="top">1.142761</td>
<td align="center" valign="top">1.04E-07</td>
<td align="center" valign="top">6.98E-06</td>
<td align="center" valign="top">5.520529</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">RAR related orphan receptor B</td>
</tr>
<tr>
<td align="center" valign="top">IGFBP4</td>
<td align="center" valign="top">1.14086</td>
<td align="center" valign="top">2.63E-07</td>
<td align="center" valign="top">1.6E-05</td>
<td align="center" valign="top">5.331239</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">insulin like growth factor binding protein 4</td>
</tr>
<tr>
<td align="center" valign="top">MUSK</td>
<td align="center" valign="top">1.140619</td>
<td align="center" valign="top">0.000245</td>
<td align="center" valign="top">0.004204</td>
<td align="center" valign="top">3.73506</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">muscle associated receptor tyrosine kinase</td>
</tr>
<tr>
<td align="center" valign="top">C1R</td>
<td align="center" valign="top">1.139833</td>
<td align="center" valign="top">1.38E-06</td>
<td align="center" valign="top">6.52E-05</td>
<td align="center" valign="top">4.9784</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">complement C1r</td>
</tr>
<tr>
<td align="center" valign="top">STAP1</td>
<td align="center" valign="top">1.139635</td>
<td align="center" valign="top">1.79E-07</td>
<td align="center" valign="top">1.13E-05</td>
<td align="center" valign="top">5.411085</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">signal transducing adaptor family member 1</td>
</tr>
<tr>
<td align="center" valign="top">KLRC1</td>
<td align="center" valign="top">1.13937</td>
<td align="center" valign="top">1.44E-06</td>
<td align="center" valign="top">6.77E-05</td>
<td align="center" valign="top">4.969682</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">killer cell lectin like receptor C1</td>
</tr>
<tr>
<td align="center" valign="top">CD69</td>
<td align="center" valign="top">1.133738</td>
<td align="center" valign="top">0.000119</td>
<td align="center" valign="top">0.002469</td>
<td align="center" valign="top">3.924855</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">CD69 molecule</td>
</tr>
<tr>
<td align="center" valign="top">PSME2</td>
<td align="center" valign="top">1.133014</td>
<td align="center" valign="top">9.12E-22</td>
<td align="center" valign="top">4.86E-19</td>
<td align="center" valign="top">10.82122</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">proteasome activator subunit 2</td>
</tr>
<tr>
<td align="center" valign="top">PML</td>
<td align="center" valign="top">1.129201</td>
<td align="center" valign="top">3.61E-17</td>
<td align="center" valign="top">1.2E-14</td>
<td align="center" valign="top">9.246657</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">promyelocyticleukemia</td>
</tr>
<tr>
<td align="center" valign="top">SLAMF8</td>
<td align="center" valign="top">1.126474</td>
<td align="center" valign="top">0.000327</td>
<td align="center" valign="top">0.005142</td>
<td align="center" valign="top">3.656317</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">SLAM family member 8</td>
</tr>
<tr>
<td align="center" valign="top">AGR3</td>
<td align="center" valign="top">1.126324</td>
<td align="center" valign="top">8.54E-07</td>
<td align="center" valign="top">4.39E-05</td>
<td align="center" valign="top">5.082692</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">anterior gradient 3, protein disulphide isomerase family member</td>
</tr>
<tr>
<td align="center" valign="top">LKAAEAR1</td>
<td align="center" valign="top">1.126315</td>
<td align="center" valign="top">3.51E-05</td>
<td align="center" valign="top">0.000959</td>
<td align="center" valign="top">4.233504</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">LKAAEAR motif containing 1</td>
</tr>
<tr>
<td align="center" valign="top">SPATS2L</td>
<td align="center" valign="top">1.12537</td>
<td align="center" valign="top">1.62E-19</td>
<td align="center" valign="top">7.19E-17</td>
<td align="center" valign="top">10.06046</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">spermatogenesis associated serine rich 2 like</td>
</tr>
<tr>
<td align="center" valign="top">RIMBP2</td>
<td align="center" valign="top">1.123332</td>
<td align="center" valign="top">0.000218</td>
<td align="center" valign="top">0.00388</td>
<td align="center" valign="top">3.765968</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">RIMS binding protein 2</td>
</tr>
<tr>
<td align="center" valign="top">WARS1</td>
<td align="center" valign="top">1.119747</td>
<td align="center" valign="top">1.65E-11</td>
<td align="center" valign="top">2.72E-09</td>
<td align="center" valign="top">7.145302</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">tryptophanyl-tRNAsynthetase 1</td>
</tr>
<tr>
<td align="center" valign="top">CENPE</td>
<td align="center" valign="top">1.115371</td>
<td align="center" valign="top">4.91E-05</td>
<td align="center" valign="top">0.001244</td>
<td align="center" valign="top">4.150575</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">centromere protein E</td>
</tr>
<tr>
<td align="center" valign="top">HLA-DMA</td>
<td align="center" valign="top">1.114999</td>
<td align="center" valign="top">4.91E-12</td>
<td align="center" valign="top">9.02E-10</td>
<td align="center" valign="top">7.353076</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">major histocompatibility complex, class II, DM alpha</td>
</tr>
<tr>
<td align="center" valign="top">SLC16A1</td>
<td align="center" valign="top">1.113249</td>
<td align="center" valign="top">2.69E-07</td>
<td align="center" valign="top">1.62E-05</td>
<td align="center" valign="top">5.32649</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">solute carrier family 16 member 1</td>
</tr>
<tr>
<td align="center" valign="top">TMEM255A</td>
<td align="center" valign="top">1.111071</td>
<td align="center" valign="top">6.43E-06</td>
<td align="center" valign="top">0.000246</td>
<td align="center" valign="top">4.635496</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">transmembrane protein 255A</td>
</tr>
<tr>
<td align="center" valign="top">TAP1</td>
<td align="center" valign="top">1.111069</td>
<td align="center" valign="top">2.41E-10</td>
<td align="center" valign="top">3.01E-08</td>
<td align="center" valign="top">6.674058</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">transporter 1, ATP binding cassette subfamily B member</td>
</tr>
<tr>
<td align="center" valign="top">H2AC13</td>
<td align="center" valign="top">1.106711</td>
<td align="center" valign="top">2.65E-05</td>
<td align="center" valign="top">0.000771</td>
<td align="center" valign="top">4.302394</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">H2A clustered histone 13</td>
</tr>
<tr>
<td align="center" valign="top">CTLA4</td>
<td align="center" valign="top">1.105201</td>
<td align="center" valign="top">0.000159</td>
<td align="center" valign="top">0.00306</td>
<td align="center" valign="top">3.850854</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">cytotoxic T-lymphocyte associated protein 4</td>
</tr>
<tr>
<td align="center" valign="top">CD38</td>
<td align="center" valign="top">1.102368</td>
<td align="center" valign="top">1.45E-08</td>
<td align="center" valign="top">1.17E-06</td>
<td align="center" valign="top">5.912062</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">CD38 molecule</td>
</tr>
<tr>
<td align="center" valign="top">TLR3</td>
<td align="center" valign="top">1.097491</td>
<td align="center" valign="top">4.84E-11</td>
<td align="center" valign="top">6.84E-09</td>
<td align="center" valign="top">6.958566</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">toll like receptor 3</td>
</tr>
<tr>
<td align="center" valign="top">POSTN</td>
<td align="center" valign="top">1.092424</td>
<td align="center" valign="top">0.001064</td>
<td align="center" valign="top">0.011754</td>
<td align="center" valign="top">3.32165</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">periostin</td>
</tr>
<tr>
<td align="center" valign="top">CX3CL1</td>
<td align="center" valign="top">1.092129</td>
<td align="center" valign="top">4.93E-07</td>
<td align="center" valign="top">2.75E-05</td>
<td align="center" valign="top">5.19956</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">C-X3-C motif chemokine ligand 1</td>
</tr>
<tr>
<td align="center" valign="top">PRH1-PRR4</td>
<td align="center" valign="top">1.091218</td>
<td align="center" valign="top">3.71E-05</td>
<td align="center" valign="top">0.001007</td>
<td align="center" valign="top">4.219694</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">PRH1-PRR4 readthrough</td>
</tr>
<tr>
<td align="center" valign="top">VAMP5</td>
<td align="center" valign="top">1.086383</td>
<td align="center" valign="top">1.91E-08</td>
<td align="center" valign="top">1.53E-06</td>
<td align="center" valign="top">5.857824</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">vesicle associated membrane protein 5</td>
</tr>
<tr>
<td align="center" valign="top">HDX</td>
<td align="center" valign="top">1.085964</td>
<td align="center" valign="top">1.32E-05</td>
<td align="center" valign="top">0.000442</td>
<td align="center" valign="top">4.468047</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">highly divergent homeobox</td>
</tr>
<tr>
<td align="center" valign="top">PLLP</td>
<td align="center" valign="top">1.084269</td>
<td align="center" valign="top">6.06E-06</td>
<td align="center" valign="top">0.000236</td>
<td align="center" valign="top">4.649178</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">plasmolipin</td>
</tr>
<tr>
<td align="center" valign="top">CD247</td>
<td align="center" valign="top">1.083968</td>
<td align="center" valign="top">0.000305</td>
<td align="center" valign="top">0.004877</td>
<td align="center" valign="top">3.675427</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">CD247 molecule</td>
</tr>
<tr>
<td align="center" valign="top">GBP5</td>
<td align="center" valign="top">1.082263</td>
<td align="center" valign="top">0.000139</td>
<td align="center" valign="top">0.002799</td>
<td align="center" valign="top">3.88492</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">guanylate binding protein 5</td>
</tr>
<tr>
<td align="center" valign="top">KLRC4</td>
<td align="center" valign="top">1.076409</td>
<td align="center" valign="top">8.57E-05</td>
<td align="center" valign="top">0.001949</td>
<td align="center" valign="top">4.010218</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">killer cell lectin like receptor C4</td>
</tr>
<tr>
<td align="center" valign="top">MYO7A</td>
<td align="center" valign="top">1.075836</td>
<td align="center" valign="top">0.000133</td>
<td align="center" valign="top">0.002688</td>
<td align="center" valign="top">3.896456</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">myosin VIIA</td>
</tr>
<tr>
<td align="center" valign="top">ENDOD1</td>
<td align="center" valign="top">1.075522</td>
<td align="center" valign="top">5.84E-08</td>
<td align="center" valign="top">4.15E-06</td>
<td align="center" valign="top">5.637511</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">endonuclease domain containing 1</td>
</tr>
<tr>
<td align="center" valign="top">NOS2</td>
<td align="center" valign="top">1.073796</td>
<td align="center" valign="top">0.000104</td>
<td align="center" valign="top">0.002246</td>
<td align="center" valign="top">3.961719</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">nitric oxide synthase 2</td>
</tr>
<tr>
<td align="center" valign="top">MUC19</td>
<td align="center" valign="top">1.071408</td>
<td align="center" valign="top">0.001711</td>
<td align="center" valign="top">0.016404</td>
<td align="center" valign="top">3.179378</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">mucin 19, oligomeric</td>
</tr>
<tr>
<td align="center" valign="top">TMEM187</td>
<td align="center" valign="top">1.070957</td>
<td align="center" valign="top">8.82E-06</td>
<td align="center" valign="top">0.000322</td>
<td align="center" valign="top">4.562525</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">transmembrane protein 187</td>
</tr>
<tr>
<td align="center" valign="top">H2BC7</td>
<td align="center" valign="top">1.06985</td>
<td align="center" valign="top">2.16E-06</td>
<td align="center" valign="top">9.49E-05</td>
<td align="center" valign="top">4.880699</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">H2B clustered histone 7</td>
</tr>
<tr>
<td align="center" valign="top">ASPM</td>
<td align="center" valign="top">1.064392</td>
<td align="center" valign="top">2.43E-05</td>
<td align="center" valign="top">0.000727</td>
<td align="center" valign="top">4.322537</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">abnormal spindle microtubule assembly</td>
</tr>
<tr>
<td align="center" valign="top">DUOXA2</td>
<td align="center" valign="top">1.06383</td>
<td align="center" valign="top">8.26E-06</td>
<td align="center" valign="top">0.000304</td>
<td align="center" valign="top">4.57778</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">dual oxidase maturation factor 2</td>
</tr>
<tr>
<td align="center" valign="top">SFRP1</td>
<td align="center" valign="top">1.060562</td>
<td align="center" valign="top">7.31E-05</td>
<td align="center" valign="top">0.00171</td>
<td align="center" valign="top">4.050696</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">secreted frizzled related protein 1</td>
</tr>
<tr>
<td align="center" valign="top">CDCA7</td>
<td align="center" valign="top">1.059395</td>
<td align="center" valign="top">4.49E-05</td>
<td align="center" valign="top">0.001155</td>
<td align="center" valign="top">4.172964</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">cell division cycle associated 7</td>
</tr>
<tr>
<td align="center" valign="top">HLA-DRB1</td>
<td align="center" valign="top">1.057518</td>
<td align="center" valign="top">2.37E-09</td>
<td align="center" valign="top">2.39E-07</td>
<td align="center" valign="top">6.255374</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">major histocompatibility complex, class II, DR beta 1</td>
</tr>
<tr>
<td align="center" valign="top">DGKI</td>
<td align="center" valign="top">1.055618</td>
<td align="center" valign="top">0.000122</td>
<td align="center" valign="top">0.002509</td>
<td align="center" valign="top">3.919005</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">diacylglycerol kinase iota</td>
</tr>
<tr>
<td align="center" valign="top">ABI3</td>
<td align="center" valign="top">1.055241</td>
<td align="center" valign="top">5.07E-05</td>
<td align="center" valign="top">0.001269</td>
<td align="center" valign="top">4.142891</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">ABI family member 3</td>
</tr>
<tr>
<td align="center" valign="top">SP140</td>
<td align="center" valign="top">1.054482</td>
<td align="center" valign="top">0.00017</td>
<td align="center" valign="top">0.003231</td>
<td align="center" valign="top">3.832679</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">SP140 nuclear body protein</td>
</tr>
<tr>
<td align="center" valign="top">TRANK1</td>
<td align="center" valign="top">1.053793</td>
<td align="center" valign="top">1.37E-08</td>
<td align="center" valign="top">1.12E-06</td>
<td align="center" valign="top">5.921916</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">tetratricopeptide repeat and ankyrin repeat containing 1</td>
</tr>
<tr>
<td align="center" valign="top">AIM2</td>
<td align="center" valign="top">1.052474</td>
<td align="center" valign="top">0.00047</td>
<td align="center" valign="top">0.006662</td>
<td align="center" valign="top">3.55603</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">absent in melanoma 2</td>
</tr>
<tr>
<td align="center" valign="top">CFB</td>
<td align="center" valign="top">1.051696</td>
<td align="center" valign="top">1.41E-12</td>
<td align="center" valign="top">2.79E-10</td>
<td align="center" valign="top">7.562965</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">complement factor B</td>
</tr>
<tr>
<td align="center" valign="top">TLR7</td>
<td align="center" valign="top">1.050929</td>
<td align="center" valign="top">5.06E-06</td>
<td align="center" valign="top">0.0002</td>
<td align="center" valign="top">4.690096</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">toll like receptor 7</td>
</tr>
<tr>
<td align="center" valign="top">MARCHF1</td>
<td align="center" valign="top">1.046483</td>
<td align="center" valign="top">1.44E-06</td>
<td align="center" valign="top">6.77E-05</td>
<td align="center" valign="top">4.969182</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">membrane associated ring-CH-type finger 1</td>
</tr>
<tr>
<td align="center" valign="top">TNFSF13B</td>
<td align="center" valign="top">1.043139</td>
<td align="center" valign="top">9.2E-05</td>
<td align="center" valign="top">0.002047</td>
<td align="center" valign="top">3.992169</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">TNF superfamily member 13b</td>
</tr>
<tr>
<td align="center" valign="top">SLAMF1</td>
<td align="center" valign="top">1.043091</td>
<td align="center" valign="top">0.000778</td>
<td align="center" valign="top">0.009461</td>
<td align="center" valign="top">3.412962</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">signaling lymphocytic activation molecule family member 1</td>
</tr>
<tr>
<td align="center" valign="top">DTX3L</td>
<td align="center" valign="top">1.042672</td>
<td align="center" valign="top">1.16E-17</td>
<td align="center" valign="top">4.01E-15</td>
<td align="center" valign="top">9.420384</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">deltex E3 ubiquitin ligase 3L</td>
</tr>
<tr>
<td align="center" valign="top">BUB1</td>
<td align="center" valign="top">1.042601</td>
<td align="center" valign="top">3.7E-06</td>
<td align="center" valign="top">0.000151</td>
<td align="center" valign="top">4.760713</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">BUB1 mitotic checkpoint serine/threonine kinase</td>
</tr>
<tr>
<td align="center" valign="top">IRF8</td>
<td align="center" valign="top">1.039334</td>
<td align="center" valign="top">0.000142</td>
<td align="center" valign="top">0.00284</td>
<td align="center" valign="top">3.878924</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">interferon regulatory factor 8</td>
</tr>
<tr>
<td align="center" valign="top">PLAAT4</td>
<td align="center" valign="top">1.039212</td>
<td align="center" valign="top">7.38E-12</td>
<td align="center" valign="top">1.3E-09</td>
<td align="center" valign="top">7.283749</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">phospholipase A and acyltransferase 4</td>
</tr>
<tr>
<td align="center" valign="top">H2AC11</td>
<td align="center" valign="top">1.037053</td>
<td align="center" valign="top">1.37E-05</td>
<td align="center" valign="top">0.000456</td>
<td align="center" valign="top">4.459439</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">H2A clustered histone 11</td>
</tr>
<tr>
<td align="center" valign="top">SLAMF7</td>
<td align="center" valign="top">1.0367</td>
<td align="center" valign="top">5.5E-05</td>
<td align="center" valign="top">0.001341</td>
<td align="center" valign="top">4.122384</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">SLAM family member 7</td>
</tr>
<tr>
<td align="center" valign="top">CCR1</td>
<td align="center" valign="top">1.035127</td>
<td align="center" valign="top">0.003333</td>
<td align="center" valign="top">0.02598</td>
<td align="center" valign="top">2.971015</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">C-C motif chemokine receptor 1</td>
</tr>
<tr>
<td align="center" valign="top">CYP19A1</td>
<td align="center" valign="top">1.03203</td>
<td align="center" valign="top">0.000447</td>
<td align="center" valign="top">0.006447</td>
<td align="center" valign="top">3.570182</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">cytochrome P450 family 19 subfamily A member 1</td>
</tr>
<tr>
<td align="center" valign="top">GFI1</td>
<td align="center" valign="top">1.031841</td>
<td align="center" valign="top">2.27E-05</td>
<td align="center" valign="top">0.000686</td>
<td align="center" valign="top">4.339154</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">growth factor independent 1 transcriptional repressor</td>
</tr>
<tr>
<td align="center" valign="top">NUPR1</td>
<td align="center" valign="top">1.03178</td>
<td align="center" valign="top">3.09E-10</td>
<td align="center" valign="top">3.76E-08</td>
<td align="center" valign="top">6.629512</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">nuclear protein 1, transcriptional regulator</td>
</tr>
<tr>
<td align="center" valign="top">UBE2T</td>
<td align="center" valign="top">1.031599</td>
<td align="center" valign="top">8.28E-07</td>
<td align="center" valign="top">4.29E-05</td>
<td align="center" valign="top">5.089484</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">ubiquitin conjugating enzyme E2 T</td>
</tr>
<tr>
<td align="center" valign="top">TPSAB1</td>
<td align="center" valign="top">1.029666</td>
<td align="center" valign="top">0.005271</td>
<td align="center" valign="top">0.035016</td>
<td align="center" valign="top">2.82105</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">tryptase alpha/beta 1</td>
</tr>
<tr>
<td align="center" valign="top">NUSAP1</td>
<td align="center" valign="top">1.027552</td>
<td align="center" valign="top">8.51E-05</td>
<td align="center" valign="top">0.001938</td>
<td align="center" valign="top">4.012021</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">nucleolar and spindle associated protein 1</td>
</tr>
<tr>
<td align="center" valign="top">IL7</td>
<td align="center" valign="top">1.026475</td>
<td align="center" valign="top">1.1E-06</td>
<td align="center" valign="top">5.42E-05</td>
<td align="center" valign="top">5.028224</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">interleukin 7</td>
</tr>
<tr>
<td align="center" valign="top">PERM1</td>
<td align="center" valign="top">1.026132</td>
<td align="center" valign="top">0.000126</td>
<td align="center" valign="top">0.002574</td>
<td align="center" valign="top">3.910663</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">PPARGC1 and ESRR induced regulator, muscle 1</td>
</tr>
<tr>
<td align="center" valign="top">ZBP1</td>
<td align="center" valign="top">1.025941</td>
<td align="center" valign="top">1.81E-05</td>
<td align="center" valign="top">0.000565</td>
<td align="center" valign="top">4.393986</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">Z-DNA binding protein 1</td>
</tr>
<tr>
<td align="center" valign="top">DOK2</td>
<td align="center" valign="top">1.024526</td>
<td align="center" valign="top">0.000311</td>
<td align="center" valign="top">0.004946</td>
<td align="center" valign="top">3.669943</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">docking protein 2</td>
</tr>
<tr>
<td align="center" valign="top">SH2D2A</td>
<td align="center" valign="top">1.022026</td>
<td align="center" valign="top">0.000112</td>
<td align="center" valign="top">0.002369</td>
<td align="center" valign="top">3.94161</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">SH2 domain containing 2A</td>
</tr>
<tr>
<td align="center" valign="top">FCGR3A</td>
<td align="center" valign="top">1.021586</td>
<td align="center" valign="top">0.00031</td>
<td align="center" valign="top">0.004935</td>
<td align="center" valign="top">3.670848</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">Fc fragment of IgG receptor IIIa</td>
</tr>
<tr>
<td align="center" valign="top">BPIFA1</td>
<td align="center" valign="top">1.017903</td>
<td align="center" valign="top">0.004576</td>
<td align="center" valign="top">0.031791</td>
<td align="center" valign="top">2.867945</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">BPI fold containing family A member 1</td>
</tr>
<tr>
<td align="center" valign="top">B4GALT6</td>
<td align="center" valign="top">1.017433</td>
<td align="center" valign="top">9.87E-07</td>
<td align="center" valign="top">4.99E-05</td>
<td align="center" valign="top">5.051571</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">beta-1,4-galactosyltransferase 6</td>
</tr>
<tr>
<td align="center" valign="top">RHEX</td>
<td align="center" valign="top">1.016556</td>
<td align="center" valign="top">1.41E-05</td>
<td align="center" valign="top">0.000465</td>
<td align="center" valign="top">4.452569</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">regulator of hemoglobinization and erythroid cell expansion</td>
</tr>
<tr>
<td align="center" valign="top">TMEM176B</td>
<td align="center" valign="top">1.015269</td>
<td align="center" valign="top">8.81E-05</td>
<td align="center" valign="top">0.001989</td>
<td align="center" valign="top">4.003184</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">transmembrane protein 176B</td>
</tr>
<tr>
<td align="center" valign="top">FAM241B</td>
<td align="center" valign="top">1.014896</td>
<td align="center" valign="top">2.51E-07</td>
<td align="center" valign="top">1.54E-05</td>
<td align="center" valign="top">5.340666</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">family with sequence similarity 241 member B</td>
</tr>
<tr>
<td align="center" valign="top">CD300E</td>
<td align="center" valign="top">1.01489</td>
<td align="center" valign="top">0.002163</td>
<td align="center" valign="top">0.019405</td>
<td align="center" valign="top">3.10745</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">CD300e molecule</td>
</tr>
<tr>
<td align="center" valign="top">MLC1</td>
<td align="center" valign="top">1.012654</td>
<td align="center" valign="top">0.002677</td>
<td align="center" valign="top">0.022462</td>
<td align="center" valign="top">3.040789</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">modulator of VRAC current 1</td>
</tr>
<tr>
<td align="center" valign="top">PSMB8</td>
<td align="center" valign="top">1.010733</td>
<td align="center" valign="top">2.32E-18</td>
<td align="center" valign="top">9.06E-16</td>
<td align="center" valign="top">9.662568</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">proteasome 20S subunit beta 8</td>
</tr>
<tr>
<td align="center" valign="top">H4C11</td>
<td align="center" valign="top">1.009858</td>
<td align="center" valign="top">1.03E-07</td>
<td align="center" valign="top">6.91E-06</td>
<td align="center" valign="top">5.524312</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">H4 clustered histone 11</td>
</tr>
<tr>
<td align="center" valign="top">BCL11B</td>
<td align="center" valign="top">1.009779</td>
<td align="center" valign="top">3.71E-05</td>
<td align="center" valign="top">0.001007</td>
<td align="center" valign="top">4.219823</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">BAF chromatin remodeling complex subunit BCL11B</td>
</tr>
<tr>
<td align="center" valign="top">TAP2</td>
<td align="center" valign="top">1.009615</td>
<td align="center" valign="top">4.6E-08</td>
<td align="center" valign="top">3.34E-06</td>
<td align="center" valign="top">5.685134</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">transporter 2, ATP binding cassette subfamily B member</td>
</tr>
<tr>
<td align="center" valign="top">ZNF311</td>
<td align="center" valign="top">1.008804</td>
<td align="center" valign="top">4E-06</td>
<td align="center" valign="top">0.000162</td>
<td align="center" valign="top">4.743075</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">zinc finger protein 311</td>
</tr>
<tr>
<td align="center" valign="top">TEDC2</td>
<td align="center" valign="top">1.00586</td>
<td align="center" valign="top">4.21E-05</td>
<td align="center" valign="top">0.0011</td>
<td align="center" valign="top">4.188573</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">tubulin epsilon and delta complex 2</td>
</tr>
<tr>
<td align="center" valign="top">BATF3</td>
<td align="center" valign="top">1.005358</td>
<td align="center" valign="top">0.000141</td>
<td align="center" valign="top">0.002828</td>
<td align="center" valign="top">3.88105</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">basic leucine zipper ATF-like transcription factor 3</td>
</tr>
<tr>
<td align="center" valign="top">CD48</td>
<td align="center" valign="top">1.001842</td>
<td align="center" valign="top">0.000649</td>
<td align="center" valign="top">0.008317</td>
<td align="center" valign="top">3.465044</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">CD48 molecule</td>
</tr>
<tr>
<td align="center" valign="top">UBQLN3</td>
<td align="center" valign="top">1.000697</td>
<td align="center" valign="top">3.92E-05</td>
<td align="center" valign="top">0.001048</td>
<td align="center" valign="top">4.206225</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">ubiquilin 3</td>
</tr>
<tr>
<td align="center" valign="top">CYP2C18</td>
<td align="center" valign="top">0.999334</td>
<td align="center" valign="top">1.85E-05</td>
<td align="center" valign="top">0.000572</td>
<td align="center" valign="top">4.388811</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">cytochrome P450 family 2 subfamily C member 18</td>
</tr>
<tr>
<td align="center" valign="top">SYT13</td>
<td align="center" valign="top">0.996966</td>
<td align="center" valign="top">3.78E-05</td>
<td align="center" valign="top">0.00102</td>
<td align="center" valign="top">4.215291</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">synaptotagmin 13</td>
</tr>
<tr>
<td align="center" valign="top">APOD</td>
<td align="center" valign="top">0.995956</td>
<td align="center" valign="top">4.16E-05</td>
<td align="center" valign="top">0.001089</td>
<td align="center" valign="top">4.191974</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">apolipoprotein D</td>
</tr>
<tr>
<td align="center" valign="top">BCL2L14</td>
<td align="center" valign="top">0.993597</td>
<td align="center" valign="top">3.63E-08</td>
<td align="center" valign="top">2.71E-06</td>
<td align="center" valign="top">5.731854</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">BCL2 like 14</td>
</tr>
<tr>
<td align="center" valign="top">MX2</td>
<td align="center" valign="top">0.992711</td>
<td align="center" valign="top">1.16E-06</td>
<td align="center" valign="top">5.71E-05</td>
<td align="center" valign="top">5.015852</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">MX dynamin like GTPase 2</td>
</tr>
<tr>
<td align="center" valign="top">GIMAP1</td>
<td align="center" valign="top">0.991907</td>
<td align="center" valign="top">1.82E-05</td>
<td align="center" valign="top">0.000566</td>
<td align="center" valign="top">4.392546</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">GTPase, IMAP family member 1</td>
</tr>
<tr>
<td align="center" valign="top">PYHIN1</td>
<td align="center" valign="top">0.99186</td>
<td align="center" valign="top">7.96E-06</td>
<td align="center" valign="top">0.000297</td>
<td align="center" valign="top">4.586198</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">pyrin and HIN domain family member 1</td>
</tr>
<tr>
<td align="center" valign="top">PROX1</td>
<td align="center" valign="top">0.990926</td>
<td align="center" valign="top">0.00025</td>
<td align="center" valign="top">0.004258</td>
<td align="center" valign="top">3.729761</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">prosperohomeobox 1</td>
</tr>
<tr>
<td align="center" valign="top">MB21D2</td>
<td align="center" valign="top">0.990392</td>
<td align="center" valign="top">2.73E-05</td>
<td align="center" valign="top">0.000786</td>
<td align="center" valign="top">4.295117</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">Mab-21 domain containing 2</td>
</tr>
<tr>
<td align="center" valign="top">CCDC103</td>
<td align="center" valign="top">0.990158</td>
<td align="center" valign="top">0.000268</td>
<td align="center" valign="top">0.00445</td>
<td align="center" valign="top">3.711104</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">coiled-coil domain containing 103</td>
</tr>
<tr>
<td align="center" valign="top">SERPINI1</td>
<td align="center" valign="top">0.988812</td>
<td align="center" valign="top">1.32E-05</td>
<td align="center" valign="top">0.000441</td>
<td align="center" valign="top">4.468814</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">serpin family I member 1</td>
</tr>
<tr>
<td align="center" valign="top">ZNF367</td>
<td align="center" valign="top">0.988292</td>
<td align="center" valign="top">1.06E-05</td>
<td align="center" valign="top">0.00037</td>
<td align="center" valign="top">4.520874</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">zinc finger protein 367</td>
</tr>
<tr>
<td align="center" valign="top">APOL1</td>
<td align="center" valign="top">0.986536</td>
<td align="center" valign="top">1.92E-11</td>
<td align="center" valign="top">3.01E-09</td>
<td align="center" valign="top">7.119218</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">apolipoprotein L1</td>
</tr>
<tr>
<td align="center" valign="top">H2BC10</td>
<td align="center" valign="top">0.984986</td>
<td align="center" valign="top">2.82E-05</td>
<td align="center" valign="top">0.000804</td>
<td align="center" valign="top">4.28716</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">H2B clustered histone 10</td>
</tr>
<tr>
<td align="center" valign="top">CLCNKB</td>
<td align="center" valign="top">0.984494</td>
<td align="center" valign="top">0.000549</td>
<td align="center" valign="top">0.007433</td>
<td align="center" valign="top">3.512335</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">chloride voltage-gated channel Kb</td>
</tr>
<tr>
<td align="center" valign="top">KCNA2</td>
<td align="center" valign="top">0.980876</td>
<td align="center" valign="top">5.09E-05</td>
<td align="center" valign="top">0.001269</td>
<td align="center" valign="top">4.141694</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">potassium voltage-gated channel subfamily A member 2</td>
</tr>
<tr>
<td align="center" valign="top">GBP4</td>
<td align="center" valign="top">0.976728</td>
<td align="center" valign="top">4.36E-10</td>
<td align="center" valign="top">5.09E-08</td>
<td align="center" valign="top">6.566822</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">guanylate binding protein 4</td>
</tr>
<tr>
<td align="center" valign="top">H4C6</td>
<td align="center" valign="top">0.976582</td>
<td align="center" valign="top">6.79E-05</td>
<td align="center" valign="top">0.001613</td>
<td align="center" valign="top">4.069274</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">H4 clustered histone 6</td>
</tr>
<tr>
<td align="center" valign="top">CD40LG</td>
<td align="center" valign="top">0.975434</td>
<td align="center" valign="top">5.67E-05</td>
<td align="center" valign="top">0.001378</td>
<td align="center" valign="top">4.114519</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">CD40 ligand</td>
</tr>
<tr>
<td align="center" valign="top">BACH2</td>
<td align="center" valign="top">0.975149</td>
<td align="center" valign="top">0.000753</td>
<td align="center" valign="top">0.009288</td>
<td align="center" valign="top">3.422335</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">BTB domain and CNC homolog 2</td>
</tr>
<tr>
<td align="center" valign="top">SP110</td>
<td align="center" valign="top">0.974814</td>
<td align="center" valign="top">1.15E-08</td>
<td align="center" valign="top">9.48E-07</td>
<td align="center" valign="top">5.956979</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">SP110 nuclear body protein</td>
</tr>
<tr>
<td align="center" valign="top">CD226</td>
<td align="center" valign="top">0.972552</td>
<td align="center" valign="top">1.9E-06</td>
<td align="center" valign="top">8.48E-05</td>
<td align="center" valign="top">4.909144</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">CD226 molecule</td>
</tr>
<tr>
<td align="center" valign="top">CXCL12</td>
<td align="center" valign="top">0.971945</td>
<td align="center" valign="top">0.000816</td>
<td align="center" valign="top">0.009774</td>
<td align="center" valign="top">3.39927</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">C-X-C motif chemokine ligand 12</td>
</tr>
<tr>
<td align="center" valign="top">TNFRSF13B</td>
<td align="center" valign="top">0.971733</td>
<td align="center" valign="top">0.000201</td>
<td align="center" valign="top">0.003651</td>
<td align="center" valign="top">3.788497</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">TNF receptor superfamily member 13B</td>
</tr>
<tr>
<td align="center" valign="top">DPP10</td>
<td align="center" valign="top">0.971373</td>
<td align="center" valign="top">1.55E-05</td>
<td align="center" valign="top">0.0005</td>
<td align="center" valign="top">4.4298</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">dipeptidyl peptidase like 10</td>
</tr>
<tr>
<td align="center" valign="top">STAT2</td>
<td align="center" valign="top">0.970844</td>
<td align="center" valign="top">4.31E-14</td>
<td align="center" valign="top">9.58E-12</td>
<td align="center" valign="top">8.136094</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">signal transducer and activator of transcription 2</td>
</tr>
<tr>
<td align="center" valign="top">ANKRD20A2</td>
<td align="center" valign="top">0.969825</td>
<td align="center" valign="top">0.000131</td>
<td align="center" valign="top">0.002661</td>
<td align="center" valign="top">3.900363</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">ankyrin repeat domain 20 family member A2</td>
</tr>
<tr>
<td align="center" valign="top">CD72</td>
<td align="center" valign="top">0.968515</td>
<td align="center" valign="top">1.87E-05</td>
<td align="center" valign="top">0.000577</td>
<td align="center" valign="top">4.386396</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">CD72 molecule</td>
</tr>
<tr>
<td align="center" valign="top">CFH</td>
<td align="center" valign="top">0.96751</td>
<td align="center" valign="top">6.39E-10</td>
<td align="center" valign="top">7.14E-08</td>
<td align="center" valign="top">6.497561</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">complement factor H</td>
</tr>
<tr>
<td align="center" valign="top">MCUB</td>
<td align="center" valign="top">0.967317</td>
<td align="center" valign="top">8.06E-07</td>
<td align="center" valign="top">4.2E-05</td>
<td align="center" valign="top">5.09509</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">mitochondrial calcium uniporter dominant negative beta subunit</td>
</tr>
<tr>
<td align="center" valign="top">TGM2</td>
<td align="center" valign="top">0.967147</td>
<td align="center" valign="top">6.73E-10</td>
<td align="center" valign="top">7.47E-08</td>
<td align="center" valign="top">6.487992</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">transglutaminase 2</td>
</tr>
<tr>
<td align="center" valign="top">WASF1</td>
<td align="center" valign="top">0.965169</td>
<td align="center" valign="top">2.71E-05</td>
<td align="center" valign="top">0.000785</td>
<td align="center" valign="top">4.296437</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">WASP family member 1</td>
</tr>
<tr>
<td align="center" valign="top">H2BC13</td>
<td align="center" valign="top">0.964089</td>
<td align="center" valign="top">0.000358</td>
<td align="center" valign="top">0.005474</td>
<td align="center" valign="top">3.631719</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">H2B clustered histone 13</td>
</tr>
<tr>
<td align="center" valign="top">CRTAM</td>
<td align="center" valign="top">0.963133</td>
<td align="center" valign="top">2.74E-05</td>
<td align="center" valign="top">0.000786</td>
<td align="center" valign="top">4.293927</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">cytotoxic and regulatory T cell molecule</td>
</tr>
<tr>
<td align="center" valign="top">CASQ2</td>
<td align="center" valign="top">0.961354</td>
<td align="center" valign="top">0.004203</td>
<td align="center" valign="top">0.03005</td>
<td align="center" valign="top">2.895852</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">calsequestrin 2</td>
</tr>
<tr>
<td align="center" valign="top">RARRES2</td>
<td align="center" valign="top">0.957694</td>
<td align="center" valign="top">5.9E-05</td>
<td align="center" valign="top">0.001415</td>
<td align="center" valign="top">4.104914</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">retinoic acid receptor responder 2</td>
</tr>
<tr>
<td align="center" valign="top">GNLY</td>
<td align="center" valign="top">0.957639</td>
<td align="center" valign="top">0.000431</td>
<td align="center" valign="top">0.006248</td>
<td align="center" valign="top">3.58068</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">granulysin</td>
</tr>
<tr>
<td align="center" valign="top">DUS4L-BCAP29</td>
<td align="center" valign="top">0.957304</td>
<td align="center" valign="top">0.002552</td>
<td align="center" valign="top">0.021804</td>
<td align="center" valign="top">3.055816</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">DUS4L-BCAP29 readthrough</td>
</tr>
<tr>
<td align="center" valign="top">RNASE6</td>
<td align="center" valign="top">0.955791</td>
<td align="center" valign="top">3.25E-05</td>
<td align="center" valign="top">0.000899</td>
<td align="center" valign="top">4.252596</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">ribonuclease A family member k6</td>
</tr>
<tr>
<td align="center" valign="top">CDC7</td>
<td align="center" valign="top">0.954561</td>
<td align="center" valign="top">1.3E-05</td>
<td align="center" valign="top">0.000437</td>
<td align="center" valign="top">4.47147</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">cell division cycle 7</td>
</tr>
<tr>
<td align="center" valign="top">CD52</td>
<td align="center" valign="top">0.953347</td>
<td align="center" valign="top">0.000691</td>
<td align="center" valign="top">0.008705</td>
<td align="center" valign="top">3.447229</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">CD52 molecule</td>
</tr>
<tr>
<td align="center" valign="top">GNGT2</td>
<td align="center" valign="top">0.952694</td>
<td align="center" valign="top">0.000341</td>
<td align="center" valign="top">0.005283</td>
<td align="center" valign="top">3.644913</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">G protein subunit gamma transducin 2</td>
</tr>
<tr>
<td align="center" valign="top">GRIK1</td>
<td align="center" valign="top">0.95212</td>
<td align="center" valign="top">0.000148</td>
<td align="center" valign="top">0.002922</td>
<td align="center" valign="top">3.868572</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">glutamate ionotropic receptor kainate type subunit 1</td>
</tr>
<tr>
<td align="center" valign="top">CARD11</td>
<td align="center" valign="top">0.951886</td>
<td align="center" valign="top">2.12E-06</td>
<td align="center" valign="top">9.33E-05</td>
<td align="center" valign="top">4.884984</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">caspase recruitment domain family member 11</td>
</tr>
<tr>
<td align="center" valign="top">COL4A3</td>
<td align="center" valign="top">0.951406</td>
<td align="center" valign="top">0.0028</td>
<td align="center" valign="top">0.023088</td>
<td align="center" valign="top">3.02652</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">collagen type IV alpha 3 chain</td>
</tr>
<tr>
<td align="center" valign="top">H3C13</td>
<td align="center" valign="top">0.949323</td>
<td align="center" valign="top">4.38E-05</td>
<td align="center" valign="top">0.001135</td>
<td align="center" valign="top">4.17917</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">H3 clustered histone 13</td>
</tr>
<tr>
<td align="center" valign="top">C7orf25</td>
<td align="center" valign="top">0.948401</td>
<td align="center" valign="top">0.000263</td>
<td align="center" valign="top">0.004394</td>
<td align="center" valign="top">3.715987</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">chromosome 7 open reading frame 25</td>
</tr>
<tr>
<td align="center" valign="top">IL15RA</td>
<td align="center" valign="top">0.948202</td>
<td align="center" valign="top">1.98E-06</td>
<td align="center" valign="top">8.82E-05</td>
<td align="center" valign="top">4.89982</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">interleukin 15 receptor subunit alpha</td>
</tr>
<tr>
<td align="center" valign="top">FXYD6</td>
<td align="center" valign="top">0.947726</td>
<td align="center" valign="top">2.27E-05</td>
<td align="center" valign="top">0.000686</td>
<td align="center" valign="top">4.339392</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">FXYD domain containing ion transport regulator 6</td>
</tr>
<tr>
<td align="center" valign="top">CPLX2</td>
<td align="center" valign="top">0.947697</td>
<td align="center" valign="top">0.001468</td>
<td align="center" valign="top">0.014604</td>
<td align="center" valign="top">3.225895</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">complexin 2</td>
</tr>
<tr>
<td align="center" valign="top">C1orf54</td>
<td align="center" valign="top">0.944952</td>
<td align="center" valign="top">2.42E-05</td>
<td align="center" valign="top">0.000723</td>
<td align="center" valign="top">4.324384</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">chromosome 1 open reading frame 54</td>
</tr>
<tr>
<td align="center" valign="top">SLFN5</td>
<td align="center" valign="top">0.944853</td>
<td align="center" valign="top">1.2E-13</td>
<td align="center" valign="top">2.59E-11</td>
<td align="center" valign="top">7.97021</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">schlafen family member 5</td>
</tr>
<tr>
<td align="center" valign="top">FYN</td>
<td align="center" valign="top">0.944334</td>
<td align="center" valign="top">8.2E-06</td>
<td align="center" valign="top">0.000302</td>
<td align="center" valign="top">4.579549</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">FYN proto-oncogene, Src family tyrosine kinase</td>
</tr>
<tr>
<td align="center" valign="top">RASGRF2</td>
<td align="center" valign="top">0.941455</td>
<td align="center" valign="top">4.05E-05</td>
<td align="center" valign="top">0.001074</td>
<td align="center" valign="top">4.198131</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">Ras protein specific guanine nucleotide releasing factor 2</td>
</tr>
<tr>
<td align="center" valign="top">IL32</td>
<td align="center" valign="top">0.939257</td>
<td align="center" valign="top">5.89E-05</td>
<td align="center" valign="top">0.001414</td>
<td align="center" valign="top">4.105383</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">interleukin 32</td>
</tr>
<tr>
<td align="center" valign="top">HASPIN</td>
<td align="center" valign="top">0.93806</td>
<td align="center" valign="top">0.000507</td>
<td align="center" valign="top">0.007088</td>
<td align="center" valign="top">3.534909</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">histone H3 associated protein kinase</td>
</tr>
<tr>
<td align="center" valign="top">HELZ2</td>
<td align="center" valign="top">0.938057</td>
<td align="center" valign="top">1.59E-07</td>
<td align="center" valign="top">1.02E-05</td>
<td align="center" valign="top">5.434373</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">helicase with zinc finger 2</td>
</tr>
<tr>
<td align="center" valign="top">RYR1</td>
<td align="center" valign="top">0.936541</td>
<td align="center" valign="top">0.003676</td>
<td align="center" valign="top">0.027722</td>
<td align="center" valign="top">2.939435</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">ryanodine receptor 1</td>
</tr>
<tr>
<td align="center" valign="top">MS4A7</td>
<td align="center" valign="top">0.936077</td>
<td align="center" valign="top">6.43E-07</td>
<td align="center" valign="top">3.46E-05</td>
<td align="center" valign="top">5.143377</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">membrane spanning 4-domains A7</td>
</tr>
<tr>
<td align="center" valign="top">TUBA8</td>
<td align="center" valign="top">0.935841</td>
<td align="center" valign="top">5.7E-05</td>
<td align="center" valign="top">0.001382</td>
<td align="center" valign="top">4.113383</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">tubulin alpha 8</td>
</tr>
<tr>
<td align="center" valign="top">PLEK2</td>
<td align="center" valign="top">0.935841</td>
<td align="center" valign="top">1.94E-07</td>
<td align="center" valign="top">1.22E-05</td>
<td align="center" valign="top">5.393574</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">pleckstrin 2</td>
</tr>
<tr>
<td align="center" valign="top">BUB1B</td>
<td align="center" valign="top">0.935804</td>
<td align="center" valign="top">0.000405</td>
<td align="center" valign="top">0.005974</td>
<td align="center" valign="top">3.597412</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">BUB1 mitotic checkpoint serine/threonine kinase B</td>
</tr>
<tr>
<td align="center" valign="top">PAK1IP1</td>
<td align="center" valign="top">0.935039</td>
<td align="center" valign="top">1.73E-06</td>
<td align="center" valign="top">7.83E-05</td>
<td align="center" valign="top">4.930142</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">PAK1 interacting protein 1</td>
</tr>
<tr>
<td align="center" valign="top">ADGRB2</td>
<td align="center" valign="top">0.933954</td>
<td align="center" valign="top">3.88E-05</td>
<td align="center" valign="top">0.001042</td>
<td align="center" valign="top">4.208588</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">adhesion G protein-coupled receptor B2</td>
</tr>
<tr>
<td align="center" valign="top">H2BC6</td>
<td align="center" valign="top">0.931813</td>
<td align="center" valign="top">2.85E-06</td>
<td align="center" valign="top">0.000122</td>
<td align="center" valign="top">4.819691</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">H2B clustered histone 6</td>
</tr>
<tr>
<td align="center" valign="top">ZSCAN23</td>
<td align="center" valign="top">0.929206</td>
<td align="center" valign="top">0.001098</td>
<td align="center" valign="top">0.012004</td>
<td align="center" valign="top">3.312596</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">zinc finger and SCAN domain containing 23</td>
</tr>
<tr>
<td align="center" valign="top">PBDC1</td>
<td align="center" valign="top">0.928296</td>
<td align="center" valign="top">7.26E-09</td>
<td align="center" valign="top">6.44E-07</td>
<td align="center" valign="top">6.044436</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">polysaccharide biosynthesis domain containing 1</td>
</tr>
<tr>
<td align="center" valign="top">SHISA8</td>
<td align="center" valign="top">0.928111</td>
<td align="center" valign="top">0.000183</td>
<td align="center" valign="top">0.003407</td>
<td align="center" valign="top">3.813359</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">shisa family member 8</td>
</tr>
<tr>
<td align="center" valign="top">SLC12A3</td>
<td align="center" valign="top">0.928031</td>
<td align="center" valign="top">0.000215</td>
<td align="center" valign="top">0.003837</td>
<td align="center" valign="top">3.769814</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">solute carrier family 12 member 3</td>
</tr>
<tr>
<td align="center" valign="top">NLRC5</td>
<td align="center" valign="top">0.927988</td>
<td align="center" valign="top">1.08E-07</td>
<td align="center" valign="top">7.18E-06</td>
<td align="center" valign="top">5.514151</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">NLR family CARD domain containing 5</td>
</tr>
<tr>
<td align="center" valign="top">CDCA2</td>
<td align="center" valign="top">0.927654</td>
<td align="center" valign="top">0.000292</td>
<td align="center" valign="top">0.004716</td>
<td align="center" valign="top">3.687852</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">cell division cycle associated 2</td>
</tr>
<tr>
<td align="center" valign="top">H2AC7</td>
<td align="center" valign="top">0.926416</td>
<td align="center" valign="top">0.000186</td>
<td align="center" valign="top">0.003441</td>
<td align="center" valign="top">3.808835</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">H2A clustered histone 7</td>
</tr>
<tr>
<td align="center" valign="top">TREX1</td>
<td align="center" valign="top">0.926046</td>
<td align="center" valign="top">4.23E-10</td>
<td align="center" valign="top">4.98E-08</td>
<td align="center" valign="top">6.572283</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">three prime repair exonuclease 1</td>
</tr>
<tr>
<td align="center" valign="top">PDE1C</td>
<td align="center" valign="top">0.925174</td>
<td align="center" valign="top">0.000443</td>
<td align="center" valign="top">0.006402</td>
<td align="center" valign="top">3.57285</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">phosphodiesterase 1C</td>
</tr>
<tr>
<td align="center" valign="top">TIMP4</td>
<td align="center" valign="top">0.924467</td>
<td align="center" valign="top">0.000108</td>
<td align="center" valign="top">0.002308</td>
<td align="center" valign="top">3.950523</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">TIMP metallopeptidase inhibitor 4</td>
</tr>
<tr>
<td align="center" valign="top">MAP10</td>
<td align="center" valign="top">0.924329</td>
<td align="center" valign="top">2.73E-05</td>
<td align="center" valign="top">0.000786</td>
<td align="center" valign="top">4.294699</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">microtubule associated protein 10</td>
</tr>
<tr>
<td align="center" valign="top">ESR1</td>
<td align="center" valign="top">0.921366</td>
<td align="center" valign="top">0.00205</td>
<td align="center" valign="top">0.018726</td>
<td align="center" valign="top">3.123955</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">estrogen receptor 1</td>
</tr>
<tr>
<td align="center" valign="top">GPC4</td>
<td align="center" valign="top">0.920969</td>
<td align="center" valign="top">1.39E-05</td>
<td align="center" valign="top">0.000462</td>
<td align="center" valign="top">4.456212</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">glypican 4</td>
</tr>
<tr>
<td align="center" valign="top">ENPP2</td>
<td align="center" valign="top">0.920702</td>
<td align="center" valign="top">5.75E-05</td>
<td align="center" valign="top">0.001389</td>
<td align="center" valign="top">4.111422</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">ectonucleotidepyrophosphatase/phosphodiesterase 2</td>
</tr>
<tr>
<td align="center" valign="top">FGD2</td>
<td align="center" valign="top">0.920517</td>
<td align="center" valign="top">1.89E-06</td>
<td align="center" valign="top">8.47E-05</td>
<td align="center" valign="top">4.909976</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">FYVE, RhoGEF and PH domain containing 2</td>
</tr>
<tr>
<td align="center" valign="top">RAMP1</td>
<td align="center" valign="top">0.919355</td>
<td align="center" valign="top">0.000273</td>
<td align="center" valign="top">0.004508</td>
<td align="center" valign="top">3.70592</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">receptor activity modifying protein 1</td>
</tr>
<tr>
<td align="center" valign="top">GAL3ST4</td>
<td align="center" valign="top">0.919244</td>
<td align="center" valign="top">1.13E-05</td>
<td align="center" valign="top">0.000391</td>
<td align="center" valign="top">4.504813</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">galactose-3-O-sulfotransferase 4</td>
</tr>
<tr>
<td align="center" valign="top">SLC26A1</td>
<td align="center" valign="top">0.918847</td>
<td align="center" valign="top">0.003472</td>
<td align="center" valign="top">0.026659</td>
<td align="center" valign="top">2.957844</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">solute carrier family 26 member 1</td>
</tr>
<tr>
<td align="center" valign="top">GOLGA8Q</td>
<td align="center" valign="top">0.917389</td>
<td align="center" valign="top">0.000119</td>
<td align="center" valign="top">0.002463</td>
<td align="center" valign="top">3.925848</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">golgin A8 family member Q</td>
</tr>
<tr>
<td align="center" valign="top">MTNR1A</td>
<td align="center" valign="top">0.916886</td>
<td align="center" valign="top">0.000501</td>
<td align="center" valign="top">0.007012</td>
<td align="center" valign="top">3.538459</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">melatonin receptor 1A</td>
</tr>
<tr>
<td align="center" valign="top">H2AC20</td>
<td align="center" valign="top">0.91586</td>
<td align="center" valign="top">8.43E-10</td>
<td align="center" valign="top">8.98E-08</td>
<td align="center" valign="top">6.446779</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">H2A clustered histone 20</td>
</tr>
<tr>
<td align="center" valign="top">TMEM42</td>
<td align="center" valign="top">0.914646</td>
<td align="center" valign="top">0.000104</td>
<td align="center" valign="top">0.002249</td>
<td align="center" valign="top">3.961002</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">transmembrane protein 42</td>
</tr>
<tr>
<td align="center" valign="top">FBXO6</td>
<td align="center" valign="top">0.914172</td>
<td align="center" valign="top">3.33E-10</td>
<td align="center" valign="top">4E-08</td>
<td align="center" valign="top">6.615821</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">F-box protein 6</td>
</tr>
<tr>
<td align="center" valign="top">ACY3</td>
<td align="center" valign="top">0.913938</td>
<td align="center" valign="top">0.000108</td>
<td align="center" valign="top">0.002308</td>
<td align="center" valign="top">3.950726</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">aminoacylase 3</td>
</tr>
<tr>
<td align="center" valign="top">TOX</td>
<td align="center" valign="top">0.91385</td>
<td align="center" valign="top">0.000877</td>
<td align="center" valign="top">0.010286</td>
<td align="center" valign="top">3.378409</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">thymocyte selection associated high mobility group box</td>
</tr>
<tr>
<td align="center" valign="top">ZNF682</td>
<td align="center" valign="top">0.913427</td>
<td align="center" valign="top">2.07E-05</td>
<td align="center" valign="top">0.000635</td>
<td align="center" valign="top">4.361432</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">zinc finger protein 682</td>
</tr>
<tr>
<td align="center" valign="top">SIT1</td>
<td align="center" valign="top">0.913282</td>
<td align="center" valign="top">0.000936</td>
<td align="center" valign="top">0.010749</td>
<td align="center" valign="top">3.359276</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">signaling threshold regulating transmembrane adaptor 1</td>
</tr>
<tr>
<td align="center" valign="top">STAT4</td>
<td align="center" valign="top">0.91098</td>
<td align="center" valign="top">0.000472</td>
<td align="center" valign="top">0.006686</td>
<td align="center" valign="top">3.554792</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">signal transducer and activator of transcription 4</td>
</tr>
<tr>
<td align="center" valign="top">CD96</td>
<td align="center" valign="top">0.910756</td>
<td align="center" valign="top">9.02E-05</td>
<td align="center" valign="top">0.002012</td>
<td align="center" valign="top">3.997339</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">CD96 molecule</td>
</tr>
<tr>
<td align="center" valign="top">PPM1K</td>
<td align="center" valign="top">0.909529</td>
<td align="center" valign="top">1.61E-15</td>
<td align="center" valign="top">4.07E-13</td>
<td align="center" valign="top">8.659512</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">protein phosphatase, Mg2+/Mn2+ dependent 1K</td>
</tr>
<tr>
<td align="center" valign="top">STAMBPL1</td>
<td align="center" valign="top">0.909026</td>
<td align="center" valign="top">2.22E-05</td>
<td align="center" valign="top">0.000675</td>
<td align="center" valign="top">4.34438</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">STAM binding protein like 1</td>
</tr>
<tr>
<td align="center" valign="top">PET117</td>
<td align="center" valign="top">0.907766</td>
<td align="center" valign="top">2.19E-05</td>
<td align="center" valign="top">0.000668</td>
<td align="center" valign="top">4.34745</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">PET117 cytochrome c oxidase chaperone</td>
</tr>
<tr>
<td align="center" valign="top">RNASE1</td>
<td align="center" valign="top">0.906595</td>
<td align="center" valign="top">0.00051</td>
<td align="center" valign="top">0.007099</td>
<td align="center" valign="top">3.533442</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">ribonuclease A family member 1, pancreatic</td>
</tr>
<tr>
<td align="center" valign="top">IRS1</td>
<td align="center" valign="top">0.906406</td>
<td align="center" valign="top">2.12E-06</td>
<td align="center" valign="top">9.33E-05</td>
<td align="center" valign="top">4.885291</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">insulin receptor substrate 1</td>
</tr>
<tr>
<td align="center" valign="top">CH25H</td>
<td align="center" valign="top">0.906185</td>
<td align="center" valign="top">0.000379</td>
<td align="center" valign="top">0.005724</td>
<td align="center" valign="top">3.615754</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">cholesterol 25-hydroxylase</td>
</tr>
<tr>
<td align="center" valign="top">SEC16B</td>
<td align="center" valign="top">0.905825</td>
<td align="center" valign="top">1.09E-05</td>
<td align="center" valign="top">0.000379</td>
<td align="center" valign="top">4.512972</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">SEC16 homolog B, endoplasmic reticulum export factor</td>
</tr>
<tr>
<td align="center" valign="top">CD33</td>
<td align="center" valign="top">0.905786</td>
<td align="center" valign="top">0.000285</td>
<td align="center" valign="top">0.00464</td>
<td align="center" valign="top">3.694461</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">CD33 molecule</td>
</tr>
<tr>
<td align="center" valign="top">EXOC3L4</td>
<td align="center" valign="top">0.905027</td>
<td align="center" valign="top">0.000219</td>
<td align="center" valign="top">0.003888</td>
<td align="center" valign="top">3.764555</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">exocyst complex component 3 like 4</td>
</tr>
<tr>
<td align="center" valign="top">LGALS9</td>
<td align="center" valign="top">0.904739</td>
<td align="center" valign="top">1.58E-16</td>
<td align="center" valign="top">4.5E-14</td>
<td align="center" valign="top">9.020451</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">galectin 9</td>
</tr>
<tr>
<td align="center" valign="top">TMSB10</td>
<td align="center" valign="top">0.903894</td>
<td align="center" valign="top">2.44E-11</td>
<td align="center" valign="top">3.68E-09</td>
<td align="center" valign="top">7.077674</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">thymosin beta 10</td>
</tr>
<tr>
<td align="center" valign="top">CD74</td>
<td align="center" valign="top">0.902704</td>
<td align="center" valign="top">5.16E-10</td>
<td align="center" valign="top">5.84E-08</td>
<td align="center" valign="top">6.536563</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">CD74 molecule</td>
</tr>
<tr>
<td align="center" valign="top">TACR1</td>
<td align="center" valign="top">0.902382</td>
<td align="center" valign="top">0.001704</td>
<td align="center" valign="top">0.016385</td>
<td align="center" valign="top">3.180656</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">tachykinin receptor 1</td>
</tr>
<tr>
<td align="center" valign="top">KIF5C</td>
<td align="center" valign="top">0.901762</td>
<td align="center" valign="top">0.000353</td>
<td align="center" valign="top">0.005431</td>
<td align="center" valign="top">3.635467</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">kinesin family member 5C</td>
</tr>
<tr>
<td align="center" valign="top">APOL2</td>
<td align="center" valign="top">0.900875</td>
<td align="center" valign="top">1.39E-08</td>
<td align="center" valign="top">1.13E-06</td>
<td align="center" valign="top">5.9197</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">apolipoprotein L2</td>
</tr>
<tr>
<td align="center" valign="top">APOC1</td>
<td align="center" valign="top">0.900681</td>
<td align="center" valign="top">0.001169</td>
<td align="center" valign="top">0.012487</td>
<td align="center" valign="top">3.293952</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">apolipoprotein C1</td>
</tr>
<tr>
<td align="center" valign="top">TGM3</td>
<td align="center" valign="top">-1.47834</td>
<td align="center" valign="top">0.000646</td>
<td align="center" valign="top">0.008303</td>
<td align="center" valign="top">-3.46619</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">transglutaminase 3</td>
</tr>
<tr>
<td align="center" valign="top">SCGB3A1</td>
<td align="center" valign="top">-1.36843</td>
<td align="center" valign="top">9.64E-05</td>
<td align="center" valign="top">0.002119</td>
<td align="center" valign="top">-3.98021</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">secretoglobin family 3A member 1</td>
</tr>
<tr>
<td align="center" valign="top">IL1R2</td>
<td align="center" valign="top">-1.2965</td>
<td align="center" valign="top">0.007366</td>
<td align="center" valign="top">0.04433</td>
<td align="center" valign="top">-2.70757</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">interleukin 1 receptor type 2</td>
</tr>
<tr>
<td align="center" valign="top">KLF15</td>
<td align="center" valign="top">-1.20548</td>
<td align="center" valign="top">0.000549</td>
<td align="center" valign="top">0.007433</td>
<td align="center" valign="top">-3.51242</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">Kruppel like factor 15</td>
</tr>
<tr>
<td align="center" valign="top">FOSB</td>
<td align="center" valign="top">-1.19521</td>
<td align="center" valign="top">4.11E-05</td>
<td align="center" valign="top">0.001083</td>
<td align="center" valign="top">-4.1945</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">FosB proto-oncogene, AP-1 transcription factor subunit</td>
</tr>
<tr>
<td align="center" valign="top">CD207</td>
<td align="center" valign="top">-1.15391</td>
<td align="center" valign="top">0.000515</td>
<td align="center" valign="top">0.007122</td>
<td align="center" valign="top">-3.53075</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">CD207 molecule</td>
</tr>
<tr>
<td align="center" valign="top">TULP2</td>
<td align="center" valign="top">-1.15196</td>
<td align="center" valign="top">0.00269</td>
<td align="center" valign="top">0.022504</td>
<td align="center" valign="top">-3.0392</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">TUB like protein 2</td>
</tr>
<tr>
<td align="center" valign="top">RGPD2</td>
<td align="center" valign="top">-1.07807</td>
<td align="center" valign="top">0.004861</td>
<td align="center" valign="top">0.033294</td>
<td align="center" valign="top">-2.84797</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">RANBP2 like and GRIP domain containing 2</td>
</tr>
<tr>
<td align="center" valign="top">SPRR3</td>
<td align="center" valign="top">-1.07407</td>
<td align="center" valign="top">0.003937</td>
<td align="center" valign="top">0.028932</td>
<td align="center" valign="top">-2.91721</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">small proline rich protein 3</td>
</tr>
<tr>
<td align="center" valign="top">PDGFRB</td>
<td align="center" valign="top">-1.07186</td>
<td align="center" valign="top">0.001018</td>
<td align="center" valign="top">0.011372</td>
<td align="center" valign="top">-3.33464</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">platelet derived growth factor receptor beta</td>
</tr>
<tr>
<td align="center" valign="top">CXCL8</td>
<td align="center" valign="top">-1.06707</td>
<td align="center" valign="top">0.003106</td>
<td align="center" valign="top">0.024817</td>
<td align="center" valign="top">-2.99357</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">C-X-C motif chemokine ligand 8</td>
</tr>
<tr>
<td align="center" valign="top">MUC7</td>
<td align="center" valign="top">-1.055</td>
<td align="center" valign="top">0.005844</td>
<td align="center" valign="top">0.037514</td>
<td align="center" valign="top">-2.78645</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">mucin 7, secreted</td>
</tr>
<tr>
<td align="center" valign="top">BEST1</td>
<td align="center" valign="top">-1.04013</td>
<td align="center" valign="top">0.002215</td>
<td align="center" valign="top">0.019712</td>
<td align="center" valign="top">-3.10003</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">bestrophin 1</td>
</tr>
<tr>
<td align="center" valign="top">CAMK1G</td>
<td align="center" valign="top">-1.03532</td>
<td align="center" valign="top">0.004051</td>
<td align="center" valign="top">0.029425</td>
<td align="center" valign="top">-2.90789</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">calcium/calmodulin dependent protein kinase IG</td>
</tr>
<tr>
<td align="center" valign="top">SRSF12</td>
<td align="center" valign="top">-1.01792</td>
<td align="center" valign="top">0.002864</td>
<td align="center" valign="top">0.023443</td>
<td align="center" valign="top">-3.0194</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">serine and arginine rich splicing factor 12</td>
</tr>
<tr>
<td align="center" valign="top">KRT13</td>
<td align="center" valign="top">-1.00058</td>
<td align="center" valign="top">0.005628</td>
<td align="center" valign="top">0.03665</td>
<td align="center" valign="top">-2.7991</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">keratin 13</td>
</tr>
<tr>
<td align="center" valign="top">KLF2</td>
<td align="center" valign="top">-0.98914</td>
<td align="center" valign="top">2.29E-08</td>
<td align="center" valign="top">1.82E-06</td>
<td align="center" valign="top">-5.82208</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">Kruppel like factor 2</td>
</tr>
<tr>
<td align="center" valign="top">PADI2</td>
<td align="center" valign="top">-0.97338</td>
<td align="center" valign="top">0.0009</td>
<td align="center" valign="top">0.01046</td>
<td align="center" valign="top">-3.37077</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">peptidyl arginine deiminase 2</td>
</tr>
<tr>
<td align="center" valign="top">DGAT2</td>
<td align="center" valign="top">-0.93702</td>
<td align="center" valign="top">0.005999</td>
<td align="center" valign="top">0.038269</td>
<td align="center" valign="top">-2.77758</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">diacylglycerol O-acyltransferase 2</td>
</tr>
<tr>
<td align="center" valign="top">THBD</td>
<td align="center" valign="top">-0.93625</td>
<td align="center" valign="top">0.003057</td>
<td align="center" valign="top">0.024538</td>
<td align="center" valign="top">-2.99861</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">thrombomodulin</td>
</tr>
<tr>
<td align="center" valign="top">FOS</td>
<td align="center" valign="top">-0.89665</td>
<td align="center" valign="top">0.001294</td>
<td align="center" valign="top">0.013392</td>
<td align="center" valign="top">-3.26371</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">Fos proto-oncogene, AP-1 transcription factor subunit</td>
</tr>
<tr>
<td align="center" valign="top">ADM</td>
<td align="center" valign="top">-0.87386</td>
<td align="center" valign="top">0.002488</td>
<td align="center" valign="top">0.021365</td>
<td align="center" valign="top">-3.06371</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">adrenomedullin</td>
</tr>
<tr>
<td align="center" valign="top">C17orf107</td>
<td align="center" valign="top">-0.86984</td>
<td align="center" valign="top">0.004991</td>
<td align="center" valign="top">0.033833</td>
<td align="center" valign="top">-2.83924</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">chromosome 17 open reading frame 107</td>
</tr>
<tr>
<td align="center" valign="top">MUC21</td>
<td align="center" valign="top">-0.85619</td>
<td align="center" valign="top">0.002935</td>
<td align="center" valign="top">0.023868</td>
<td align="center" valign="top">-3.01161</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">mucin 21, cell surface associated</td>
</tr>
<tr>
<td align="center" valign="top">HBEGF</td>
<td align="center" valign="top">-0.85044</td>
<td align="center" valign="top">0.002272</td>
<td align="center" valign="top">0.020037</td>
<td align="center" valign="top">-3.0921</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">heparin binding EGF like growth factor</td>
</tr>
<tr>
<td align="center" valign="top">DCUN1D3</td>
<td align="center" valign="top">-0.83153</td>
<td align="center" valign="top">5.2E-05</td>
<td align="center" valign="top">0.001291</td>
<td align="center" valign="top">-4.13616</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">defective in cullinneddylation 1 domain containing 3</td>
</tr>
<tr>
<td align="center" valign="top">ATP8</td>
<td align="center" valign="top">-0.83079</td>
<td align="center" valign="top">7.05E-05</td>
<td align="center" valign="top">0.001661</td>
<td align="center" valign="top">-4.05996</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">ATP synthase F0 subunit 8</td>
</tr>
<tr>
<td align="center" valign="top">STATH</td>
<td align="center" valign="top">-0.81643</td>
<td align="center" valign="top">0.006636</td>
<td align="center" valign="top">0.041179</td>
<td align="center" valign="top">-2.74335</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">statherin</td>
</tr>
<tr>
<td align="center" valign="top">BTBD19</td>
<td align="center" valign="top">-0.81195</td>
<td align="center" valign="top">0.00112</td>
<td align="center" valign="top">0.012161</td>
<td align="center" valign="top">-3.3067</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">BTB domain containing 19</td>
</tr>
<tr>
<td align="center" valign="top">KLF7</td>
<td align="center" valign="top">-0.81111</td>
<td align="center" valign="top">1.55E-05</td>
<td align="center" valign="top">0.000499</td>
<td align="center" valign="top">-4.43075</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">Kruppel like factor 7</td>
</tr>
<tr>
<td align="center" valign="top">DSC2</td>
<td align="center" valign="top">-0.79948</td>
<td align="center" valign="top">0.000114</td>
<td align="center" valign="top">0.002392</td>
<td align="center" valign="top">-3.9371</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">desmocollin 2</td>
</tr>
<tr>
<td align="center" valign="top">ICAM3</td>
<td align="center" valign="top">-0.79631</td>
<td align="center" valign="top">0.000294</td>
<td align="center" valign="top">0.00474</td>
<td align="center" valign="top">-3.68565</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">intercellular adhesion molecule 3</td>
</tr>
<tr>
<td align="center" valign="top">DUSP1</td>
<td align="center" valign="top">-0.79617</td>
<td align="center" valign="top">4.07E-05</td>
<td align="center" valign="top">0.001076</td>
<td align="center" valign="top">-4.19696</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">dual specificity phosphatase 1</td>
</tr>
<tr>
<td align="center" valign="top">LOXHD1</td>
<td align="center" valign="top">-0.79464</td>
<td align="center" valign="top">0.007319</td>
<td align="center" valign="top">0.044242</td>
<td align="center" valign="top">-2.70977</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">lipoxygenase homology domains 1</td>
</tr>
<tr>
<td align="center" valign="top">FTH1</td>
<td align="center" valign="top">-0.79153</td>
<td align="center" valign="top">8.32E-09</td>
<td align="center" valign="top">7.23E-07</td>
<td align="center" valign="top">-6.01825</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">ferritin heavy chain 1</td>
</tr>
<tr>
<td align="center" valign="top">PNRC1</td>
<td align="center" valign="top">-0.78805</td>
<td align="center" valign="top">3.64E-09</td>
<td align="center" valign="top">3.46E-07</td>
<td align="center" valign="top">-6.17547</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">proline rich nuclear receptor coactivator 1</td>
</tr>
<tr>
<td align="center" valign="top">NAMPT</td>
<td align="center" valign="top">-0.78417</td>
<td align="center" valign="top">0.005423</td>
<td align="center" valign="top">0.035674</td>
<td align="center" valign="top">-2.81155</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">nicotinamidephosphoribosyltransferase</td>
</tr>
<tr>
<td align="center" valign="top">IL1R1</td>
<td align="center" valign="top">-0.78387</td>
<td align="center" valign="top">8.07E-06</td>
<td align="center" valign="top">0.0003</td>
<td align="center" valign="top">-4.58321</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">interleukin 1 receptor type 1</td>
</tr>
<tr>
<td align="center" valign="top">EGR1</td>
<td align="center" valign="top">-0.78372</td>
<td align="center" valign="top">0.000884</td>
<td align="center" valign="top">0.010347</td>
<td align="center" valign="top">-3.37586</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">early growth response 1</td>
</tr>
<tr>
<td align="center" valign="top">TREML2</td>
<td align="center" valign="top">-0.76808</td>
<td align="center" valign="top">0.008381</td>
<td align="center" valign="top">0.048314</td>
<td align="center" valign="top">-2.66284</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">triggering receptor expressed on myeloid cells like 2</td>
</tr>
<tr>
<td align="center" valign="top">ADRB3</td>
<td align="center" valign="top">-0.76534</td>
<td align="center" valign="top">0.001114</td>
<td align="center" valign="top">0.012113</td>
<td align="center" valign="top">-3.30832</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">adrenoceptor beta 3</td>
</tr>
<tr>
<td align="center" valign="top">ALPL</td>
<td align="center" valign="top">-0.76002</td>
<td align="center" valign="top">0.000591</td>
<td align="center" valign="top">0.007804</td>
<td align="center" valign="top">-3.49159</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">alkaline phosphatase, biomineralization associated</td>
</tr>
<tr>
<td align="center" valign="top">AMPD2</td>
<td align="center" valign="top">-0.75693</td>
<td align="center" valign="top">0.000279</td>
<td align="center" valign="top">0.004578</td>
<td align="center" valign="top">-3.69953</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">adenosine monophosphate deaminase 2</td>
</tr>
<tr>
<td align="center" valign="top">FCER1A</td>
<td align="center" valign="top">-0.75615</td>
<td align="center" valign="top">0.008706</td>
<td align="center" valign="top">0.049511</td>
<td align="center" valign="top">-2.64956</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">Fc fragment of IgE receptor Ia</td>
</tr>
<tr>
<td align="center" valign="top">ARHGEF40</td>
<td align="center" valign="top">-0.74698</td>
<td align="center" valign="top">0.000164</td>
<td align="center" valign="top">0.003152</td>
<td align="center" valign="top">-3.84141</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">Rho guanine nucleotide exchange factor 40</td>
</tr>
<tr>
<td align="center" valign="top">ZFP36</td>
<td align="center" valign="top">-0.73956</td>
<td align="center" valign="top">0.00066</td>
<td align="center" valign="top">0.008423</td>
<td align="center" valign="top">-3.46029</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">ZFP36 ring finger protein</td>
</tr>
<tr>
<td align="center" valign="top">EGR3</td>
<td align="center" valign="top">-0.73321</td>
<td align="center" valign="top">0.008221</td>
<td align="center" valign="top">0.047609</td>
<td align="center" valign="top">-2.66957</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">early growth response 3</td>
</tr>
<tr>
<td align="center" valign="top">BTG2</td>
<td align="center" valign="top">-0.73249</td>
<td align="center" valign="top">0.000255</td>
<td align="center" valign="top">0.004312</td>
<td align="center" valign="top">-3.7242</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">BTG anti-proliferation factor 2</td>
</tr>
<tr>
<td align="center" valign="top">ZSWIM4</td>
<td align="center" valign="top">-0.73012</td>
<td align="center" valign="top">3.02E-06</td>
<td align="center" valign="top">0.000128</td>
<td align="center" valign="top">-4.80662</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">zinc finger SWIM-type containing 4</td>
</tr>
<tr>
<td align="center" valign="top">SEC14L6</td>
<td align="center" valign="top">-0.72167</td>
<td align="center" valign="top">0.000339</td>
<td align="center" valign="top">0.005271</td>
<td align="center" valign="top">-3.6463</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">SEC14 like lipid binding 6</td>
</tr>
<tr>
<td align="center" valign="top">OR2B11</td>
<td align="center" valign="top">-0.72005</td>
<td align="center" valign="top">0.005408</td>
<td align="center" valign="top">0.035648</td>
<td align="center" valign="top">-2.81247</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">olfactory receptor family 2 subfamily B member 11</td>
</tr>
<tr>
<td align="center" valign="top">TMEM71</td>
<td align="center" valign="top">-0.71806</td>
<td align="center" valign="top">0.003467</td>
<td align="center" valign="top">0.026644</td>
<td align="center" valign="top">-2.95839</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">transmembrane protein 71</td>
</tr>
<tr>
<td align="center" valign="top">C5AR2</td>
<td align="center" valign="top">-0.71584</td>
<td align="center" valign="top">0.000961</td>
<td align="center" valign="top">0.010963</td>
<td align="center" valign="top">-3.35151</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">complement component 5a receptor 2</td>
</tr>
<tr>
<td align="center" valign="top">FOSL2</td>
<td align="center" valign="top">-0.71292</td>
<td align="center" valign="top">1.91E-05</td>
<td align="center" valign="top">0.00059</td>
<td align="center" valign="top">-4.38054</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">FOS like 2, AP-1 transcription factor subunit</td>
</tr>
<tr>
<td align="center" valign="top">IER3</td>
<td align="center" valign="top">-0.71147</td>
<td align="center" valign="top">3.81E-05</td>
<td align="center" valign="top">0.001027</td>
<td align="center" valign="top">-4.21335</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">immediate early response 3</td>
</tr>
<tr>
<td align="center" valign="top">ANPEP</td>
<td align="center" valign="top">-0.70961</td>
<td align="center" valign="top">4.8E-05</td>
<td align="center" valign="top">0.001224</td>
<td align="center" valign="top">-4.1561</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">alanylaminopeptidase, membrane</td>
</tr>
<tr>
<td align="center" valign="top">ZNF219</td>
<td align="center" valign="top">-0.70613</td>
<td align="center" valign="top">4.82E-06</td>
<td align="center" valign="top">0.000191</td>
<td align="center" valign="top">-4.70116</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">zinc finger protein 219</td>
</tr>
<tr>
<td align="center" valign="top">CASS4</td>
<td align="center" valign="top">-0.70362</td>
<td align="center" valign="top">0.003212</td>
<td align="center" valign="top">0.025338</td>
<td align="center" valign="top">-2.98288</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">Cas scaffold protein family member 4</td>
</tr>
<tr>
<td align="center" valign="top">NCCRP1</td>
<td align="center" valign="top">-0.70258</td>
<td align="center" valign="top">0.004876</td>
<td align="center" valign="top">0.033336</td>
<td align="center" valign="top">-2.84698</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">NCCRP1, F-box associated domain containing</td>
</tr>
<tr>
<td align="center" valign="top">TRIB1</td>
<td align="center" valign="top">-0.70221</td>
<td align="center" valign="top">0.001394</td>
<td align="center" valign="top">0.014121</td>
<td align="center" valign="top">-3.24149</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">tribblespseudokinase 1</td>
</tr>
<tr>
<td align="center" valign="top">PLEKHG2</td>
<td align="center" valign="top">-0.69201</td>
<td align="center" valign="top">0.002074</td>
<td align="center" valign="top">0.018849</td>
<td align="center" valign="top">-3.12036</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">pleckstrin homology and RhoGEF domain containing G2</td>
</tr>
<tr>
<td align="center" valign="top">GK3P</td>
<td align="center" valign="top">-0.69041</td>
<td align="center" valign="top">0.005238</td>
<td align="center" valign="top">0.034877</td>
<td align="center" valign="top">-2.82311</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">glycerol kinase 3 pseudogene</td>
</tr>
<tr>
<td align="center" valign="top">PFKFB3</td>
<td align="center" valign="top">-0.68222</td>
<td align="center" valign="top">0.008618</td>
<td align="center" valign="top">0.049214</td>
<td align="center" valign="top">-2.65313</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3</td>
</tr>
<tr>
<td align="center" valign="top">LYPD3</td>
<td align="center" valign="top">-0.66375</td>
<td align="center" valign="top">0.005074</td>
<td align="center" valign="top">0.034126</td>
<td align="center" valign="top">-2.83371</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">LY6/PLAUR domain containing 3</td>
</tr>
<tr>
<td align="center" valign="top">PYGL</td>
<td align="center" valign="top">-0.66104</td>
<td align="center" valign="top">3.2E-07</td>
<td align="center" valign="top">1.91E-05</td>
<td align="center" valign="top">-5.29031</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">glycogen phosphorylase L</td>
</tr>
<tr>
<td align="center" valign="top">SCN2A</td>
<td align="center" valign="top">-0.65842</td>
<td align="center" valign="top">0.002758</td>
<td align="center" valign="top">0.022886</td>
<td align="center" valign="top">-3.03127</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">sodium voltage-gated channel alpha subunit 2</td>
</tr>
<tr>
<td align="center" valign="top">A2ML1</td>
<td align="center" valign="top">-0.65205</td>
<td align="center" valign="top">0.008659</td>
<td align="center" valign="top">0.049346</td>
<td align="center" valign="top">-2.65144</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">alpha-2-macroglobulin like 1</td>
</tr>
<tr>
<td align="center" valign="top">LITAF</td>
<td align="center" valign="top">-0.64871</td>
<td align="center" valign="top">0.001169</td>
<td align="center" valign="top">0.012487</td>
<td align="center" valign="top">-3.29393</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">lipopolysaccharide induced TNF factor</td>
</tr>
<tr>
<td align="center" valign="top">ABHD5</td>
<td align="center" valign="top">-0.64294</td>
<td align="center" valign="top">6.84E-06</td>
<td align="center" valign="top">0.00026</td>
<td align="center" valign="top">-4.62127</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">abhydrolase domain containing 5</td>
</tr>
<tr>
<td align="center" valign="top">TSC22D3</td>
<td align="center" valign="top">-0.63973</td>
<td align="center" valign="top">2.59E-06</td>
<td align="center" valign="top">0.000112</td>
<td align="center" valign="top">-4.8405</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">TSC22 domain family member 3</td>
</tr>
<tr>
<td align="center" valign="top">KREMEN1</td>
<td align="center" valign="top">-0.63687</td>
<td align="center" valign="top">5.49E-05</td>
<td align="center" valign="top">0.001341</td>
<td align="center" valign="top">-4.1227</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">kringle containing transmembrane protein 1</td>
</tr>
<tr>
<td align="center" valign="top">NEDD9</td>
<td align="center" valign="top">-0.63269</td>
<td align="center" valign="top">0.00293</td>
<td align="center" valign="top">0.023838</td>
<td align="center" valign="top">-3.01216</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">neural precursor cell expressed, developmentally down-regulated 9</td>
</tr>
<tr>
<td align="center" valign="top">ZNF442</td>
<td align="center" valign="top">-0.63162</td>
<td align="center" valign="top">0.00247</td>
<td align="center" valign="top">0.021275</td>
<td align="center" valign="top">-3.06605</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">zinc finger protein 442</td>
</tr>
<tr>
<td align="center" valign="top">C5AR1</td>
<td align="center" valign="top">-0.63159</td>
<td align="center" valign="top">0.000449</td>
<td align="center" valign="top">0.006465</td>
<td align="center" valign="top">-3.56895</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">complement C5a receptor 1</td>
</tr>
<tr>
<td align="center" valign="top">JUNB</td>
<td align="center" valign="top">-0.62547</td>
<td align="center" valign="top">0.00411</td>
<td align="center" valign="top">0.02962</td>
<td align="center" valign="top">-2.90321</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">JunB proto-oncogene, AP-1 transcription factor subunit</td>
</tr>
<tr>
<td align="center" valign="top">CTDSP1</td>
<td align="center" valign="top">-0.62535</td>
<td align="center" valign="top">0.000231</td>
<td align="center" valign="top">0.004041</td>
<td align="center" valign="top">-3.7512</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">CTD small phosphatase 1</td>
</tr>
<tr>
<td align="center" valign="top">IFRD1</td>
<td align="center" valign="top">-0.61939</td>
<td align="center" valign="top">0.006351</td>
<td align="center" valign="top">0.039861</td>
<td align="center" valign="top">-2.75827</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">interferon related developmental regulator 1</td>
</tr>
<tr>
<td align="center" valign="top">GPR85</td>
<td align="center" valign="top">-0.61483</td>
<td align="center" valign="top">0.004632</td>
<td align="center" valign="top">0.032097</td>
<td align="center" valign="top">-2.86393</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">G protein-coupled receptor 85</td>
</tr>
<tr>
<td align="center" valign="top">GYS1</td>
<td align="center" valign="top">-0.61203</td>
<td align="center" valign="top">0.003398</td>
<td align="center" valign="top">0.026318</td>
<td align="center" valign="top">-2.96483</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">glycogen synthase 1</td>
</tr>
<tr>
<td align="center" valign="top">NDRG1</td>
<td align="center" valign="top">-0.60552</td>
<td align="center" valign="top">0.000261</td>
<td align="center" valign="top">0.004375</td>
<td align="center" valign="top">-3.71795</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">N-myc downstream regulated 1</td>
</tr>
<tr>
<td align="center" valign="top">SOD2</td>
<td align="center" valign="top">-0.6012</td>
<td align="center" valign="top">0.007303</td>
<td align="center" valign="top">0.044236</td>
<td align="center" valign="top">-2.71055</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">superoxide dismutase 2</td>
</tr>
<tr>
<td align="center" valign="top">ABTB1</td>
<td align="center" valign="top">-0.60117</td>
<td align="center" valign="top">0.000526</td>
<td align="center" valign="top">0.007201</td>
<td align="center" valign="top">-3.52478</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">ankyrin repeat and BTB domain containing 1</td>
</tr>
<tr>
<td align="center" valign="top">DENND5A</td>
<td align="center" valign="top">-0.59892</td>
<td align="center" valign="top">0.003162</td>
<td align="center" valign="top">0.025098</td>
<td align="center" valign="top">-2.98791</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">DENN domain containing 5A</td>
</tr>
<tr>
<td align="center" valign="top">ARRB2</td>
<td align="center" valign="top">-0.59646</td>
<td align="center" valign="top">0.002132</td>
<td align="center" valign="top">0.01921</td>
<td align="center" valign="top">-3.11193</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">arrestin beta 2</td>
</tr>
<tr>
<td align="center" valign="top">OXSR1</td>
<td align="center" valign="top">-0.59472</td>
<td align="center" valign="top">0.000116</td>
<td align="center" valign="top">0.002423</td>
<td align="center" valign="top">-3.93181</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">oxidative stress responsive kinase 1</td>
</tr>
<tr>
<td align="center" valign="top">ATG9B</td>
<td align="center" valign="top">-0.5935</td>
<td align="center" valign="top">0.000582</td>
<td align="center" valign="top">0.007714</td>
<td align="center" valign="top">-3.49615</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">autophagy related 9B</td>
</tr>
<tr>
<td align="center" valign="top">SLC25A37</td>
<td align="center" valign="top">-0.58982</td>
<td align="center" valign="top">0.008419</td>
<td align="center" valign="top">0.048459</td>
<td align="center" valign="top">-2.66129</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">solute carrier family 25 member 37</td>
</tr>
<tr>
<td align="center" valign="top">UPP1</td>
<td align="center" valign="top">-0.58603</td>
<td align="center" valign="top">0.004169</td>
<td align="center" valign="top">0.02991</td>
<td align="center" valign="top">-2.89856</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">uridinephosphorylase 1</td>
</tr>
<tr>
<td align="center" valign="top">NR4A1</td>
<td align="center" valign="top">-0.58478</td>
<td align="center" valign="top">0.001571</td>
<td align="center" valign="top">0.0154</td>
<td align="center" valign="top">-3.20538</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">nuclear receptor subfamily 4 group A member 1</td>
</tr>
<tr>
<td align="center" valign="top">GPCPD1</td>
<td align="center" valign="top">-0.5831</td>
<td align="center" valign="top">0.000793</td>
<td align="center" valign="top">0.009574</td>
<td align="center" valign="top">-3.40763</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">glycerophosphocholinephosphodiesterase 1</td>
</tr>
<tr>
<td align="center" valign="top">LAMB3</td>
<td align="center" valign="top">-0.5818</td>
<td align="center" valign="top">0.004963</td>
<td align="center" valign="top">0.033719</td>
<td align="center" valign="top">-2.84107</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">laminin subunit beta 3</td>
</tr>
<tr>
<td align="center" valign="top">IVNS1ABP</td>
<td align="center" valign="top">-0.58168</td>
<td align="center" valign="top">0.002567</td>
<td align="center" valign="top">0.021899</td>
<td align="center" valign="top">-3.05395</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">influenza virus NS1A binding protein</td>
</tr>
<tr>
<td align="center" valign="top">IMPDH1</td>
<td align="center" valign="top">-0.58013</td>
<td align="center" valign="top">6.18E-06</td>
<td align="center" valign="top">0.000239</td>
<td align="center" valign="top">-4.64451</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">inosine monophosphate dehydrogenase 1</td>
</tr>
<tr>
<td align="center" valign="top">METRNL</td>
<td align="center" valign="top">-0.57826</td>
<td align="center" valign="top">0.00137</td>
<td align="center" valign="top">0.013939</td>
<td align="center" valign="top">-3.24672</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">meteorin like, glial cell differentiation regulator</td>
</tr>
<tr>
<td align="center" valign="top">TCN1</td>
<td align="center" valign="top">-0.57779</td>
<td align="center" valign="top">0.006792</td>
<td align="center" valign="top">0.041813</td>
<td align="center" valign="top">-2.73543</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">transcobalamin 1</td>
</tr>
<tr>
<td align="center" valign="top">PLEKHG6</td>
<td align="center" valign="top">-0.57288</td>
<td align="center" valign="top">0.001999</td>
<td align="center" valign="top">0.018352</td>
<td align="center" valign="top">-3.13171</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">pleckstrin homology and RhoGEF domain containing G6</td>
</tr>
<tr>
<td align="center" valign="top">BCL6</td>
<td align="center" valign="top">-0.57252</td>
<td align="center" valign="top">0.000547</td>
<td align="center" valign="top">0.007418</td>
<td align="center" valign="top">-3.51374</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">BCL6 transcription repressor</td>
</tr>
<tr>
<td align="center" valign="top">IL6R</td>
<td align="center" valign="top">-0.57246</td>
<td align="center" valign="top">0.000611</td>
<td align="center" valign="top">0.007963</td>
<td align="center" valign="top">-3.48244</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">interleukin 6 receptor</td>
</tr>
<tr>
<td align="center" valign="top">ATP2B1</td>
<td align="center" valign="top">-0.5717</td>
<td align="center" valign="top">0.001263</td>
<td align="center" valign="top">0.013194</td>
<td align="center" valign="top">-3.27087</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">ATPase plasma membrane Ca2+ transporting 1</td>
</tr>
<tr>
<td align="center" valign="top">CD44</td>
<td align="center" valign="top">-0.5714</td>
<td align="center" valign="top">0.004209</td>
<td align="center" valign="top">0.030058</td>
<td align="center" valign="top">-2.89537</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">CD44 molecule (Indian blood group)</td>
</tr>
<tr>
<td align="center" valign="top">KLLN</td>
<td align="center" valign="top">-0.56584</td>
<td align="center" valign="top">0.000684</td>
<td align="center" valign="top">0.008631</td>
<td align="center" valign="top">-3.4499</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">killin, p53 regulated DNA replication inhibitor</td>
</tr>
<tr>
<td align="center" valign="top">PHLDA1</td>
<td align="center" valign="top">-0.56267</td>
<td align="center" valign="top">0.001149</td>
<td align="center" valign="top">0.012344</td>
<td align="center" valign="top">-3.29893</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">pleckstrin homology like domain family A member 1</td>
</tr>
<tr>
<td align="center" valign="top">COL6A3</td>
<td align="center" valign="top">-0.56185</td>
<td align="center" valign="top">0.006948</td>
<td align="center" valign="top">0.042489</td>
<td align="center" valign="top">-2.72764</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">collagen type VI alpha 3 chain</td>
</tr>
<tr>
<td align="center" valign="top">TLE3</td>
<td align="center" valign="top">-0.55702</td>
<td align="center" valign="top">0.001969</td>
<td align="center" valign="top">0.018212</td>
<td align="center" valign="top">-3.13635</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">TLE family member 3, transcriptional corepressor</td>
</tr>
<tr>
<td align="center" valign="top">PPIF</td>
<td align="center" valign="top">-0.55572</td>
<td align="center" valign="top">0.004779</td>
<td align="center" valign="top">0.032882</td>
<td align="center" valign="top">-2.85362</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">peptidylprolylisomerase F</td>
</tr>
<tr>
<td align="center" valign="top">MAP2K3</td>
<td align="center" valign="top">-0.55394</td>
<td align="center" valign="top">0.000259</td>
<td align="center" valign="top">0.004355</td>
<td align="center" valign="top">-3.71976</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">mitogen-activated protein kinase kinase 3</td>
</tr>
<tr>
<td align="center" valign="top">GAB2</td>
<td align="center" valign="top">-0.5507</td>
<td align="center" valign="top">0.006989</td>
<td align="center" valign="top">0.042671</td>
<td align="center" valign="top">-2.72565</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">GRB2 associated binding protein 2</td>
</tr>
<tr>
<td align="center" valign="top">NDEL1</td>
<td align="center" valign="top">-0.54893</td>
<td align="center" valign="top">0.001085</td>
<td align="center" valign="top">0.011929</td>
<td align="center" valign="top">-3.31587</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">nudE neurodevelopment protein 1 like 1</td>
</tr>
<tr>
<td align="center" valign="top">OPA3</td>
<td align="center" valign="top">-0.54683</td>
<td align="center" valign="top">4.36E-05</td>
<td align="center" valign="top">0.001134</td>
<td align="center" valign="top">-4.18028</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">outer mitochondrial membrane lipid metabolism regulator OPA3</td>
</tr>
<tr>
<td align="center" valign="top">JOSD1</td>
<td align="center" valign="top">-0.54542</td>
<td align="center" valign="top">0.0011</td>
<td align="center" valign="top">0.012027</td>
<td align="center" valign="top">-3.31182</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">Josephin domain containing 1</td>
</tr>
<tr>
<td align="center" valign="top">PLB1</td>
<td align="center" valign="top">-0.54522</td>
<td align="center" valign="top">0.005709</td>
<td align="center" valign="top">0.036981</td>
<td align="center" valign="top">-2.79427</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">phospholipase B1</td>
</tr>
<tr>
<td align="center" valign="top">REPS2</td>
<td align="center" valign="top">-0.54355</td>
<td align="center" valign="top">1.35E-05</td>
<td align="center" valign="top">0.000451</td>
<td align="center" valign="top">-4.46299</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">RALBP1 associated Eps domain containing 2</td>
</tr>
<tr>
<td align="center" valign="top">TNFRSF10D</td>
<td align="center" valign="top">-0.54115</td>
<td align="center" valign="top">0.007126</td>
<td align="center" valign="top">0.04333</td>
<td align="center" valign="top">-2.71899</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">TNF receptor superfamily member 10d</td>
</tr>
<tr>
<td align="center" valign="top">NFKBIA</td>
<td align="center" valign="top">-0.54054</td>
<td align="center" valign="top">0.007014</td>
<td align="center" valign="top">0.042809</td>
<td align="center" valign="top">-2.72442</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">NFKB inhibitor alpha</td>
</tr>
<tr>
<td align="center" valign="top">PI3</td>
<td align="center" valign="top">-0.53928</td>
<td align="center" valign="top">0.001287</td>
<td align="center" valign="top">0.013352</td>
<td align="center" valign="top">-3.26536</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">peptidase inhibitor 3</td>
</tr>
<tr>
<td align="center" valign="top">OR2L2</td>
<td align="center" valign="top">-0.5338</td>
<td align="center" valign="top">0.008356</td>
<td align="center" valign="top">0.048213</td>
<td align="center" valign="top">-2.6639</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">olfactory receptor family 2 subfamily L member 2</td>
</tr>
<tr>
<td align="center" valign="top">GSTO2</td>
<td align="center" valign="top">-0.53008</td>
<td align="center" valign="top">0.00374</td>
<td align="center" valign="top">0.027951</td>
<td align="center" valign="top">-2.93388</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">glutathione S-transferase omega 2</td>
</tr>
<tr>
<td align="center" valign="top">ST3GAL4</td>
<td align="center" valign="top">-0.52905</td>
<td align="center" valign="top">0.003713</td>
<td align="center" valign="top">0.027827</td>
<td align="center" valign="top">-2.93621</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">ST3 beta-galactoside alpha-2,3-sialyltransferase 4</td>
</tr>
<tr>
<td align="center" valign="top">LRG1</td>
<td align="center" valign="top">-0.52771</td>
<td align="center" valign="top">0.008031</td>
<td align="center" valign="top">0.046922</td>
<td align="center" valign="top">-2.67768</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">leucine rich alpha-2-glycoprotein 1</td>
</tr>
<tr>
<td align="center" valign="top">TP53INP2</td>
<td align="center" valign="top">-0.52568</td>
<td align="center" valign="top">6.08E-06</td>
<td align="center" valign="top">0.000236</td>
<td align="center" valign="top">-4.64824</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">tumor protein p53 inducible nuclear protein 2</td>
</tr>
<tr>
<td align="center" valign="top">CEBPB</td>
<td align="center" valign="top">-0.52347</td>
<td align="center" valign="top">0.001649</td>
<td align="center" valign="top">0.015958</td>
<td align="center" valign="top">-3.19071</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">CCAAT enhancer binding protein beta</td>
</tr>
<tr>
<td align="center" valign="top">USP32</td>
<td align="center" valign="top">-0.52337</td>
<td align="center" valign="top">0.002161</td>
<td align="center" valign="top">0.019405</td>
<td align="center" valign="top">-3.10772</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">ubiquitin specific peptidase 32</td>
</tr>
<tr>
<td align="center" valign="top">SLC45A4</td>
<td align="center" valign="top">-0.52164</td>
<td align="center" valign="top">0.000429</td>
<td align="center" valign="top">0.006246</td>
<td align="center" valign="top">-3.58195</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">solute carrier family 45 member 4</td>
</tr>
<tr>
<td align="center" valign="top">KATNBL1</td>
<td align="center" valign="top">-0.51907</td>
<td align="center" valign="top">0.000403</td>
<td align="center" valign="top">0.00596</td>
<td align="center" valign="top">-3.59889</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">katanin regulatory subunit B1 like 1</td>
</tr>
<tr>
<td align="center" valign="top">PNPLA8</td>
<td align="center" valign="top">-0.51402</td>
<td align="center" valign="top">0.00014</td>
<td align="center" valign="top">0.002803</td>
<td align="center" valign="top">-3.88419</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">patatin like phospholipase domain containing 8</td>
</tr>
<tr>
<td align="center" valign="top">MAPK13</td>
<td align="center" valign="top">-0.51365</td>
<td align="center" valign="top">0.001167</td>
<td align="center" valign="top">0.01248</td>
<td align="center" valign="top">-3.29447</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">mitogen-activated protein kinase 13</td>
</tr>
<tr>
<td align="center" valign="top">FGD4</td>
<td align="center" valign="top">-0.51363</td>
<td align="center" valign="top">0.002003</td>
<td align="center" valign="top">0.018366</td>
<td align="center" valign="top">-3.13109</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">FYVE, RhoGEF and PH domain containing 4</td>
</tr>
<tr>
<td align="center" valign="top">CD302</td>
<td align="center" valign="top">-0.50813</td>
<td align="center" valign="top">0.006418</td>
<td align="center" valign="top">0.040184</td>
<td align="center" valign="top">-2.75474</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">CD302 molecule</td>
</tr>
<tr>
<td align="center" valign="top">INPP5A</td>
<td align="center" valign="top">-0.50485</td>
<td align="center" valign="top">0.000956</td>
<td align="center" valign="top">0.01091</td>
<td align="center" valign="top">-3.35321</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">inositol polyphosphate-5-phosphatase A</td>
</tr>
<tr>
<td align="center" valign="top">MYADM</td>
<td align="center" valign="top">-0.50339</td>
<td align="center" valign="top">4.83E-05</td>
<td align="center" valign="top">0.001228</td>
<td align="center" valign="top">-4.15485</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">myeloid associated differentiation marker</td>
</tr>
<tr>
<td align="center" valign="top">GPX3</td>
<td align="center" valign="top">-0.50185</td>
<td align="center" valign="top">0.00043</td>
<td align="center" valign="top">0.006248</td>
<td align="center" valign="top">-3.5807</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">glutathione peroxidase 3</td>
</tr>
<tr>
<td align="center" valign="top">PLK3</td>
<td align="center" valign="top">-0.49613</td>
<td align="center" valign="top">0.004072</td>
<td align="center" valign="top">0.029525</td>
<td align="center" valign="top">-2.90618</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">polo like kinase 3</td>
</tr>
<tr>
<td align="center" valign="top">SHKBP1</td>
<td align="center" valign="top">-0.49605</td>
<td align="center" valign="top">0.004754</td>
<td align="center" valign="top">0.032787</td>
<td align="center" valign="top">-2.85533</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">SH3KBP1 binding protein 1</td>
</tr>
<tr>
<td align="center" valign="top">SLC12A6</td>
<td align="center" valign="top">-0.49412</td>
<td align="center" valign="top">0.004123</td>
<td align="center" valign="top">0.029697</td>
<td align="center" valign="top">-2.90215</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">solute carrier family 12 member 6</td>
</tr>
<tr>
<td align="center" valign="top">CNOT11</td>
<td align="center" valign="top">-0.49107</td>
<td align="center" valign="top">0.002198</td>
<td align="center" valign="top">0.01962</td>
<td align="center" valign="top">-3.10242</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">CCR4-NOT transcription complex subunit 11</td>
</tr>
<tr>
<td align="center" valign="top">CPD</td>
<td align="center" valign="top">-0.488</td>
<td align="center" valign="top">0.000706</td>
<td align="center" valign="top">0.008859</td>
<td align="center" valign="top">-3.44083</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">carboxypeptidase D</td>
</tr>
<tr>
<td align="center" valign="top">PRKDC</td>
<td align="center" valign="top">-0.48758</td>
<td align="center" valign="top">0.000507</td>
<td align="center" valign="top">0.007088</td>
<td align="center" valign="top">-3.53471</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">protein kinase, DNA-activated, catalytic subunit</td>
</tr>
<tr>
<td align="center" valign="top">MBOAT2</td>
<td align="center" valign="top">-0.48227</td>
<td align="center" valign="top">0.00078</td>
<td align="center" valign="top">0.009476</td>
<td align="center" valign="top">-3.41214</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">membrane bound O-acyltransferase domain containing 2</td>
</tr>
<tr>
<td align="center" valign="top">PID1</td>
<td align="center" valign="top">-0.48159</td>
<td align="center" valign="top">0.00501</td>
<td align="center" valign="top">0.03391</td>
<td align="center" valign="top">-2.83792</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">phosphotyrosine interaction domain containing 1</td>
</tr>
<tr>
<td align="center" valign="top">RALGDS</td>
<td align="center" valign="top">-0.4811</td>
<td align="center" valign="top">3.26E-06</td>
<td align="center" valign="top">0.000136</td>
<td align="center" valign="top">-4.78946</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">ral guanine nucleotide dissociation stimulator</td>
</tr>
<tr>
<td align="center" valign="top">RABGEF1</td>
<td align="center" valign="top">-0.47821</td>
<td align="center" valign="top">0.000767</td>
<td align="center" valign="top">0.009382</td>
<td align="center" valign="top">-3.41727</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">RAB guanine nucleotide exchange factor 1</td>
</tr>
<tr>
<td align="center" valign="top">RASA2</td>
<td align="center" valign="top">-0.47776</td>
<td align="center" valign="top">0.002722</td>
<td align="center" valign="top">0.022682</td>
<td align="center" valign="top">-3.03548</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">RAS p21 protein activator 2</td>
</tr>
<tr>
<td align="center" valign="top">PFKFB2</td>
<td align="center" valign="top">-0.47681</td>
<td align="center" valign="top">0.000241</td>
<td align="center" valign="top">0.004154</td>
<td align="center" valign="top">-3.73992</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2</td>
</tr>
<tr>
<td align="center" valign="top">FAM53C</td>
<td align="center" valign="top">-0.47554</td>
<td align="center" valign="top">0.000236</td>
<td align="center" valign="top">0.004093</td>
<td align="center" valign="top">-3.74529</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">family with sequence similarity 53 member C</td>
</tr>
<tr>
<td align="center" valign="top">MAML3</td>
<td align="center" valign="top">-0.47245</td>
<td align="center" valign="top">0.000172</td>
<td align="center" valign="top">0.003273</td>
<td align="center" valign="top">-3.82896</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">mastermind like transcriptional coactivator 3</td>
</tr>
<tr>
<td align="center" valign="top">PPP1R15A</td>
<td align="center" valign="top">-0.46809</td>
<td align="center" valign="top">0.001775</td>
<td align="center" valign="top">0.016877</td>
<td align="center" valign="top">-3.16816</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">protein phosphatase 1 regulatory subunit 15A</td>
</tr>
<tr>
<td align="center" valign="top">STAT5B</td>
<td align="center" valign="top">-0.46796</td>
<td align="center" valign="top">0.007994</td>
<td align="center" valign="top">0.046789</td>
<td align="center" valign="top">-2.67931</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">signal transducer and activator of transcription 5B</td>
</tr>
<tr>
<td align="center" valign="top">LFNG</td>
<td align="center" valign="top">-0.46785</td>
<td align="center" valign="top">0.003845</td>
<td align="center" valign="top">0.028522</td>
<td align="center" valign="top">-2.9249</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase</td>
</tr>
<tr>
<td align="center" valign="top">FOXO4</td>
<td align="center" valign="top">-0.46785</td>
<td align="center" valign="top">0.001931</td>
<td align="center" valign="top">0.017953</td>
<td align="center" valign="top">-3.14236</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">forkhead box O4</td>
</tr>
<tr>
<td align="center" valign="top">CEP68</td>
<td align="center" valign="top">-0.46753</td>
<td align="center" valign="top">0.0017</td>
<td align="center" valign="top">0.016352</td>
<td align="center" valign="top">-3.18146</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">centrosomal protein 68</td>
</tr>
<tr>
<td align="center" valign="top">NIN</td>
<td align="center" valign="top">-0.46502</td>
<td align="center" valign="top">9.79E-06</td>
<td align="center" valign="top">0.000349</td>
<td align="center" valign="top">-4.53826</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">ninein</td>
</tr>
<tr>
<td align="center" valign="top">MAN2B1</td>
<td align="center" valign="top">-0.46365</td>
<td align="center" valign="top">1.22E-05</td>
<td align="center" valign="top">0.000419</td>
<td align="center" valign="top">-4.48669</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">mannosidase alpha class 2B member 1</td>
</tr>
<tr>
<td align="center" valign="top">BICD2</td>
<td align="center" valign="top">-0.46337</td>
<td align="center" valign="top">4.37E-06</td>
<td align="center" valign="top">0.000176</td>
<td align="center" valign="top">-4.72323</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">BICD cargo adaptor 2</td>
</tr>
<tr>
<td align="center" valign="top">SPAG9</td>
<td align="center" valign="top">-0.46006</td>
<td align="center" valign="top">0.000438</td>
<td align="center" valign="top">0.006344</td>
<td align="center" valign="top">-3.57619</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">sperm associated antigen 9</td>
</tr>
<tr>
<td align="center" valign="top">NIBAN1</td>
<td align="center" valign="top">-0.45525</td>
<td align="center" valign="top">0.00108</td>
<td align="center" valign="top">0.011891</td>
<td align="center" valign="top">-3.31741</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">niban apoptosis regulator 1</td>
</tr>
<tr>
<td align="center" valign="top">MAP4K4</td>
<td align="center" valign="top">-0.4546</td>
<td align="center" valign="top">0.000732</td>
<td align="center" valign="top">0.009111</td>
<td align="center" valign="top">-3.43054</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">mitogen-activated protein kinase kinasekinasekinase 4</td>
</tr>
<tr>
<td align="center" valign="top">MTURN</td>
<td align="center" valign="top">-0.45158</td>
<td align="center" valign="top">0.00053</td>
<td align="center" valign="top">0.007239</td>
<td align="center" valign="top">-3.52257</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">maturin, neural progenitor differentiation regulator homolog</td>
</tr>
<tr>
<td align="center" valign="top">PER1</td>
<td align="center" valign="top">-0.45133</td>
<td align="center" valign="top">0.000111</td>
<td align="center" valign="top">0.002353</td>
<td align="center" valign="top">-3.94413</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">period circadian regulator 1</td>
</tr>
<tr>
<td align="center" valign="top">CDC42EP3</td>
<td align="center" valign="top">-0.44984</td>
<td align="center" valign="top">0.002209</td>
<td align="center" valign="top">0.019679</td>
<td align="center" valign="top">-3.10081</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">CDC42 effector protein 3</td>
</tr>
<tr>
<td align="center" valign="top">ETS2</td>
<td align="center" valign="top">-0.44904</td>
<td align="center" valign="top">0.00178</td>
<td align="center" valign="top">0.01689</td>
<td align="center" valign="top">-3.16738</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">ETS proto-oncogene 2, transcription factor</td>
</tr>
<tr>
<td align="center" valign="top">MANSC1</td>
<td align="center" valign="top">-0.44787</td>
<td align="center" valign="top">0.006674</td>
<td align="center" valign="top">0.041333</td>
<td align="center" valign="top">-2.74142</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">MANSC domain containing 1</td>
</tr>
<tr>
<td align="center" valign="top">HIP1R</td>
<td align="center" valign="top">-0.44744</td>
<td align="center" valign="top">0.001356</td>
<td align="center" valign="top">0.013823</td>
<td align="center" valign="top">-3.2496</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">huntingtin interacting protein 1 related</td>
</tr>
<tr>
<td align="center" valign="top">NR4A2</td>
<td align="center" valign="top">-0.44532</td>
<td align="center" valign="top">0.003766</td>
<td align="center" valign="top">0.028091</td>
<td align="center" valign="top">-2.93163</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">nuclear receptor subfamily 4 group A member 2</td>
</tr>
<tr>
<td align="center" valign="top">HHLA1</td>
<td align="center" valign="top">-0.44407</td>
<td align="center" valign="top">0.0004</td>
<td align="center" valign="top">0.005925</td>
<td align="center" valign="top">-3.60075</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">HERV-H LTR-associating 1</td>
</tr>
<tr>
<td align="center" valign="top">MAEA</td>
<td align="center" valign="top">-0.44405</td>
<td align="center" valign="top">7.51E-05</td>
<td align="center" valign="top">0.001753</td>
<td align="center" valign="top">-4.04404</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">macrophage erythroblast attacher</td>
</tr>
<tr>
<td align="center" valign="top">SH3BP2</td>
<td align="center" valign="top">-0.4436</td>
<td align="center" valign="top">0.005716</td>
<td align="center" valign="top">0.036994</td>
<td align="center" valign="top">-2.79388</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">SH3 domain binding protein 2</td>
</tr>
<tr>
<td align="center" valign="top">PACSIN2</td>
<td align="center" valign="top">-0.44102</td>
<td align="center" valign="top">0.000822</td>
<td align="center" valign="top">0.00982</td>
<td align="center" valign="top">-3.39702</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">protein kinase C and casein kinase substrate in neurons 2</td>
</tr>
<tr>
<td align="center" valign="top">PICALM</td>
<td align="center" valign="top">-0.43931</td>
<td align="center" valign="top">0.000875</td>
<td align="center" valign="top">0.010274</td>
<td align="center" valign="top">-3.37899</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">phosphatidylinositol binding clathrin assembly protein</td>
</tr>
<tr>
<td align="center" valign="top">INPP5K</td>
<td align="center" valign="top">-0.43911</td>
<td align="center" valign="top">0.002037</td>
<td align="center" valign="top">0.018636</td>
<td align="center" valign="top">-3.12588</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">inositol polyphosphate-5-phosphatase K</td>
</tr>
<tr>
<td align="center" valign="top">MYH9</td>
<td align="center" valign="top">-0.4341</td>
<td align="center" valign="top">0.001152</td>
<td align="center" valign="top">0.012346</td>
<td align="center" valign="top">-3.29839</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">myosin heavy chain 9</td>
</tr>
<tr>
<td align="center" valign="top">EIF3L</td>
<td align="center" valign="top">-0.43251</td>
<td align="center" valign="top">0.000558</td>
<td align="center" valign="top">0.007514</td>
<td align="center" valign="top">-3.50807</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">eukaryotic translation initiation factor 3 subunit L</td>
</tr>
<tr>
<td align="center" valign="top">IRS2</td>
<td align="center" valign="top">-0.43244</td>
<td align="center" valign="top">0.000379</td>
<td align="center" valign="top">0.005717</td>
<td align="center" valign="top">-3.61633</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">insulin receptor substrate 2</td>
</tr>
<tr>
<td align="center" valign="top">KDM4B</td>
<td align="center" valign="top">-0.42986</td>
<td align="center" valign="top">0.002404</td>
<td align="center" valign="top">0.020934</td>
<td align="center" valign="top">-3.0745</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">lysine demethylase 4B</td>
</tr>
<tr>
<td align="center" valign="top">UBAP1</td>
<td align="center" valign="top">-0.42924</td>
<td align="center" valign="top">6.92E-05</td>
<td align="center" valign="top">0.001636</td>
<td align="center" valign="top">-4.06448</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">ubiquitin associated protein 1</td>
</tr>
<tr>
<td align="center" valign="top">NBPF9</td>
<td align="center" valign="top">-0.42916</td>
<td align="center" valign="top">0.003767</td>
<td align="center" valign="top">0.028091</td>
<td align="center" valign="top">-2.93151</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">NBPF member 9</td>
</tr>
<tr>
<td align="center" valign="top">SSH2</td>
<td align="center" valign="top">-0.42856</td>
<td align="center" valign="top">0.004931</td>
<td align="center" valign="top">0.033584</td>
<td align="center" valign="top">-2.84325</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">slingshot protein phosphatase 2</td>
</tr>
<tr>
<td align="center" valign="top">ABHD12B</td>
<td align="center" valign="top">-0.42706</td>
<td align="center" valign="top">0.003739</td>
<td align="center" valign="top">0.027951</td>
<td align="center" valign="top">-2.93394</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">abhydrolase domain containing 12B</td>
</tr>
<tr>
<td align="center" valign="top">PCDHB1</td>
<td align="center" valign="top">-0.42614</td>
<td align="center" valign="top">0.005683</td>
<td align="center" valign="top">0.036912</td>
<td align="center" valign="top">-2.79585</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">protocadherin beta 1</td>
</tr>
<tr>
<td align="center" valign="top">SDCBP</td>
<td align="center" valign="top">-0.42408</td>
<td align="center" valign="top">0.001025</td>
<td align="center" valign="top">0.011418</td>
<td align="center" valign="top">-3.33283</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">syndecan binding protein</td>
</tr>
<tr>
<td align="center" valign="top">RASSF5</td>
<td align="center" valign="top">-0.42344</td>
<td align="center" valign="top">0.005139</td>
<td align="center" valign="top">0.034489</td>
<td align="center" valign="top">-2.82948</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">Ras association domain family member 5</td>
</tr>
<tr>
<td align="center" valign="top">TPD52L2</td>
<td align="center" valign="top">-0.42323</td>
<td align="center" valign="top">1.35E-06</td>
<td align="center" valign="top">6.43E-05</td>
<td align="center" valign="top">-4.98332</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">TPD52 like 2</td>
</tr>
<tr>
<td align="center" valign="top">TPM4</td>
<td align="center" valign="top">-0.42223</td>
<td align="center" valign="top">0.000186</td>
<td align="center" valign="top">0.003446</td>
<td align="center" valign="top">-3.80814</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">tropomyosin 4</td>
</tr>
<tr>
<td align="center" valign="top">SH3BP5</td>
<td align="center" valign="top">-0.42121</td>
<td align="center" valign="top">0.002223</td>
<td align="center" valign="top">0.019753</td>
<td align="center" valign="top">-3.09895</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">SH3 domain binding protein 5</td>
</tr>
<tr>
<td align="center" valign="top">RAB31</td>
<td align="center" valign="top">-0.42061</td>
<td align="center" valign="top">0.003548</td>
<td align="center" valign="top">0.02711</td>
<td align="center" valign="top">-2.95095</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">RAB31, member RAS oncogene family</td>
</tr>
<tr>
<td align="center" valign="top">KLHL2</td>
<td align="center" valign="top">-0.42058</td>
<td align="center" valign="top">0.000272</td>
<td align="center" valign="top">0.0045</td>
<td align="center" valign="top">-3.70694</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">kelch like family member 2</td>
</tr>
<tr>
<td align="center" valign="top">TNIP1</td>
<td align="center" valign="top">-0.41705</td>
<td align="center" valign="top">0.004106</td>
<td align="center" valign="top">0.029617</td>
<td align="center" valign="top">-2.90353</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">TNFAIP3 interacting protein 1</td>
</tr>
<tr>
<td align="center" valign="top">TMCO3</td>
<td align="center" valign="top">-0.41689</td>
<td align="center" valign="top">0.000515</td>
<td align="center" valign="top">0.007122</td>
<td align="center" valign="top">-3.5305</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">transmembrane and coiled-coil domains 3</td>
</tr>
<tr>
<td align="center" valign="top">SULF2</td>
<td align="center" valign="top">-0.41581</td>
<td align="center" valign="top">0.004203</td>
<td align="center" valign="top">0.03005</td>
<td align="center" valign="top">-2.89586</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">sulfatase 2</td>
</tr>
<tr>
<td align="center" valign="top">EIF2D</td>
<td align="center" valign="top">-0.4151</td>
<td align="center" valign="top">0.000356</td>
<td align="center" valign="top">0.005455</td>
<td align="center" valign="top">-3.63319</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">eukaryotic translation initiation factor 2D</td>
</tr>
<tr>
<td align="center" valign="top">MORC4</td>
<td align="center" valign="top">-0.41342</td>
<td align="center" valign="top">0.0051</td>
<td align="center" valign="top">0.034269</td>
<td align="center" valign="top">-2.83203</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">MORC family CW-type zinc finger 4</td>
</tr>
<tr>
<td align="center" valign="top">OSBPL1A</td>
<td align="center" valign="top">-0.41211</td>
<td align="center" valign="top">0.003202</td>
<td align="center" valign="top">0.025288</td>
<td align="center" valign="top">-2.98392</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">oxysterol binding protein like 1A</td>
</tr>
<tr>
<td align="center" valign="top">PTPN12</td>
<td align="center" valign="top">-0.4119</td>
<td align="center" valign="top">0.003463</td>
<td align="center" valign="top">0.02664</td>
<td align="center" valign="top">-2.95873</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">protein tyrosine phosphatase non-receptor type 12</td>
</tr>
<tr>
<td align="center" valign="top">DOT1L</td>
<td align="center" valign="top">-0.41137</td>
<td align="center" valign="top">0.00764</td>
<td align="center" valign="top">0.045333</td>
<td align="center" valign="top">-2.69498</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">DOT1 like histone lysine methyltransferase</td>
</tr>
<tr>
<td align="center" valign="top">C16orf72</td>
<td align="center" valign="top">-0.40652</td>
<td align="center" valign="top">3.06E-05</td>
<td align="center" valign="top">0.000857</td>
<td align="center" valign="top">-4.26681</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">chromosome 16 open reading frame 72</td>
</tr>
<tr>
<td align="center" valign="top">ATP6V1B2</td>
<td align="center" valign="top">-0.40561</td>
<td align="center" valign="top">0.00533</td>
<td align="center" valign="top">0.035283</td>
<td align="center" valign="top">-2.81729</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">ATPase H+ transporting V1 subunit B2</td>
</tr>
<tr>
<td align="center" valign="top">CDC42BPG</td>
<td align="center" valign="top">-0.40461</td>
<td align="center" valign="top">0.004898</td>
<td align="center" valign="top">0.033433</td>
<td align="center" valign="top">-2.84545</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">CDC42 binding protein kinase gamma</td>
</tr>
<tr>
<td align="center" valign="top">CXCL16</td>
<td align="center" valign="top">-0.40444</td>
<td align="center" valign="top">0.002518</td>
<td align="center" valign="top">0.02157</td>
<td align="center" valign="top">-3.06005</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">C-X-C motif chemokine ligand 16</td>
</tr>
<tr>
<td align="center" valign="top">PTEN</td>
<td align="center" valign="top">-0.40275</td>
<td align="center" valign="top">0.004977</td>
<td align="center" valign="top">0.033768</td>
<td align="center" valign="top">-2.84017</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">phosphatase and tensin homolog</td>
</tr>
<tr>
<td align="center" valign="top">PELI1</td>
<td align="center" valign="top">-0.40258</td>
<td align="center" valign="top">0.003722</td>
<td align="center" valign="top">0.027859</td>
<td align="center" valign="top">-2.93541</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">pellino E3 ubiquitin protein ligase 1</td>
</tr>
<tr>
<td align="center" valign="top">GXYLT2</td>
<td align="center" valign="top">-0.4003</td>
<td align="center" valign="top">0.004254</td>
<td align="center" valign="top">0.030302</td>
<td align="center" valign="top">-2.89195</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">glucosidexylosyltransferase 2</td>
</tr>
<tr>
<td align="center" valign="top">MAP3K20</td>
<td align="center" valign="top">-0.39795</td>
<td align="center" valign="top">0.007986</td>
<td align="center" valign="top">0.046763</td>
<td align="center" valign="top">-2.67963</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">mitogen-activated protein kinase kinasekinase 20</td>
</tr>
<tr>
<td align="center" valign="top">ERGIC1</td>
<td align="center" valign="top">-0.39654</td>
<td align="center" valign="top">7.63E-05</td>
<td align="center" valign="top">0.001778</td>
<td align="center" valign="top">-4.03977</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">endoplasmic reticulum-golgi intermediate compartment 1</td>
</tr>
<tr>
<td align="center" valign="top">ACTN1</td>
<td align="center" valign="top">-0.39536</td>
<td align="center" valign="top">0.007246</td>
<td align="center" valign="top">0.04399</td>
<td align="center" valign="top">-2.71324</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">actinin alpha 1</td>
</tr>
<tr>
<td align="center" valign="top">OSBPL8</td>
<td align="center" valign="top">-0.39507</td>
<td align="center" valign="top">0.001578</td>
<td align="center" valign="top">0.015443</td>
<td align="center" valign="top">-3.20399</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">oxysterol binding protein like 8</td>
</tr>
<tr>
<td align="center" valign="top">NATD1</td>
<td align="center" valign="top">-0.39499</td>
<td align="center" valign="top">0.001023</td>
<td align="center" valign="top">0.011406</td>
<td align="center" valign="top">-3.33334</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">N-acetyltransferase domain containing 1</td>
</tr>
<tr>
<td align="center" valign="top">RXRA</td>
<td align="center" valign="top">-0.39432</td>
<td align="center" valign="top">0.001122</td>
<td align="center" valign="top">0.012161</td>
<td align="center" valign="top">-3.30607</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">retinoid X receptor alpha</td>
</tr>
<tr>
<td align="center" valign="top">SEC14L1</td>
<td align="center" valign="top">-0.39413</td>
<td align="center" valign="top">0.000463</td>
<td align="center" valign="top">0.006583</td>
<td align="center" valign="top">-3.56033</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">SEC14 like lipid binding 1</td>
</tr>
<tr>
<td align="center" valign="top">SYAP1</td>
<td align="center" valign="top">-0.38996</td>
<td align="center" valign="top">3.2E-05</td>
<td align="center" valign="top">0.000889</td>
<td align="center" valign="top">-4.25609</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">synapse associated protein 1</td>
</tr>
<tr>
<td align="center" valign="top">MAP3K11</td>
<td align="center" valign="top">-0.38943</td>
<td align="center" valign="top">0.004389</td>
<td align="center" valign="top">0.030941</td>
<td align="center" valign="top">-2.88168</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">mitogen-activated protein kinase kinasekinase 11</td>
</tr>
<tr>
<td align="center" valign="top">NIBAN2</td>
<td align="center" valign="top">-0.38681</td>
<td align="center" valign="top">0.006264</td>
<td align="center" valign="top">0.039467</td>
<td align="center" valign="top">-2.76298</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">niban apoptosis regulator 2</td>
</tr>
<tr>
<td align="center" valign="top">STEAP4</td>
<td align="center" valign="top">-0.38453</td>
<td align="center" valign="top">0.003898</td>
<td align="center" valign="top">0.028768</td>
<td align="center" valign="top">-2.92046</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">STEAP4 metalloreductase</td>
</tr>
<tr>
<td align="center" valign="top">CCNG2</td>
<td align="center" valign="top">-0.384</td>
<td align="center" valign="top">0.001118</td>
<td align="center" valign="top">0.012157</td>
<td align="center" valign="top">-3.30704</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">cyclin G2</td>
</tr>
<tr>
<td align="center" valign="top">MAPKAPK2</td>
<td align="center" valign="top">-0.38391</td>
<td align="center" valign="top">0.000604</td>
<td align="center" valign="top">0.00792</td>
<td align="center" valign="top">-3.48542</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">MAPK activated protein kinase 2</td>
</tr>
<tr>
<td align="center" valign="top">CCNQ</td>
<td align="center" valign="top">-0.38366</td>
<td align="center" valign="top">0.005702</td>
<td align="center" valign="top">0.036965</td>
<td align="center" valign="top">-2.79468</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">cyclin Q</td>
</tr>
<tr>
<td align="center" valign="top">NUDT3</td>
<td align="center" valign="top">-0.38348</td>
<td align="center" valign="top">0.004299</td>
<td align="center" valign="top">0.030544</td>
<td align="center" valign="top">-2.88847</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">nudix hydrolase 3</td>
</tr>
<tr>
<td align="center" valign="top">FRAT2</td>
<td align="center" valign="top">-0.38298</td>
<td align="center" valign="top">0.007429</td>
<td align="center" valign="top">0.044476</td>
<td align="center" valign="top">-2.70464</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">FRAT regulator of WNT signaling pathway 2</td>
</tr>
<tr>
<td align="center" valign="top">TLCD2</td>
<td align="center" valign="top">-0.3801</td>
<td align="center" valign="top">0.000278</td>
<td align="center" valign="top">0.004566</td>
<td align="center" valign="top">-3.7005</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">TLC domain containing 2</td>
</tr>
<tr>
<td align="center" valign="top">ERF</td>
<td align="center" valign="top">-0.37846</td>
<td align="center" valign="top">0.000263</td>
<td align="center" valign="top">0.004394</td>
<td align="center" valign="top">-3.71566</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">ETS2 repressor factor</td>
</tr>
<tr>
<td align="center" valign="top">ZMIZ1</td>
<td align="center" valign="top">-0.37414</td>
<td align="center" valign="top">0.004463</td>
<td align="center" valign="top">0.031289</td>
<td align="center" valign="top">-2.87621</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">zinc finger MIZ-type containing 1</td>
</tr>
<tr>
<td align="center" valign="top">TUBA4A</td>
<td align="center" valign="top">-0.374</td>
<td align="center" valign="top">0.00868</td>
<td align="center" valign="top">0.049431</td>
<td align="center" valign="top">-2.65059</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">tubulin alpha 4a</td>
</tr>
<tr>
<td align="center" valign="top">SLC44A2</td>
<td align="center" valign="top">-0.37399</td>
<td align="center" valign="top">0.000184</td>
<td align="center" valign="top">0.003417</td>
<td align="center" valign="top">-3.81169</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">solute carrier family 44 member 2</td>
</tr>
<tr>
<td align="center" valign="top">SORT1</td>
<td align="center" valign="top">-0.37329</td>
<td align="center" valign="top">0.001334</td>
<td align="center" valign="top">0.013703</td>
<td align="center" valign="top">-3.25471</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">sortilin 1</td>
</tr>
<tr>
<td align="center" valign="top">LYST</td>
<td align="center" valign="top">-0.37303</td>
<td align="center" valign="top">0.005249</td>
<td align="center" valign="top">0.034931</td>
<td align="center" valign="top">-2.82245</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">lysosomal trafficking regulator</td>
</tr>
<tr>
<td align="center" valign="top">PHF20L1</td>
<td align="center" valign="top">-0.37185</td>
<td align="center" valign="top">0.004569</td>
<td align="center" valign="top">0.031759</td>
<td align="center" valign="top">-2.86842</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">PHD finger protein 20 like 1</td>
</tr>
<tr>
<td align="center" valign="top">PIM3</td>
<td align="center" valign="top">-0.36926</td>
<td align="center" valign="top">0.00086</td>
<td align="center" valign="top">0.010147</td>
<td align="center" valign="top">-3.3841</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">Pim-3 proto-oncogene, serine/threonine kinase</td>
</tr>
<tr>
<td align="center" valign="top">NDRG2</td>
<td align="center" valign="top">-0.36889</td>
<td align="center" valign="top">0.000738</td>
<td align="center" valign="top">0.009146</td>
<td align="center" valign="top">-3.42832</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">NDRG family member 2</td>
</tr>
<tr>
<td align="center" valign="top">STX3</td>
<td align="center" valign="top">-0.36716</td>
<td align="center" valign="top">0.00614</td>
<td align="center" valign="top">0.038903</td>
<td align="center" valign="top">-2.76973</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">syntaxin 3</td>
</tr>
<tr>
<td align="center" valign="top">ELL2</td>
<td align="center" valign="top">-0.36667</td>
<td align="center" valign="top">0.00281</td>
<td align="center" valign="top">0.023157</td>
<td align="center" valign="top">-3.02541</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">elongation factor for RNA polymerase II 2</td>
</tr>
<tr>
<td align="center" valign="top">TPT1</td>
<td align="center" valign="top">-0.36627</td>
<td align="center" valign="top">0.000566</td>
<td align="center" valign="top">0.007586</td>
<td align="center" valign="top">-3.50374</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">tumor protein, translationally-controlled 1</td>
</tr>
<tr>
<td align="center" valign="top">R3HDM4</td>
<td align="center" valign="top">-0.36105</td>
<td align="center" valign="top">0.005795</td>
<td align="center" valign="top">0.037307</td>
<td align="center" valign="top">-2.78924</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">R3H domain containing 4</td>
</tr>
<tr>
<td align="center" valign="top">NUP98</td>
<td align="center" valign="top">-0.35983</td>
<td align="center" valign="top">0.003404</td>
<td align="center" valign="top">0.026339</td>
<td align="center" valign="top">-2.96426</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">nucleoporin 98</td>
</tr>
<tr>
<td align="center" valign="top">FOXO3</td>
<td align="center" valign="top">-0.35774</td>
<td align="center" valign="top">1.45E-05</td>
<td align="center" valign="top">0.000472</td>
<td align="center" valign="top">-4.44649</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">forkhead box O3</td>
</tr>
<tr>
<td align="center" valign="top">DDIT4</td>
<td align="center" valign="top">-0.356</td>
<td align="center" valign="top">0.000593</td>
<td align="center" valign="top">0.007822</td>
<td align="center" valign="top">-3.49059</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">DNA damage inducible transcript 4</td>
</tr>
<tr>
<td align="center" valign="top">ZC3H3</td>
<td align="center" valign="top">-0.35548</td>
<td align="center" valign="top">0.00825</td>
<td align="center" valign="top">0.047726</td>
<td align="center" valign="top">-2.66836</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">zinc finger CCCH-type containing 3</td>
</tr>
<tr>
<td align="center" valign="top">VPS37B</td>
<td align="center" valign="top">-0.35522</td>
<td align="center" valign="top">0.000756</td>
<td align="center" valign="top">0.009288</td>
<td align="center" valign="top">-3.42149</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">VPS37B subunit of ESCRT-I</td>
</tr>
<tr>
<td align="center" valign="top">TBC1D14</td>
<td align="center" valign="top">-0.35285</td>
<td align="center" valign="top">0.001397</td>
<td align="center" valign="top">0.014146</td>
<td align="center" valign="top">-3.24078</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">TBC1 domain family member 14</td>
</tr>
<tr>
<td align="center" valign="top">TFE3</td>
<td align="center" valign="top">-0.35236</td>
<td align="center" valign="top">0.004362</td>
<td align="center" valign="top">0.030857</td>
<td align="center" valign="top">-2.88372</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">transcription factor binding to IGHM enhancer 3</td>
</tr>
<tr>
<td align="center" valign="top">MAP1LC3B</td>
<td align="center" valign="top">-0.3501</td>
<td align="center" valign="top">9.94E-06</td>
<td align="center" valign="top">0.000353</td>
<td align="center" valign="top">-4.53486</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">microtubule associated protein 1 light chain 3 beta</td>
</tr>
<tr>
<td align="center" valign="top">FRMD4B</td>
<td align="center" valign="top">-0.34955</td>
<td align="center" valign="top">0.004943</td>
<td align="center" valign="top">0.033639</td>
<td align="center" valign="top">-2.84242</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">FERM domain containing 4B</td>
</tr>
<tr>
<td align="center" valign="top">H3-3A</td>
<td align="center" valign="top">-0.34767</td>
<td align="center" valign="top">0.000148</td>
<td align="center" valign="top">0.002916</td>
<td align="center" valign="top">-3.8696</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">H3.3 histone A</td>
</tr>
<tr>
<td align="center" valign="top">EEF2</td>
<td align="center" valign="top">-0.34745</td>
<td align="center" valign="top">0.001604</td>
<td align="center" valign="top">0.015577</td>
<td align="center" valign="top">-3.19905</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">eukaryotic translation elongation factor 2</td>
</tr>
<tr>
<td align="center" valign="top">ASAH1</td>
<td align="center" valign="top">-0.34715</td>
<td align="center" valign="top">5.29E-05</td>
<td align="center" valign="top">0.001309</td>
<td align="center" valign="top">-4.13197</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">N-acylsphingosineamidohydrolase 1</td>
</tr>
<tr>
<td align="center" valign="top">MAP3K8</td>
<td align="center" valign="top">-0.34658</td>
<td align="center" valign="top">0.004083</td>
<td align="center" valign="top">0.029576</td>
<td align="center" valign="top">-2.90532</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">mitogen-activated protein kinase kinasekinase 8</td>
</tr>
<tr>
<td align="center" valign="top">SEMA4A</td>
<td align="center" valign="top">-0.34648</td>
<td align="center" valign="top">0.00489</td>
<td align="center" valign="top">0.033408</td>
<td align="center" valign="top">-2.84599</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">semaphorin 4A</td>
</tr>
<tr>
<td align="center" valign="top">PXN</td>
<td align="center" valign="top">-0.34593</td>
<td align="center" valign="top">0.000275</td>
<td align="center" valign="top">0.004529</td>
<td align="center" valign="top">-3.70385</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">paxillin</td>
</tr>
<tr>
<td align="center" valign="top">ARFGAP3</td>
<td align="center" valign="top">-0.34357</td>
<td align="center" valign="top">0.000236</td>
<td align="center" valign="top">0.004098</td>
<td align="center" valign="top">-3.7445</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">ADP ribosylation factor GTPase activating protein 3</td>
</tr>
<tr>
<td align="center" valign="top">RNF144B</td>
<td align="center" valign="top">-0.34274</td>
<td align="center" valign="top">0.002253</td>
<td align="center" valign="top">0.019946</td>
<td align="center" valign="top">-3.09477</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">ring finger protein 144B</td>
</tr>
<tr>
<td align="center" valign="top">UBE2R2</td>
<td align="center" valign="top">-0.34042</td>
<td align="center" valign="top">0.00023</td>
<td align="center" valign="top">0.004029</td>
<td align="center" valign="top">-3.75232</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">ubiquitin conjugating enzyme E2 R2</td>
</tr>
<tr>
<td align="center" valign="top">NBPF14</td>
<td align="center" valign="top">-0.34008</td>
<td align="center" valign="top">0.001432</td>
<td align="center" valign="top">0.014368</td>
<td align="center" valign="top">-3.23326</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">NBPF member 14</td>
</tr>
<tr>
<td align="center" valign="top">RHOQ</td>
<td align="center" valign="top">-0.34</td>
<td align="center" valign="top">0.002276</td>
<td align="center" valign="top">0.020061</td>
<td align="center" valign="top">-3.09155</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">ras homolog family member Q</td>
</tr>
<tr>
<td align="center" valign="top">IRF2BP2</td>
<td align="center" valign="top">-0.33749</td>
<td align="center" valign="top">0.000184</td>
<td align="center" valign="top">0.003417</td>
<td align="center" valign="top">-3.81134</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">interferon regulatory factor 2 binding protein 2</td>
</tr>
<tr>
<td align="center" valign="top">GABARAPL1</td>
<td align="center" valign="top">-0.33722</td>
<td align="center" valign="top">0.000609</td>
<td align="center" valign="top">0.007959</td>
<td align="center" valign="top">-3.48311</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">GABA type A receptor associated protein like 1</td>
</tr>
<tr>
<td align="center" valign="top">RAB3D</td>
<td align="center" valign="top">-0.33666</td>
<td align="center" valign="top">0.002283</td>
<td align="center" valign="top">0.020095</td>
<td align="center" valign="top">-3.09067</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">RAB3D, member RAS oncogene family</td>
</tr>
<tr>
<td align="center" valign="top">PINK1</td>
<td align="center" valign="top">-0.33551</td>
<td align="center" valign="top">0.000119</td>
<td align="center" valign="top">0.002463</td>
<td align="center" valign="top">-3.92585</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">PTEN induced kinase 1</td>
</tr>
<tr>
<td align="center" valign="top">SERINC3</td>
<td align="center" valign="top">-0.33472</td>
<td align="center" valign="top">0.000521</td>
<td align="center" valign="top">0.007167</td>
<td align="center" valign="top">-3.52743</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">serine incorporator 3</td>
</tr>
<tr>
<td align="center" valign="top">PABPC1</td>
<td align="center" valign="top">-0.33444</td>
<td align="center" valign="top">0.000567</td>
<td align="center" valign="top">0.007589</td>
<td align="center" valign="top">-3.50338</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">poly(A) binding protein cytoplasmic 1</td>
</tr>
<tr>
<td align="center" valign="top">ZNF185</td>
<td align="center" valign="top">-0.33247</td>
<td align="center" valign="top">0.006736</td>
<td align="center" valign="top">0.041572</td>
<td align="center" valign="top">-2.73826</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">zinc finger protein 185 with LIM domain</td>
</tr>
<tr>
<td align="center" valign="top">UBE2D1</td>
<td align="center" valign="top">-0.33144</td>
<td align="center" valign="top">0.004895</td>
<td align="center" valign="top">0.033426</td>
<td align="center" valign="top">-2.84567</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">ubiquitin conjugating enzyme E2 D1</td>
</tr>
<tr>
<td align="center" valign="top">CPEB4</td>
<td align="center" valign="top">-0.32973</td>
<td align="center" valign="top">0.003715</td>
<td align="center" valign="top">0.027827</td>
<td align="center" valign="top">-2.93608</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">cytoplasmic polyadenylation element binding protein 4</td>
</tr>
<tr>
<td align="center" valign="top">KLHL21</td>
<td align="center" valign="top">-0.32456</td>
<td align="center" valign="top">0.000783</td>
<td align="center" valign="top">0.009487</td>
<td align="center" valign="top">-3.41137</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">kelch like family member 21</td>
</tr>
<tr>
<td align="center" valign="top">IDI1</td>
<td align="center" valign="top">-0.31705</td>
<td align="center" valign="top">0.000668</td>
<td align="center" valign="top">0.008477</td>
<td align="center" valign="top">-3.45662</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">isopentenyl-diphosphate delta isomerase 1</td>
</tr>
<tr>
<td align="center" valign="top">GABARAP</td>
<td align="center" valign="top">-0.31514</td>
<td align="center" valign="top">0.000191</td>
<td align="center" valign="top">0.00352</td>
<td align="center" valign="top">-3.801</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">GABA type A receptor-associated protein</td>
</tr>
<tr>
<td align="center" valign="top">IQGAP1</td>
<td align="center" valign="top">-0.3113</td>
<td align="center" valign="top">0.001355</td>
<td align="center" valign="top">0.013817</td>
<td align="center" valign="top">-3.24999</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">IQ motif containing GTPase activating protein 1</td>
</tr>
<tr>
<td align="center" valign="top">TTPAL</td>
<td align="center" valign="top">-0.31108</td>
<td align="center" valign="top">0.005399</td>
<td align="center" valign="top">0.035625</td>
<td align="center" valign="top">-2.81302</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">alpha tocopherol transfer protein like</td>
</tr>
<tr>
<td align="center" valign="top">BLOC1S6</td>
<td align="center" valign="top">-0.31029</td>
<td align="center" valign="top">0.003798</td>
<td align="center" valign="top">0.028251</td>
<td align="center" valign="top">-2.92889</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">biogenesis of lysosomal organelles complex 1 subunit 6</td>
</tr>
<tr>
<td align="center" valign="top">ZFP36L1</td>
<td align="center" valign="top">-0.30501</td>
<td align="center" valign="top">0.006474</td>
<td align="center" valign="top">0.040439</td>
<td align="center" valign="top">-2.75178</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">ZFP36 ring finger protein like 1</td>
</tr>
<tr>
<td align="center" valign="top">RIOK3</td>
<td align="center" valign="top">-0.30287</td>
<td align="center" valign="top">0.002094</td>
<td align="center" valign="top">0.018965</td>
<td align="center" valign="top">-3.11748</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">RIO kinase 3</td>
</tr>
<tr>
<td align="center" valign="top">ADIPOR1</td>
<td align="center" valign="top">-0.30265</td>
<td align="center" valign="top">3.3E-06</td>
<td align="center" valign="top">0.000137</td>
<td align="center" valign="top">-4.78639</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">adiponectin receptor 1</td>
</tr>
<tr>
<td align="center" valign="top">PPARD</td>
<td align="center" valign="top">-0.3019</td>
<td align="center" valign="top">0.003562</td>
<td align="center" valign="top">0.027186</td>
<td align="center" valign="top">-2.94963</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">peroxisome proliferator activated receptor delta</td>
</tr>
<tr>
<td align="center" valign="top">SLC25A40</td>
<td align="center" valign="top">-0.30097</td>
<td align="center" valign="top">0.005503</td>
<td align="center" valign="top">0.03599</td>
<td align="center" valign="top">-2.80666</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">solute carrier family 25 member 40</td>
</tr>
<tr>
<td align="center" valign="top">YPEL3</td>
<td align="center" valign="top">-0.29906</td>
<td align="center" valign="top">0.007547</td>
<td align="center" valign="top">0.045029</td>
<td align="center" valign="top">-2.69923</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">yippee like 3</td>
</tr>
<tr>
<td align="center" valign="top">SNX18</td>
<td align="center" valign="top">-0.29867</td>
<td align="center" valign="top">0.002638</td>
<td align="center" valign="top">0.02223</td>
<td align="center" valign="top">-3.04539</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">sorting nexin 18</td>
</tr>
<tr>
<td align="center" valign="top">WDR1</td>
<td align="center" valign="top">-0.2972</td>
<td align="center" valign="top">0.001094</td>
<td align="center" valign="top">0.011994</td>
<td align="center" valign="top">-3.31345</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">WD repeat domain 1</td>
</tr>
<tr>
<td align="center" valign="top">MSL1</td>
<td align="center" valign="top">-0.29603</td>
<td align="center" valign="top">0.004073</td>
<td align="center" valign="top">0.029525</td>
<td align="center" valign="top">-2.90612</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">MSL complex subunit 1</td>
</tr>
<tr>
<td align="center" valign="top">TKT</td>
<td align="center" valign="top">-0.29601</td>
<td align="center" valign="top">0.001792</td>
<td align="center" valign="top">0.016955</td>
<td align="center" valign="top">-3.1653</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">transketolase</td>
</tr>
<tr>
<td align="center" valign="top">EIF4EBP2</td>
<td align="center" valign="top">-0.29523</td>
<td align="center" valign="top">0.001382</td>
<td align="center" valign="top">0.014026</td>
<td align="center" valign="top">-3.24409</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">eukaryotic translation initiation factor 4E binding protein 2</td>
</tr>
<tr>
<td align="center" valign="top">MTMR3</td>
<td align="center" valign="top">-0.29205</td>
<td align="center" valign="top">0.007323</td>
<td align="center" valign="top">0.044242</td>
<td align="center" valign="top">-2.70958</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">myotubularin related protein 3</td>
</tr>
<tr>
<td align="center" valign="top">EIF1</td>
<td align="center" valign="top">-0.29128</td>
<td align="center" valign="top">7.23E-05</td>
<td align="center" valign="top">0.001698</td>
<td align="center" valign="top">-4.05365</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">eukaryotic translation initiation factor 1</td>
</tr>
<tr>
<td align="center" valign="top">RANBP2</td>
<td align="center" valign="top">-0.28835</td>
<td align="center" valign="top">0.00612</td>
<td align="center" valign="top">0.038791</td>
<td align="center" valign="top">-2.77084</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">RAN binding protein 2</td>
</tr>
<tr>
<td align="center" valign="top">GLUL</td>
<td align="center" valign="top">-0.28774</td>
<td align="center" valign="top">0.001254</td>
<td align="center" valign="top">0.013146</td>
<td align="center" valign="top">-3.27311</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">glutamate-ammonia ligase</td>
</tr>
<tr>
<td align="center" valign="top">DNM2</td>
<td align="center" valign="top">-0.28768</td>
<td align="center" valign="top">0.005212</td>
<td align="center" valign="top">0.0348</td>
<td align="center" valign="top">-2.82482</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">dynamin 2</td>
</tr>
<tr>
<td align="center" valign="top">PRKCD</td>
<td align="center" valign="top">-0.28536</td>
<td align="center" valign="top">0.00501</td>
<td align="center" valign="top">0.03391</td>
<td align="center" valign="top">-2.83797</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">protein kinase C delta</td>
</tr>
<tr>
<td align="center" valign="top">USF2</td>
<td align="center" valign="top">-0.28423</td>
<td align="center" valign="top">0.000968</td>
<td align="center" valign="top">0.010992</td>
<td align="center" valign="top">-3.34957</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">upstream transcription factor 2, c-fos interacting</td>
</tr>
<tr>
<td align="center" valign="top">DOP1B</td>
<td align="center" valign="top">-0.28185</td>
<td align="center" valign="top">0.007237</td>
<td align="center" valign="top">0.043955</td>
<td align="center" valign="top">-2.71365</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">DOP1 leucine zipper like protein B</td>
</tr>
<tr>
<td align="center" valign="top">STK38L</td>
<td align="center" valign="top">-0.27657</td>
<td align="center" valign="top">0.006341</td>
<td align="center" valign="top">0.039827</td>
<td align="center" valign="top">-2.7588</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">serine/threonine kinase 38 like</td>
</tr>
<tr>
<td align="center" valign="top">TFDP1</td>
<td align="center" valign="top">-0.27631</td>
<td align="center" valign="top">0.001671</td>
<td align="center" valign="top">0.016116</td>
<td align="center" valign="top">-3.18663</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">transcription factor Dp-1</td>
</tr>
<tr>
<td align="center" valign="top">ZSWIM6</td>
<td align="center" valign="top">-0.2704</td>
<td align="center" valign="top">0.006811</td>
<td align="center" valign="top">0.04191</td>
<td align="center" valign="top">-2.73444</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">zinc finger SWIM-type containing 6</td>
</tr>
<tr>
<td align="center" valign="top">YPEL5</td>
<td align="center" valign="top">-0.26608</td>
<td align="center" valign="top">0.000443</td>
<td align="center" valign="top">0.006402</td>
<td align="center" valign="top">-3.57266</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">yippee like 5</td>
</tr>
<tr>
<td align="center" valign="top">CAMK1D</td>
<td align="center" valign="top">-0.26524</td>
<td align="center" valign="top">0.004032</td>
<td align="center" valign="top">0.029403</td>
<td align="center" valign="top">-2.90946</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">calcium/calmodulin dependent protein kinase ID</td>
</tr>
<tr>
<td align="center" valign="top">GNAQ</td>
<td align="center" valign="top">-0.2631</td>
<td align="center" valign="top">0.003636</td>
<td align="center" valign="top">0.027507</td>
<td align="center" valign="top">-2.94302</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">G protein subunit alpha q</td>
</tr>
<tr>
<td align="center" valign="top">SGK1</td>
<td align="center" valign="top">-0.26184</td>
<td align="center" valign="top">0.004447</td>
<td align="center" valign="top">0.03122</td>
<td align="center" valign="top">-2.87736</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">serum/glucocorticoid regulated kinase 1</td>
</tr>
<tr>
<td align="center" valign="top">UBE2H</td>
<td align="center" valign="top">-0.26171</td>
<td align="center" valign="top">0.003338</td>
<td align="center" valign="top">0.026007</td>
<td align="center" valign="top">-2.97052</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">ubiquitin conjugating enzyme E2 H</td>
</tr>
<tr>
<td align="center" valign="top">RNF10</td>
<td align="center" valign="top">-0.2591</td>
<td align="center" valign="top">0.003397</td>
<td align="center" valign="top">0.026318</td>
<td align="center" valign="top">-2.96489</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">ring finger protein 10</td>
</tr>
<tr>
<td align="center" valign="top">CMIP</td>
<td align="center" valign="top">-0.25797</td>
<td align="center" valign="top">0.000785</td>
<td align="center" valign="top">0.009508</td>
<td align="center" valign="top">-3.41052</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">c-Maf inducing protein</td>
</tr>
<tr>
<td align="center" valign="top">WBP2</td>
<td align="center" valign="top">-0.25642</td>
<td align="center" valign="top">0.0003</td>
<td align="center" valign="top">0.004812</td>
<td align="center" valign="top">-3.68016</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">WW domain binding protein 2</td>
</tr>
<tr>
<td align="center" valign="top">IDS</td>
<td align="center" valign="top">-0.25232</td>
<td align="center" valign="top">0.002736</td>
<td align="center" valign="top">0.022752</td>
<td align="center" valign="top">-3.03385</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">iduronate 2-sulfatase</td>
</tr>
<tr>
<td align="center" valign="top">ANXA11</td>
<td align="center" valign="top">-0.2512</td>
<td align="center" valign="top">0.005195</td>
<td align="center" valign="top">0.034762</td>
<td align="center" valign="top">-2.82586</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">annexin A11</td>
</tr>
<tr>
<td align="center" valign="top">RBM47</td>
<td align="center" valign="top">-0.2503</td>
<td align="center" valign="top">0.004286</td>
<td align="center" valign="top">0.030478</td>
<td align="center" valign="top">-2.88947</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">RNA binding motif protein 47</td>
</tr>
<tr>
<td align="center" valign="top">KAT8</td>
<td align="center" valign="top">-0.24712</td>
<td align="center" valign="top">0.004379</td>
<td align="center" valign="top">0.030931</td>
<td align="center" valign="top">-2.88245</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">lysine acetyltransferase 8</td>
</tr>
<tr>
<td align="center" valign="top">RNF141</td>
<td align="center" valign="top">-0.24646</td>
<td align="center" valign="top">0.001755</td>
<td align="center" valign="top">0.016717</td>
<td align="center" valign="top">-3.17162</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">ring finger protein 141</td>
</tr>
<tr>
<td align="center" valign="top">WDR45</td>
<td align="center" valign="top">-0.24604</td>
<td align="center" valign="top">0.004381</td>
<td align="center" valign="top">0.030937</td>
<td align="center" valign="top">-2.88224</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">WD repeat domain 45</td>
</tr>
<tr>
<td align="center" valign="top">CASC3</td>
<td align="center" valign="top">-0.24371</td>
<td align="center" valign="top">0.002782</td>
<td align="center" valign="top">0.023038</td>
<td align="center" valign="top">-3.02854</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">CASC3 exon junction complex subunit</td>
</tr>
<tr>
<td align="center" valign="top">RAB7A</td>
<td align="center" valign="top">-0.24268</td>
<td align="center" valign="top">0.002251</td>
<td align="center" valign="top">0.019946</td>
<td align="center" valign="top">-3.09494</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">RAB7A, member RAS oncogene family</td>
</tr>
<tr>
<td align="center" valign="top">MLLT1</td>
<td align="center" valign="top">-0.24026</td>
<td align="center" valign="top">0.007512</td>
<td align="center" valign="top">0.044855</td>
<td align="center" valign="top">-2.70083</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">MLLT1 super elongation complex subunit</td>
</tr>
<tr>
<td align="center" valign="top">DNAJC5</td>
<td align="center" valign="top">-0.23976</td>
<td align="center" valign="top">0.002324</td>
<td align="center" valign="top">0.02033</td>
<td align="center" valign="top">-3.08502</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">DnaJ heat shock protein family (Hsp40) member C5</td>
</tr>
<tr>
<td align="center" valign="top">B4GALT1</td>
<td align="center" valign="top">-0.23721</td>
<td align="center" valign="top">0.004137</td>
<td align="center" valign="top">0.029747</td>
<td align="center" valign="top">-2.90107</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">beta-1,4-galactosyltransferase 1</td>
</tr>
<tr>
<td align="center" valign="top">ZCCHC14</td>
<td align="center" valign="top">-0.23514</td>
<td align="center" valign="top">0.006633</td>
<td align="center" valign="top">0.041176</td>
<td align="center" valign="top">-2.7435</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">zinc finger CCHC-type containing 14</td>
</tr>
<tr>
<td align="center" valign="top">BZW1</td>
<td align="center" valign="top">-0.23476</td>
<td align="center" valign="top">0.003892</td>
<td align="center" valign="top">0.028748</td>
<td align="center" valign="top">-2.92093</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">basic leucine zipper and W2 domains 1</td>
</tr>
<tr>
<td align="center" valign="top">RYBP</td>
<td align="center" valign="top">-0.23443</td>
<td align="center" valign="top">0.005895</td>
<td align="center" valign="top">0.037786</td>
<td align="center" valign="top">-2.78349</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">RING1 and YY1 binding protein</td>
</tr>
<tr>
<td align="center" valign="top">GNB2</td>
<td align="center" valign="top">-0.23408</td>
<td align="center" valign="top">0.001941</td>
<td align="center" valign="top">0.018019</td>
<td align="center" valign="top">-3.14088</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">G protein subunit beta 2</td>
</tr>
<tr>
<td align="center" valign="top">EEF1D</td>
<td align="center" valign="top">-0.23373</td>
<td align="center" valign="top">0.00569</td>
<td align="center" valign="top">0.036912</td>
<td align="center" valign="top">-2.79544</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">eukaryotic translation elongation factor 1 delta</td>
</tr>
<tr>
<td align="center" valign="top">MAPK1</td>
<td align="center" valign="top">-0.23171</td>
<td align="center" valign="top">0.002436</td>
<td align="center" valign="top">0.021124</td>
<td align="center" valign="top">-3.07031</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">mitogen-activated protein kinase 1</td>
</tr>
<tr>
<td align="center" valign="top">KLHL24</td>
<td align="center" valign="top">-0.23087</td>
<td align="center" valign="top">0.008307</td>
<td align="center" valign="top">0.048029</td>
<td align="center" valign="top">-2.66594</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">kelch like family member 24</td>
</tr>
<tr>
<td align="center" valign="top">PPP4R1</td>
<td align="center" valign="top">-0.23022</td>
<td align="center" valign="top">0.005951</td>
<td align="center" valign="top">0.038035</td>
<td align="center" valign="top">-2.78032</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">protein phosphatase 4 regulatory subunit 1</td>
</tr>
<tr>
<td align="center" valign="top">CHP1</td>
<td align="center" valign="top">-0.22577</td>
<td align="center" valign="top">0.002763</td>
<td align="center" valign="top">0.02291</td>
<td align="center" valign="top">-3.03076</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">calcineurin like EF-hand protein 1</td>
</tr>
<tr>
<td align="center" valign="top">CDK16</td>
<td align="center" valign="top">-0.21855</td>
<td align="center" valign="top">0.005028</td>
<td align="center" valign="top">0.033925</td>
<td align="center" valign="top">-2.83678</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">cyclin dependent kinase 16</td>
</tr>
<tr>
<td align="center" valign="top">FDPS</td>
<td align="center" valign="top">-0.21774</td>
<td align="center" valign="top">0.003361</td>
<td align="center" valign="top">0.026106</td>
<td align="center" valign="top">-2.96837</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">farnesyldiphosphate synthase</td>
</tr>
<tr>
<td align="center" valign="top">OSBPL2</td>
<td align="center" valign="top">-0.21684</td>
<td align="center" valign="top">0.006654</td>
<td align="center" valign="top">0.041245</td>
<td align="center" valign="top">-2.74241</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">oxysterol binding protein like 2</td>
</tr>
<tr>
<td align="center" valign="top">PRKACA</td>
<td align="center" valign="top">-0.21604</td>
<td align="center" valign="top">0.005</td>
<td align="center" valign="top">0.033866</td>
<td align="center" valign="top">-2.83864</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">protein kinase cAMP-activated catalytic subunit alpha</td>
</tr>
<tr>
<td align="center" valign="top">LAMP1</td>
<td align="center" valign="top">-0.20879</td>
<td align="center" valign="top">0.006045</td>
<td align="center" valign="top">0.038424</td>
<td align="center" valign="top">-2.775</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">lysosomal associated membrane protein 1</td>
</tr>
<tr>
<td align="center" valign="top">DNAJB1</td>
<td align="center" valign="top">-0.20621</td>
<td align="center" valign="top">0.00732</td>
<td align="center" valign="top">0.044242</td>
<td align="center" valign="top">-2.70975</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">DnaJ heat shock protein family (Hsp40) member B1</td>
</tr>
<tr>
<td align="center" valign="top">CCNI</td>
<td align="center" valign="top">-0.20561</td>
<td align="center" valign="top">0.005766</td>
<td align="center" valign="top">0.037193</td>
<td align="center" valign="top">-2.79098</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">cyclin I</td>
</tr>
<tr>
<td align="center" valign="top">RNASEK</td>
<td align="center" valign="top">-0.20408</td>
<td align="center" valign="top">0.007377</td>
<td align="center" valign="top">0.04435</td>
<td align="center" valign="top">-2.70706</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">ribonuclease K</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="T2" position="float" orientation="portrait">
<label>Table 2</label>
<caption>
<title>The enriched GO terms of the up and down regulated differentially expressed genes</title>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr style="border-bottom: solid thin">
<th align="center" valign="top">GO ID</th>
<th align="center" valign="top">CATEGORY</th>
<th align="center" valign="top">GO Name</th>
<th align="center" valign="top">Adjusted p value</th>
<th align="center" valign="top">negative log10 of adjusted p value</th>
<th align="center" valign="top">Gene Count</th>
<th align="center" valign="top">Gene</th>
</tr>
<tr>
<th align="center" valign="top" colspan="7">Up regulated genes</th>
</tr>
</thead>
<tbody>
<tr style="border-top: solid thin">
<td align="left" valign="top">GO:0002376</td>
<td align="left" valign="top">BP</td>
<td align="left" valign="top">immune system process</td>
<td align="left" valign="top">1.62E-50</td>
<td align="left" valign="top">49.78916342</td>
<td align="left" valign="top">207</td>
<td align="left" valign="top">CXCL11,CXCL10,ISG15,IFI6,CXCL9,IFI44L,IFIT3,IFIT1,BST2,IFI27,RSAD2,OASL,SERPING1,IFIT2,USP18,UBD,IFI44,CCL8,LAG3,PLVAP,OAS3,IFITM1,GZMB,RTP4,IFITM3,OAS2,OAS1,DDX60,CXCL13,CCL2,PRF1,IDO1,CD80,DDX58,HERC5,GZMA,C1QA,BATF2,MX1,C1QB,IFIT5,PTPRO,IL4I1,IFNG,H3C7,IFIH1,JCHAIN,TICAM2,CD2,H3C12,MUC13,IGLL5,ACOD1,ADAMDEC1,PARP9,C1QC,STAT1,KLRC2,CCR5,PARP14,PTN,BTN3A3,SAA1,C4B,PDCD1LG2,H2BC11,IFI35,ADCY5,HLA-DOB,MT2A,FPR3,DPP4,TNFSF10,H3C2,TBX21,PSMB9,CAMK4,FASLG,DHX58,HLA-DMB,H4C13,BTN3A1,CD3D,CD3E,CMKLR1,ICOS,GBP1,H4C14,GRAP2,XAF1,TRIM22,LAMP3,H3C3,NMI,EOMES,THEMIS,PDCD1,ISG20,NT5C3A,SUCNR1,IRF7,HLA-F,GPR171,ADGRF5,DEFB1,SHFL,CD8A,H3C8,HLA-G,CD8B,MDK,GGT1,H3C10,IRF4,SIRPG,C4A,EIF2AK2,SH2D1A,ZAP70,TIGIT,RGS1,ZNF683,KIF15,HLA-DRB5,GSDMB,UBASH3A,CD244,C1R,STAP1,KLRC1,PSME2,PML,SLAMF8,CENPE,HLA-DMA,SLC16A1,TAP1,CTLA4,CD38,TLR3,CX3CL1,CD247,GBP5,NOS2,H2BC7,SFRP1,HLA-DRB1,AIM2,CFB,TLR7,MARCHF1,TNFSF13B,SLAMF1,DTX3L,IRF8,SLAMF7,CCR1,GFI1,IL7,ZBP1,DOK2,FCGR3A,BPIFA1,RHEX,TMEM176B,CD300E,PSMB8,H4C11,BCL11B,TAP2,BATF3,CD48,APOD,MX2,PYHIN1,APOL1,H2BC10,GBP4,H4C6,CD40LG,BACH2,CD226,CXCL12,TNFRSF13B,STAT2,CFH,CRTAM,RARRES2,GNLY,RNASE6,CARD11,H3C13,IL15RA,CPLX2,FYN,IL32,H2BC6,NLRC5,ENPP2,RAMP1,TOX,SIT1,CD96,CH25H,CD33,LGALS9,CD74</td>
</tr>
<tr>
<td align="left" valign="top">GO:0050896</td>
<td align="left" valign="top">BP</td>
<td align="left" valign="top">response to stimulus</td>
<td align="left" valign="top">1.87E-17</td>
<td align="left" valign="top">16.72713193</td>
<td align="left" valign="top">286</td>
<td align="left" valign="top">CXCL11,CXCL10,ISG15,IFI6,SIGLEC1,CXCL9,IFI44L,IFIT3,IFIT1,BST2,IFI27,RSAD2,OASL,SERPING1,IFIT2,USP18,UBD,IFI44,CMPK2,CCL8,LAG3,PLVAP,OAS3,IFITM1,RUFY4,GZMB,RTP4,IFITM3,OAS2,PTPRCAP,SMTNL1,OAS1,DDX60,TFEC,CXCL13,CCL2,PRF1,SAA4,CD80,DDX58,HERC5,GZMA,C1QA,BATF2,MX1,C1QB,IFIT5,ACE2,PTPRO,IL4I1,IFNG,APOL3,SAA2-SAA4,H3C7,IFIH1,JCHAIN,TICAM2,CD2,LRRN2,H3C12,MUC13,IGLL5,ACOD1,ADAMDEC1,PARP9,C1QC,MYBL2,STAT1,KLRC2,FAP,CCR5,PARP14,PTN,UBE2L6,BTN3A3,SAA1,SAA2,C4B,LGR6,LY6E,PDCD1LG2,H2BC11,IFI35,ADCY5,HLA-DOB,MT2A,FPR3,DPP4,TNFSF10,H3C2,TBX21,PPAN-P2RY11,FAM83A,PSMB9,CAMK4,FASLG,DHX58,HLA-DMB,ABCB1,H4C13,RNF43,BTN3A1,CD3D,CD3E,P2RX5,CMKLR1,ICOS,GBP1,H4C14,GRAP2,XAF1,PRLR,TRIM22,TPX2,LAMP3,IQSEC3,H3C3,NMI,EOMES,COL5A1,THEMIS,PDCD1,ISG20,NT5C3A,SUCNR1,IRF7,HLA-F,MGAT3,GABRB2,HESX1,LGALS3BP,GPR171,ADGRF5,DEFB1,SHFL,CD8A,H3C8,GRAP,HLA-G,HSH2D,CD8B,MDK,GGT1,H3C10,CACNA2D1,RBM11,IRF4,SIRPG,C4A,EIF2AK2,SH2D1A,ZAP70,RGS1,ZNF683,HLA-DRB5,GSDMB,UBASH3A,CD244,RORB,IGFBP4,MUSK,C1R,STAP1,KLRC1,PSME2,PML,SLAMF8,HLA-DMA,SLC16A1,TAP1,CTLA4,CD38,TLR3,POSTN,CX3CL1,PLLP,CD247,GBP5,NOS2,H2BC7,ASPM,DUOXA2,SFRP1,HLA-DRB1,DGKI,ABI3,SP140,AIM2,CFB,TLR7,MARCHF1,TNFSF13B,SLAMF1,DTX3L,BUB1,IRF8,SLAMF7,CCR1,CYP19A1,GFI1,NUPR1,UBE2T,TPSAB1,IL7,PERM1,ZBP1,DOK2,SH2D2A,FCGR3A,BPIFA1,RHEX,CD300E,MLC1,PSMB8,H4C11,BCL11B,TAP2,TEDC2,BATF3,CD48,CYP2C18,SYT13,APOD,BCL2L14,MX2,PYHIN1,PROX1,APOL1,H2BC10,GBP4,H4C6,CD40LG,BACH2,CD226,CXCL12,TNFRSF13B,STAT2,CFH,TGM2,WASF1,CRTAM,CASQ2,RARRES2,GNLY,RNASE6,CDC7,GNGT2,GRIK1,CARD11,COL4A3,H3C13,IL15RA,CPLX2,FYN,RASGRF2,IL32,HASPIN,RYR1,PLEK2,BUB1B,PAK1IP1,ADGRB2,H2BC6,SHISA8,NLRC5,PDE1C,TIMP4,ESR1,GPC4,ENPP2,FGD2,RAMP1,MTNR1A,FBXO6,SIT1,STAT4,CD96,IRS1,CH25H,CD33,LGALS9,CD74,TACR1,KIF5C,APOL2,APOC1</td>
</tr>
<tr>
<td align="left" valign="top">GO:0071944</td>
<td align="left" valign="top">CC</td>
<td align="left" valign="top">cell periphery</td>
<td align="left" valign="top">2.30055E-05</td>
<td align="left" valign="top">4.638168411</td>
<td align="left" valign="top">177</td>
<td align="left" valign="top">CXCL10,IFI6,SIGLEC1,CXCL9,BST2,SERPING1,LAG3,PLVAP,OAS3,IFITM1,GZMB,IFITM3,PTPRCAP,PRF1,OTOF,CD80,DDX58,GZMA,C1QA,MX1,IFIT5,ACE2,TRO,PTPRO,KCNA3,NKG7,IL4I1,SLC38A5,TICAM2,CD2,LRRN2,SLC43A1,MUC13,IGLL5,ADAMDEC1,C1QC,KLRC2,FAP,CCR5,PARP14,PTN,BTN3A3,C4B,LGR6,LY6E,PDCD1LG2,H2BC11,BOLL,ADCY5,HLA-DOB,FPR3,DPP4,TNFSF10,HAPLN3,PPAN-P2RY11,FASLG,HLA-DMB,ABCB1,MS4A4A,RNF43,BTN3A1,CD3D,CD3E,IGSF9B,P2RX5,CMKLR1,ICOS,CALHM6,GBP1,GRAP2,PRLR,LAMP3,COL5A1,PDCD1,SUCNR1,PLK4,HLA-F,GABRB2,LGALS3BP,GPR171,ADGRF5,ATP10A,CD8A,HLA-G,CD8B,MDK,GGT1,CACNA2D1,SIRPG,C4A,ZAP70,TIGIT,RGS1,PCDH17,HLA-DRB5,GSDMB,CD244,MUSK,KLRC1,CD69,RIMBP2,HLA-DMA,SLC16A1,CTLA4,CD38,TLR3,POSTN,CX3CL1,VAMP5,CD247,MYO7A,NOS2,ASPM,DUOXA2,SFRP1,HLA-DRB1,DGKI,CFB,TLR7,MARCHF1,TNFSF13B,SLAMF1,SLAMF7,CCR1,TPSAB1,IL7,FCGR3A,RHEX,CD300E,MLC1,CD48,SYT13,MX2,CLCNKB,KCNA2,GBP4,CD40LG,CD226,CXCL12,TNFRSF13B,DPP10,STAT2,CD72,TGM2,CRTAM,RARRES2,CD52,GNGT2,GRIK1,CARD11,COL4A3,IL15RA,FXYD6,FYN,RASGRF2,RYR1,PLEK2,ADGRB2,SHISA8,SLC12A3,TIMP4,ESR1,GPC4,ENPP2,FGD2,RAMP1,SLC26A1,MTNR1A,ACY3,SIT1,CD96,IRS1,CD33,EXOC3L4,LGALS9,CD74,TACR1</td>
</tr>
<tr>
<td align="left" valign="top">GO:0005886</td>
<td align="left" valign="top">CC</td>
<td align="left" valign="top">plasma membrane</td>
<td align="left" valign="top">0.000248423</td>
<td align="left" valign="top">3.604808763</td>
<td align="left" valign="top">160</td>
<td align="left" valign="top">CXCL10,IFI6,SIGLEC1,CXCL9,BST2,LAG3,PLVAP,OAS3,IFITM1,GZMB,IFITM3,PTPRCAP,PRF1,OTOF,CD80,DDX58,GZMA,MX1,IFIT5,ACE2,TRO,PTPRO,KCNA3,NKG7,IL4I1,SLC38A5,TICAM2,CD2,SLC43A1,MUC13,IGLL5,KLRC2,FAP,CCR5,PARP14,PTN,BTN3A3,C4B,LGR6,LY6E,PDCD1LG2,H2BC11,BOLL,ADCY5,HLA-DOB,FPR3,DPP4,TNFSF10,PPAN-P2RY11,FASLG,HLA-DMB,ABCB1,MS4A4A,RNF43,BTN3A1,CD3D,CD3E,IGSF9B,P2RX5,CMKLR1,ICOS,CALHM6,GBP1,GRAP2,PRLR,LAMP3,PDCD1,SUCNR1,PLK4,HLA-F,GABRB2,GPR171,ADGRF5,ATP10A,CD8A,HLA-G,CD8B,GGT1,CACNA2D1,SIRPG,C4A,ZAP70,TIGIT,RGS1,PCDH17,HLA-DRB5,GSDMB,CD244,MUSK,KLRC1,CD69,RIMBP2,HLA-DMA,SLC16A1,CTLA4,CD38,TLR3,CX3CL1,VAMP5,CD247,MYO7A,NOS2,ASPM,DUOXA2,SFRP1,HLA-DRB1,DGKI,CFB,TLR7,MARCHF1,TNFSF13B,SLAMF1,SLAMF7,CCR1,FCGR3A,RHEX,CD300E,MLC1,CD48,SYT13,MX2,CLCNKB,KCNA2,GBP4,CD40LG,CD226,CXCL12,TNFRSF13B,DPP10,STAT2,CD72,TGM2,CRTAM,CD52,GNGT2,GRIK1,CARD11,IL15RA,FXYD6,FYN,RASGRF2,RYR1,PLEK2,ADGRB2,SHISA8,SLC12A3,ESR1,GPC4,ENPP2,FGD2,RAMP1,SLC26A1,MTNR1A,ACY3,SIT1,CD96,IRS1,CD33,CD74,TACR1</td>
</tr>
<tr>
<td align="left" valign="top">GO:0005488</td>
<td align="left" valign="top">MF</td>
<td align="left" valign="top">binding</td>
<td align="left" valign="top">0.000131237</td>
<td align="left" valign="top">3.881945019</td>
<td align="left" valign="top">385</td>
<td align="left" valign="top">CXCL11,CXCL10,ISG15,IFI6,SIGLEC1,CXCL9,IFI44L,IFIT3,IFIT1,BST2,IFI27,RSAD2,OASL,SERPING1,IFIT2,USP18,EPSTI1,UBD,IFI44,CMPK2,KLHDC7B,CCL8,LAG3,PLVAP,OAS3,IFITM1,RUFY4,PLAAT2,GZMB,RTP4,IFITM3,OAS2,GIMAP7,PTPRCAP,ANXA10,SMTNL1,OAS1,DDX60,TFEC,CXCL13,CCL2,PRF1,SAA4,ETV7,OTOF,SAMD9L,GIMAP8,IDO1,CD80,GIMAP5,DDX58,HERC5,GZMA,C1QA,BATF2,MX1,C1QB,IFIT5,GIMAP6,ACE2,TRO,PRRX2,PTPRO,KCNA3,NKG7,GIMAP4,IL4I1,H2AC16,IFNG,APOL3,PCSK5,H3C7,H2AC19,IFIH1,JCHAIN,TICAM2,CD2,LRRN2,ZNF831,H3C12,SLC43A1,MUC13,IGLL5,ADAMDEC1,PARP9,C1QC,MYBL2,STAT1,KLRC2,UBQLNL,H2AC14,FAP,CCR5,PARP14,NRSN1,PTN,UBE2L6,BTN3A3,SAA1,SAA2,H1-5,C4B,LGR6,LY6E,LAP3,SAMD9,PDCD1LG2,H2BC11,BOLL,IFI35,ADCY5,HLA-DOB,MT2A,WDR74,FBXO39,DPP4,TNFSF10,H3C2,HAPLN3,TBX21,H2BC14,H2BC17,H2AC12,PPAN-P2RY11,FAM83A,PSMB9,CAMK4,FASLG,DHX58,HLA-DMB,ABCB1,H4C13,MS4A4A,RNF43,BTN3A1,CD3D,CD3E,IGSF9B,P2RX5,CMKLR1,ICOS,CALHM6,H2BC3,GBP1,H4C14,GRAP2,XAF1,PRLR,TRIM22,TPX2,IQSEC3,H3C3,NMI,EOMES,COL5A1,THEMIS,PDCD1,ISG20,NT5C3A,SUCNR1,PSAT1,PLK4,IRF7,HLA-F,MGAT3,PPM1J,HESX1,LGALS3BP,ADGRF5,PARP12,ATP10A,DEFB1,SHFL,CD8A,H3C8,GRAP,KRT39,HLA-G,HSH2D,CD8B,C17ORF67,FUOM,MDK,GGT1,H3C10,CACNA2D1,RBM11,IRF4,SIRPG,ASCL3,C4A,EIF2AK2,SH2D1A,ZAP70,TIGIT,RGS1,ZNF683,KIF15,PCDH17,HLA-DRB5,GSDMB,UBASH3A,H2AC17,CD244,RORB,IGFBP4,MUSK,C1R,STAP1,KLRC1,CD69,PSME2,PML,SLAMF8,AGR3,LKAAEAR1,SPATS2L,RIMBP2,WARS1,CENPE,HLA-DMA,SLC16A1,TAP1,H2AC13,CTLA4,CD38,TLR3,POSTN,CX3CL1,VAMP5,HDX,PLLP,CD247,GBP5,MYO7A,ENDOD1,NOS2,MUC19,TMEM187,H2BC7,ASPM,DUOXA2,SFRP1,CDCA7,HLA-DRB1,DGKI,ABI3,SP140,TRANK1,AIM2,CFB,TLR7,MARCHF1,TNFSF13B,SLAMF1,DTX3L,BUB1,IRF8,PLAAT4,SLAMF7,CCR1,CYP19A1,GFI1,NUPR1,UBE2T,TPSAB1,NUSAP1,IL7,ZBP1,DOK2,SH2D2A,FCGR3A,BPIFA1,B4GALT6,RHEX,TMEM176B,FAM241B,CD300E,MLC1,PSMB8,H4C11,BCL11B,TAP2,ZNF311,TEDC2,BATF3,CD48,UBQLN3,CYP2C18,SYT13,APOD,BCL2L14,MX2,GIMAP1,PYHIN1,PROX1,MB21D2,CCDC103,ZNF367,APOL1,H2BC10,CLCNKB,KCNA2,GBP4,H4C6,CD40LG,BACH2,SP110,CD226,CXCL12,TNFRSF13B,DPP10,STAT2,CD72,CFH,TGM2,WASF1,H2BC13,CRTAM,CASQ2,RARRES2,GNLY,DUS4L-BCAP29,RNASE6,CDC7,GNGT2,CARD11,COL4A3,H3C13,IL15RA,FXYD6,CPLX2,SLFN5,FYN,RASGRF2,IL32,HASPIN,HELZ2,RYR1,MS4A7,TUBA8,PLEK2,BUB1B,PAK1IP1,ADGRB2,H2BC6,ZSCAN23,SLC12A3,NLRC5,H2AC7,PDE1C,TIMP4,MAP10,ESR1,GPC4,ENPP2,FGD2,RAMP1,GAL3ST4,SLC26A1,GOLGA8Q,MTNR1A,H2AC20,TMEM42,FBXO6,ACY3,TOX,ZNF682,SIT1,STAT4,PPM1K,STAMBPL1,RNASE1,IRS1,CH25H,SEC16B,CD33,EXOC3L4,LGALS9,TMSB10,CD74,TACR1,KIF5C,APOL2,APOC1</td>
</tr>
<tr>
<td align="left" valign="top">GO:0042802</td>
<td align="left" valign="top">MF</td>
<td align="left" valign="top">identical protein binding</td>
<td align="left" valign="top">0.000745002</td>
<td align="left" valign="top">3.127842328</td>
<td align="left" valign="top">72</td>
<td align="left" valign="top">IFIT3,BST2,IFI27,PLVAP,GIMAP7,PRF1,DDX58,GZMA,MX1,ACE2,PTPRO,IFIH1,JCHAIN,CD2,MUC13,STAT1,FAP,CCR5,IFI35,DPP4,TNFSF10,FAM83A,CD3D,CD3E,GBP1,TRIM22,NMI,PSAT1,PLK4,HESX1,DEFB1,SHFL,HLA-G,RBM11,EIF2AK2,TIGIT,CD69,PSME2,PML,SLAMF8,WARS1,SLC16A1,TAP1,CD38,TLR3,CD247,GBP5,MYO7A,NOS2,H2BC7,SFRP1,ABI3,AIM2,SLAMF1,SLAMF7,TPSAB1,ZBP1,MLC1,CCDC103,H2BC10,GBP4,STAT2,CFH,TGM2,CRTAM,CASQ2,FYN,H2BC6,ESR1,ACY3,STAT4,CD74</td>
</tr>
<tr style="border-top: solid thin">
<td align="center" valign="top" colspan="7">Down regulated genes</td>
</tr>
<tr style="border-top: solid thin">
<td align="left" valign="top">GO:0007154</td>
<td align="left" valign="top">BP</td>
<td align="left" valign="top">cell communication</td>
<td align="left" valign="top">2.39175E-06</td>
<td align="left" valign="top">5.621283626</td>
<td align="left" valign="top">165</td>
<td align="left" valign="top">SCGB3A1,IL1R2,KLF15,PDGFRB,CXCL8,MUC7,KLF2,PADI2,DGAT2,FOS,ADM,MUC21,HBEGF,KLF7,DSC2,ICAM3,DUSP1,NAMPT,IL1R1,EGR1,ADRB3,FCER1A,ZFP36,EGR3,BTG2,OR2B11,C5AR2,IER3,ANPEP,ZNF219,CASS4,TRIB1,PLEKHG2,SCN2A,LITAF,KREMEN1,NEDD9,C5AR1,JUNB,GPR85,NDRG1,SOD2,ARRB2,OXSR1,UPP1,NR4A1,IVNS1ABP,METRNL,BCL6,IL6R,ATP2B1,CD44,TLE3,PPIF,MAP2K3,GAB2,NDEL1,REPS2,TNFRSF10D,NFKBIA,OR2L2,LRG1,CEBPB,MAPK13,FGD4,INPP5A,MYADM,PLK3,SHKBP1,SLC12A6,CNOT11,PRKDC,PID1,RALGDS,RASA2,PFKFB2,MAML3,PPP1R15A,STAT5B,LFNG,FOXO4,SPAG9,MAP4K4,MTURN,PER1,CDC42EP3,HIP1R,NR4A2,SH3BP2,PACSIN2,INPP5K,MYH9,IRS2,SDCBP,RASSF5,SH3BP5,TNIP1,SULF2,PTPN12,DOT1L,ATP6V1B2,CDC42BPG,CXCL16,PTEN,PELI1,MAP3K20,OSBPL8,RXRA,SEC14L1,SYAP1,MAP3K11,NIBAN2,MAPKAPK2,NUDT3,FRAT2,ZMIZ1,SLC44A2,SORT1,PIM3,NDRG2,STX3,TPT1,FOXO3,DDIT4,ZC3H3,MAP1LC3B,MAP3K8,SEMA4A,PXN,RHOQ,GABARAPL1,PINK1,SERINC3,UBE2D1,CPEB4,GABARAP,IQGAP1,BLOC1S6,ZFP36L1,RIOK3,ADIPOR1,PPARD,EIF4EBP2,MTMR3,GLUL,DNM2,PRKCD,USF2,STK38L,TFDP1,GNAQ,SGK1,WBP2,WDR45,RAB7A,DNAJC5,GNB2,EEF1D,MAPK1,KLHL24,PPP4R1,CHP1,CDK16,PRKACA,LAMP1</td>
</tr>
<tr>
<td align="left" valign="top">GO:0051179</td>
<td align="left" valign="top">BP</td>
<td align="left" valign="top">localization</td>
<td align="left" valign="top">7.21663E-06</td>
<td align="left" valign="top">5.141665586</td>
<td align="left" valign="top">162</td>
<td align="left" valign="top">KLF15,CD207,TULP2,RGPD2,PDGFRB,CXCL8,BEST1,PADI2,DGAT2,THBD,ADM,HBEGF,ATP8,STATH,KLF7,DSC2,ICAM3,DUSP1,FTH1,IL1R1,ZFP36,EGR3,ZSWIM4,C5AR2,ANPEP,CASS4,TRIB1,PYGL,SCN2A,ABHD5,TSC22D3,NEDD9,C5AR1,SOD2,DENND5A,ARRB2,OXSR1,ATG9B,SLC25A37,NR4A1,LAMB3,IMPDH1,TCN1,BCL6,IL6R,ATP2B1,CD44,PPIF,MAP2K3,GAB2,NDEL1,REPS2,TNFRSF10D,NFKBIA,ST3GAL4,LRG1,TP53INP2,CEBPB,SLC45A4,PNPLA8,CD302,MYADM,PLK3,SLC12A6,PID1,RABGEF1,PFKFB2,FAM53C,PPP1R15A,STAT5B,FOXO4,CEP68,NIN,MAN2B1,BICD2,SPAG9,MAP4K4,PER1,HIP1R,NR4A2,PACSIN2,PICALM,INPP5K,MYH9,IRS2,UBAP1,SSH2,SDCBP,RASSF5,RAB31,TMCO3,EIF2D,OSBPL1A,ATP6V1B2,CXCL16,PTEN,ERGIC1,ACTN1,OSBPL8,RXRA,SEC14L1,NIBAN2,STEAP4,MAPKAPK2,ZMIZ1,TUBA4A,SLC44A2,SORT1,LYST,PIM3,STX3,TPT1,NUP98,FOXO3,DDIT4,ZC3H3,VPS37B,TBC1D14,EEF2,ASAH1,SEMA4A,PXN,ARFGAP3,RHOQ,RAB3D,PINK1,UBE2D1,KLHL21,GABARAP,IQGAP1,BLOC1S6,ZFP36L1,ADIPOR1,PPARD,SLC25A40,SNX18,WDR1,RANBP2,GLUL,DNM2,PRKCD,USF2,DOP1B,TFDP1,ZSWIM6,YPEL5,CAMK1D,SGK1,WBP2,ANXA11,WDR45,CASC3,RAB7A,DNAJC5,B4GALT1,MAPK1,KLHL24,CHP1,CDK16,OSBPL2,PRKACA,LAMP1</td>
</tr>
<tr>
<td align="left" valign="top">GO:0005829</td>
<td align="left" valign="top">CC</td>
<td align="left" valign="top">cytosol</td>
<td align="left" valign="top">9.83E-13</td>
<td align="left" valign="top">12.00737015</td>
<td align="left" valign="top">154</td>
<td align="left" valign="top">SPRR3,BEST1,KRT13,PADI2,DGAT2,FOS,KLF7,FTH1,NAMPT,AMPD2,ARHGEF40,ZFP36,BTG2,IER3,TRIB1,PLEKHG2,PFKFB3,PYGL,ABHD5,TSC22D3,NEDD9,GYS1,NDRG1,ABTB1,DENND5A,ARRB2,OXSR1,UPP1,NR4A1,GPCPD1,IVNS1ABP,IMPDH1,CD44,PHLDA1,MAP2K3,GAB2,NDEL1,JOSD1,REPS2,NFKBIA,PI3,GSTO2,TP53INP2,USP32,MAPK13,FGD4,CNOT11,PRKDC,RALGDS,RABGEF1,RASA2,PFKFB2,PPP1R15A,STAT5B,FOXO4,CEP68,BICD2,SPAG9,NIBAN1,PER1,CDC42EP3,ETS2,HIP1R,PACSIN2,PICALM,INPP5K,MYH9,EIF3L,IRS2,KDM4B,UBAP1,SDCBP,TPM4,RAB31,KLHL2,TNIP1,EIF2D,OSBPL1A,PTPN12,ATP6V1B2,CDC42BPG,PTEN,PELI1,MAP3K20,ACTN1,OSBPL8,RXRA,SEC14L1,SYAP1,NIBAN2,MAPKAPK2,NUDT3,FRAT2,ERF,ZMIZ1,TUBA4A,SORT1,LYST,PIM3,NDRG2,TPT1,NUP98,FOXO3,DDIT4,TBC1D14,TFE3,MAP1LC3B,EEF2,MAP3K8,PXN,ARFGAP3,RNF144B,UBE2R2,RHOQ,GABARAPL1,PINK1,PABPC1,UBE2D1,KLHL21,IDI1,GABARAP,IQGAP1,BLOC1S6,ZFP36L1,RIOK3,WDR1,TKT,MTMR3,RANBP2,GLUL,DNM2,PRKCD,DOP1B,STK38L,TFDP1,SGK1,UBE2H,CMIP,ANXA11,WDR45,CASC3,RAB7A,MLLT1,DNAJC5,GNB2,EEF1D,MAPK1,CHP1,CDK16,FDPS,OSBPL2,PRKACA,LAMP1,DNAJB1</td>
</tr>
<tr>
<td align="left" valign="top">GO:0005622</td>
<td align="left" valign="top">CC</td>
<td align="left" valign="top">intracellular anatomical structure</td>
<td align="left" valign="top">0.00246019</td>
<td align="left" valign="top">2.609031391</td>
<td align="left" valign="top">270</td>
<td align="left" valign="top">TGM3,IL1R2,KLF15,FOSB,CD207,TULP2,RGPD2,SPRR3,PDGFRB,MUC7,BEST1,CAMK1G,SRSF12,KRT13,KLF2,PADI2,DGAT2,THBD,FOS,ADM,MUC21,HBEGF,DCUN1D3,ATP8,KLF7,DSC2,DUSP1,FTH1,PNRC1,NAMPT,EGR1,AMPD2,ARHGEF40,ZFP36,EGR3,BTG2,TMEM71,FOSL2,IER3,ANPEP,ZNF219,CASS4,NCCRP1,TRIB1,PLEKHG2,GK3P,PFKFB3,PYGL,LITAF,ABHD5,TSC22D3,NEDD9,ZNF442,C5AR1,JUNB,CTDSP1,GPR85,GYS1,NDRG1,SOD2,ABTB1,DENND5A,ARRB2,OXSR1,ATG9B,SLC25A37,UPP1,NR4A1,GPCPD1,IVNS1ABP,IMPDH1,TCN1,PLEKHG6,BCL6,ATP2B1,CD44,KLLN,PHLDA1,COL6A3,TLE3,PPIF,MAP2K3,GAB2,NDEL1,OPA3,JOSD1,REPS2,NFKBIA,PI3,GSTO2,ST3GAL4,LRG1,TP53INP2,CEBPB,USP32,KATNBL1,PNPLA8,MAPK13,FGD4,CD302,MYADM,PLK3,SHKBP1,CNOT11,PRKDC,MBOAT2,PID1,RALGDS,RABGEF1,RASA2,PFKFB2,FAM53C,MAML3,PPP1R15A,STAT5B,LFNG,FOXO4,CEP68,NIN,MAN2B1,BICD2,SPAG9,NIBAN1,MAP4K4,MTURN,PER1,CDC42EP3,ETS2,HIP1R,NR4A2,MAEA,PACSIN2,PICALM,INPP5K,MYH9,EIF3L,IRS2,KDM4B,UBAP1,NBPF9,SSH2,ABHD12B,SDCBP,RASSF5,TPD52L2,TPM4,SH3BP5,RAB31,KLHL2,TNIP1,SULF2,EIF2D,MORC4,OSBPL1A,PTPN12,DOT1L,ATP6V1B2,CDC42BPG,PTEN,PELI1,MAP3K20,ERGIC1,ACTN1,OSBPL8,RXRA,SEC14L1,SYAP1,MAP3K11,NIBAN2,STEAP4,CCNG2,MAPKAPK2,CCNQ,NUDT3,FRAT2,ERF,ZMIZ1,TUBA4A,SLC44A2,SORT1,LYST,PHF20L1,PIM3,NDRG2,STX3,ELL2,TPT1,R3HDM4,NUP98,FOXO3,DDIT4,ZC3H3,VPS37B,TBC1D14,TFE3,MAP1LC3B,FRMD4B,EEF2,ASAH1,MAP3K8,PXN,ARFGAP3,RNF144B,UBE2R2,RHOQ,IRF2BP2,GABARAPL1,RAB3D,PINK1,SERINC3,PABPC1,ZNF185,UBE2D1,CPEB4,KLHL21,IDI1,GABARAP,IQGAP1,BLOC1S6,ZFP36L1,RIOK3,PPARD,SLC25A40,YPEL3,SNX18,WDR1,MSL1,TKT,EIF4EBP2,MTMR3,EIF1,RANBP2,GLUL,DNM2,PRKCD,USF2,DOP1B,STK38L,TFDP1,YPEL5,CAMK1D,GNAQ,SGK1,UBE2H,RNF10,CMIP,WBP2,ANXA11,RBM47,KAT8,WDR45,CASC3,RAB7A,MLLT1,DNAJC5,B4GALT1,BZW1,RYBP,GNB2,EEF1D,MAPK1,KLHL24,CHP1,CDK16,FDPS,OSBPL2,PRKACA,LAMP1,DNAJB1,CCNI</td>
</tr>
<tr>
<td align="left" valign="top">GO:0005515</td>
<td align="left" valign="top">MF</td>
<td align="left" valign="top">protein binding</td>
<td align="left" valign="top">0.00811341</td>
<td align="left" valign="top">2.090796575</td>
<td align="left" valign="top">269</td>
<td align="left" valign="top">SCGB3A1,IL1R2,KLF15,FOSB,CD207,RGPD2,SPRR3,PDGFRB,CXCL8,MUC7,BEST1,CAMK1G,SRSF12,KRT13,KLF2,PADI2,DGAT2,THBD,FOS,ADM,HBEGF,DCUN1D3,STATH,BTBD19,DSC2,ICAM3,DUSP1,LOXHD1,FTH1,PNRC1,NAMPT,IL1R1,EGR1,TREML2,ADRB3,ALPL,AMPD2,FCER1A,ZFP36,BTG2,TMEM71,C5AR2,FOSL2,IER3,ZNF219,CASS4,NCCRP1,TRIB1,PLEKHG2,PFKFB3,LYPD3,PYGL,SCN2A,A2ML1,LITAF,ABHD5,TSC22D3,KREMEN1,NEDD9,C5AR1,JUNB,CTDSP1,GPR85,GYS1,NDRG1,SOD2,ABTB1,DENND5A,ARRB2,OXSR1,SLC25A37,UPP1,NR4A1,LAMB3,IVNS1ABP,IMPDH1,METRNL,TCN1,PLEKHG6,BCL6,IL6R,ATP2B1,CD44,PHLDA1,COL6A3,TLE3,PPIF,MAP2K3,GAB2,NDEL1,JOSD1,REPS2,TNFRSF10D,NFKBIA,GSTO2,LRG1,TP53INP2,CEBPB,USP32,KATNBL1,MAPK13,FGD4,CD302,INPP5A,MYADM,GPX3,PLK3,SHKBP1,SLC12A6,CNOT11,PRKDC,PID1,RALGDS,RABGEF1,PFKFB2,FAM53C,PPP1R15A,STAT5B,FOXO4,CEP68,NIN,BICD2,SPAG9,NIBAN1,MAP4K4,MTURN,PER1,CDC42EP3,ETS2,MANSC1,HIP1R,NR4A2,MAEA,SH3BP2,PACSIN2,PICALM,INPP5K,MYH9,EIF3L,IRS2,UBAP1,SSH2,ABHD12B,SDCBP,RASSF5,TPD52L2,TPM4,SH3BP5,RAB31,KLHL2,TNIP1,MORC4,OSBPL1A,PTPN12,DOT1L,C16ORF72,ATP6V1B2,CDC42BPG,CXCL16,PTEN,PELI1,MAP3K20,ERGIC1,ACTN1,OSBPL8,NATD1,RXRA,SEC14L1,SYAP1,MAP3K11,NIBAN2,MAPKAPK2,CCNQ,NUDT3,ERF,ZMIZ1,TUBA4A,SORT1,LYST,PHF20L1,PIM3,NDRG2,STX3,ELL2,TPT1,NUP98,FOXO3,DDIT4,ZC3H3,VPS37B,TBC1D14,TFE3,MAP1LC3B,EEF2,ASAH1,MAP3K8,SEMA4A,PXN,ARFGAP3,RNF144B,UBE2R2,RHOQ,GABARAPL1,RAB3D,PINK1,SERINC3,PABPC1,ZNF185,UBE2D1,CPEB4,KLHL21,IDI1,GABARAP,IQGAP1,BLOC1S6,ZFP36L1,RIOK3,ADIPOR1,PPARD,SNX18,WDR1,MSL1,TKT,EIF4EBP2,MTMR3,EIF1,RANBP2,GLUL,DNM2,PRKCD,USF2,DOP1B,STK38L,TFDP1,YPEL5,CAMK1D,GNAQ,SGK1,UBE2H,RNF10,CMIP,WBP2,ANXA11,RBM47,KAT8,RNF141,WDR45,CASC3,RAB7A,MLLT1,DNAJC5,B4GALT1,ZCCHC14,BZW1,RYBP,GNB2,EEF1D,MAPK1,KLHL24,PPP4R1,CHP1,CDK16,FDPS,OSBPL2,PRKACA,LAMP1,DNAJB1,CCNI,RNASEK</td>
</tr>
<tr>
<td align="left" valign="top">GO:0043167</td>
<td align="left" valign="top">MF</td>
<td align="left" valign="top">ion binding</td>
<td align="left" valign="top">0.025064963</td>
<td align="left" valign="top">1.600932924</td>
<td align="left" valign="top">127</td>
<td align="left" valign="top">TGM3,KLF15,PDGFRB,CAMK1G,KLF2,PADI2,THBD,KLF7,DSC2,FTH1,EGR1,ALPL,AMPD2,ZFP36,EGR3,ZSWIM4,ANPEP,ZNF219,TRIB1,GK3P,PFKFB3,PYGL,LITAF,ZNF442,CTDSP1,SOD2,OXSR1,NR4A1,IMPDH1,BCL6,ATP2B1,MAP2K3,GAB2,REPS2,USP32,PNPLA8,MAPK13,FGD4,PLK3,CPD,PRKDC,RABGEF1,RASA2,PFKFB2,LFNG,NIN,MAN2B1,MAP4K4,HIP1R,NR4A2,MAEA,PACSIN2,PICALM,MYH9,KDM4B,PCDHB1,SDCBP,RASSF5,TPM4,RAB31,SULF2,MORC4,ATP6V1B2,CDC42BPG,MAP3K20,ACTN1,RXRA,MAP3K11,STEAP4,MAPKAPK2,NUDT3,ZMIZ1,TUBA4A,PHF20L1,PIM3,STX3,TPT1,ZC3H3,EEF2,MAP3K8,PXN,ARFGAP3,RNF144B,UBE2R2,RHOQ,IRF2BP2,RAB3D,PINK1,ZNF185,UBE2D1,CPEB4,IDI1,IQGAP1,ZFP36L1,RIOK3,ADIPOR1,PPARD,YPEL3,SNX18,TKT,MTMR3,RANBP2,GLUL,DNM2,PRKCD,STK38L,ZSWIM6,YPEL5,CAMK1D,GNAQ,SGK1,UBE2H,RNF10,ANXA11,KAT8,RNF141,WDR45,RAB7A,B4GALT1,ZCCHC14,RYBP,MAPK1,CHP1,CDK16,FDPS,OSBPL2,PRKACA</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="T3" position="float" orientation="portrait">
<label>Table 3</label>
<caption>
<title>The enriched pathway terms of the up and down regulated differentially expressed genes</title>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr style="border-bottom: solid thin">
<th align="center" valign="top">Pathway ID</th>
<th align="center" valign="top">Pathway Name</th>
<th align="center" valign="top">Adjusted p value</th>
<th align="center" valign="top">Negative log10 of adjusted p value</th>
<th align="center" valign="top">Gene Count</th>
<th align="center" valign="top">Gene</th>
</tr>
<tr>
<th align="center" valign="top" colspan="7">Up regulated genes</th>
</tr>
</thead>
<tbody>
<tr style="border-top: solid thin">
<td align="left" valign="top">REAC:R-HSA-168256</td>
<td align="left" valign="top">Immune System</td>
<td align="left" valign="top">5.34E-25</td>
<td align="left" valign="top">24.27238886</td>
<td align="left" valign="top">127</td>
<td align="left" valign="top">CXCL10,ISG15,IFI6,SIGLEC1,IFIT3,IFIT1,BST2,IFI27,RSAD2,OASL,SERPING1,IFIT2,USP18,LAG3,HERC6,OAS3,IFITM1,IFITM3,OAS2,OAS1,CCL2,CD80,DDX58,HERC5,C1QA,MX1,IFIT5,IFNG,H3C7,IFIH1,TICAM2,H3C12,MUC13,C1QC,STAT1,KLRC2,CCR5,UBE2L6,BTN3A3,SAA1,C4B,PDCD1LG2,IFI35,HLA-DOB,MT2A,H3C2,PSMB9,FASLG,DHX58,HLA-DMB,BTN3A1,CD3D,CD3E,GBP1,GRAP2,XAF1,PRLR,TRIM22,H3C3,PDCD1,ISG20,IRF7,HLA-F,DEFB1,CD8A,H3C8,HLA-G,CD8B,H3C10,IRF4,C4A,EIF2AK2,SH2D1A,ZAP70,KIF15,HLA-DRB5,KLRC1,PSME2,PML,CENPE,HLA-DMA,TAP1,CTLA4,TLR3,GBP5,NOS2,HLA-DRB1,AIM2,CFB,TLR7,TNFSF13B,DTX3L,IRF8,SLAMF7,CCR1,IL7,ZBP1,FCGR3A,BPIFA1,CD300E,PSMB8,TAP2,MX2,GBP4,CD40LG,CD226,TNFRSF13B,STAT2,CFH,WASF1,CRTAM,GNLY,RNASE6,CARD11,H3C13,IL15RA,FYN,IL32,TUBA8,NLRC5,FBXO6,STAT4,CD96,IRS1,CD33,LGALS9,CD74</td>
</tr>
<tr>
<td align="left" valign="top">REAC:R-HSA-3214815</td>
<td align="left" valign="top">HDACs deacetylate histones</td>
<td align="left" valign="top">1.06E-19</td>
<td align="left" valign="top">18.97494292</td>
<td align="left" valign="top">27</td>
<td align="left" valign="top">H2AC16,H3C7,H2AC19,H3C12,H2AC14,H2BC11,H3C2,H2BC14,H2BC17,H2AC12,H4C13,H2BC3,H4C14,H3C3,H3C8,H3C10,H2AC17,H2AC13,H2BC7,H4C11,H2BC10,H4C6,H2BC13,H3C13,H2BC6,H2AC7,H2AC20</td>
</tr>
<tr>
<td align="left" valign="top">REAC:R-HSA-5689880</td>
<td align="left" valign="top">Ub-specific processing proteases</td>
<td align="left" valign="top">2.76E-07</td>
<td align="left" valign="top">6.558680932</td>
<td align="left" valign="top">22</td>
<td align="left" valign="top">USP18,DDX58,H2AC16,H2AC19,IFIH1,H2AC14,H2BC11,H2BC14,H2BC17,H2AC12,PSMB9,H2BC3,H2AC17,PSME2,H2AC13,H2BC7,PSMB8,H2BC10,H2BC13,H2BC6,H2AC7,H2AC20</td>
</tr>
<tr>
<td align="left" valign="top">REAC:R-HSA-1280218</td>
<td align="left" valign="top">Adaptive Immune System</td>
<td align="left" valign="top">6.37E-08</td>
<td align="left" valign="top">7.195827239</td>
<td align="left" valign="top">48</td>
<td align="left" valign="top">SIGLEC1,LAG3,HERC6,IFITM1,CD80,HERC5,UBE2L6,BTN3A3,PDCD1LG2,HLA-DOB,PSMB9,HLA-DMB,BTN3A1,CD3D,CD3E,GRAP2,PDCD1,HLA-F,CD8A,HLA-G,CD8B,SH2D1A,ZAP70,KIF15,HLA-DRB5,KLRC1,PSME2,CENPE,HLA-DMA,TAP1,CTLA4,HLA-DRB1,DTX3L,SLAMF7,FCGR3A,CD300E,PSMB8,TAP2,CD40LG,CD226,CRTAM,CARD11,FYN,TUBA8,FBXO6,CD96,CD33,CD74</td>
</tr>
<tr>
<td align="left" valign="top">REAC:R-HSA-5663205</td>
<td align="left" valign="top">Infectious disease</td>
<td align="left" valign="top">6.85E-08</td>
<td align="left" valign="top">7.164097591</td>
<td align="left" valign="top">52</td>
<td align="left" valign="top">ISG15,ACE2,H2AC16,H3C7,H2AC19,H3C12,PARP9,H2AC14,CCR5,PARP14,H2BC11,ADCY5,H3C2,H2BC14,H2BC17,H2AC12,PSMB9,H4C13,H2BC3,H4C14,H3C3,PDCD1,H3C8,CD8B,GGT1,H3C10,EIF2AK2,H2AC17,PSME2,PML,H2AC13,NOS2,H2BC7,TLR7,ZBP1,FCGR3A,PSMB8,H4C11,H2BC10,H4C6,STAT2,WASF1,H2BC13,GNGT2,H3C13,FXYD6,FYN,TUBA8,H2BC6,H2AC7,RAMP1,H2AC20</td>
</tr>
<tr>
<td align="left" valign="top">REAC:R-HSA-198933</td>
<td align="left" valign="top">Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell</td>
<td align="left" valign="top">4.88047E-06</td>
<td align="left" valign="top">5.311538043</td>
<td align="left" valign="top">18</td>
<td align="left" valign="top">SIGLEC1,IFITM1,CD3D,CD3E,HLA-F,CD8A,HLA-G,CD8B,SH2D1A,KLRC1,SLAMF7,FCGR3A,CD300E,CD40LG,CD226,CRTAM,CD96,CD33</td>
</tr>
<tr style="border-top: solid thin">
<td align="center" valign="top" colspan="7">Down regulated genes</td>
</tr>
<tr style="border-top: solid thin">
<td align="left" valign="top">REAC:R-HSA-187037</td>
<td align="left" valign="top">   Signaling by NTRK1 (TRKA)</td>
<td align="left" valign="top">0.000139886</td>
<td align="left" valign="top">3.854225447</td>
<td align="left" valign="top">13</td>
<td align="left" valign="top">FOSB,FOS,EGR1,EGR3,TRIB1,JUNB,MAPK13,RALGDS,IRS2,MAPKAPK2,DNM2,SGK1,MAPK1</td>
</tr>
<tr>
<td align="left" valign="top">REAC:R-HSA-168256</td>
<td align="left" valign="top">  Immune System</td>
<td align="left" valign="top">0.000483116</td>
<td align="left" valign="top">3.315948984</td>
<td align="left" valign="top">68</td>
<td align="left" valign="top">IL1R2,CD207,CXCL8,MUC7,PADI2,FOS,MUC21,ICAM3,FTH1,IL1R1,EGR1,TREML2,FCER1A,C5AR2,ANPEP,PYGL,C5AR1,JUNB,SOD2,IMPDH1,TCN1,BCL6,IL6R,CD44,MAP2K3,GAB2,NFKBIA,PI3,LRG1,MAPK13,PRKDC,STAT5B,MAN2B1,MYH9,IRS2,SDCBP,RAB31,KLHL2,OSBPL1A,PTPN12,ATP6V1B2,PTEN,PELI1,MAPKAPK2,TUBA4A,SLC44A2,STX3,FOXO3,EEF2,ASAH1,MAP3K8,RNF144B,UBE2R2,RAB3D,UBE2D1,KLHL21,IQGAP1,RANBP2,DNM2,PRKCD,YPEL5,UBE2H,RAB7A,DNAJC5,B4GALT1,MAPK1,PRKACA,LAMP1</td>
</tr>
<tr>
<td align="left" valign="top">REAC:R-HSA-168249</td>
<td align="left" valign="top">  Innate Immune System</td>
<td align="left" valign="top">0.000483116</td>
<td align="left" valign="top">3.315948984</td>
<td align="left" valign="top">44</td>
<td align="left" valign="top">MUC7,PADI2,FOS,MUC21,ICAM3,FTH1,FCER1A,C5AR2,ANPEP,PYGL,C5AR1,IMPDH1,TCN1,CD44,MAP2K3,GAB2,NFKBIA,PI3,LRG1,MAPK13,PRKDC,MAN2B1,MYH9,SDCBP,RAB31,ATP6V1B2,PELI1,MAPKAPK2,SLC44A2,EEF2,ASAH1,MAP3K8,RAB3D,UBE2D1,IQGAP1,DNM2,PRKCD,YPEL5,RAB7A,DNAJC5,B4GALT1,MAPK1,PRKACA,LAMP1</td>
</tr>
<tr>
<td align="left" valign="top">REAC:R-HSA-6798695</td>
<td align="left" valign="top">  Neutrophil degranulation</td>
<td align="left" valign="top">0.003082493</td>
<td align="left" valign="top">2.511097929</td>
<td align="left" valign="top">24</td>
<td align="left" valign="top">PADI2,FTH1,ANPEP,PYGL,C5AR1,IMPDH1,TCN1,CD44,LRG1,MAN2B1,SDCBP,RAB31,SLC44A2,EEF2,ASAH1,RAB3D,IQGAP1,PRKCD,YPEL5,RAB7A,DNAJC5,B4GALT1,MAPK1,LAMP1</td>
</tr>
<tr>
<td align="left" valign="top">REAC:R-HSA-9006934</td>
<td align="left" valign="top">  Signaling by Receptor Tyrosine Kinases</td>
<td align="left" valign="top">0.003779389</td>
<td align="left" valign="top">2.422578418</td>
<td align="left" valign="top">24</td>
<td align="left" valign="top">FOSB,PDGFRB,FOS,HBEGF,EGR1,EGR3,TRIB1,JUNB,LAMB3,COL6A3,GAB2,MAPK13,RALGDS,STAT5B,IRS2,PTPN12,ATP6V1B2,MAPKAPK2,PXN,DNM2,PRKCD,SGK1,MAPK1,PRKACA</td>
</tr>
<tr>
<td align="left" valign="top">REAC:R-HSA-199991</td>
<td align="left" valign="top">  Membrane Trafficking</td>
<td align="left" valign="top">0.021636488</td>
<td align="left" valign="top">1.664813234</td>
<td align="left" valign="top">26</td>
<td align="left" valign="top">HBEGF,FTH1,DENND5A,ARRB2,REPS2,CPD,RABGEF1,BICD2,HIP1R,PACSIN2,PICALM,MYH9,UBAP1,RAB31,TUBA4A,SORT1,VPS37B,TBC1D14,MAP1LC3B,ARFGAP3,RHOQ,GABARAP,BLOC1S6,SNX18,DNM2,RAB7A</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="T4" position="float" orientation="portrait">
<label>Table 4</label>
<caption>
<title>Topology table for up and down regulated genes.</title>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" valign="top">Category</th>
<th align="center" valign="top">Node</th>
<th align="center" valign="top">Degree</th>
<th align="center" valign="top">Betweenness</th>
<th align="center" valign="top">Stress</th>
<th align="center" valign="top">Closeness</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">ESR1</td>
<td align="center" valign="top">798</td>
<td align="center" valign="top">0.192517</td>
<td align="center" valign="top">1.77E+08</td>
<td align="center" valign="top">0.408682</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">UBD</td>
<td align="center" valign="top">502</td>
<td align="center" valign="top">0.118413</td>
<td align="center" valign="top">96176834</td>
<td align="center" valign="top">0.369243</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">FYN</td>
<td align="center" valign="top">273</td>
<td align="center" valign="top">0.061939</td>
<td align="center" valign="top">30015938</td>
<td align="center" valign="top">0.359012</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">STAT1</td>
<td align="center" valign="top">223</td>
<td align="center" valign="top">0.05064</td>
<td align="center" valign="top">18096366</td>
<td align="center" valign="top">0.397044</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">ISG15</td>
<td align="center" valign="top">188</td>
<td align="center" valign="top">0.027621</td>
<td align="center" valign="top">17693852</td>
<td align="center" valign="top">0.366029</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">NOS2</td>
<td align="center" valign="top">170</td>
<td align="center" valign="top">0.023391</td>
<td align="center" valign="top">17364304</td>
<td align="center" valign="top">0.360678</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">PML</td>
<td align="center" valign="top">163</td>
<td align="center" valign="top">0.02224</td>
<td align="center" valign="top">15000134</td>
<td align="center" valign="top">0.36002</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">FBXO6</td>
<td align="center" valign="top">153</td>
<td align="center" valign="top">0.029751</td>
<td align="center" valign="top">15338582</td>
<td align="center" valign="top">0.345429</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">PTN</td>
<td align="center" valign="top">108</td>
<td align="center" valign="top">0.019461</td>
<td align="center" valign="top">7122098</td>
<td align="center" valign="top">0.338033</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">FASLG</td>
<td align="center" valign="top">83</td>
<td align="center" valign="top">0.014694</td>
<td align="center" valign="top">4374476</td>
<td align="center" valign="top">0.35841</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">EIF2AK2</td>
<td align="center" valign="top">81</td>
<td align="center" valign="top">0.010682</td>
<td align="center" valign="top">5028286</td>
<td align="center" valign="top">0.349214</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">IRF8</td>
<td align="center" valign="top">73</td>
<td align="center" valign="top">0.009166</td>
<td align="center" valign="top">3207394</td>
<td align="center" valign="top">0.351752</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">TGM2</td>
<td align="center" valign="top">69</td>
<td align="center" valign="top">0.008347</td>
<td align="center" valign="top">3649916</td>
<td align="center" valign="top">0.345615</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">IRF7</td>
<td align="center" valign="top">66</td>
<td align="center" valign="top">0.009403</td>
<td align="center" valign="top">3212578</td>
<td align="center" valign="top">0.348905</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">IRF4</td>
<td align="center" valign="top">60</td>
<td align="center" valign="top">0.007151</td>
<td align="center" valign="top">2266524</td>
<td align="center" valign="top">0.347959</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">IFIT3</td>
<td align="center" valign="top">60</td>
<td align="center" valign="top">0.003302</td>
<td align="center" valign="top">1795640</td>
<td align="center" valign="top">0.330435</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">DDX58</td>
<td align="center" valign="top">56</td>
<td align="center" valign="top">0.006449</td>
<td align="center" valign="top">2057946</td>
<td align="center" valign="top">0.346408</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">IRS1</td>
<td align="center" valign="top">56</td>
<td align="center" valign="top">0.003937</td>
<td align="center" valign="top">1608812</td>
<td align="center" valign="top">0.357287</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">BUB1B</td>
<td align="center" valign="top">53</td>
<td align="center" valign="top">0.005921</td>
<td align="center" valign="top">2158524</td>
<td align="center" valign="top">0.336724</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">ZAP70</td>
<td align="center" valign="top">53</td>
<td align="center" valign="top">0.004798</td>
<td align="center" valign="top">1904462</td>
<td align="center" valign="top">0.34328</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">IFIT2</td>
<td align="center" valign="top">49</td>
<td align="center" valign="top">0.002087</td>
<td align="center" valign="top">1246440</td>
<td align="center" valign="top">0.324009</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">IFIT1</td>
<td align="center" valign="top">49</td>
<td align="center" valign="top">0.004345</td>
<td align="center" valign="top">1582522</td>
<td align="center" valign="top">0.334224</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">NMI</td>
<td align="center" valign="top">47</td>
<td align="center" valign="top">0.007103</td>
<td align="center" valign="top">1727992</td>
<td align="center" valign="top">0.345941</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">STAT2</td>
<td align="center" valign="top">45</td>
<td align="center" valign="top">0.003261</td>
<td align="center" valign="top">1208362</td>
<td align="center" valign="top">0.349523</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">GFI1</td>
<td align="center" valign="top">45</td>
<td align="center" valign="top">0.005993</td>
<td align="center" valign="top">2163282</td>
<td align="center" valign="top">0.337699</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">PSMB8</td>
<td align="center" valign="top">42</td>
<td align="center" valign="top">0.00213</td>
<td align="center" valign="top">1084100</td>
<td align="center" valign="top">0.336879</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">UBE2L6</td>
<td align="center" valign="top">40</td>
<td align="center" valign="top">0.003621</td>
<td align="center" valign="top">1208660</td>
<td align="center" valign="top">0.334354</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">GZMB</td>
<td align="center" valign="top">38</td>
<td align="center" valign="top">0.004228</td>
<td align="center" valign="top">1177768</td>
<td align="center" valign="top">0.321915</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">PSME2</td>
<td align="center" valign="top">37</td>
<td align="center" valign="top">0.002791</td>
<td align="center" valign="top">1085450</td>
<td align="center" valign="top">0.335272</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">MYBL2</td>
<td align="center" valign="top">36</td>
<td align="center" valign="top">0.003331</td>
<td align="center" valign="top">1073716</td>
<td align="center" valign="top">0.320627</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">LGALS3BP</td>
<td align="center" valign="top">36</td>
<td align="center" valign="top">0.002906</td>
<td align="center" valign="top">1015894</td>
<td align="center" valign="top">0.35396</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">BUB1</td>
<td align="center" valign="top">34</td>
<td align="center" valign="top">0.003714</td>
<td align="center" valign="top">1122524</td>
<td align="center" valign="top">0.33668</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">TAP1</td>
<td align="center" valign="top">33</td>
<td align="center" valign="top">0.003564</td>
<td align="center" valign="top">1048476</td>
<td align="center" valign="top">0.340862</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">TPX2</td>
<td align="center" valign="top">32</td>
<td align="center" valign="top">0.003285</td>
<td align="center" valign="top">1158360</td>
<td align="center" valign="top">0.335272</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">CD247</td>
<td align="center" valign="top">32</td>
<td align="center" valign="top">0.002306</td>
<td align="center" valign="top">611176</td>
<td align="center" valign="top">0.343303</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">CCR5</td>
<td align="center" valign="top">31</td>
<td align="center" valign="top">0.004564</td>
<td align="center" valign="top">1252458</td>
<td align="center" valign="top">0.323988</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">GRAP2</td>
<td align="center" valign="top">30</td>
<td align="center" valign="top">0.003826</td>
<td align="center" valign="top">1039970</td>
<td align="center" valign="top">0.336018</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">PTPRO</td>
<td align="center" valign="top">29</td>
<td align="center" valign="top">0.002308</td>
<td align="center" valign="top">639118</td>
<td align="center" valign="top">0.335162</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">CCL2</td>
<td align="center" valign="top">29</td>
<td align="center" valign="top">0.004485</td>
<td align="center" valign="top">1056792</td>
<td align="center" valign="top">0.320808</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">CD3E</td>
<td align="center" valign="top">28</td>
<td align="center" valign="top">0.002918</td>
<td align="center" valign="top">706426</td>
<td align="center" valign="top">0.335425</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">ABCB1</td>
<td align="center" valign="top">28</td>
<td align="center" valign="top">0.002424</td>
<td align="center" valign="top">759344</td>
<td align="center" valign="top">0.342523</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">CDC7</td>
<td align="center" valign="top">28</td>
<td align="center" valign="top">0.002973</td>
<td align="center" valign="top">878770</td>
<td align="center" valign="top">0.335097</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">SH2D1A</td>
<td align="center" valign="top">27</td>
<td align="center" valign="top">0.004057</td>
<td align="center" valign="top">742976</td>
<td align="center" valign="top">0.343855</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">BATF3</td>
<td align="center" valign="top">27</td>
<td align="center" valign="top">0.001939</td>
<td align="center" valign="top">569966</td>
<td align="center" valign="top">0.294124</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">TLR3</td>
<td align="center" valign="top">25</td>
<td align="center" valign="top">0.002148</td>
<td align="center" valign="top">559984</td>
<td align="center" valign="top">0.314863</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">PSAT1</td>
<td align="center" valign="top">24</td>
<td align="center" valign="top">0.002325</td>
<td align="center" valign="top">756588</td>
<td align="center" valign="top">0.334376</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">TNFSF10</td>
<td align="center" valign="top">24</td>
<td align="center" valign="top">0.00138</td>
<td align="center" valign="top">426574</td>
<td align="center" valign="top">0.312828</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">MTNR1A</td>
<td align="center" valign="top">24</td>
<td align="center" valign="top">0.001564</td>
<td align="center" valign="top">1286488</td>
<td align="center" valign="top">0.287886</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">IFNG</td>
<td align="center" valign="top">24</td>
<td align="center" valign="top">0.001178</td>
<td align="center" valign="top">365080</td>
<td align="center" valign="top">0.321189</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">PSMB9</td>
<td align="center" valign="top">24</td>
<td align="center" valign="top">0.001442</td>
<td align="center" valign="top">381174</td>
<td align="center" valign="top">0.352476</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">CARD11</td>
<td align="center" valign="top">23</td>
<td align="center" valign="top">0.001688</td>
<td align="center" valign="top">663288</td>
<td align="center" valign="top">0.333767</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">PRLR</td>
<td align="center" valign="top">23</td>
<td align="center" valign="top">0.001176</td>
<td align="center" valign="top">469112</td>
<td align="center" valign="top">0.339172</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">C1QA</td>
<td align="center" valign="top">23</td>
<td align="center" valign="top">0.002946</td>
<td align="center" valign="top">1093304</td>
<td align="center" valign="top">0.297122</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">WASF1</td>
<td align="center" valign="top">23</td>
<td align="center" valign="top">0.002571</td>
<td align="center" valign="top">472204</td>
<td align="center" valign="top">0.337388</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">IFIH1</td>
<td align="center" valign="top">22</td>
<td align="center" valign="top">0.001263</td>
<td align="center" valign="top">491138</td>
<td align="center" valign="top">0.335754</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">HERC5</td>
<td align="center" valign="top">22</td>
<td align="center" valign="top">0.002237</td>
<td align="center" valign="top">725500</td>
<td align="center" valign="top">0.354743</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">DTX3L</td>
<td align="center" valign="top">22</td>
<td align="center" valign="top">0.001709</td>
<td align="center" valign="top">565192</td>
<td align="center" valign="top">0.334812</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">GZMA</td>
<td align="center" valign="top">21</td>
<td align="center" valign="top">0.001501</td>
<td align="center" valign="top">1112872</td>
<td align="center" valign="top">0.304348</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">MT2A</td>
<td align="center" valign="top">21</td>
<td align="center" valign="top">0.003383</td>
<td align="center" valign="top">615218</td>
<td align="center" valign="top">0.339352</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">CENPE</td>
<td align="center" valign="top">20</td>
<td align="center" valign="top">0.001417</td>
<td align="center" valign="top">401202</td>
<td align="center" valign="top">0.339374</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">BCL11B</td>
<td align="center" valign="top">20</td>
<td align="center" valign="top">0.001121</td>
<td align="center" valign="top">474760</td>
<td align="center" valign="top">0.334115</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">DOK2</td>
<td align="center" valign="top">20</td>
<td align="center" valign="top">0.00153</td>
<td align="center" valign="top">524938</td>
<td align="center" valign="top">0.333095</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">STAT4</td>
<td align="center" valign="top">20</td>
<td align="center" valign="top">7.57E-04</td>
<td align="center" valign="top">243488</td>
<td align="center" valign="top">0.309078</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">IFIT5</td>
<td align="center" valign="top">20</td>
<td align="center" valign="top">0.001119</td>
<td align="center" valign="top">410524</td>
<td align="center" valign="top">0.339217</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">STAMBPL1</td>
<td align="center" valign="top">18</td>
<td align="center" valign="top">0.001077</td>
<td align="center" valign="top">398602</td>
<td align="center" valign="top">0.332707</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">LAP3</td>
<td align="center" valign="top">18</td>
<td align="center" valign="top">0.001222</td>
<td align="center" valign="top">391612</td>
<td align="center" valign="top">0.331439</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">UBE2T</td>
<td align="center" valign="top">18</td>
<td align="center" valign="top">6.27E-04</td>
<td align="center" valign="top">352842</td>
<td align="center" valign="top">0.334093</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">C7orf25</td>
<td align="center" valign="top">18</td>
<td align="center" valign="top">0.002466</td>
<td align="center" valign="top">690114</td>
<td align="center" valign="top">0.30653</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">KIF5C</td>
<td align="center" valign="top">18</td>
<td align="center" valign="top">0.00143</td>
<td align="center" valign="top">447542</td>
<td align="center" valign="top">0.346642</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">CD8A</td>
<td align="center" valign="top">18</td>
<td align="center" valign="top">0.001532</td>
<td align="center" valign="top">323014</td>
<td align="center" valign="top">0.332685</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">HLA-DRB1</td>
<td align="center" valign="top">18</td>
<td align="center" valign="top">0.001445</td>
<td align="center" valign="top">467308</td>
<td align="center" valign="top">0.333463</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">GBP1</td>
<td align="center" valign="top">18</td>
<td align="center" valign="top">3.90E-04</td>
<td align="center" valign="top">148994</td>
<td align="center" valign="top">0.324685</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">CD2</td>
<td align="center" valign="top">18</td>
<td align="center" valign="top">0.001782</td>
<td align="center" valign="top">349704</td>
<td align="center" valign="top">0.339172</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">LGALS9</td>
<td align="center" valign="top">17</td>
<td align="center" valign="top">0.00215</td>
<td align="center" valign="top">355432</td>
<td align="center" valign="top">0.305981</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">DHX58</td>
<td align="center" valign="top">17</td>
<td align="center" valign="top">0.001152</td>
<td align="center" valign="top">332654</td>
<td align="center" valign="top">0.309134</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">CXCL10</td>
<td align="center" valign="top">17</td>
<td align="center" valign="top">0.001168</td>
<td align="center" valign="top">350182</td>
<td align="center" valign="top">0.312314</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">PROX1</td>
<td align="center" valign="top">17</td>
<td align="center" valign="top">0.001217</td>
<td align="center" valign="top">289316</td>
<td align="center" valign="top">0.308465</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">OAS3</td>
<td align="center" valign="top">16</td>
<td align="center" valign="top">0.001148</td>
<td align="center" valign="top">310514</td>
<td align="center" valign="top">0.332836</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">MX1</td>
<td align="center" valign="top">16</td>
<td align="center" valign="top">0.002524</td>
<td align="center" valign="top">376922</td>
<td align="center" valign="top">0.336901</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">RYR1</td>
<td align="center" valign="top">16</td>
<td align="center" valign="top">0.002311</td>
<td align="center" valign="top">432186</td>
<td align="center" valign="top">0.331824</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">PLK4</td>
<td align="center" valign="top">15</td>
<td align="center" valign="top">0.001828</td>
<td align="center" valign="top">415966</td>
<td align="center" valign="top">0.33262</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">TAP2</td>
<td align="center" valign="top">15</td>
<td align="center" valign="top">9.76E-04</td>
<td align="center" valign="top">246018</td>
<td align="center" valign="top">0.335184</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">RNF43</td>
<td align="center" valign="top">15</td>
<td align="center" valign="top">0.001445</td>
<td align="center" valign="top">297884</td>
<td align="center" valign="top">0.337632</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">ABI3</td>
<td align="center" valign="top">15</td>
<td align="center" valign="top">0.00213</td>
<td align="center" valign="top">1231380</td>
<td align="center" valign="top">0.256422</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">CFH</td>
<td align="center" valign="top">15</td>
<td align="center" valign="top">0.0012</td>
<td align="center" valign="top">263858</td>
<td align="center" valign="top">0.317709</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">KCNA2</td>
<td align="center" valign="top">15</td>
<td align="center" valign="top">6.23E-04</td>
<td align="center" valign="top">141946</td>
<td align="center" valign="top">0.289282</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">CYP19A1</td>
<td align="center" valign="top">14</td>
<td align="center" valign="top">3.07E-04</td>
<td align="center" valign="top">115996</td>
<td align="center" valign="top">0.303789</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">DPP4</td>
<td align="center" valign="top">14</td>
<td align="center" valign="top">0.002365</td>
<td align="center" valign="top">447304</td>
<td align="center" valign="top">0.277982</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">CCR1</td>
<td align="center" valign="top">14</td>
<td align="center" valign="top">0.001606</td>
<td align="center" valign="top">603916</td>
<td align="center" valign="top">0.246837</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">SP110</td>
<td align="center" valign="top">14</td>
<td align="center" valign="top">0.001349</td>
<td align="center" valign="top">851082</td>
<td align="center" valign="top">0.278148</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">NUSAP1</td>
<td align="center" valign="top">14</td>
<td align="center" valign="top">0.001144</td>
<td align="center" valign="top">264292</td>
<td align="center" valign="top">0.334463</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">CD40LG</td>
<td align="center" valign="top">14</td>
<td align="center" valign="top">0.001271</td>
<td align="center" valign="top">269880</td>
<td align="center" valign="top">0.344247</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">FXYD6</td>
<td align="center" valign="top">14</td>
<td align="center" valign="top">0.002095</td>
<td align="center" valign="top">420154</td>
<td align="center" valign="top">0.332125</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">SERPING1</td>
<td align="center" valign="top">13</td>
<td align="center" valign="top">0.001794</td>
<td align="center" valign="top">274630</td>
<td align="center" valign="top">0.293771</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">CD33</td>
<td align="center" valign="top">13</td>
<td align="center" valign="top">6.01E-04</td>
<td align="center" valign="top">159724</td>
<td align="center" valign="top">0.332858</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">ZBP1</td>
<td align="center" valign="top">13</td>
<td align="center" valign="top">0.001638</td>
<td align="center" valign="top">1766968</td>
<td align="center" valign="top">0.269996</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">WDR74</td>
<td align="center" valign="top">13</td>
<td align="center" valign="top">0.001739</td>
<td align="center" valign="top">291056</td>
<td align="center" valign="top">0.338166</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">CTLA4</td>
<td align="center" valign="top">13</td>
<td align="center" valign="top">6.33E-04</td>
<td align="center" valign="top">132938</td>
<td align="center" valign="top">0.312485</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">KIF15</td>
<td align="center" valign="top">13</td>
<td align="center" valign="top">0.001676</td>
<td align="center" valign="top">307736</td>
<td align="center" valign="top">0.345266</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">MDK</td>
<td align="center" valign="top">13</td>
<td align="center" valign="top">8.84E-04</td>
<td align="center" valign="top">565792</td>
<td align="center" valign="top">0.278874</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">CD3D</td>
<td align="center" valign="top">13</td>
<td align="center" valign="top">7.11E-04</td>
<td align="center" valign="top">205180</td>
<td align="center" valign="top">0.328847</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">HLA-G</td>
<td align="center" valign="top">13</td>
<td align="center" valign="top">0.00164</td>
<td align="center" valign="top">260418</td>
<td align="center" valign="top">0.327838</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">CD74</td>
<td align="center" valign="top">12</td>
<td align="center" valign="top">0.001173</td>
<td align="center" valign="top">235748</td>
<td align="center" valign="top">0.335075</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">BACH2</td>
<td align="center" valign="top">12</td>
<td align="center" valign="top">3.79E-04</td>
<td align="center" valign="top">146352</td>
<td align="center" valign="top">0.336261</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">ASPM</td>
<td align="center" valign="top">12</td>
<td align="center" valign="top">5.62E-04</td>
<td align="center" valign="top">216470</td>
<td align="center" valign="top">0.332642</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">SLC16A1</td>
<td align="center" valign="top">11</td>
<td align="center" valign="top">0.001648</td>
<td align="center" valign="top">262392</td>
<td align="center" valign="top">0.33355</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">UBASH3A</td>
<td align="center" valign="top">11</td>
<td align="center" valign="top">4.97E-04</td>
<td align="center" valign="top">160866</td>
<td align="center" valign="top">0.331996</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">KCNA3</td>
<td align="center" valign="top">11</td>
<td align="center" valign="top">9.51E-04</td>
<td align="center" valign="top">181440</td>
<td align="center" valign="top">0.331781</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">SLC12A3</td>
<td align="center" valign="top">11</td>
<td align="center" valign="top">4.71E-04</td>
<td align="center" valign="top">159292</td>
<td align="center" valign="top">0.327901</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">MYO7A</td>
<td align="center" valign="top">11</td>
<td align="center" valign="top">9.03E-04</td>
<td align="center" valign="top">219204</td>
<td align="center" valign="top">0.332512</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">CXCL11</td>
<td align="center" valign="top">11</td>
<td align="center" valign="top">5.54E-04</td>
<td align="center" valign="top">192692</td>
<td align="center" valign="top">0.311177</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">TBX21</td>
<td align="center" valign="top">11</td>
<td align="center" valign="top">6.87E-04</td>
<td align="center" valign="top">139852</td>
<td align="center" valign="top">0.31065</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">GRAP</td>
<td align="center" valign="top">10</td>
<td align="center" valign="top">7.31E-05</td>
<td align="center" valign="top">39208</td>
<td align="center" valign="top">0.287967</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">IFITM1</td>
<td align="center" valign="top">10</td>
<td align="center" valign="top">9.96E-04</td>
<td align="center" valign="top">194092</td>
<td align="center" valign="top">0.333225</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">APOD</td>
<td align="center" valign="top">10</td>
<td align="center" valign="top">0.001108</td>
<td align="center" valign="top">491794</td>
<td align="center" valign="top">0.306493</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">BST2</td>
<td align="center" valign="top">10</td>
<td align="center" valign="top">9.30E-04</td>
<td align="center" valign="top">185754</td>
<td align="center" valign="top">0.33131</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">HLA-DRB5</td>
<td align="center" valign="top">10</td>
<td align="center" valign="top">2.46E-04</td>
<td align="center" valign="top">129660</td>
<td align="center" valign="top">0.326774</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">USP18</td>
<td align="center" valign="top">10</td>
<td align="center" valign="top">8.64E-04</td>
<td align="center" valign="top">134798</td>
<td align="center" valign="top">0.336283</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">TNFRSF13B</td>
<td align="center" valign="top">10</td>
<td align="center" valign="top">6.43E-04</td>
<td align="center" valign="top">297044</td>
<td align="center" valign="top">0.28414</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">C4A</td>
<td align="center" valign="top">10</td>
<td align="center" valign="top">0.001095</td>
<td align="center" valign="top">531836</td>
<td align="center" valign="top">0.286041</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">CD38</td>
<td align="center" valign="top">4</td>
<td align="center" valign="top">6.28E-05</td>
<td align="center" valign="top">20058</td>
<td align="center" valign="top">0.284171</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">CCL8</td>
<td align="center" valign="top">4</td>
<td align="center" valign="top">8.97E-05</td>
<td align="center" valign="top">52842</td>
<td align="center" valign="top">0.271611</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">CD244</td>
<td align="center" valign="top">3</td>
<td align="center" valign="top">1.01E-06</td>
<td align="center" valign="top">282</td>
<td align="center" valign="top">0.266809</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">CXCL9</td>
<td align="center" valign="top">3</td>
<td align="center" valign="top">4.32E-04</td>
<td align="center" valign="top">118944</td>
<td align="center" valign="top">0.307043</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">IFITM3</td>
<td align="center" valign="top">3</td>
<td align="center" valign="top">2.30E-05</td>
<td align="center" valign="top">5666</td>
<td align="center" valign="top">0.285866</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">NLRC5</td>
<td align="center" valign="top">2</td>
<td align="center" valign="top">3.30E-07</td>
<td align="center" valign="top">254</td>
<td align="center" valign="top">0.258476</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">IDO1</td>
<td align="center" valign="top">2</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.284581</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">C1R</td>
<td align="center" valign="top">2</td>
<td align="center" valign="top">5.02E-06</td>
<td align="center" valign="top">1022</td>
<td align="center" valign="top">0.238252</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">SIT1</td>
<td align="center" valign="top">2</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.265264</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">IFI27</td>
<td align="center" valign="top">2</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.284518</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">IFI35</td>
<td align="center" valign="top">2</td>
<td align="center" valign="top">1.50E-05</td>
<td align="center" valign="top">6072</td>
<td align="center" valign="top">0.284676</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">PRF1</td>
<td align="center" valign="top">2</td>
<td align="center" valign="top">2.61E-06</td>
<td align="center" valign="top">974</td>
<td align="center" valign="top">0.250049</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">C1QB</td>
<td align="center" valign="top">2</td>
<td align="center" valign="top">2.70E-04</td>
<td align="center" valign="top">32182</td>
<td align="center" valign="top">0.277501</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">CD48</td>
<td align="center" valign="top">2</td>
<td align="center" valign="top">8.18E-06</td>
<td align="center" valign="top">2242</td>
<td align="center" valign="top">0.259246</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">IFI6</td>
<td align="center" valign="top">2</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.284518</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">SLAMF1</td>
<td align="center" valign="top">2</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.266642</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">TICAM2</td>
<td align="center" valign="top">2</td>
<td align="center" valign="top">4.90E-06</td>
<td align="center" valign="top">1370</td>
<td align="center" valign="top">0.258789</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">HELZ2</td>
<td align="center" valign="top">2</td>
<td align="center" valign="top">2.73E-05</td>
<td align="center" valign="top">21354</td>
<td align="center" valign="top">0.274253</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">SLAMF7</td>
<td align="center" valign="top">2</td>
<td align="center" valign="top">7.09E-05</td>
<td align="center" valign="top">15008</td>
<td align="center" valign="top">0.282125</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">GRIK1</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.250171</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">TNFSF13B</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.221278</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">C1QC</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.229073</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">CD226</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.264185</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">CD80</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.238097</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">SAA2</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.275239</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">GSDMB</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.276798</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">STAP1</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.276798</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">CDCA2</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.276798</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">BCL2L14</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.276798</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">TFEC</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.237943</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">CXCL12</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.217526</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">TLR7</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.262187</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">PARP12</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.262187</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">ACY3</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.250207</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">XAF1</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.284219</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">RSAD2</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.284219</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">GGT1</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.251655</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">TRO</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.259653</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">RORB</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.242555</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">PARP9</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.250843</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">GNGT2</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.261759</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">AIM2</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.249951</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">CRTAM</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.276798</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">OAS1</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.259011</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">CD8B</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.249647</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">IL32</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.264785</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">TMSB10</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.277952</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">SLFN5</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.260682</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">ENPP2</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.269684</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">PTPRCAP</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.276798</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">BATF2</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.256717</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">TUBA8</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.26916</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">ETV7</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.258151</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">EGR1</td>
<td align="center" valign="top">518</td>
<td align="center" valign="top">0.137274</td>
<td align="center" valign="top">73984308</td>
<td align="center" valign="top">0.382711</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">ARRB2</td>
<td align="center" valign="top">311</td>
<td align="center" valign="top">0.0549</td>
<td align="center" valign="top">47924518</td>
<td align="center" valign="top">0.368262</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">UBE2D1</td>
<td align="center" valign="top">238</td>
<td align="center" valign="top">0.047029</td>
<td align="center" valign="top">25945120</td>
<td align="center" valign="top">0.357486</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">PRKDC</td>
<td align="center" valign="top">220</td>
<td align="center" valign="top">0.03817</td>
<td align="center" valign="top">19097472</td>
<td align="center" valign="top">0.370202</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">FOS</td>
<td align="center" valign="top">214</td>
<td align="center" valign="top">0.043308</td>
<td align="center" valign="top">15087474</td>
<td align="center" valign="top">0.384921</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">MAPK1</td>
<td align="center" valign="top">187</td>
<td align="center" valign="top">0.036123</td>
<td align="center" valign="top">10770246</td>
<td align="center" valign="top">0.3953</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">PXN</td>
<td align="center" valign="top">181</td>
<td align="center" valign="top">0.029271</td>
<td align="center" valign="top">18299458</td>
<td align="center" valign="top">0.360121</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">CEBPB</td>
<td align="center" valign="top">154</td>
<td align="center" valign="top">0.026379</td>
<td align="center" valign="top">9111334</td>
<td align="center" valign="top">0.379737</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">PABPC1</td>
<td align="center" valign="top">152</td>
<td align="center" valign="top">0.024666</td>
<td align="center" valign="top">9387102</td>
<td align="center" valign="top">0.377279</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">RXRA</td>
<td align="center" valign="top">150</td>
<td align="center" valign="top">0.027</td>
<td align="center" valign="top">7639360</td>
<td align="center" valign="top">0.379063</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">NFKBIA</td>
<td align="center" valign="top">142</td>
<td align="center" valign="top">0.018107</td>
<td align="center" valign="top">11480668</td>
<td align="center" valign="top">0.359994</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">BCL6</td>
<td align="center" valign="top">139</td>
<td align="center" valign="top">0.026812</td>
<td align="center" valign="top">10769616</td>
<td align="center" valign="top">0.355332</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">EEF2</td>
<td align="center" valign="top">118</td>
<td align="center" valign="top">0.015181</td>
<td align="center" valign="top">5494630</td>
<td align="center" valign="top">0.379259</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">MAP1LC3B</td>
<td align="center" valign="top">116</td>
<td align="center" valign="top">0.019024</td>
<td align="center" valign="top">7093962</td>
<td align="center" valign="top">0.343878</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">MYH9</td>
<td align="center" valign="top">114</td>
<td align="center" valign="top">0.018836</td>
<td align="center" valign="top">6847402</td>
<td align="center" valign="top">0.372568</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">PRKACA</td>
<td align="center" valign="top">111</td>
<td align="center" valign="top">0.022264</td>
<td align="center" valign="top">7520924</td>
<td align="center" valign="top">0.354057</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">NR4A1</td>
<td align="center" valign="top">107</td>
<td align="center" valign="top">0.020235</td>
<td align="center" valign="top">8432996</td>
<td align="center" valign="top">0.357611</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">EEF1D</td>
<td align="center" valign="top">99</td>
<td align="center" valign="top">0.012436</td>
<td align="center" valign="top">6378050</td>
<td align="center" valign="top">0.342569</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">MAPK13</td>
<td align="center" valign="top">96</td>
<td align="center" valign="top">0.010247</td>
<td align="center" valign="top">6734144</td>
<td align="center" valign="top">0.347205</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">IQGAP1</td>
<td align="center" valign="top">92</td>
<td align="center" valign="top">0.011294</td>
<td align="center" valign="top">4572162</td>
<td align="center" valign="top">0.367787</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">PTEN</td>
<td align="center" valign="top">92</td>
<td align="center" valign="top">0.017001</td>
<td align="center" valign="top">4610068</td>
<td align="center" valign="top">0.373762</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">NDRG1</td>
<td align="center" valign="top">88</td>
<td align="center" valign="top">0.009487</td>
<td align="center" valign="top">4980860</td>
<td align="center" valign="top">0.357038</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">GABARAP</td>
<td align="center" valign="top">87</td>
<td align="center" valign="top">0.010537</td>
<td align="center" valign="top">3939104</td>
<td align="center" valign="top">0.338479</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">ACTN1</td>
<td align="center" valign="top">87</td>
<td align="center" valign="top">0.012382</td>
<td align="center" valign="top">4256206</td>
<td align="center" valign="top">0.359389</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">RANBP2</td>
<td align="center" valign="top">82</td>
<td align="center" valign="top">0.008093</td>
<td align="center" valign="top">4767628</td>
<td align="center" valign="top">0.348953</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">SGK1</td>
<td align="center" valign="top">82</td>
<td align="center" valign="top">0.01006</td>
<td align="center" valign="top">5455636</td>
<td align="center" valign="top">0.342729</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">GABARAPL1</td>
<td align="center" valign="top">81</td>
<td align="center" valign="top">0.009201</td>
<td align="center" valign="top">3841908</td>
<td align="center" valign="top">0.339083</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">DNM2</td>
<td align="center" valign="top">81</td>
<td align="center" valign="top">0.013143</td>
<td align="center" valign="top">4359556</td>
<td align="center" valign="top">0.340072</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">UBE2H</td>
<td align="center" valign="top">76</td>
<td align="center" valign="top">0.009903</td>
<td align="center" valign="top">4234864</td>
<td align="center" valign="top">0.338323</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">PDGFRB</td>
<td align="center" valign="top">74</td>
<td align="center" valign="top">0.008996</td>
<td align="center" valign="top">3335988</td>
<td align="center" valign="top">0.353643</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">FOXO3</td>
<td align="center" valign="top">74</td>
<td align="center" valign="top">0.008196</td>
<td align="center" valign="top">3288092</td>
<td align="center" valign="top">0.369376</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">TUBA4A</td>
<td align="center" valign="top">71</td>
<td align="center" valign="top">0.006319</td>
<td align="center" valign="top">3097846</td>
<td align="center" valign="top">0.347959</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">PRKCD</td>
<td align="center" valign="top">70</td>
<td align="center" valign="top">0.009284</td>
<td align="center" valign="top">3892990</td>
<td align="center" valign="top">0.350694</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">ATP6V1B2</td>
<td align="center" valign="top">65</td>
<td align="center" valign="top">0.008552</td>
<td align="center" valign="top">3330612</td>
<td align="center" valign="top">0.340184</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">STAT5B</td>
<td align="center" valign="top">62</td>
<td align="center" valign="top">0.006782</td>
<td align="center" valign="top">2481222</td>
<td align="center" valign="top">0.344733</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">JUNB</td>
<td align="center" valign="top">62</td>
<td align="center" valign="top">0.007011</td>
<td align="center" valign="top">2447096</td>
<td align="center" valign="top">0.345359</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">PTPN12</td>
<td align="center" valign="top">57</td>
<td align="center" valign="top">0.007343</td>
<td align="center" valign="top">2176734</td>
<td align="center" valign="top">0.343832</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">CD44</td>
<td align="center" valign="top">56</td>
<td align="center" valign="top">0.008336</td>
<td align="center" valign="top">2860602</td>
<td align="center" valign="top">0.360247</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">RNF10</td>
<td align="center" valign="top">56</td>
<td align="center" valign="top">0.006127</td>
<td align="center" valign="top">2367936</td>
<td align="center" valign="top">0.341816</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">SOD2</td>
<td align="center" valign="top">53</td>
<td align="center" valign="top">0.008034</td>
<td align="center" valign="top">2443178</td>
<td align="center" valign="top">0.337544</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">RNF144B</td>
<td align="center" valign="top">53</td>
<td align="center" valign="top">0.005069</td>
<td align="center" valign="top">2017554</td>
<td align="center" valign="top">0.336724</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">DNAJB1</td>
<td align="center" valign="top">50</td>
<td align="center" valign="top">0.006088</td>
<td align="center" valign="top">2062626</td>
<td align="center" valign="top">0.339936</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">EIF3L</td>
<td align="center" valign="top">48</td>
<td align="center" valign="top">0.00468</td>
<td align="center" valign="top">1955518</td>
<td align="center" valign="top">0.332125</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">NDEL1</td>
<td align="center" valign="top">47</td>
<td align="center" valign="top">0.007994</td>
<td align="center" valign="top">1584292</td>
<td align="center" valign="top">0.340591</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">GNB2</td>
<td align="center" valign="top">46</td>
<td align="center" valign="top">0.008922</td>
<td align="center" valign="top">1639312</td>
<td align="center" valign="top">0.354547</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">RAB7A</td>
<td align="center" valign="top">46</td>
<td align="center" valign="top">0.006877</td>
<td align="center" valign="top">1677636</td>
<td align="center" valign="top">0.35396</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">ETS2</td>
<td align="center" valign="top">46</td>
<td align="center" valign="top">0.004714</td>
<td align="center" valign="top">1536566</td>
<td align="center" valign="top">0.353691</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">TPD52L2</td>
<td align="center" valign="top">46</td>
<td align="center" valign="top">0.006465</td>
<td align="center" valign="top">1995176</td>
<td align="center" valign="top">0.335469</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">PINK1</td>
<td align="center" valign="top">45</td>
<td align="center" valign="top">0.00464</td>
<td align="center" valign="top">1826106</td>
<td align="center" valign="top">0.345895</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">TNFRSF10D</td>
<td align="center" valign="top">44</td>
<td align="center" valign="top">0.003308</td>
<td align="center" valign="top">1603192</td>
<td align="center" valign="top">0.337855</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">USF2</td>
<td align="center" valign="top">44</td>
<td align="center" valign="top">0.006294</td>
<td align="center" valign="top">2069964</td>
<td align="center" valign="top">0.335645</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">TFE3</td>
<td align="center" valign="top">44</td>
<td align="center" valign="top">0.003494</td>
<td align="center" valign="top">2757172</td>
<td align="center" valign="top">0.312219</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">KAT8</td>
<td align="center" valign="top">43</td>
<td align="center" valign="top">0.005464</td>
<td align="center" valign="top">1597380</td>
<td align="center" valign="top">0.323865</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">FTH1</td>
<td align="center" valign="top">43</td>
<td align="center" valign="top">0.004707</td>
<td align="center" valign="top">1493774</td>
<td align="center" valign="top">0.335689</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">TPM4</td>
<td align="center" valign="top">42</td>
<td align="center" valign="top">0.003909</td>
<td align="center" valign="top">1867058</td>
<td align="center" valign="top">0.339217</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">TKT</td>
<td align="center" valign="top">41</td>
<td align="center" valign="top">0.003604</td>
<td align="center" valign="top">1344208</td>
<td align="center" valign="top">0.361848</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">RYBP</td>
<td align="center" valign="top">39</td>
<td align="center" valign="top">0.005665</td>
<td align="center" valign="top">1677814</td>
<td align="center" valign="top">0.335272</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">GAB2</td>
<td align="center" valign="top">38</td>
<td align="center" valign="top">0.001218</td>
<td align="center" valign="top">711446</td>
<td align="center" valign="top">0.323111</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">TNIP1</td>
<td align="center" valign="top">38</td>
<td align="center" valign="top">0.004626</td>
<td align="center" valign="top">1381986</td>
<td align="center" valign="top">0.351438</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">MAP3K11</td>
<td align="center" valign="top">38</td>
<td align="center" valign="top">0.003908</td>
<td align="center" valign="top">1706650</td>
<td align="center" valign="top">0.336194</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">NUDT3</td>
<td align="center" valign="top">38</td>
<td align="center" valign="top">0.005959</td>
<td align="center" valign="top">1613400</td>
<td align="center" valign="top">0.330457</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">GNAQ</td>
<td align="center" valign="top">37</td>
<td align="center" valign="top">0.007581</td>
<td align="center" valign="top">1632484</td>
<td align="center" valign="top">0.330138</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">IRS2</td>
<td align="center" valign="top">37</td>
<td align="center" valign="top">0.001379</td>
<td align="center" valign="top">715496</td>
<td align="center" valign="top">0.355949</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">NUP98</td>
<td align="center" valign="top">35</td>
<td align="center" valign="top">0.003469</td>
<td align="center" valign="top">1591646</td>
<td align="center" valign="top">0.334965</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">MAP3K8</td>
<td align="center" valign="top">35</td>
<td align="center" valign="top">0.001498</td>
<td align="center" valign="top">677496</td>
<td align="center" valign="top">0.33368</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">TFDP1</td>
<td align="center" valign="top">34</td>
<td align="center" valign="top">0.004349</td>
<td align="center" valign="top">1304508</td>
<td align="center" valign="top">0.334703</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">PPARD</td>
<td align="center" valign="top">34</td>
<td align="center" valign="top">0.002647</td>
<td align="center" valign="top">976048</td>
<td align="center" valign="top">0.339509</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">NEDD9</td>
<td align="center" valign="top">33</td>
<td align="center" valign="top">0.002263</td>
<td align="center" valign="top">650036</td>
<td align="center" valign="top">0.344779</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">RASSF5</td>
<td align="center" valign="top">33</td>
<td align="center" valign="top">0.00421</td>
<td align="center" valign="top">853638</td>
<td align="center" valign="top">0.337788</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">PACSIN2</td>
<td align="center" valign="top">32</td>
<td align="center" valign="top">0.003634</td>
<td align="center" valign="top">812032</td>
<td align="center" valign="top">0.338501</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">MAPKAPK2</td>
<td align="center" valign="top">32</td>
<td align="center" valign="top">0.003363</td>
<td align="center" valign="top">726882</td>
<td align="center" valign="top">0.341953</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">TPT1</td>
<td align="center" valign="top">32</td>
<td align="center" valign="top">0.002106</td>
<td align="center" valign="top">917626</td>
<td align="center" valign="top">0.347888</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">WDR1</td>
<td align="center" valign="top">32</td>
<td align="center" valign="top">0.004819</td>
<td align="center" valign="top">1012580</td>
<td align="center" valign="top">0.360703</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">ZFP36</td>
<td align="center" valign="top">31</td>
<td align="center" valign="top">0.004454</td>
<td align="center" valign="top">1090138</td>
<td align="center" valign="top">0.350072</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">DUSP1</td>
<td align="center" valign="top">30</td>
<td align="center" valign="top">0.002677</td>
<td align="center" valign="top">870036</td>
<td align="center" valign="top">0.354939</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">NR4A2</td>
<td align="center" valign="top">30</td>
<td align="center" valign="top">0.003467</td>
<td align="center" valign="top">814860</td>
<td align="center" valign="top">0.311215</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">TSC22D3</td>
<td align="center" valign="top">29</td>
<td align="center" valign="top">0.002154</td>
<td align="center" valign="top">635518</td>
<td align="center" valign="top">0.360931</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">DOT1L</td>
<td align="center" valign="top">29</td>
<td align="center" valign="top">0.002244</td>
<td align="center" valign="top">720134</td>
<td align="center" valign="top">0.322319</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">SPAG9</td>
<td align="center" valign="top">28</td>
<td align="center" valign="top">0.002956</td>
<td align="center" valign="top">613724</td>
<td align="center" valign="top">0.339554</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">MAP2K3</td>
<td align="center" valign="top">28</td>
<td align="center" valign="top">0.002387</td>
<td align="center" valign="top">736730</td>
<td align="center" valign="top">0.334638</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">SDCBP</td>
<td align="center" valign="top">27</td>
<td align="center" valign="top">0.005582</td>
<td align="center" valign="top">1210604</td>
<td align="center" valign="top">0.333615</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">FOSL2</td>
<td align="center" valign="top">27</td>
<td align="center" valign="top">0.002273</td>
<td align="center" valign="top">705484</td>
<td align="center" valign="top">0.354498</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">PPP1R15A</td>
<td align="center" valign="top">27</td>
<td align="center" valign="top">0.001703</td>
<td align="center" valign="top">1037016</td>
<td align="center" valign="top">0.311328</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">UBE2R2</td>
<td align="center" valign="top">27</td>
<td align="center" valign="top">0.003032</td>
<td align="center" valign="top">777410</td>
<td align="center" valign="top">0.334376</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">MLLT1</td>
<td align="center" valign="top">26</td>
<td align="center" valign="top">0.001525</td>
<td align="center" valign="top">390820</td>
<td align="center" valign="top">0.296213</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">PPIF</td>
<td align="center" valign="top">26</td>
<td align="center" valign="top">0.003794</td>
<td align="center" valign="top">881822</td>
<td align="center" valign="top">0.333615</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">PICALM</td>
<td align="center" valign="top">26</td>
<td align="center" valign="top">0.002516</td>
<td align="center" valign="top">757500</td>
<td align="center" valign="top">0.336569</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">MAP4K4</td>
<td align="center" valign="top">25</td>
<td align="center" valign="top">0.002758</td>
<td align="center" valign="top">917576</td>
<td align="center" valign="top">0.333117</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">TLE3</td>
<td align="center" valign="top">25</td>
<td align="center" valign="top">0.003223</td>
<td align="center" valign="top">628204</td>
<td align="center" valign="top">0.335403</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">SH3BP2</td>
<td align="center" valign="top">24</td>
<td align="center" valign="top">0.001216</td>
<td align="center" valign="top">410836</td>
<td align="center" valign="top">0.339666</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">BLOC1S6</td>
<td align="center" valign="top">24</td>
<td align="center" valign="top">0.004921</td>
<td align="center" valign="top">2205528</td>
<td align="center" valign="top">0.298297</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">IL1R1</td>
<td align="center" valign="top">24</td>
<td align="center" valign="top">0.003639</td>
<td align="center" valign="top">728952</td>
<td align="center" valign="top">0.344895</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">USP32</td>
<td align="center" valign="top">24</td>
<td align="center" valign="top">0.002234</td>
<td align="center" valign="top">766640</td>
<td align="center" valign="top">0.333095</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">LYST</td>
<td align="center" valign="top">24</td>
<td align="center" valign="top">0.004414</td>
<td align="center" valign="top">1162826</td>
<td align="center" valign="top">0.32765</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">RALGDS</td>
<td align="center" valign="top">23</td>
<td align="center" valign="top">0.003002</td>
<td align="center" valign="top">711328</td>
<td align="center" valign="top">0.301611</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">LAMP1</td>
<td align="center" valign="top">22</td>
<td align="center" valign="top">0.003428</td>
<td align="center" valign="top">700048</td>
<td align="center" valign="top">0.333225</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">FOXO4</td>
<td align="center" valign="top">22</td>
<td align="center" valign="top">0.001106</td>
<td align="center" valign="top">455348</td>
<td align="center" valign="top">0.356394</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">GYS1</td>
<td align="center" valign="top">22</td>
<td align="center" valign="top">0.003454</td>
<td align="center" valign="top">678486</td>
<td align="center" valign="top">0.349785</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">OXSR1</td>
<td align="center" valign="top">22</td>
<td align="center" valign="top">0.00287</td>
<td align="center" valign="top">500966</td>
<td align="center" valign="top">0.352573</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">PELI1</td>
<td align="center" valign="top">21</td>
<td align="center" valign="top">0.001214</td>
<td align="center" valign="top">477420</td>
<td align="center" valign="top">0.338613</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">GLUL</td>
<td align="center" valign="top">21</td>
<td align="center" valign="top">0.003434</td>
<td align="center" valign="top">834082</td>
<td align="center" valign="top">0.357188</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">IVNS1ABP</td>
<td align="center" valign="top">21</td>
<td align="center" valign="top">0.001213</td>
<td align="center" valign="top">471132</td>
<td align="center" valign="top">0.346105</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">PYGL</td>
<td align="center" valign="top">20</td>
<td align="center" valign="top">0.00345</td>
<td align="center" valign="top">602684</td>
<td align="center" valign="top">0.332663</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">NAMPT</td>
<td align="center" valign="top">20</td>
<td align="center" valign="top">0.002212</td>
<td align="center" valign="top">380268</td>
<td align="center" valign="top">0.336261</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">BTG2</td>
<td align="center" valign="top">20</td>
<td align="center" valign="top">0.002656</td>
<td align="center" valign="top">551622</td>
<td align="center" valign="top">0.332018</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">PNRC1</td>
<td align="center" valign="top">19</td>
<td align="center" valign="top">0.001899</td>
<td align="center" valign="top">443316</td>
<td align="center" valign="top">0.320207</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">CAMK1D</td>
<td align="center" valign="top">19</td>
<td align="center" valign="top">0.002449</td>
<td align="center" valign="top">987922</td>
<td align="center" valign="top">0.296162</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">RAB31</td>
<td align="center" valign="top">19</td>
<td align="center" valign="top">0.002284</td>
<td align="center" valign="top">614060</td>
<td align="center" valign="top">0.327671</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">BZW1</td>
<td align="center" valign="top">19</td>
<td align="center" valign="top">0.00303</td>
<td align="center" valign="top">357544</td>
<td align="center" valign="top">0.352283</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">ELL2</td>
<td align="center" valign="top">18</td>
<td align="center" valign="top">0.00274</td>
<td align="center" valign="top">321386</td>
<td align="center" valign="top">0.338859</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">INPP5K</td>
<td align="center" valign="top">18</td>
<td align="center" valign="top">0.002393</td>
<td align="center" valign="top">526368</td>
<td align="center" valign="top">0.333117</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">CDK16</td>
<td align="center" valign="top">18</td>
<td align="center" valign="top">5.60E-04</td>
<td align="center" valign="top">330784</td>
<td align="center" valign="top">0.334725</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">RIOK3</td>
<td align="center" valign="top">17</td>
<td align="center" valign="top">0.001547</td>
<td align="center" valign="top">464048</td>
<td align="center" valign="top">0.327713</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">FOSB</td>
<td align="center" valign="top">17</td>
<td align="center" valign="top">8.83E-05</td>
<td align="center" valign="top">66880</td>
<td align="center" valign="top">0.296864</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">PLK3</td>
<td align="center" valign="top">16</td>
<td align="center" valign="top">0.001804</td>
<td align="center" valign="top">408658</td>
<td align="center" valign="top">0.333702</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">CCNG2</td>
<td align="center" valign="top">16</td>
<td align="center" valign="top">8.68E-04</td>
<td align="center" valign="top">216670</td>
<td align="center" valign="top">0.354229</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">ANXA11</td>
<td align="center" valign="top">16</td>
<td align="center" valign="top">0.001671</td>
<td align="center" valign="top">301984</td>
<td align="center" valign="top">0.331889</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">FDPS</td>
<td align="center" valign="top">15</td>
<td align="center" valign="top">7.11E-04</td>
<td align="center" valign="top">275776</td>
<td align="center" valign="top">0.332642</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">ERGIC1</td>
<td align="center" valign="top">15</td>
<td align="center" valign="top">0.004069</td>
<td align="center" valign="top">571924</td>
<td align="center" valign="top">0.325881</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">SH3BP5</td>
<td align="center" valign="top">15</td>
<td align="center" valign="top">8.56E-04</td>
<td align="center" valign="top">284762</td>
<td align="center" valign="top">0.327566</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">EGR3</td>
<td align="center" valign="top">3</td>
<td align="center" valign="top">3.96E-06</td>
<td align="center" valign="top">1002</td>
<td align="center" valign="top">0.283465</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">IER3</td>
<td align="center" valign="top">3</td>
<td align="center" valign="top">1.70E-05</td>
<td align="center" valign="top">7456</td>
<td align="center" valign="top">0.289429</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">HBEGF</td>
<td align="center" valign="top">2</td>
<td align="center" valign="top">2.31E-05</td>
<td align="center" valign="top">7130</td>
<td align="center" valign="top">0.274576</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">ASAH1</td>
<td align="center" valign="top">2</td>
<td align="center" valign="top">3.49E-05</td>
<td align="center" valign="top">12710</td>
<td align="center" valign="top">0.257503</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">IDS</td>
<td align="center" valign="top">2</td>
<td align="center" valign="top">6.65E-05</td>
<td align="center" valign="top">88902</td>
<td align="center" valign="top">0.300199</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">CAMK1G</td>
<td align="center" valign="top">2</td>
<td align="center" valign="top">1.73E-04</td>
<td align="center" valign="top">159302</td>
<td align="center" valign="top">0.292448</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">KDM4B</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.290133</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">NDRG2</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.290133</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">NIN</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.261492</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">KLF2</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.276798</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">PHLDA1</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.253708</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">C5AR1</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.26916</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">OSBPL1A</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.262187</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">SNX18</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.263859</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">SERINC3</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.250134</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">HIP1R</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.251828</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">PHF20L1</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.244648</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">IFRD1</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.258841</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">ANPEP</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.261292</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">B4GALT1</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.259312</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">ZFP36L1</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.25483</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">TGM3</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.261292</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">UPP1</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.263358</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">PFKFB3</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.26916</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">MSL1</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.244648</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">NCCRP1</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.290133</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">MAEA</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.269684</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">PID1</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.276798</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">TP53INP2</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.252896</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">BICD2</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.258697</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">SEC14L1</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.257296</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">MYADM</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.276798</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">OSBPL8</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.269684</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">PLEKHG2</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.276798</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">SPRR3</td>
<td align="center" valign="top">1</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0</td>
<td align="center" valign="top">0.264717</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="T5" position="float" orientation="portrait">
<label>Table 5</label>
<caption>
<title>miRNA - target gene and TF - target gene interaction</title>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" valign="top">Regulation</th>
<th align="center" valign="top">Target Genes</th>
<th align="center" valign="top">Degree</th>
<th align="center" valign="top">MicroRNA</th>
<th align="center" valign="top">Regulation</th>
<th align="center" valign="top">Target Genes</th>
<th align="center" valign="top">Degree</th>
<th align="center" valign="top">TF</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">IRF4</td>
<td align="center" valign="top">140</td>
<td align="center" valign="top">hsa-mir-4484</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">ESR1</td>
<td align="center" valign="top">22</td>
<td align="center" valign="top">STAT3</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">ESR1</td>
<td align="center" valign="top">98</td>
<td align="center" valign="top">hsa-mir-3668</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">IRF7</td>
<td align="center" valign="top">14</td>
<td align="center" valign="top">KLF5</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">EIF2AK2</td>
<td align="center" valign="top">98</td>
<td align="center" valign="top">hsa-mir-190b</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">IRF8</td>
<td align="center" valign="top">12</td>
<td align="center" valign="top">MAX</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">STAT1</td>
<td align="center" valign="top">63</td>
<td align="center" valign="top">hsa-mir-4693-5p</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">EIF2AK2</td>
<td align="center" valign="top">10</td>
<td align="center" valign="top">POU2F2</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">FYN</td>
<td align="center" valign="top">61</td>
<td align="center" valign="top">hsa-mir-4326</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">FYN</td>
<td align="center" valign="top">10</td>
<td align="center" valign="top">ARID3A</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">UBD</td>
<td align="center" valign="top">34</td>
<td align="center" valign="top">hsa-mir-4287</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">IRF4</td>
<td align="center" valign="top">10</td>
<td align="center" valign="top">JUN</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">FBXO6</td>
<td align="center" valign="top">30</td>
<td align="center" valign="top">hsa-mir-5095</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">ISG15</td>
<td align="center" valign="top">10</td>
<td align="center" valign="top">NR2E3</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">ISG15</td>
<td align="center" valign="top">29</td>
<td align="center" valign="top">hsa-mir-206</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">STAT1</td>
<td align="center" valign="top">9</td>
<td align="center" valign="top">GATA2</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">TGM2</td>
<td align="center" valign="top">27</td>
<td align="center" valign="top">hsa-mir-1285-3p</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">TGM2</td>
<td align="center" valign="top">7</td>
<td align="center" valign="top">USF2</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">PML</td>
<td align="center" valign="top">26</td>
<td align="center" valign="top">hsa-mir-378a-3p</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">FBXO6</td>
<td align="center" valign="top">6</td>
<td align="center" valign="top">HNF4A</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">FASLG</td>
<td align="center" valign="top">25</td>
<td align="center" valign="top">hsa-mir-7703</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">UBD</td>
<td align="center" valign="top">6</td>
<td align="center" valign="top">TEAD1</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">IRF8</td>
<td align="center" valign="top">18</td>
<td align="center" valign="top">hsa-mir-4686</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">PTN</td>
<td align="center" valign="top">6</td>
<td align="center" valign="top">FOXC1</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">IRF7</td>
<td align="center" valign="top">17</td>
<td align="center" valign="top">hsa-mir-520c-3p</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">FASLG</td>
<td align="center" valign="top">5</td>
<td align="center" valign="top">NR3C1</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">PTN</td>
<td align="center" valign="top">12</td>
<td align="center" valign="top">hsa-mir-449a</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">PML</td>
<td align="center" valign="top">5</td>
<td align="center" valign="top">NFIC</td>
</tr>
<tr>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">NOS2</td>
<td align="center" valign="top">6</td>
<td align="center" valign="top">hsa-mir-1291</td>
<td align="center" valign="top">Up</td>
<td align="center" valign="top">NOS2</td>
<td align="center" valign="top">4</td>
<td align="center" valign="top">NFYA</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">MAPK1</td>
<td align="center" valign="top">286</td>
<td align="center" valign="top">hsa-mir-1470</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">BCL6</td>
<td align="center" valign="top">17</td>
<td align="center" valign="top">SREBF2</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">EEF2</td>
<td align="center" valign="top">229</td>
<td align="center" valign="top">hsa-mir-2110</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">CEBPB</td>
<td align="center" valign="top">12</td>
<td align="center" valign="top">E2F6</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">MYH9</td>
<td align="center" valign="top">226</td>
<td align="center" valign="top">hsa-mir-3615</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">EGR1</td>
<td align="center" valign="top">12</td>
<td align="center" valign="top">SRF</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">PRKDC</td>
<td align="center" valign="top">164</td>
<td align="center" valign="top">hsa-mir-4511</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">RXRA</td>
<td align="center" valign="top">12</td>
<td align="center" valign="top">GATA3</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">PABPC1</td>
<td align="center" valign="top">151</td>
<td align="center" valign="top">hsa-mir-1825</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">ARRB2</td>
<td align="center" valign="top">12</td>
<td align="center" valign="top">USF1</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">EGR1</td>
<td align="center" valign="top">132</td>
<td align="center" valign="top">hsa-mir-500b-5p</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">FOS</td>
<td align="center" valign="top">11</td>
<td align="center" valign="top">FOXD1</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">FOS</td>
<td align="center" valign="top">105</td>
<td align="center" valign="top">hsa-mir-204-3p</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">EEF2</td>
<td align="center" valign="top">10</td>
<td align="center" valign="top">NRF1</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">CEBPB</td>
<td align="center" valign="top">94</td>
<td align="center" valign="top">hsa-mir-573</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">PXN</td>
<td align="center" valign="top">10</td>
<td align="center" valign="top">IRF2</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">UBE2D1</td>
<td align="center" valign="top">84</td>
<td align="center" valign="top">hsa-mir-326</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">UBE2D1</td>
<td align="center" valign="top">9</td>
<td align="center" valign="top">HOXA5</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">MAP1LC3B</td>
<td align="center" valign="top">68</td>
<td align="center" valign="top">hsa-mir-3180-5p</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">MAPK1</td>
<td align="center" valign="top">9</td>
<td align="center" valign="top">TP53</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">PXN</td>
<td align="center" valign="top">60</td>
<td align="center" valign="top">hsa-mir-1255a</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">MAP1LC3B</td>
<td align="center" valign="top">8</td>
<td align="center" valign="top">ZNF354C</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">NFKBIA</td>
<td align="center" valign="top">54</td>
<td align="center" valign="top">hsa-mir-548f-3p</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">NFKBIA</td>
<td align="center" valign="top">8</td>
<td align="center" valign="top">TFAP2C</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">ARRB2</td>
<td align="center" valign="top">54</td>
<td align="center" valign="top">hsa-mir-4298</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">PABPC1</td>
<td align="center" valign="top">7</td>
<td align="center" valign="top">SOX5</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">BCL6</td>
<td align="center" valign="top">43</td>
<td align="center" valign="top">hsa-mir-409-5p</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">MYH9</td>
<td align="center" valign="top">5</td>
<td align="center" valign="top">CREB1</td>
</tr>
<tr>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">RXRA</td>
<td align="center" valign="top">41</td>
<td align="center" valign="top">hsa-mir-6782-3p</td>
<td align="center" valign="top">Down</td>
<td align="center" valign="top">PRKDC</td>
<td align="center" valign="top">3</td>
<td align="center" valign="top">E2F1</td>
</tr>
</tbody>
</table>
</table-wrap>
</floats-group>
</article>
